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 ABSTRACT 
 
A detailed understanding of the genes and mechanisms that regulate oocyte growth and 
maturation underpins the development of improved methods of assisted conception. 
Gametocyte specific factor 1 (GTSF1)-a putative marker of gamete developmental 
competence, is highly conserved across species but in mammals demonstrates a sexual 
dimorphism in its function. In mice, male mutants for Gtsf1 have an infertile phenotype, 
whereas female mutants appear to have normal ovarian function. It is hypothesised that 
GTSF1 regulates oocyte development in monovular species such as the sheep.  
 
Initial studies characterised the expression and cellular distribution of GTSF1 across 
cDNA libraries spanning ovine oogenesis and embryogenesis and by using in situ 
hybridisation of fixed tissue. GTSF1 expression was confined to gonadal and embryonic 
tissues with highest expression in the ooplasm of germinal vesicle (GV)-staged 
secondary oocytes. The gene sequence of GTSF1 was obtained and the gene and 
predicted protein sequences revealed close homology across many species with two 
conserved CHHC zinc finger domains known to bind RNA. 
 
Functional analysis of the role of GTSF1 during sheep oocyte maturation was conducted 
using short interference RNA (siRNA injection) in conjunction with oocyte in vitro 
maturation (IVM) and oocytectomised cumulus shell co-culture. This system was 
validated using siRNA knockdown (kd) for a known oocyte-specific gene, Growth 
differentiation factor 9 (GDF9). The effect on GTSF1 kd was evaluated following the 
microinjection of 770 GV oocytes with siRNA target against the sixth exon of ovine 
GTSF1. The effects of GTSF1 kd were evaluated in 57 MII oocytes and cumulus shells. 
Targeted kd of GTSF1 in GV oocytes followed by IVM and cumulus shell co-culture 
did not affect oocyte meiotic progression or cumulus expansion. Microarray analysis 
using the bovine GeneChip Affymetrix array revealed that 6 down-regulated genes 
(TCOF1, RPS8, CACNA1D, SREK1IP1, TIMP1, MYL9) following the GTSF1 kd were 
associated with developmental competence, RNA storage, post-transcriptional 
modifications and translation. Immunofluorescent studies localized GTSF1 protein to 
the P-body in GV ovine oocytes.  
 
Collectively these results suggest a possible role of GTSF1 in post-transcriptional 
control of RNA processing, translational regulation and RNA storage which may impact 
on oocyte developmental competence.  
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Chapter 1: General introduction 
 
1.1 INTRODUCTION 
The basic functional unit of the ovary is the ovarian follicle which consists of an oocyte 
(female gamete) arrested at prophase I of meiosis I and surrounded by somatic cells. 
Follicles provide a specialised compartment for oocyte development, create signals and 
gather nutrients. The development of ovarian follicles and oocytes as well as the 
acquisition of fertilisation potential of the oocyte are dynamic processes controlled by 
endocrine as well as paracrine factors (Richards et al., 1995; Gougeon, 1996). From 
birth, ovaries contain a certain number of immature follicles, the primordial follicles, 
although opposing views also exist (Johnson et al., 2004). Cyclic gonadotrophin 
stimulation initiated at puberty, directs growth of the follicles and in monovular species 
such as humans, a single or small number of germ cells will resume meiosis during an 
ovarian cycle. This results in the release of a single oocyte by the dominant follicle 
following the preovulatory gonadotrophin surge, while most of the follicles undergo 
atresia (Mcgee and Hsueh, 2000). From around 400,000 primordial follicles present in 
human ovaries at puberty, only 300-400 oocytes will ovulate throughout the female 
reproductive life span (Gougeon, 1989; Gougeon, 1996; Starz-Gaiano and Lehmann, 
2001). The fate of the great majority of ovarian follicles and the oocytes they contain is 
therefore degeneration. 
 
An understanding of the factors that control follicle and oocyte growth and maturation 
is very important to human reproduction. In the post-genomic era, elucidation of gene 
functions can help in the development of gene based drug targets and therapies.  In the 
field of assisted conception in commercially relevant species and humans, identification 
of vital genes and mechanisms can lead to improvement of success rates and to the 
development of new and improved technologies and culture environments such as the 
addition of improved supplements to the culture media used for the in vitro maturation 
(IVM) of oocytes. These technological advances can provide options for better 
treatments for patients at risk of ovarian hyper-stimulation syndrome following 
stimulation of the ovaries for the production of mature oocytes. It can also provide 
options for fertility preservation strategies in cancer patients where chemotherapy often 
results in the partial or complete depletion of the pool of primordial follicles 
(Demeestere et al., 2012). 
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Advances in recombinant deoxyribonucleic acid (DNA) technology and in silico 
analysis have allowed identification and isolation of genes expressed during well 
defined periods of development during oogenesis and folliculogenesis. Although 
extensive research has been conducted on follicle and oocyte growth and development 
in rodents, more knowledge is required in the study of monovular species that provide a 
better model for the study of human reproductive function. A number of novel genes 
which are thought to regulate gamete quality have recently been identified. For 
example, gametocyte specific factor 1 (GTSF1)-a putative marker of gamete 
developmental competence, is highly conserved across species, but as shown in mice, it 
demonstrates a sexual dimorphism in its function (Yoshimura et al., 2009). Male 
mutants for Gtsf1 have an infertile phenotype, whereas female mutants appear normal 
(Yoshimura et al., 2009).  This review aims to provide an insight into the regulation of 
oocyte and follicle development as well as the background literature on GTSF1 and the 
means of evaluating the function of this novel gene.  
 
1.2 OOCYTE AND FOLLICLE DEVELOPMENT  
1.2.1 Origin of germ cells 
The mammalian ovary is responsible for the differentiation and maturation of the 
oocytes. In addition, the ovary is responsible for the production of steroids that allow 
the development of female secondary sexual characteristics and support pregnancy. It is 
estimated that human fetal ovary contains 4-7 million oocytes (Oktem and Urman, 2010), 
while sheep ovaries contain 2-3 million (Russe et al., 1992). Dogma suggests that the 
oocyte population is established during fetal development and germ cells are not 
replenished after birth. Even though this is the basic doctrine of reproductive biology, 
studies in mice have shown that germ cells originating from the ovarian surface 
epithelium or bone marrow can be proliferative and sustain limited levels of oocyte and 
follicle production in the postnatal murine ovary (Johnson et al., 2004; Tilly and Telfer, 
2009). Additionally, embryonic stem cells (ESC) isolated from the ovarian surface 
epithelium of women with no naturally present follicles and oocytes, were shown to 
express specific markers of the germ line (Bukovsky et al., 2005). None-the-less, the 
results obtained in the above studies could be explained differently. Specifically, DNA 
synthesis in the germ cells of the mouse ovary could be due to mitochondrial genome 
replication and DNA repair of oocytes that do not progress meiotically (Notarianni, 
2011). False recognition of ovarian epithelium as oogonia from derived cultures of the 
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above studies or over-estimation of atresia could explain the obtained results. Similarly, 
there are arguments for the false identification of ovarian somatic cells as de novo 
oocytes (Notarianni, 2011). In general, the spontaneous generation of large number of 
de novo oocytes to sustain oogenesis in the adult ovary can be considered as an 
unrealistic assumption. Although in vitro cultured somatic cells may in some 
circumstances have the potential of developing into oocytes, or somatic cells may be 
transformed into oocytes, there is as yet little evidence to show that these oocytes are 
able to grow, be fertilised and develop into embryos (Notarianni, 2011). Only 1 study 
has shown the production of offspring when labelled mouse ESCs were injected into 
mouse embryos (Boland et al., 2012). However even in that case it cannot be excluded 
that some primordial follicles were also collected along with the ESCs. The implications 
of such capability in humans could be immense for the preservation of fertility as well 
as for the prevention of health problems for women with premature ovarian failure due 
to aging or gonadotoxic chemotherapy and radiation (Oktem and Oktay, 2007).  
 
Although the ovary is responsible for the differentiation and specialisation of the female 
gametes, their precursors arise from the somatic cells of the developing gonad, thus 
have to migrate across the embryo to reach their site of function (Raz, 2004). Female 
gametes arise from a group of uncommitted epiblast cells that during gastrulation move 
to the posterior part of the primitive streak to become primordial germ cells (PGC). The 
expression of bone morphogenetic proteins (BMP) 4 and 8b in extra-embryonic tissue 
has been shown to induce the formation of mouse PGCs in the proximal epiblast 
(Lawson et al., 1999). Knowledge of PGC migration has emerged from model genetic 
organisms Drosophila melanogaster, Danio rerio and Mus musculus where live and 
fixed imaging approaches have identified PGC morphology, embryonic position and 
gene expression profile. These techniques in combination with genetic analysis have 
begun to indicate the mechanisms and behaviours that underlie PGC migration 
(Richardson and Lehmann, 2010). In the Bos taurus, PGCs which are originally 
recognised in the yolk sac at the fourth week of gestation, migrate through the hindgut 
into the genital ridge (Marion and Gier, 1971). In Ovis aries, migration into the gonad 
occurs around 23-35 days post fertilisation and by day 40, PGCs are situated in the 
cortex of the ovary (McNatty et al., 2000). During migration, the PGCs actively 
proliferate; however a study in D. melanogaster suggests that not all PGCs migrate 
successfully to the gonads (Yamada et al., 2008). Those PGCs that migrate incorrectly 
have been correlated with locations of germ cell tumours in humans (Schneider et al., 
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2001). At the end of migration, when PGCs associate with the presumptive somatic 
cells of the gonad, they lose their motile properties. Evidence from D. rerio and D. 
melanogaster indicates that a simple model drives PGC’s directional migration and this 
is due to localisation at the site of the highest attractant expression (Van Doren et al., 
1998; Reichman-Fried et al., 2004). Also migration is assisted by the involution of 
development of other embryonic tissues which help the PGCs along their migrational 
path (Starz-Gaiano and Lehmann, 2001). Once the presumptive gonad is assembled 
containing somatic and germ cells, the PGCs termed oogonia, differentiate into primary 
oocytes when meiosis starts. In some mammals including M. musculus, O. aries and 
Homo sapiens, somatic cells from the rete ovary and/or the surface epithelium correlate 
with growing oocytes and form follicles (Buccione et al., 1990a; Eppig, 1991), while in 
other species such as sea cucumber, junctions between somatic cells and oocyte surface 
are formed without forming follicles (Frick et al., 1996). In mice, the PGC transition to 
meiosis has been shown to be regulated by signals from the somatic cells (Chuma and 
Nakatsuji, 2001). Oocytes do not complete meiosis, but rather they arrest at the 
diplotene stage of prophase I of the first meiotic division. In humans and sheep this 
occurs approximately 5 and 3 months into gestation, respectively (Peters, 1969; Sawyer 
et al., 2002). The prophase I oocyte may remain at that stage of development for long 
periods of time until further meiotic progression occurs in the ovulatory follicle 
following puberty, when the cyclic stimulation of gonadotrophins initiates ovulatory 
reproductive cycles. In humans, primary oocytes can be arrested in the prophase I for up 
to 50 years (Mcgee and Hsueh, 2000). 
 
1.2.2 Folliculogenesis 
In all vertebrates, the number of germ cells is significantly diminished at birth in 
comparison with the number of cells present during fetal life (Aerts and Bols, 2010). In 
the bovine ovary for example, the number drops from several millions to approximately 
130,000 (Aerts and Bols, 2010). The mechanism which regulates this process is 
believed to be apoptosis (Oktem and Urman, 2010). Loss of oocytes is continued 
through postnatal life. In mice, approximately 2/3 of oocytes are lost in the first 5 days 
of postnatal life (Pepling and Spradling, 1998). In sheep, these processes are not well 
described, however the majority of oocytes within ovarian follicles are lost prenatally 
(Juengel et al., 2002). In humans the size of ovarian reserve decreases drastically with 
age (Figure 1.1), with follicles lost in a continuous stream (Gougeon, 2005). This rate of 
follicular depletion accelerates in women from the age of about 38 years onwards. By 
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the time women reach their 40
th
 year of age, their fecundity is impaired and from the 
age of 45 onwards fecundity is progressively lost and the ovarian reserve is 
progressively depleted (Lass, 2001; Gougeon, 2005). Depletion of ovarian reserve leads 
to reproductive senescence and in humans this is termed menopause (Mcgee and Hsueh, 
2000). 
 
 
Figure1.1: Schematic representation of the life history of germ cells in humans. The cluster of 
100 germ cells migrates, proliferates and colonizes the gonads from where their growth reaches 
around 600 X 10
3
 at 8 weeks of gestation and to 7 million at 20 weeks of gestation. The number 
of the germ cells starts to decline after 20 weeks of gestation due to atresia and progressively 
declines, with only 300-400 oocytes (<1%) ovulating during the female reproductive life span. 
Image adapted from Oktem and Urman, (2010).  
 
Follicular growth can be classified into 3 phases depending on developmental stage and 
gonadotrophin control. These are: (i) the gonadotrophin-independent phase, (ii) the 
gonadotrophin-responsive phase and (iii) the gonadotrophin-dependent phase. The first 
phase consists of growth from the primordial to primary and secondary stages of follicle 
development. During these stages, granulosa cells change from a single layer of 
flattened pre-granulosa cells in primordial follicles to a cuboidal morphology as cell 
division is initiated and progresses to form multi-layered granulosa cells in secondary 
follicles onwards. In the secondary stage follicles, ovarian cortical cells are actively 
transformed into theca cells by the presence of granulosa cells (Orisaka et al., 2006). 
The theca cells are located on the outside of the basement membrane, separated from 
the granulosa cells. The second phase of follicle development involves growth from the 
secondary stage to the early antral stage at which point the follicles become 
gonadotrophin-responsive and the formation of the antral cavity occurs. In sheep, the 
end of the gonadotrophin-responsive phase is characterised by a peak in the mitotic 
index of granulosa cells at a follicle diameter of around 1.2 mm (Turnbull et al., 1977). 
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Follicles at this phase are responsive to gonadotrophins as shown by studies where pre-
pubertal animals respond to the external contribution of gonadotrophins and ovulate 
(Mcleod et al., 1985; Sumbung et al., 1987). With the onset of cyclic gonadotrophin 
stimulation initiated at puberty, follicles can enter the final gonadotrophin-dependent 
phase of their growth (Hirshfield, 1991; Gougeon, 1996). During this phase, follicle size 
in sheep increases from a diameter of 2-2.5 mm up to around 7-8 mm with the 
formation of the pre-ovulatory follicle also known as Graafian follicle. This change is 
accompanied by the loss of the majority of antral follicles by atresia in addition to 
increasing levels of steroidogenic enzymes and endocrine factors produced, as the 
somatic cells on the follicles differentiate (Mcnatty et al., 1999). Very few follicles and 
in the majority of cases only 1 ovulatory follicle will be developed throughout each 
menstrual cycle (humans) and oestrous cycle (other placental animals including sheep). 
The gonadotrophin-dependent phase of follicular growth is characterised by increased 
follicular oestrogen production and the induction of the gonadotrophin surge during 
each reproductive cycle that will allow the Graafian follicle to ovulate and release the 
mature oocyte for fertilisation. Studies in sheep have shown that when gonadotrophin 
concentrations are maintained below threshold, follicle development is impaired with 
follicles being atretic and not progressing beyond the early antral stage (Picton et al., 
1990). Following ovulation, the granulosa and theca cells of the follicle are remodelled 
to form the corpus luteum at the luteal phase of the reproductive cycle that ends in either 
pregnancy or luteolysis (Gougeon, 1996). The stages of follicular development along 
with oocyte factors, somatic cell factors and endocrine signalling that affect each stage 
are shown in Figure 1.2. The individual stages of folliculogenesis and the factors 
involved are analysed in the sections that follow. 
 
1.2.3 Primordial follicle development 
The first stage of follicular development is the primordial follicle. Primordial follicles 
are formed when oocyte nests in the ovary breakdown resulting in segregation of 
individual germ cells (Pepling and Spradling, 2001). The individual germ cells recruit 
pre-granulosa germ cells with which they form a close association. Identification of 
oocyte factors as stimulators for the formation of follicles suggests that the ovary is the 
essential regulator of follicle assembly. Each stage of follicular development is 
characterised by follicle size and morphology. The size of the primordial follicle ranges 
from around 40 μm in humans and ruminants to 20 μm in the mouse (Gosden et al., 
1989; Picton et al., 2003).  
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Figure 1.2: Schematic representation of folliculogenesis and signaling. The stages of follicular 
development from primordial follicle to ovulation along with the factors that affect each stage of 
development are shown. Endocrine signals: Follicle stimulating hormone (FSH), Anti-
Müllerian hormone (AMH), Insulin, Growth Hormone (GH), Luteinising hormone (LH). 
Somatic factors: Activin A, Oestrogens, Kit ligand (KITL), Leukaemia inhibitory factor (LIF), 
Basic fibroblast growth factor (bFGF), Transforming growth factor β (TGFB), Activin-like 
receptor kinases 3, 4, 6 (ALK), Insulin-like growth factors 1, 2 (IGF), Epidermal growth factor 
(EGF), Amphiregulin (AREG), Epiregulin (EREG), Betacellulin (BTC), Progesterone, Nuclear 
receptor subfamily 5, group A, member 2 (NR5A2). Oocyte factors: Mammalian target of 
rapamycin (mTOR), Phosphatase and tensin homolog (PTEN), Factor in the germline α 
(FIGLA), Newborn ovary homeobox (NOBOX), Lim homeobox (LHX8), Phosphoinositide-
dependent kinase 1 (PDK1), Spermatogenesis and oogenesis basic helix-loop-helix 2 
(SOHLH2), Nerve growth factor (NGF), bFGF, Forkhead box L2 and O3a (FOX), Inhibin beta 
α (INHBΑ), Growth differentiation factor 9 (GDF9), BMPs 4, 7, 15,  Fibroblast growth factor 8 
(FGF8). Image adapted from Erickson, (1978). 
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It is believed that just after follicle formation, a small number of follicles are recruited 
(initial recruitment) to initiate growth while the rest remain quiescent (Wandji et al., 
1996). Initial recruitment of follicles in the mammalian ovary is an irreversible process 
and it is being driven by intra-ovarian and/or other unknown factors or alternatively by 
the release of an inhibitory stimuli that keeps follicles inactive (Hirshfield, 1991). 
Following activation, there is a gradual increase of oocyte diameter accompanied by 
proliferation of granulosa cells and change of their conformation from flattened to 
cuboidal. Initial recruitment is a continuous process and is not related to the cyclicity of 
gonadotrophic hormones (Mcgee and Hsueh, 2000).  
 
Evidence suggests that several oocyte transcription factors have important roles in the 
regulation of oogenesis at this stage of follicle and oocyte development. Depletion of 
the oocyte-derived transcription factor in the germline α (Figlα) in mice was shown to 
prevent follicular assembly (Liang et al., 1997). This gene is also responsible for the 
regulation and expression of other oocyte-specific genes (Eppig, 1991).  Mouse Figlα 
protein has been shown to play a role in expression of zona pellucida (ZP) genes Zp1, 
Zp2 and Zp3 and in their coordinated expression (Liang et al., 1997). In sheep, FIGLA 
was shown to be expressed mostly at primary and secondary follicle stages with limited 
expression at the primordial stage (Cotterill, 2008). Similarly in humans, FIGLA is 
detected at primordial, primary and secondary follicle stages as well as MII oocytes 
(Huntriss et al., 2002). Thereafter, follicle growth is regulated by upstream transcription 
factors including newborn ovary homeobox (Nobox), lim homeobox (Lhx8) and 
spermatogenesis and oogenesis basic helix-loop-helix 2 (Sohlh2). From these factors, 
Nobox in particular is encoded by an oocyte-specific homeobox gene expressed in germ 
cell cysts and in primordial and growing oocytes (Suzumori et al., 2002).  
 
Knockout of the Nobox gene in mice was shown to accelerate the postnatal loss of 
oocytes and prevent further development of primordial follicles (Rajkovic et al. 2004). 
In addition, lack of Nobox was also shown to induce down-regulation of genes 
preferentially expressed in oocytes including growth differentiation factor 9 (Gdf9) and 
Bmp15 (Rajkovic et al., 2004; Krotz et al., 2009). The transcription factor Sohlh2 was 
also shown to be critical for maintenance and differentiation of the oocyte during early 
mouse oogenesis (Choi et al., 2008a). Following knockout of this gene in mice, the 
majority of follicles were lost prenatally while primordial follicles were unable to 
progress through development and exhibited abnormal expression of several germ-cell 
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and oocyte-specific genes (Choi et al., 2008a). Another germ cell-specific gene, Sohlh1, 
encodes a basic helix-loop-helix protein (Pangas et al., 2006). This particular gene has 
also been shown to be essential for oogenesis regulating the transcriptional stimulation 
of Lhx8 and Zp1 promoter activity, both of which are crucial for the primordial to 
primary follicle transition (Pangas et al., 2006). The Lhx8 transcription factor in 
particular is critical for early follicle formation and oocyte differentiation as shown in 
murine studies and it acts by regulating the Nobox pathway (Choi et al., 2008b). Both 
Sohlh1 and Sohlh2 were shown to have similar effects on the male gonad impairing 
spermatogonia progression and their mechanism of action was shown to be induced by 
stimulating transcription of the Kit gene (Barrios et al., 2012). Oocyte-derived factors 
Bmp15 and Gdf9, both members of the transforming growth factor β (TGFB) 
superfamily, are also involved in follicle activation, however activation of follicles can 
initiate in their absence (Choi and Rajkovic, 2006). None-the-less, exogenous 
supplementation of Bmp4 and Bmp7 has been shown to enhance the primordial to 
primary transition (Drummond, 2005). Expression of mammalian target of rapamycin 
(mTOR) is also essential with inhibition of this protein in human in vitro cultures of 
ovarian cortical strips resulting in the destruction of the oocyte by the adjacent 
granulosa cells (Mclaughlin et al., 2011). A tumour suppressor gene phosphatase and 
tensin homolog (Pten), is another gene that when lacking, the entire primordial follicle 
pool is activated, leading in the depletion of follicles and resulting in POF in mice 
(Adhikari et al., 2010). 
 
Somatic cell factors are also important for follicle development beyond the primordial 
stage. Deletion of the stem cell factor gene also known as Kit ligand (Kitl), expressed in 
granulosa cells was shown to impair mouse oocyte growth and follicle development 
(Moniruzzaman et al., 2007). The Müllerian inhibiting substance also known as anti-
müllerian hormone (AMH) is a granulosa cell factor that acts as an endogenous 
inhibitor of follicle growth (Durlinger et al., 2002a). Even though early growth is 
independent of gonadotrophins, small growing follicles are responsive to follicle 
stimulating hormone (FSH). Different studies have shown that FSH receptor (FSHR) 
localizes exclusively on the granulosa cells of the rat, pig, sheep, cow and human with 
the expression starting from the primordial to primary follicle transition in some species 
and from secondary stage follicles in others (Sites et al., 1994; Rannikki et al., 1995; 
Yuan et al., 1996; Oktay et al., 1997). The reduction of the oestrogen levels in cattle has 
been shown to be tightly correlated with fetal follicular activation, indicating that 
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control of oestrogen production is essential for follicle activation (Yang and Fortune, 
2008). Further to this, Forkhead box protein L2 transcription factor expression by 
granulosa cells in mice is essential for activation of follicles (Pisarska et al., 2004).  
 
1.2.4 Preantral follicle development 
Granulosa cell numbers increase exponentially as the follicle develops (Channing et al., 
1980). During the primordial to primary transition, 2 layers of undifferentiated stromal 
cells are formed around the developing follicle (Orisaka et al., 2006). When the follicle 
is recruited, these layers differentiate into the theca interna and the theca externa 
(Young and McNeilly, 2010). This stage is termed the secondary stage of follicle 
development and it is characterized by the development of a thecal blood supply in 
addition to the beginning of follicular fluid secretion from the granulosa cells which 
leads to follicle expansion (Young and McNeilly, 2010). The size of the follicles before 
cavity formation (pre-antral follicles) reaches 250 μm in humans and 200 μm in mice 
(Gosden et al., 1989; Picton and Gosden, 2000). These early stages of development are 
characterized by the involvement of multiple paracrine factors in the communication 
between the oocyte and somatic cells with Bmp15 and Gdf9 in particular having 
significant roles. In null mice for Gdf9 it has been shown that theca cells fail to organise 
around follicles and there is abnormal oocyte growth (Elvin et al., 1999). In addition, 
granulosa cells fail to proliferate in primary follicles following Gdf9 knockout (Dong et 
al., 1996). This illustrates the importance of oocyte-granulosa cell interactions during 
the early stages of folliculogenesis. Regarding somatic cell factors, several factors 
including TGFB, follistatin, activin-like receptor kinases (ALK) 3, 5 and 6 and inhibin 
beta a (INHBA) have been found to be expressed in sheep preantral follicles (Mcnatty et 
al., 2007). In particular, AMH has been shown to inhibit preantral follicle development, 
while insulin-like growth factors (IGF) 1 and 2 have been shown to stimulate 
development in vitro (Silva et al., 2009). Growth hormone (GH) has also been related 
with survival of the preantral follicles (Slot et al., 2006). During the transition from the 
preantral to early antral stage, follicle growth has been shown to be unaffected by the 
absence of gonadotrophins (Cattanach et al., 1977; Halpin et al., 1986), but FSH has 
been shown to stimulate growth (Mcgee and Hsueh, 2000; Fortune, 2003). Specifically, 
FSH is associated with bovine late preantral follicle diameter increase in addition to 
stimulation of growth and antral cavity formation (Hulshof et al., 1995). Additionally, 
histological examinations of women with hypo-gonadotrophic hypo-gonadism have 
shown multi-layer follicle development in the ovaries (Goldenberg et al., 1976). In 
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sheep, the effect of gonadotrophin supplementation in the culture media was tested on 
antrum formation of frozen-thawed granulosa oocyte complexes with the follicles 
grown in media lacking gonadotrophins resulting in reduced antrum formation (Newton 
et al., 1999). None-the-less, the oocytes that survived the 30 days of culture were viable 
and had increased diameters (Newton et al., 1999). In mice, luteinising hormone (LH) 
has been shown to be required for in vitro development of small preantral follicles (Wu 
et al., 2000; Lefebvre et al., 2002). 
 
1.2.5 Antral follicle development 
The next stage of development is the antral follicle with this stage marked by the 
formation of the antrum, a fluid filled cavity containing muco-polysaccharides and 
serum transudate (Pan et al., 2005). This cavity is formed when fluid derived from the 
serum is attracted by an osmotic gradient between follicle and serum in the theca cell 
vasculature (Pan et al., 2005). Antrum development is characterised by continuous 
granulosa and theca cell proliferation which is correlated with antrum volume increase. 
As the antrum forms, granulosa cells differentiate into a thin layer of cells that surround 
the oocyte, termed cumulus oophorus and to the mural granulosa cells that line the 
follicle wall. Healthy oocytes maintained at the GV stage of the oocyte form a 
heterologous gap junction syncytium-like structure with the surrounding layers of 
compact cumulus cells termed cumulus oocyte complex (COC) (Hunter et al., 2004). 
Homologous gap junctions between granulosa cells as well as between theca cells are 
also important for follicle and oocyte development. In the mouse, the oocyte is attached 
to the mural layer and it acquires the capacity to resume meiosis at the same time as 
antrum formation (Eppig et al., 1996).  
 
Sex steroids have important roles in the growth and differentiation of the reproductive 
tissues. Cholesterol is the precursor to all steroid hormones including androgens, 
oestrogens and corticosteroids (Armstrong et al., 1981). Different studies have 
formulated a hypothesis named the 2 cell, 2 gonadotrophin theory of ovarian 
steroidogenesis (Figure 1.3) (Baird et al., 1974; Moon et al., 1978; Armstrong et al., 
1981). The 2 cell, 2 gonadotrophin model suggests that LH stimulates androgen 
production by the theca cells. Thereafter, androgens defuse through the basal lamina and 
are converted to oestrogen by the aromatase enzyme in granulosa cells following FSH 
action upon them (Armstrong et al., 1981). This model has been used to explain 
follicular oestrogen biosynthesis in several species including rat, pig, cow and rabbit 
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(Holder et al., 1981; Mathews et al., 1986; Murphy et al., 1987). In accordance with 
this theory, a study in mice has shown that deletion of the Lhr gene resulted in the 
halting of follicle development at the antral stage even when exogenous gonadotrophins 
were supplied (Ahtiainen et al., 2007).  
 
Figure 1.3: Schematic representation of the 2 cell, 2 gonadotrophin theory of ovarian 
steroidogenesis, according to which the ovarian steroids are synthesized from the co-operation 
of theca and granulosa cells. Originally in the theca cells, LH that binds to its receptor (LHR) 
stimulates the expression of steroidogenic enzymes that are essential for the production of 
androgens. Specifically, the steroidogenic acute regulatory protein (STAR) protein is 
responsible for the gathering of cholesterol inside the mitochondria where it is converted to 
pregnelenone by the cholesterol side-chain cleavage enzyme (CYP11A1). From there, 
pregnelenone is dispersed inside the endoplasmic reticulum and is metabolized by either the 
action of 17α-hydroxylase/17, 20-desmolase (CYP17A1) or hydroxysteroid dehydrogenase 3β 
(HSD3B) to produce dehydroepiandrosterone or progesterone respectively. The 
dehydroepiandrosterone is then either converted to androstenedione by HSD3B or to 
androstenediol by hydroxysteroid dehydrogenase 17β (HSD17B). Testosterone is synthesised 
from androstenedione by the action of HSD17B. Alternatively, androstenedione diffuses into 
the granulosa cell and by the actions of FSH can be used as a substrate for oestrone synthesis by 
the aromatase cytochrome P450 19 enzyme (CYP19) or testosterone synthesis by HSD17B. 
Oestrone and testosterone are converted to oestradiol-17β by HSD17B and CYP19A1 
respectively. Image adapted from Payne and Hales, (2004). 
 
The pituitary gonadotrophins FSH and LH are the major trophic hormones that drive 
follicular development. Both hormones bind to receptor proteins in the follicle (Simoni 
et al., 1997). The gonadotrophin receptors belong to the family of G protein-coupled 
receptors (GPCRs) which are trans-membrane proteins characterised by hydrophobic 
helices inserted in plasma-lemma and by intracellular and extracellular domains 
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(Gudermann et al., 1995). The biological effects of the gonadotrophins occur as a result 
of a cascade of events following the coupling of the intracellular part of the 
gonadotrophin receptor to a G protein (G) that results in receptor activation by the 
hormonal interaction with the extracellular domain (Simoni et al., 1997). It is believed 
that at the stage of antral follicle development, increased sensitivity towards FSH builds 
up and the majority of follicles undergo atresia. The role of FSH is defined by the 
alteration of granulosa cell gene expression, increased proliferation of somatic cells and 
formation of the antrum for the separation of the COC from the mural layer of 
endocrine cells. This is caused by FSH action on granulosa cells which results in 
oestrogen production. In particular, FSH stimulates proliferation of granulosa cells by 
acting as a mitogen. In addition, FSH synergises with epidermal growth factor (Egf) for 
the initiation of proliferation and differentiation of granulosa cells as shown by a study 
in hamsters where Egf mediates the FSH effect by stimulation of the Egf receptor (Egfr) 
kinase that initiates DNA synthesis (Yang and Roy, 2006). Oestrogens that are 
produced following the action of FSH are potent mitogens themselves and can drive cell 
proliferation both in vivo and in vitro (Quirk et al., 2004).   
 
The moment at which FSH becomes required (gonadotrophin-dependant phase of 
follicle development), is as soon as granulosa cell proliferation and follicle growth 
reaches the stage at which cumulus cells are separated from mural granulosa cells.  This 
separation suggests that control of mural granulosa cell function might be regulated by 
different factors and hormones than those originating from the COC (Richards, 2001a). 
In fact, there is growing evidence for the presence of survival factors for sustainability 
of folliculogenesis (Mcgee and Hsueh, 2000). A study in rodents has shown that culture 
of preantral follicles in serum-free conditions results in apoptosis even if the follicles 
are treated with gonadotrophins or cyclic adenosine monophosphate (cAMP) analogs 
(Mcgee et al., 1997). None-the-less, the system in which follicles were cultured in the 
above study might have been suboptimal, thus resulting in the observations of the study. 
Even so, transition of small antral follicles to preovulatory follicles is not only 
dependent on gonadotrophins but on local organizational factors as well. The oocyte 
itself takes a part in antrum formation as shown when human cultured preantral and 
antral granulosa cells were unable to form antrum in the absence of an oocyte (Huang et 
al., 2006). Oocytes from different species including mouse, rat and cow express 
fibroblast growth factor 8 (FGF8) at this stage, although oocyte-specific factor Gdf9, 
Bmp15 and Fgf8 transcripts are reduced during early antral formation in the mouse (Pan 
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et al., 2005; Sanchez et al., 2009). Human oocytes were also shown to express EGF and 
EGFR after the preantral stage (Bennett et al., 1996). It is hypothesised that within the 
antral follicle, mammalian oocytes continue to affect the surrounding granulosa cells 
with the production of oocyte secreted factors such as GDF9, BMP15 and BMP6 
(Eppig, 2001). Studies in sheep have shown that BMP15 is necessary for development 
to the preovulatory stage (Juengel et al., 2002). In addition, both Bmp15 and Bmp6 in 
rats were shown to suppress the expression of FSHR (Otsuka et al., 2000). In a similar 
matter, Gdf9 has been shown to suppress both the FSH stimulated steroidogenesis and 
the FSH induced formation of the LHR (Vitt et al., 2000). Progesterone secretion 
following gonadotrophin stimulation was shown to be inhibited by Bmp6, Bmp15 as 
well as Gdf9 (Otsuka et al., 2001). In particular, Gdf9 has been shown to suppress the 
P450 aromatase activity (Vitt et al., 2000). Studies in sheep and cow have shown that 
GDF9 and BMP15 alone and in combination can suppress the FSH-induced 
progesterone secretion (Mcnatty et al., 2005).  
 
Somatic cell factors are also regarded as essential for antrum formation. This is because 
in the female reproductive system, granulosa cells are the only cells expressing FSHR. 
In addition, insulin-like growth factors (IGF) 1 and 2 have been shown to induce antrum 
formation in serum-free cultures of bovine follicles (Itoh et al., 2002).  Further 
supporting evidence comes from Igf1 knockout studies in mice, where the follicular 
antrum is not formed (Baker et al., 1996). In bovine follicles, addition of IGF1 in vitro, 
drives antrum formation (Itoh et al., 2002). The 2 TGFB superfamily members in 
particular, inhibins and activins, that are up-regulated by FSH action upon granulosa 
cells, are considered as key regulators of gonadotrophic stimulation. Both activins and 
inhibins act on the oocyte as well as the granulosa cells and have been shown to 
promote in vitro maturation of primate oocytes (Alak et al., 1996). Inhibin A can 
suppress pituitary FSH by negative feedback on the anterior pituitary and increase LH 
induced androgen synthesis in human theca cells (Hillier et al., 1991). Inhibin B on the 
other hand, has an important role in follicle development and regulation of FSH. Inhibin 
B is secreted by granulosa cells of preantral follicles while Inhibin A is secreted from 
small antral follicles (Fraser et al., 1999; Welt and Schneyer, 2001). Both inhibins are 
made of 2 subunits with Inhibin A having the αβA subunits and Inhibin B the αβB which 
is the predominant form in the follicular fluid (Groome et al., 1996). Binding of FSH to 
its receptor results in the increase of cyclic adenosine monophosphate (cAMP) levels 
with the cAMP response element binding protein up-regulating the inhibin gene by 
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binding to its promoter regions (Bernard et al., 2001). Activins on the other hand 
stimulate FSH production and granulosa cell proliferation (Mclachlan et al., 1989). In 
mammals including humans and rats, theca cell cultures in the presence of both LH and 
activin resulted in reduced levels of androgen production (Muttukrishna et al., 2004).  
 
Activins have different forms (A, B, AB) and function as homodimers like Activin A: 
βΑβΑ and Activin B: βBβB or heterodimers like Activin ΑΒ: βAβB (De Kretser et al., 
2002). Other homodimers have also been identified including (C, D, E) that have not 
been shown to stimulate FSH production (Hotten et al., 1995). The mechanism by 
which activins act is the serine/threonine kinase cell surface receptors found on 
granulosa cells, where activin binds initially to the activin type I receptor (ACTRI) 
which then recruits the type II receptor, ACTRII (Findlay et al., 2002). Follistatin, also 
known as activin-binding protein, is another molecule secreted from the cells of the 
pituitary shown in rats which has been shown to have an inhibitory effect on FSH 
secretion which might be induced through neutralisation of pituitary Activin A (Ling et 
al., 1986; Muttukrishna and Knight, 1991; Liu et al., 1996).  
 
Another factor that influences folliculogenesis at this stage of development is AMH 
which is expressed in the granulosa cells from the primary stage until the early antral 
stage in mice and from the primordial stage until the mid-antral stage in humans 
(Durlinger et al., 2002a; Durlinger et al., 2002b; Visser and Themmen, 2005). As 
discussed previously, AMH regulates the recruitment of primordial follicles (Durlinger 
et al., 2001). It has been shown however that recombinant AMH inhibits late pre-antral 
murine follicles from entering the gonadotrophin-dependent phase, indicating a 
continuous functional involvement of AMH in folliculogenesis (Durlinger et al., 2001). 
The actions of inhibins and activins as well as IGF1 suggests that there must be a 
feedback mechanism in follicles involving inhibins, activins, binding proteins, 
gonadotrophins and growth hormone (GH, Roche, 1996). The FSH and Igf pathways 
interact with each other and consequently activate specific kinase cascades like the 
serum and glucocorticoid-inducible kinase and protein kinase B (PkB) that activate 
transcription factors and survival pathways including expression and movement of 
glucose transporter type-4 to the plasma membrane (Gonzalez-Robayna et al., 2000; 
Richards, 2001b). Overlapping hormonal cascades like this are responsible for the 
maintenance of follicle development to this stage.  
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1.2.6 Preovulatory follicle development 
In monovular species, amongst the group of antral follicles, 1 is selected to continue to 
grow and to produce higher levels of oestrogens and inhibins  (Zeleznik, 2004). This 
results in the suppression of the pituitary levels of FSH and the rest of growing follicles 
are subsequently deprived of FSH which is the ultimate survival factor and hence 
follicles cannot enter the gonadotrophin-dependent stage of development and they 
undergo atresia (Dizerega and Hodgen, 1981). During preovulatory development, 
biochemical remodelling of the follicle occurs. During differentiation of bovine 
preovulatory follicles, more than 7500 genes are activated in their somatic cells 
(Skinner et al., 2008). Indeed, different stages of follicle development activate the 
transcription of different genes. Some of these genes are necessary for the progression 
of follicles to the preovulatory stage.  
 
Specifically, the aromatase cytochrome P450 19 enzyme (CYP19A1), responsible for the 
production of the aromatase enzyme that regulates production of oestrogens, has 
maximal activity during preovulatory follicle development. In a similar manner, LHR is 
acquired in granulosa cells from the latter stages of antral development (Jeppesen et al., 
2012). The LH sensitivity and aromatase activity initiated by binding of LH to 
granulosa cell receptors results in the abundant secretion of oestrogens which are 
required for the terminal stages of ovulatory follicle development. The follicle that 
expresses both CYP19A1 and LHR is ‘selected’ from the cohort of growing antral 
follicles to become the dominant follicle while growth of the rest of the follicles is 
inhibited. The rising levels of oestrogen produced by the dominant follicle that are 
secreted into the ovarian vein have a negative feedback on the secretion of pituitary 
FSH, thus impairing the ability of less advanced follicles to enter the gonadotrophin-
dependent stage of development. Exogenous administration of FSH during the follicular 
phase therefore counteracts the natural follicular phase suppression of FSH and so 
stimulates the development of more than 1 preovulatory follicle (Edwards et al., 1972). 
 
Studies in sheep have shown that during the follicular phase of the oestrous cycle, the 
increased secretion of oestrogen from the preovulatory follicle is due to episodic pulses 
of LH which occur with increasing frequency (Baird, 1978). In the adult non-pregnant 
sheep, secretion of FSH results in the continuous growth and development of antral 
follicles to a size around 3-5 mm (gonadotrophin-responsive stage of development) with 
further development depending on adequate stimulation by LH (Baird and McNeilly, 
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1981). During both seasonal anoestrous and the luteal phase of the sheep oestrous cycle, 
LH pulses are not frequent enough to stimulate oestrogen production at the levels 
necessary to induce the preovulatory gonadotrophin surge (Baird and McNeilly, 1981). 
The frequency of LH pulses is controlled by the levels of another steroid hormone, 
progesterone. The elevated levels of progesterone which are found during the luteal 
phase of the oestrous cycle in combination with low levels of oestrogen result in low 
frequency LH pulses which cannot support growth of the dominant follicle if 
dominance is acquired at this stage of the cycle (Kasa-Vubu et al., 1992). At the time of 
luteal regression in the sheep, the frequency of LH pulses increases due to the fall in 
progesterone secretion with a resultant increase in androgen synthesis by the theca cells 
(Baird, 1978). The increasing levels of oestrogen from the growing dominant follicle 
will eventually induce the gonadotrophin releasing hormone (GnRH) surge leading to a 
preovulatory surge of LH and FSH (Moenter et al., 1990). When the dominant follicle 
regresses, the levels of oestrogen and inhibin production are reduced and the inhibition 
of FSH secretion from the pituitary is withdrawn. Thereafter a new rise in FSH will 
result in the recruitment of a new crop of small antral follicles that enter the 
gonadotrophin-dependent phase of terminal growth (Adams et al., 1992). Dominance 
acquired at the follicular phase of the oestrous cycle, results in further development due 
to positive feedback of oestrogen on the hypothalamic-pituitary-ovarian axis and the 
resulting high frequency of LH pulses. In humans, the fall in progesterone and 
oestrogen during luteal regression is followed by the increase of the concentration of 
gonadotrophins with the LH pulse frequency increasing from <1 pulse per 6 hours 
during the mid-luteal phase, to around 4 pulses per 6 hours during the early follicular 
stages of the cycle (Backstrom et al., 1982).  
 
The LH surge itself initiates the expression of a number of genes, while somatic cells 
act in an autocrine and paracrine way in order to promote further development 
(Richards, 2001a). The follicular programme of gene expression in granulosa cells stops 
with the gonadotrophin surge and at the same time several genes such as cyclo-
oxygenase 2, hyaluronan synthase 2 (HAS2) and tumour necrosis factor α stimulated 
gene 6, that control cumulus expansion are activated in the cumulus granulosa cells, 
while LH acts directly on somatic cells of the follicle and indirectly on the cumulus 
cells.  
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The action of the LH surge  upon granulosa cells is also responsible for the expression 
of genes required for COC maturation and follicular luteinisation and ovulation 
(Richards et al., 1998). Several signalling pathways are thought to be involved in this 
process including the protein kinase A (PKA) pathway, the cyclic guanosine 
monophosphate (cGMP) and the mitogen activated protein kinase (MAPK) cascades 1 
and 3 (Duggavathi and Murphy, 2009; Fan et al., 2009). Interestingly, studies in mice 
have shown that the follicular Egfr network mediates the LH-induced maturation of the 
COC (Conti et al., 2006). Three members of the EGF family, amphiregulin (Areg), 
epiregulin (Ereg) and betacellulin (Btc) are induced by LH in mural granulosa to bind to 
the Egfr and induce COC maturation (Park et al., 2004; Hsieh et al., 2007). Their 
necessity for maturation of the cumulus cells in vitro has been indicated as these ligands 
have been shown to induce oocyte maturation in COC cultures but not in cultures of 
denuded oocytes (Park et al., 2004). In addition, mutant mice for Egfr and Areg as well 
as double mutant animals were unable to undergo complete COC mucification and 
expansion, further exemplifying the necessity of the Egfr network in COC maturation in 
vivo in this species (Hsieh et al., 2007). Recent data in sheep further support the 
hypothesis that AREG and EGFR are involved in gonadotrophin-induced cumulus 
expansion and oocyte maturation for oocytes matured in vitro (Cotterill et al., 2012). 
The signalling of EGF is therefore a prerequisite for cumulus expansion and re-
initiation of meiosis. Expression of EREG and AREG is induced by PKA following the 
LH surge and the downstream effectors of EGFR in cumulus cells are MAPK3/1 which 
are subsequently phosphorylated leading to COC maturation (Fan et al., 2009). Another 
study in mice showed that Egfr knockout reduced the expression of Gdf9 and Bmp15 in 
the cumulus cells (Su et al., 2010). Furthermore, removal of oocytes from COCs 
resulted in reduction of Egfr in cumulus cells with the levels restored after treatment 
with recombinant Gdf9 or recombinant Gdf9 with Bmp15 (Su et al., 2010). In addition, 
blocking phosphorylation of small body size (Sma-) and mothers against 
decapentaplegic (Mad-) related protein 2/3 (Smad2/3) in vitro, inhibits Egfr expression 
in COCs, with similar phenotype resulting in vivo by knocking out Smad2 and Smad3 
(Su et al., 2010).  
 
A number of other factors have been shown to be critical for COC maturation and 
ovulation. Prostaglandins are examples of other somatic factors required for ovulation. 
Specifically, prostaglandin endoperoxide synthetase 2 (PTGS2) has been shown to be a 
downstream effector of the EGF response in granulosa cells (Park et al., 2004). 
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Blocking this gene stops cumulus expansion and does not allow progression of growth 
and ovulation (Park et al., 2004). Granulosa cell receptors are also required for 
ovulation. Progesterone receptor knockout in mice results in developmental halt prior to 
ovulation while oestrogen receptor α knockout prevents development to the 
preovulatory stage and oestrogen receptor β knockout results in sub-fertility (Conneely 
et al., 2000; Hewitt et al., 2005).  
 
1.2.7 Peri-ovulatory follicle development and oocyte control of granulosa and 
cumulus cell function 
Prior to ovulation, the follicle undergoes significant changes. The LH surge stimulates 
the COC expansion (Duggavathi and Murphy, 2009). The cumulus oophorus structure 
in mice is consisted of around 3000-5000 cumulus cells that are held together by a gap 
junction network and an extensive extracellular matrix before and after gonadotrophin 
surge respectively (Zhuo and Kimata, 2001). The cumulus oophorus matrix is rich in 
hyaluronic acid as shown by studies in mice (Salustri et al., 1989). Cumulus cells 
secrete hyaluronic acid following gonadotrophin stimulation (Tirone et al., 1997). 
Synthesis of hyaluronic acid in the cumulus oophorus is controlled by the messenger 
ribo-nucleic acid (mRNA) expression of Has2 (Fulop et al., 1997). The preovulatory 
deposition of the cumulus oophorus matrix results in the enlargement of COC and 
dissociation of the complex from the follicle wall which is thinned and broken down, 
followed by ovulation and transportation of the COC through the oviduct, while the 
oocyte resumes meiosis as characterised by germinal vesicle (GV) breakdown (GVBD) 
and extrusion of the first polar body by the oocyte (Zhuo and Kimata, 2001).  
 
The LH surge-induced ovulation involves a continuous cross talk between the mural 
granulosa cells, the cumulus cells and the oocyte. Following the LH surge, different 
signalling pathways including the calcium-dependent pathway, phosphoinositol 
pathway, chloride ion influx and cAMP-dependent pathway are activated through the 
trans-membrane LHR in the granulosa and cumulus cells (Amsterdam et al., 1999; 
Cooke, 1999; Mattioli and Barboni, 2000). In the cAMP dependent pathway in 
particular, the responses to the oocyte are transmitted through the gap junctions 
(Mattioli and Barboni, 2000). Following the LH surge, the ligand binding of LH to its 
cognitive receptors activates Gs which then stimulate adenylyl cyclase to increase the 
levels of intracellular cAMP (Cooke, 1999). The increased levels of cAMP activate the 
cyclo-oxygenase/Lipoxysenase pathway to produce prostaglandin and leukotriene 
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(Richards, 2001b). Another action of cAMP is to activate protein kinases to stimulate 
steroidogenesis (Downs and Hunzicker-Dunn, 1995). 
 
Cumulus expansion is considered as 1 of the key steps for oocyte maturation, ovulation 
and fertilisation. One or more factors derived from the ovary and termed cumulus 
expansion enabling factors are considered to drive cumulus expansion (Buccione et al., 
1990b). One factor in particular, oocyte-derived Gdf9, which plays an essential role 
during early follicular development was proposed to be 1 of these factors when it was 
shown to induce cumulus expansion in vitro (Elvin et al., 1999). Null mutation of Gdf9 
in mice resulted in the restraint of cumulus expansion in vitro supporting the 
involvement of this gene as a cumulus expansion enabling factor. In another study, a 
recombinant form of Gdf9 was shown to promote cumulus expansion in vitro (Elvin et 
al., 1999). In both of these studies however, folliculogenesis did not progress to the 
preovulatory stage at which point it is believed that the cumulus expansion enabling 
factors act (Vanderhyden, 1993). A number of other genes, including Has2, cyclo-
oxygenase 2, the steroidogenic acute regulatory gene (Star) and the Bmp antagonist 
Gremlin have been shown to be induced following Gdf9 expression in mice granulosa 
cells (Elvin et al., 1999; Pangas et al., 2004; Rajkovic et al., 2004). In humans, 
increased expression of those genes has been correlated with better embryo quality 
(Mckenzie et al., 2004). Another oocyte-derived factor believed to act in a paracrine 
way at the stage of the preovulatory follicle is BMP15 which is also considered as a 
potential cumulus expansion enabling factor (Hussein et al., 2005). Addition of Bmp6 or 
Bmp15 to cumulus cells without the presence of oocytes in vitrο was shown to result in 
the expression of anti-apoptotic genes such as B-cell lymphoma 2 (Hussein et al., 
2005). The role of BMP15 is well established in folliculogenesis. It has been reported to 
inhibit the induction of FSH-induced progesterone synthesis and it has also been 
implicated with the inhibition of luteinisation (Otsuka et al., 2000; Shimasaki et al., 
2004).  
 
Taken together, a number of other lines of evidence suggest that BMP15 and GDF9 are 
of great importance to mammalian oogenesis.  Sheep homozygous for gene mutations 
that encode the BMP15 and GDF9 protein like the inverdale prolificacy gene (FecXI) 
have been shown to be anovulatory, whereas heterozygous animals for the mutations 
have higher ovulation rates (Galloway et al., 2000). In addition, immunisation of ewes 
for either GDF9 or BMP15 identified them as crucial for normal follicular development 
21 
 
and for controlling ovulation rate (Mcnatty et al., 2005). Studies in vitro have shown 
that both GDF9 and BMP15 are secreted into media as non-covalently linked 
homodimers or co-expressed as heterodimers (Liao et al., 2003). In mammals, both 
GDF9 and BMP15 interact with their target cell(s) through 2 types of membrane 
serine/threonine kinases of which there are 7 type I receptors (ALK1-7) and 5 type II 
receptors (ACTRII, ACTRIIB, AMHRII, BMPRII and TGFBRII) (McNatty et al., 
2004). From these, GDF9 binds to a TGFB type I and BMPRII receptors and BMP15 
binds to a BMPRI and BMPRII (Vitt et al., 2002; Mazerbourg et al., 2004). In sheep, 
ALK5, ALK6 and BMPRII are found in granulosa cells and oocytes of preantral 
follicles indicating the involvement of GDF9 and BMP15 in follicular development 
(Wilson et al., 2001; Souza et al., 2002). The downstream action of GDF9 and BMP15 
involves activation of the SMAD proteins (Udagawa et al., 2000; Kloos et al., 2002; 
Miyazawa et al., 2002). Smad proteins are major signalling molecules that act 
downstream of the serine/threonine kinase receptors (Heldin et al., 1997). SMADs are 
divided into 3 classes being the receptor-regulated SMADS (R-SMADS), common 
partner Smads (Co-SMADS) and inhibitory Smads (I-SMADS). From the R-Smads, 
Smad2 and Smad3 are activated by activin, nodal and Alk receptors 4, 5 and 7. Other R-
Smads including Smad1, Smad5 and Smad8, are activated by Bmp type I receptors 
Alk3 and Alk6. In mammals, only Smad4 acts as a Co-Smad, while Smad6 and 7 both 
function as I-Smads (Miyazawa et al., 2002). Signalling of GDF9 has been shown to 
activate the SMAD2/3 pathway, while BMP15 activates the SMAD1/5/8 pathway 
(Kaivo-Oja et al., 2003; Moore et al., 2003). However, it is hypothesized that additional 
second messenger pathways other than the SMAD pathways might also be involved in 
signal transduction following GDF9 and BMP15 activation, as shown by the inhibition 
of human granulosa cell proliferation following BMP15 signalling and by the inhibition 
of the extracellular signal-regulated kinase (ERK)-MAPK pathway (Moore et al., 2003). 
A recent study has indicated species specific differences in the cooperative actions of 
GDF9 and BMP15, where the SMAD2/3 but not the SMAD1/5/8 pathways were 
involved in both ovine and murine species, with the Nuclear factor kappa-light-chain-
enhancer of activated B cells pathway and possibly the P38-MAPK pathway being 
important for mediating signalling following the synergistic action in the sheep, while 
the ERK-MAPK pathway was involved in signal transduction of murine subjects 
(Reader et al., 2011). 
 
22 
 
As it is understood, the role of oocyte-secreted factors is very important for oocyte 
maturation.  In a study conducted in cattle, it was shown that oocyte-secreted factors 
prevent cumulus cell apoptosis by creating a morphogenic gradient (Hussein et al., 
2005). Specifically it was shown that the anti-apoptotic actions of oocytes towards 
cumulus cells followed a gradient from the site of the oocytes with the layer of cumulus 
closest to the oocytes demonstrating lower levels of apoptosis while the levels of 
apoptosis increased with increased distance from the oocyte (Hussein et al., 2005). 
None-the-less, the role of oocyte-secreted factors is not limited to the prevention of 
apoptosis or to cumulus cell expansion (Buccione et al., 1990b; Vanderhyden et al., 
1992). Oocyte-derived factors perform a number of different functions from inhibition 
of luteinisation, to the regulation of energy metabolism and sterol biosynthesis 
(Vanderhyden, 1993; Sugiura et al., 2005; Su et al., 2008). On this basis it is considered 
that the oocyte drives the cumulus cells to perform a number of tasks which are crucial 
for the acquisition of oocyte developmental competence and which the gamete itself 
cannot perform, such as cumulus glycolysis (Sutton-Mcdowall et al., 2010). 
 
1.3 OOCYTE GROWTH AND MATURATION 
Throughout folliculogenesis, the oocyte undergoes extensive growth and differentiation. 
Ovulation results in the release of the COC in most species with the oocyte arrested at 
the metaphase (MII) stage until fertilization occurs. The oocyte must undergo both 
nuclear and cytoplasmic maturation. Cytoplasmic maturation will prepare the gamete 
for fertilisation, activation and embryo development and is considered as the first step 
initiating the maturation process, while nuclear maturation and progression to the MII 
stage of meiosis I will result in the reduction of the chromosomes from a diploid to a 
haploid content (Eppig, 1996; Voronina and Wessel, 2003). The oocyte contains much 
more RNA and protein than an average somatic cell (Wassarman and Kinloch, 1992). 
Molecular reprogramming at this stage is important for the oocyte to acquire the 
expression of genes that are necessary for maturation as well as for the development of 
the zygote following fertilization until activation of the embryonic genome occurs.  
 
Before the initiation of maturation, the oocyte has a large GV nucleus containing a large 
nucleolus. The chromosomes of the oocyte at this stage are decondensed and 
transcriptionally active (Wassarman and Kinloch, 1992). When maturation initiates, this 
transcription stops and the chromosomes start to condense and the nucleoli disperses 
(Masui and Clarke, 1979). At metaphase I (MI), the paired homologous chromosomes 
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are aligned in the middle of the forming meiotic spindle and separation of the paired 
homologous chromosomes is followed by cytokinesis as marked by extrusion of the 
first polar body (Voronina and Wessel, 2003). At this stage, the oocyte undergoes 
molecular reprogramming and the coordinated expression of essential genes result in 
replication of key organelles such as mitochondria, large numbers of Golgi, generate 
receptors; and in oviparous animals, gather nutritional reserves for embryonic 
development (Van Blerkom and Davis, 1995). Following extrusion of the first polar 
body, the MII oocyte enters a second meiotic block checkpoint which prevents 
completion of meiosis II. It takes approximately 14 hours (h) for the mouse oocyte to 
progress to the MII stage (Szollosi et al., 1972), while in species such as sheep it takes 
up to 24 h (Moor and Crosby, 1985). Nuclear maturation of the oocyte resumes only 
upon fertilisation or parthenogenetic activation, at which point meiosis will be 
completed and extrusion of the second polar body occurs.  
 
The gap junctions between the oocyte and somatic cells allow nutrient transfer to the 
developing oocyte and are the functional unit until the initiation of oocyte maturation 
(Eppig, 1996). In addition to cytoplasmic gap junctional communications, bidirectional 
cell to cell communications, as in follicle development, coordinate the development of 
the oocyte. These interactions are in the form of autocrine, paracrine and endocrine 
regulation. Gap junctions are not only important for oocyte growth but also for the 
maintenance of meiotic arrest in the oocyte, by allowing the passage of molecules that 
inhibit meiotic progression. When the cumulus cells expand and mucify, the gap 
junctions break and the contact between cumulus cells and the oocyte is lost, resulting 
in the removal of the inhibitory factors that prevent the resumption of meiosis (Isobe et 
al., 1998). Studies in sheep have shown that connexin 43 which is 1 of the major gap 
junctional proteins expressed in the COC is still present between oocyte and cumulus 
cells suggesting that some sort of communication is still present (Valdimarsson et al., 
1993; Pant et al., 2005).  
 
As mentioned previously, the oocyte remains in meiotic arrest for extensive periods. 
One molecule in particular that has a role in the meiotic inhibition is cAMP, which 
maintains meiotic arrest (Dekel, 1988). Meiosis I has been shown to progress when 
cAMP concentrations were reduced in vitro (Downs, 1995). Also, oocytes have been 
shown to resume meiosis when removed from the follicular environment (Edwards, 
1965). The oocyte has been shown to be able to produce cAMP without the presence of 
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cumulus cells (Mehlmann, 2005). However, following the LH surge, gap junctions 
break and it is generally suggested that this disruption of the communication decreases 
the concentration of cAMP in the oocyte so facilitating the progression of meiosis 
(Dekel, 1988). The actions of cAMP for maintenance of meiotic arrest are shown in 
Figure 1.4. 
 
Figure 1.4:  Schematic representation of the gap junctional communication in mammals where 
high levels of cAMP inhibit meiotic maturation. The oocyte produces cAMP by activating the 
GPCR3/G protein/adenylyl cyclase pathway. Cumulus cells produce cyclic guanosine 
monophosphate (cGMP) and through gap junctions cGMP is transferred into the oocyte and 
inhibits phosphodiesterase 3 (PDE3) that hydrolyses cAMP. The oocyte expresses natriuretic 
peptide receptor 2 which is a guanylyl cyclase in the cumulus cells (shown in red) Mural 
granulosa cells then secrete the NPR2 ligand, natriuretic peptide precursor type C (shown in 
green) that induces the generation of cGMP. The LH then binds to the GPCR (blue) and 
reverses the inhibition of maturation by decreasing cGMP synthesis in the somatic cells and the 
diffusion through gap junctions. Image adapted from Von Stetina and Orr-Weaver, (2011). 
 
1.3.1 Nuclear maturation of oocytes 
Resumption of meiosis is finely controlled by the endocrine actions of gonadotrophins 
along with intercellular kinases and phosphatases. A number of key proteins take part in 
the resumption of meiosis with the production of maturation promoting factor (MPF) 
being an essential component required for the nuclear maturation in oocytes (Abrieu et 
al., 2001). The progesterone in Xenopus laevis and the LH surge in mammals are 
responsible for the inhibition of adenylyl cyclase that results in the decrease of cAMP 
levels and the subsequent reduction of PKA activity that results in the initiation of 
several intracellular signalling cascades. In X. laevis, the early events that regulate 
maturation begin with the induction of the G2/M progression in oocytes and the 
initiation of the rapid inducer of G2/M progression in oocytes/speedy (Ringo/Spy) that 
initiate mRNA translation resulting in activation of the cyclin-dependent kinase 2 
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(Cdk2) and aurora kinase A (AurkA) as well as other intracellular signalling pathways 
(Cheng et al., 2005; Padmanabhan and Richter, 2006; Kim and Richter, 2007). 
Following the LH surge, disruption of gap junctions is triggered and results in a 
decrease of oocyte concentration of cAMP further activating MPF for continuation of 
meiosis (Rime et al., 1992). The MPF is also believed to be involved in disassembly of 
the nucleus, chromosome condensation, cytoskeletal rearrangements and arrest of 
transcription (Moreno and Nurse, 1990). The MPF molecule is comprised of 2 different 
proteins, a regulatory subunit Cyclin B and a catalytic subunit Cdk1 also known as Cell 
division control protein 2 homolog (Cdc2) (Dunphy et al., 1988). The MPF protein 
complex is controlled by phosphorylation and dephosphorylation of the 2 subunits. 
Specifically, MPF is maintained inactive by specific phosphorylation of the Cdc2 kinase 
while Cyclin B controls meiotic division (Murray and Kirschner, 1989). The molecular 
event that promotes meiotic maturation and release from the prophase arrest is 
activation of the Cdk1/Cyclin B (Sagata, 1996). The 2 protein kinases, Wee1 and Mik 
have been shown to be responsible for the inhibition of Cdc2 phosphorylation 
(Lundgren et al., 1991). In mammals, regulation of the 2 subunits is achieved by the 
actions of Cdc25 that is activated following the reduction of cAMP concentration which 
subsequently removes the inhibition of Cdk1/Cyclin B (Karaiskou et al., 2004). The 
downstream targets of Cdk1/Cyclin B results in GVBD, spindle assembly and 
chromosome condensation (Jones, 2004). The CDC25 molecule controls 
dephosphorylation and activation of MPF and is also a target of MPF and this catalytic 
loop that is formed might be necessary for the quick activation of MPF (Perry and 
Kornbluth, 2007). In mice, knockdown of 2 subunits of the constitutive 
photomorphogenic singnalosome resulted in disrupted activity of MPF accompanied by 
reduced degradation of the Anaphase promoting complex/Cyclosome (Apc/C) 
substrates; Cyclin B1 and Securin, demonstrating that constitutive photomorphogenic 
singnalosome subunits are involved in oocyte meiosis (Kim et al., 2011). The LH surge 
also activates the MAPK which is another protein involved in cell cycle regulation as 
well as spindle formation (Liang et al., 2007). The actions of MAPK also include 
phosphorylation of connexin 43 that results in a reduction of the permeability of the gap 
junctions (Norris et al., 2008). Breakage of gap junctions results in reduced 
concentrations of cGMP and the release of phosphodiesterase 3 (PDE3A) which 
hydrolyses cAMP (Norris et al., 2009). As mentioned previously, the gonadotrophin-
induced signalling is transmitted by activation of the Egfr (Conti et al., 2006). Binding 
of LH to the GPCR activates the G proteins and results in the production of cAMP that 
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in turn will promote PKA activation followed by synthesis and release of the Egfr 
ligands (Panigone et al., 2008). The induction of Egfr in mice is necessary for the 
partial activation of MAPK which inhibits gap junctions (Panigone et al., 2008). In 
addition, the LH surge induced Egfr activation results in the decrease of cGMP in 
murine granulosa cells (Vaccari et al., 2009). A protein kinase named Proto-oncogene 
serine/threonine-protein kinase Mos (c-Mos) has been shown to up-regulate MPF 
activity in the oocytes from re-initiation of meiosis until fertilisation (Sagata et al., 
1989). Blockage of c-Mos activity in mouse oocytes has been shown to prevent meiosis 
and cause defects during meiosis II (Zhao et al., 1990; Gebauer et al., 1994). In X. 
laevis but not in mammals, c-Mos is required for complete activation of MPF forming a 
heterodimer with Cyclin B and Cdc2 (Brook et al., 2009). In both mammals and X. 
laevis, c-Mos activates the cytostatic factor that maintains MPF activity causing meiosis 
MII metaphase arrest (Brook et al., 2009). 
 
It has also been suggested that adenosine monophosphate (AMP) produced following 
degradation of cAMP by PDE enzymes is involved in the control of nuclear maturation 
(Bilodeau-Goeseels, 2008). Activity of PDE within the oocyte could result in AMP 
generation followed by activation of AMP-activated protein kinase (AMPK); known to 
induce oocyte maturation in arrested mouse oocytes (Downs et al., 2002). However, 
bovine and porcine oocyte meiotic resumption was inhibited when cultured in the 
presence of activators of AMPK (Mayes et al., 2007; Bilodeau-Goeseels, 2008).  
 
Other molecules have also been reported to be involved in the maturation process. 
Oocytes have been shown to overcome the inhibitory effects of cAMP when stimulated 
with maturation inducing substances (Grondahl et al., 2003). In mammals, follicular 
fluid meiosis activating sterol is considered as a stimulatory factor for the meiotic 
resumption of the oocytes (Ruan et al., 1998). This sterol was shown to induce 
maturation of cumulus denuded oocytes as well as in rat perfused ovaries in vitro (Ruan 
et al., 1998; Hegele-Hartung et al., 2001). Phoshoinositide 3 kinase is another proposed 
mediator of hormone induced maturation. Phoshoinositide 3 kinase binds to the PKB 
and this leads to PKB phosphorylation by pyruvate dehydrogenase kinase isozyme 1 
(Okumura et al., 2002). The activity of PKB can induce several cellular changes 
including cell polarisation, entry into the cell cycle, cell survival and oocyte maturation. 
A target of PKB is the myelin transcription factor 1 (Myt1) which is a kinase that 
phosphorylates and inhibits Cyclin B. When PKB is phosphorylated, Cyclin B 
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production results in re-initiation of meiosis (Okumura et al., 2002). It has also been 
proposed that following increased Cyclin B synthesis and the appearance of active MPF 
complexes, Myt1 is inhibited upstream of the MPF/Cdc25 amplification loop (Gaffre et 
al., 2011). An overview of the important signalling cascades and gene expression which 
occurs during oocyte maturation in vertebrates is shown in Figure 1.5. 
 
 
Figure 1.5:  Schematic representation of important signaling and gene expression pathways 
during oocyte maturation in humans. Initially maturation is induced by hormones that activate 
cascades and translationally regulated mRNA. CPEB: Cytoplasmic polyadenylation binding 
protein, RSK: Ribosomal S6 kinase. Phosphorylation is shown by an encircled (P). Image 
adapted from Brook et al., (2009). 
 
1.3.2 Cytoplasmic maturation of oocytes 
Other than the correct chromosome separation that consists nuclear maturation, the 
oocyte also undergoes cytoplasmic maturation which involves reorganisation of its 
intracellular machinery. Along with this, transcripts within the oocyte must be 
replicated and packaged in order to assist meiotic progression and early embryo 
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development. Cytoplasmic maturation therefore includes: (i) cytoskeletal dynamics, (ii) 
organelle redistribution and (iii) molecular maturation (Ferreira et al., 2009). With 
regard to cytoskeletal dynamics, spindle formation is essential for the correct 
chromosome segregation and for the 2 asymmetric cell divisions that involve formation 
of polar bodies along with the polarised oocyte (Schatten and Sun, 2011). Following the 
gonadotrophin surge and GVBD, the first meiotic spindle is formed. In mice, around 4 h 
after meiotic resumption, the MI spindle migrates along its long axis (Verlhac et al., 
2000). This migration takes around 4 h to complete and at the end of it, anaphase occurs 
and the first polar body is extruded (Verlhac et al., 2000). The second meiotic spindle 
forms following the first polar body extrusion. Following fertilisation and re-initiation 
of meiosis, the MII spindle rotates 90° before extrusion of the second polar body 
(Chaigne et al., 2012). Positioning of the spindles is important for the asymmetric 
divisions and oocyte polarisation that follows (Chaigne et al., 2012). Both oocyte 
divisions in meiosis for the production of the haploid gamete are very asymmetric and 
result in different sizes between polar bodies and the oocyte. In mammals, it is 
considered that the asymmetric divisions help the maintenance of maternal reserve of 
nutrients and organelles necessary for embryo support in early embryogenesis (Chaigne 
et al., 2012). An alternative hypothesis is that the reason for the asymmetric divisions is 
a means to ensure that the sperm only fertilises the large oocyte and not the tiny first 
polar body (Brunet and Verlhac, 2011).  
 
Microtubules are central to oocyte cytoplasmic maturation. They are cytoskeletal 
filaments involved in spindle formation which are constructed by asymmetric α/β-
tubulin heterodimers  which confers microtubule polarity and transport molecules and 
organelles (Desai and Mitchison, 1997). Microtubule polarity is responsible for the 
selective transport to one end of the polymer and is mediated by microtubule motor 
proteins that hydrolyse adenosine triphosphate (ATP). These proteins can be either 
Dyneins or members of the Kinesin superfamily (Kamal and Goldstein, 2002). 
Although in spermatogenesis there are centriole microtubule organising centres 
(MTOCs) that replicate during the S-phase as in mitosis, which results in the formation 
of the bipolar spindle with fusiform and astral poles, in oocytes, spindle formation is 
conducted in a different manner (Vogt et al., 2008). In mammalian oocytes, the 
microtubules originate from the MTOCs but they lack centrioles (Szollosi et al., 1972). 
The bipolar spindle is formed in the ooplasm as a result of the organisational capacity of 
the microtubules themselves along with motor proteins and microtubule associated 
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factors (Karsenti and Vernos, 2001; Eichenlaub-Ritter et al., 2004; Brunet and Maro, 
2005). AurkA has been shown to drive MTOC biogenesis in mouse oocytes matured in 
vivo (Solc et al., 2012). Following GVDB the microtubules organise into a bipolar 
spindle (Albertini, 1992; Brunet et al., 1998). Even though the microtubules have been 
shown to be able to form the bipolar spindle in the absence of chromosomes, the 
chromosomes as well as other factors including mitogen activated proteins and motor 
proteins have been shown to be involved in the regulation of the size of the spindle in 
correlation with the oocyte (Brunet et al., 1998). In addition kinetochore structures 
located at the centromeres of both mitotic and meiotic chromosomes bind together with 
the forming microtubules (Vogt et al., 2008).  
 
Kinetochores are trilaminar structures located on the opposite sides of centromeric 
heterochromatin at the centromeres of each of the sister chromatids which are bound 
together by inner centromere proteins and cohesins (Vogt et al., 2008). In mitosis, the 
kinetochores function to stabilise the microtubules by forming kinetochore fibers and 
along with the microtubules they result in the transportation of the chromosome to the 
equator of the spindle, once the 2 kinetochores of each chromosome connect to 
kinetochore fibers on the opposite spindle poles (Biggins and Walczak, 2003). In mouse 
oocytes where chromosomes are not able to connect with microtubules and form 
kinetochore fibers, the chromosomes are transferred to the equator of the spindle by 
microtubule motors of the kinesin like family (Vernos et al., 1995; Funabiki and 
Murray, 2000). The chromosomes are then segregated during anaphase of meiosis. 
These processes are mediated by kinetochore motor proteins including cytoplasmic 
dynein, conserved centromere protein E and mitotic centromere associated kinesin 
(MCAK) (Schaar et al., 1997; Maney et al., 1998; Hunter et al., 2003). From these 
proteins, cytoplasmic dynein is responsible for the direct movement of chromosomes, 
while conserved centromere protein E contributes to chromosome alignment (Wood et 
al., 1997). The MCAK protein on the other hand is associated with disassembly of 
kinetochore fibres that allows movement of the chromosomes during anaphase  (Hunter 
et al., 2003). Aurora kinase B (AURKB) and MAP kinases have been shown to activate 
MCAK and other proteins associated with the kinetochore (Zhao and Chen, 2006; Ma et 
al., 2010). AURKB in addition to other molecules like inner centromeric protein 
(Incenp) and Survivin that belong to the chromosomal passenger complex may be 
involved in cytokinesis due to the interaction of the chromosomal passenger complex 
with interpolar microtubules (Kelly et al., 2007). It is considered therefore that both 
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MCAK and AURKB act upstream of the spindle assembly checkpoint that monitors 
microtubule attachment and tension on chromosomes in both meiosis and mitosis (Vogt 
et al., 2008). Specifically, spindle assembly checkpoint (SAC) monitors the attachment 
of spindle fibres on the kinetochores of chromosomes as well as the tension by 
controlling the pulling forces from spindle fibres before entry into anaphase 
(Malmanche et al., 2006). Studies in mice have confirmed the presence of SAC, when 
microtubule dynamics at both meiosis I and II were chemically impaired resulting in 
meiotic arrest (Eichenlaub-Ritter et al., 2004; Tsurumi et al., 2004).  
 
Other than cytoskeletal dynamics, the second subcategory of cytoplasmic maturation is 
organelle redistribution. The transport of cytoplasmic organelles during maturation is 
controlled by cytoskeletal microfilaments and microtubules based on the necessities of 
the oocyte at different stages of development (Ferreira et al., 2009). The mitochondria 
which constitute the energy providers of the oocyte by utilising ATP, associate more 
towards the perinuclear region as oocytes mature from MI to MII, thus changing from 
their original even homogenous distribution throughout the cytoplasm during growth of 
the GV oocytes in many species including human and bovine (Stojkovic et al., 2001; 
Wilding et al., 2001). Studies in mice have shown that the mitochondria rearrange 
around the MII spindle during meiotic maturation (Li and Fan, 1997). In addition, the 
number of mitochondria within the oocyte change through development and increase in 
readiness for maturation as shown in sheep (Cotterill et al., 2013). In several species 
including human and mice it has also been shown that some polarised mitochondria 
localise in the sub-cortical/sub-plasmalemmal region of the cytoplasm and are involved 
in the acquisition of developmental competence (Van Blerkom et al., 2002; Van 
Blerkom, 2008).  
 
Protein synthesis itself is of imperative importance, not only for oocyte maturation but 
also for early embryo development. It is therefore essential that an adequate number of 
ribosomes exists during the maturation process (Ferreira et al., 2009). Ribosomes are 
synthesised by the transcription of ribosomal RNA (rRNA) genes followed by 
processing of the transcripts and addition of ribosomal proteins to their subunits. During 
MI of meiosis, the protein synthesis in cattle oocytes is increased by 3 times in 
comparison to the GVBD stage, while at the ΜII, the oocytes exhibit basic levels of 
mRNA translation (Ferreira et al., 2009).  
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Other cytoplasmic organelles are also subjected to change during maturation (Figure 
1.6). One of these, the Golgi complex, present at the GV stage of bovine oocytes 
transforms into vesicles during GVBD (Payne and Schatten, 2003). Although the role of 
the Golgi membranes in maturation is still to be elucidated, there has been evidence to 
suggest that extracellular matrix proteins are phosphorylated and co-localised only with 
sites of endoplasmic reticulum in MII oocytes and not with the spindle as in mitosis 
(Payne and Schatten, 2003). Biochemical changes to the endoplasmic reticulum during 
maturation play an important role in intracellular calcium regulation (Ferreira et al., 
2009). In mammalian species such as the mouse, the endoplasmic reticulum is situated 
in small clusters of cortical regions throughout the oocyte cytoplasm and as maturation 
progresses to the MII stage, the endoplasmic reticulum becomes located around the 
meiotic apparatus (Kline, 2000). During fertilisation, a marked release of Ca
2+
 from the 
endoplasmic reticulum follows sperm binding. In mouse, Ca
2+
 oscillations depend upon 
inositol 1,4,5-triphosphate that come from the endoplasmic reticulum (Fitzharris et al., 
2007). The cortical granules are derived from the Golgi apparatus and are specific to 
oocytes (Hoodbhoy and Talbot, 1994). They are responsible for the prevention of 
polyspermic fertilisation at the ZP to prevent sperm adhesion, a process known as 
cortical reaction (Hoodbhoy and Talbot, 1994). In order for the cortical reaction to take 
place, granules migrate to the periphery of the oocyte and become associated with the 
Golgi apparatus at the MII stage (Fair et al., 1997).  
 
 
Figure 1.6: Schematic overview of bovine cytoplasmic organelle distribution during oocyte 
maturation, fertilization and zygote formation. B: The mechanism of cortical reaction following 
Ca
2+
 release when the spermatozoon enters the oocyte. Image adapted fromFerreira et al., 
(2009). 
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The third subcategory of cytoplasmic maturation is molecular maturation and this 
involves the transcription, storage and processing of mRNA that is necessary for oocyte 
maturation and for the subsequent development, including fertilisation and early embryo 
development (Figure 1.7). 
 
 
Figure 1.7:  Schematic overview of the general events involved in the regulation of expression 
in the oocyte during growth and maturation. The fate of the mRNAs varies and following 
transcription, mRNAs can either be translated after polyadenylation or they can undergo 
deadenylation and be stored to be translated when needed. Gathering of the oocyte transcripts 
and proteins is necessary for both meiotic and cytoplasmic development. UTR: Untranslated 
region, PAP: Poly-(A) polymerase, MSY1: Male specific region of the Y chromosome 1. Image 
adapted from Sanchez and Smitz, (2012). 
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Since there is no gene expression, the mRNA transcribed during that maturation stage is 
gathered into an inactive state following the resumption of meiosis (Sirard, 2001). The 
proteins necessary for fertilisation and early embryo development are therefore stored 
until they are required (Sirard, 2001). The mRNA in its packed form is protected from 
nucleolytic degradation (Fulka et al., 1998). There are many mechanisms that take place 
in order to activate these inactive mRNAs and these include phosphorylation of factors 
that initiate translation, phosphorylation of ribosomal associated molecules and de-
phosphorylation of poly-adenine (A) polymerase (Thach, 1992; Colgan et al., 1996; 
Gavin and Schorderetslatkine, 1997). The addition of 250 to 300 A residues to the 
mRNA (polyadenylation) for the formation of the poly-(A) tail, stimulates the release of 
repressor molecules and initiates translation (Meric et al., 1996). The mRNA is 
transported to the cytoplasm by splicing the poly-(A) tail whereas shortening the poly-
(A) tail inhibits effective translation, while deletion of the poly-(A) tail results in 
degradation of the molecule (Tomek et al., 2002). Therefore, addition of the poly-(A) 
tail activates translation and the deadenylation that follows results in the degradation of 
that mRNA. In the bovine species it was observed that abnormal levels of 
polyadenylation in some maternal mRNAs of the oocyte were associated with lower 
developmental competence to the embryo stage (Brevini et al., 2002). The main 
transcripts produced during molecular maturation of the bovine COC encode molecules 
like MPF, Cyclin B, CDC2, c-MOS, MAPK, ATP molecules and numerous other 
important molecules required for maturation (Stojkovic et al., 2001; Calder et al., 
2003). 
 
1.4 THE ROLE OF GTSF1 IN THE REGULATION OF 
GAMETOGENESIS 
As it is understood, there is a complexity of signals regulating follicle and oocyte 
growth and maturation. Prior to oocyte maturation there are several developmental 
checkpoints that oocytes and follicles have to progress through and which require the 
coordination of endocrine, autocrine and paracrine control mechanisms. The oocyte and 
the somatic cells of the follicle play inter-dependent roles in all stages of development. 
There are still however many unanswered questions regarding the control of oocyte and 
follicle development. Therefore, the identification of genes, pathways and mechanisms 
that drive growth and regulate maturation of both cellular compartments is of 
importance to advance understanding of these processes. Many genes that are involved 
in gametogenesis are preferentially expressed in germ cells. There are a lot of expressed 
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sequence tags available in databases that have allowed the analysis of gene expression 
profiles in silico. One expressed sequence tag which exhibits high expression in the 
unfertilised oocyte, high expression in the germ cells of the testis or ovary and lacks 
expression in somatic cells, is GTSF1. In addition, germ cell specific-patterns of gene 
expression during maturation have allowed identification of novel genes from analysis 
of microarray data (Li et al., 2013). A number of potential genes involved in maturation 
have been identified with these methods. Global gene analysis from early stages of 
human folliculogenesis showed high expression of genes including the anti-proliferative 
trans-membrane protein with an epidermal growth factor-like and 2 follistatin-like 
domains, the Rho-GTPase-activating protein oligophrenin 1 and the mitochondrial-
encoded ATPase6 (Markholt et al., 2012).  
 
Preparations of cDNA libraries from X. laevis oocyte mRNA have been used for the 
isolation of maternal RNAs that are solely expressed in oogenesis and early 
embryogenesis and are possibly coding for proteins important in oocyte maturation 
(Dworkin et al., 1985). Using this approach a cDNA clone called D7.0 (originally D7) 
(Dworkin et al., 1985), derived from X. laevis maternal mRNA (D7 mRNA), was 
shown to be present throughout oogenesis but decreased after 2 days of embryo 
development (Smith et al., 1988). Antibodies to the T7 protein that were obtained from 
immunised rabbits against the T7 polypeptide fused with β–galactosidase recognised a 
single 36 kDa protein expressed in a developmentally restricted pattern from oocytes 
until the early stage embryo (Smith et al., 1988). The level of D7 protein was highest in 
embryos during the first day of development and then was decreased. The first study of 
the function for D7 protein was attempted by constructing phenocopies of null mutants 
for D7 by eliminating D7 mRNA from the X. laevis oocyte. This was performed by 
injecting 20-mer oligonucleotides into oocytes (Smith et al., 1988). The loss of D7 was 
shown to affect the progesterone induced maturation process by significantly delaying 
the time of GVBD. However, it was shown that injections of D7 RNA into full grown 
oocytes followed by translation to D7 protein did not induce oocyte maturation or affect 
the kinetics of hormone-induced maturation (Smith et al., 1991). Unfertilised X. laevis 
oocytes lacking D7 protein could be activated and fertilised and embryos developed 
normally to the tailbud stage. It was therefore proposed that D7 is not essential for 
oocyte maturation, activation, fertilisation or early embryonic development in X. laevis 
(Smith et al., 1991). In a later study, in order to examine whether D7 synthesis was 
associated with the induction of oocyte maturation, agents other than progesterone were 
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tested for their ability to induce D7 synthesis (Smith et al., 1992). The hormones insulin 
and testosterone were shown to induce D7 protein synthesis and also injections of X. 
laevis Cyclin B1 and c-Mos had a similar effect to progesterone treatment. All of these 
agents acted through activation of Mpf and crude preparations of Mpf were also shown 
to induce D7 protein synthesis (Smith et al., 1992). Although Mpf as a protein kinase is 
believed to induce protein phosphorylation during X. laevis oocyte maturation, 
phosphatases were unable to affect the modification and D7 was not labelled by [
32
P]-
ATP, therefore protein modification of D7 was not shown to be performed through 
phosphorylation (Smith et al., 1992).   
 
Another study of expression profile analysis in silico that used real-time polymerase 
chain reaction (PCR) also known as quantitative reverse transcription PCR (qRT-PCR) 
to identify mouse embryonic sequence tags, showed that Cue110 (a previous name for 
GTSF1) was exclusively expressed at moderate levels in unfertilised oocytes and 
ovaries and was abundant in the testis of the adult mouse (Yoshimura et al., 2007). The 
full sequence of the gene was acquired by performing rapid amplification of cDNA ends 
(RACE)-PCR and as shown in Figure 1.8, the gene is comprised of nine exons with the 
protein being encoded by 7 exons (Yoshimura et al., 2007).  
 
Using a conserved domain database, it was shown that the gene belongs to the 
uncharacterised protein family 0224 (UPF0224) similar to the D7 protein identified in 
X. laevis (Yoshimura et al., 2007). Several genes of the UPF0224 exist in many species 
including invertebrates, showing the evolutionary preservation of this family 
(Yoshimura et al., 2007). Specifically, there is a 28-48% shared amino acid sequence in 
the N-terminal region. In addition, a hypothetical protein encoded by the human 
ortholog-family with sequence similarity 112 member B (FAM112B) was shown to 
have a 91% identity to the murine GTSF1. Using in situ hybridisation (ISH), the GTSF1 
gene was shown to be specifically expressed in the differentiating germ cells in both the 
testis and the ovary of mice (Yoshimura et al., 2007). Specifically, GTSF1 was 
expressed from the pre-leptotene spermatocytes to the elongating spermatic in the testis, 
while in the ovary it was shown to be expressed in the primary oocytes (Yoshimura et 
al., 2007).. Immunostaining showed that GTSF1 protein was present in the cytoplasm of 
pachytene spermatocytes and round spermatids while it was not detected in oocytes. 
Similar results were also supported by real-time PCR and Western blotting (Yoshimura 
et al., 2007).  
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Figure 1.8: The murine sequence and structure of the Gtsf1 gene is shown. (a): cDNA, derived 
from exons 1–9, is 796 nucleotides long and encodes a 167-amino acid protein. Exon 1.1 is 
single underlined. (b): Schematic representation of the Gtsf1 locus. * and @ indicate the 
positions of the start and stop codons, respectively. Image adapted from Yoshimura et al., 
(2007). 
 
Initial functional studies of the role of Gtsf1 during mammalian gametogenesis involved 
the generation of Gtsf1 knockout mice (Yoshimura et al., 2009). Although the mice 
grew normally and appeared healthy in the absence of Gtsf1, the males were sterile due 
to apoptotic death of their germ cells after postnatal day 14, while the null female mice 
were fertile. In null males, meiocytes were specifically shown to cease meiotic 
progression before the zygotene stage, thereby indicating the significance of this factor 
in meiotic progression beyond the early stages (Yoshimura et al., 2009). The same 
study showed that loss of Gtsf1 increased the transcription of Long interspersed nuclear 
elements 1 (Line1) and Intracisternal A-particle (Iap) retrotransposons and 
demethylations of their promoter regions, thus leading to a retrotransposon activation 
(Yoshimura et al., 2009). Recently, it was shown that expression of Line1 and Iap in the 
male gonad is regulated by a transcriptional silencing mechanism involving DNA 
methylation (Aravin and Bourc'his, 2008).  This silencing mechanism requires Mili and 
Miwi2 which are P-element-induced wimpy testis (Piwi) family members that act by 
recognising specific methylation targets. The silencing mechanism controls the 
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expression of retrotransposons in the germline, over-expression of which can be 
deleterious for the offsprings (Aravin et al., 2007a). Although, the effects of Gtsf1 
knockdown did not result in loss of female fertility in mice, it could be that the gene still 
affects female fertility indirectly. The reason for the sexual dimorphism of the mutants 
has not been clarified. However, the cellular mechanisms that regulate prophase I events 
during mammalian meiosis appear to be more sensitive in males than females and this 
might be the reason for the fertility preservation of female Gtsf1 knockouts (Hunt and 
Hassold, 2002). During oogenesis there are 2 meiotic checkpoints, 1 that responds to 
synaptic failure and 1 that responds to DNA damage, in marked contrast to 
spermatogenesis where such checkpoints do not exist (Odorisio et al., 1998; Di 
Giacomo et al., 2005). This is of particular interest considering the high degree of 
localisation of Gtsf1 to the cytoplasm of primary follicles and to less extend to 
primordial follicles in murine ovaries as identified by ISH (Krotz et al., 2009). In 
addition, expression analysis of GTSF1 in human ovarian tissue by real-time PCR has 
revealed expression in primordial, primary, secondary, GV, MII oocytes as well as in 
pronuclear zygotes and late stage preimplantation embryos (JD Huntriss and HM 
Picton, unpublished data). Similar data have also been replicated in bovine tissue (Lu et 
al., 2012). 
 
1.4.1 The function of GTSF1 
A previously uncharacterised CHHC Zn-finger domain was identified in the GTSF1 
sequence of many species including humans and mice, in addition to U11-48K proteins 
and tRNA methyl-transferases (TRM13) (Andreeva and Tidow, 2008). Homologs of 
U11-48K are found in vertebrates, plants and insects  and their presence goes hand in 
hand with the suggested early evolutionary stages of the minor spliceosome (Russell et 
al., 2006). In contrast, the TRM13 family is found in protozoa, plants and metazoan and 
in yeast the enzyme catalyses ribose methylation, a modification that is conserved in 
many species including humans. Both the U11-48K and TRM13 domains are 
characterised by the presence of 4 invariant Cystein and Histidine residues. The Cystein 
and Histidine residues are usually involved in metal ion coordination (Morcock et al., 
2000; Shi et al., 2005). The size of the identified fragments in addition to their repetitive 
nature and conservation suggests that this independent domain is folded around a 
central zinc ion such that it is referred as the CHHC Zn-finger domain (Michalek et al., 
2011). There are 2 copies of this motif found in GTSF1 homologs of different species 
separated by a short linker (Andreeva and Tidow, 2008). This could be due to a gene 
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duplication event taking place in the early stages of eukaryotic evolution (Andreeva and 
Tidow, 2008). This domain does not have any similarity to other characterised Zn-
finger domains. Multiple alignment of all previously identified Zn-finger domains 
showed the presence of several conserved residues that may be a prerequisite for a 
specific backbone conformation (Andreeva and Tidow, 2008). Also, the positively 
charged residues might have a functional role. In addition, CHHC Zn-fingers can exist 
as an independent folding unit (Andreeva and Tidow, 2008). A possible biological 
function for this motif arises from the fact that the domain is present in 2 protein forms 
that are known to bind RNA (U11-48K and TRM13) (Turunen et al., 2008). 
Additionally, the motif contains sequence determinants that can mediate functions like 
RNA-binding.  
 
Drawn together, the gamete-specific expression patterns of the GTSF1 gene alongside 
its conserved domain containing 2 tandem copies of CHHC Zn-finger suggests that the 
gene may play a role in RNA-binding which makes this gene a very promising 
candidate for functional investigation in relation to mammalian oocyte development. 
The importance of RNA-binding is described in detail in the section that follows.  
 
1.4.2 RNA-binding 
While the oocyte progresses through maturation, it is necessary to perform transcription, 
storage and processing of the mRNA that is expressed from the chromosomes which 
will be later translated by the ribosomes (Ferreira et al., 2009). In eukaryotes, 
transcription and translation takes place in the nucleus and the cytoplasm respectively 
and post-transcriptional modification of precursor mRNA (pre-mRNA) enables further 
gene regulation (Glisovic et al., 2008). Pre-mRNA processing involves splicing, editing 
and polyadenylation and these are all mechanisms that initiate when pre-mRNA is 
transcribed. Post-transcriptional modification of mRNA and storage is crucial for 
translation of important proteins for maturation, fertilisation and early embryo 
development (Ferreira et al., 2009). It is therefore necessary for some of these proteins 
to be stored until the stage that are to be employed (Sirard, 2001).  
 
In mouse oocytes, an mRNA storage region has been identified recently called the 
subcortical ribonucleoprotein (RNP) particle domain (Flemr et al., 2010). In somatic 
cells, RNPs like processing bodies (P-bodies) as well as stress granules, regulate mRNA 
metabolism (Balagopal and Parker, 2009). In particular, P-bodies regulate repression of 
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translation and mRNA decay (Sheth and Parker, 2003). In the germ cells of many 
species, RNAs are localised to germ cell granules that regulate the maternal RNAs 
(Anderson and Kedersha, 2006). The germ cell granules contain both stress granule 
components as well as orthologs of the P-body demonstrating a conserved role of these 
proteins (Anderson and Kedersha, 2006). Although there are no specific germ cell 
granules identified in mice, Balbiani bodies which are clusters of organelles in young 
oocytes have been identified (Kloc et al., 2004; Li et al., 2008). Packaging of mRNA 
protects it from nucleolytic degradation and the mRNA will remain stored until the 
appropriate signals are generated for either maturation, zygote formation or early 
embryo development (Fulka et al., 1998). 
 
Along with RNPs, regulation of pre-mRNA processing is controlled by RNA-binding 
proteins (RBP) (Burd and Dreyfuss, 1994). The capacity for RBP to bind to RNAs is 
based upon different specificities and affinities of their sequence (Lunde et al., 2007). 
The most characterised RNA-binding molecule is the RNA-recognition motif, also 
known as the RNA-binding domain (RBD) (Lunde et al., 2007). The RBDs are 
composed of 80-90 amino acids that form a 4 stranded anti-parallel β-sheet with 2 
helices packed against it (Oubridge et al., 1994). Thousands of RBDs have been 
identified so far and most of them function in post-transcriptional modifications (Finn et 
al., 2006). There are some well characterised RBDs and these domains include the K-
homology domain, the Arginine-Glycine-Glycine box, the Sm domain, the Asp-Glu-
Ala-Asp (DEAD)/Asp-Glu-Ala-His (DEAH) box, the Zn-finger, the double stranded 
(ds)RBD, the cold-shock domain Pumilio/Fem 3 binding factor domain and the 
Piwi/Argonaute/Zwille (PAZ) domain (Baugh et al., 2005; Shalom-Paz et al., 2010). In 
humans, 0.5-1% of all genes contain RBDs and often in multiple copies within 1 
polypeptide (Finn et al., 2006). In other species like Caenorhabditis elegans and D. 
melanogaster, studies have shown that around 2% of the genome corresponds to RBDs 
(Lasko, 2000). This percentage could be even higher due to the number of RNA-binding 
proteins which have not yet been discovered. One possible explanation for the 
abundance of RBPs might be evolutionary development of the post-transcription 
processes by eukaryotes to regulate gene expression (Anantharaman et al., 2002). 
 
The RBPs have various functions and are involved in different cellular processes. 
Following mRNA translation, post-transcriptional control of gene expression is 
initiated. This process is largely regulated by RBPs (Finn et al., 2006). The RBPs 
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associate with mRNA and a lot of different RBPs interact with different small non-
coding RNAs (Anantharaman et al., 2002). The resulting RNP complexes that form are 
implicated in multiple aspects of cell metabolism, like DNA-replication, expression of 
histone genes, regulation of transcription and translational control (Anantharaman et al., 
2002; Glisovic et al., 2008). In addition, RBPs cover every aspect of RNA biology from 
transcription, pre-mRNA splicing and polyadenylation of mRNA, as well as 
modification, transport, localisation and mRNA turnover (Hilleren et al., 2001). The 
role of RBPs extends the regulation of these processes into providing a cross-link 
between them (Hilleren et al., 2001; Millevoi et al., 2006). 
 
Alternative splicing entails utilisation of RBPs and through this mechanism, the 
majority of human genes express multiple mRNAs (Johnson et al., 2003). Modification 
of RNA changes the sequence from the 1 encoded by the genome, thus resulting in an 
increase of gene products and diversity (Valente and Nishikura, 2005). Although most 
RNA editing takes place in non-coding regions, some genes have been identified that 
appear to be edited in their coding regions (Nishikura, 2006). The most common RNA 
modification is the deamination of adenosine-inosine, which occurs by conversion of an 
adenosine to an inosine (Valente and Nishikura, 2005).  
 
Polyadenylation, is regulated by RBPs (Jackson and Standart, 1990). Polyadenylation is 
the addition of adenine of the 3´ terminal portion of the cytoplasmic mRNA, that 
stimulates the release of repressor molecules that are linked at the 5´ end and in that way 
initiates translation (Jackson and Standart, 1990). The process of adding a 3´ poly-(A) 
tail of around 200 nucleotides has a significant effect on the nuclear transport, 
translation and stability of mRNA (Tomek et al., 2002). All eukaryotic mRNAs undergo 
polyadenylation except for replication dependent histone mRNAs (Glisovic et al., 
2008). Following pre-mRNA processing, mRNA is exported from the nucleus to the 
cytoplasm where translation takes place. In order for the mRNA to be exported, it must 
be fully processed. In other words, transcription, splicing and polyadenylation of the 
mRNA must be completed (Glisovic et al., 2008). Export of mRNA is a complicated 
procedure in which RBDs have an active role and it involves the generation of a carrier 
complex inside the nucleus followed by translocation of the complex through the 
nuclear pore and the subsequent release of the mRNA in the cytoplasm. The carrier 
complex is then recycled (Gruter et al., 1998). The export of RNA is an energy 
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dependent process and that different pathways are involved with different RNA species 
(Gerace, 1995). 
 
Different RNA-binding proteins are involved in mRNA localisation, a process critical 
for gene expression and regulated protein production. In Sacharomyces cerevisiae for 
example, the absent-small or homeotic mRNA localises to the bud of the daughter cell 
when it associates with the binding proteins Myosin 4 and Actin (Bobola et al., 1996). 
In a different example, Beta actin localises to the lamella region in different asymmetric 
cell types by the help of the Zipcode binding protein 1 (Ross et al., 1997). Regulation of 
translation can control gene expression and there are many regulatory proteins that 
control the initiation step of this mechanism in a range of cellular processes like 
metabolism, cell growth and differentiation (Mootz et al., 2004). Translational silencing 
during different stages of development is used by many species as a method of 
translational regulation and offers gene control (Mootz et al., 2004). In transcriptionally 
active cells, regulation of translation offers accurate spatial and temporal expression of 
proteins (Berleth et al., 1988). A characteristic example comes from D. Melanogaster 
where it was shown that the Bicoid mRNA is localised to the anterior pole of the oocyte 
only to be translated following fertilisation to create an anterior to posterior protein 
gradient (Driever and Nusslein-Volhard, 1988). In contrast, although the Caudal mRNA 
is localised in a uniform pattern, its protein is expressed in a posterior to anterior 
gradient following translational repression of the gene (Rivera-Pomar et al., 1996).  
 
The diversity of RBD functions extends into the regulation of meiotic procedures. The 
early development of metazoans is regulated by translation and localisation of maternal 
mRNA in the embryo. This process is achieved by RBDs (Colegrove-Otero et al., 
2005). Hermes is 1 of those RBDs found in oocytes of several species from X. laevis to 
H. sapiens and it was shown to targets RNA encoding proteins that are involved in 
meiotic maturation, early cleavage and germline development (Song et al., 2007). 
Several other RBDs have been identified as mediators of meiotic maturation. The 
Translin protein, functions as a post-transcriptional regulator of a group of genes in post 
meiotic male germ cells. Knockout of Translin in male mice results in a reduced sperm 
count as a consequence of apoptosis, which indicates a possible role for Translin during 
meiosis (Cho et al., 2005).  
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An additional role for RBDs is the regulation of mRNA storage in the oocyte. It is well 
established that the differentiation of an oocyte into a 2 cell embryo is controlled by 
regulated translation of maternal mRNAs (Pepling, 2010). In order for this to be 
achieved, these mRNAs must be stored in the oocyte and activated at the specific time 
of development (Colegrove-Otero et al., 2005). Other than the subcortical RNP particle 
domain, several other RBDs have been identified to be involved in the storage of both 
paternal and maternal mRNAs (Flemr et al., 2010). In X. laevis, the Y-box proteins 
mRNP3 and Frgy2/mRNP4 are major RNA-binding components of maternal storage 
mRNPs in oocytes (Matsumoto et al., 2003). In mouse male germ cells, the DNA-RNA 
binding protein Msy2 has been shown to mark specific transcripts for cytoplasmic 
storage in mouse male germ cells (Yang et al., 2005). 
 
1.5 EVALUATION OF NOVEL GENE FUNCITON 
Even though the genomes of a number of species including C. elegans (Consortium., 
1998) D. melanogaster (Adams et al., 2000) and H. sapiens (Gregory et al., 2006) have 
been completely sequenced, the function of the majority of genes remains 
undetermined. In the post-genomic era, elucidation of gene functions can help in the 
development of gene based drug targets and therapies. The complexity however of 
acquiring all protein encoding genes in addition to events such as RNA-splicing and 
post-transcriptional modification make this a challenging task. In order to overcome it, 
the whole of non-coding RNAs and their functions must be identified (Appasani, 2004).   
 
Until recently, knockout experiments in mice were the primary method used to 
determine the function of an unknown gene (Larue et al., 1994; Roy and Matzuk, 2006). 
This technology however has the disadvantage of being very laborious with the effects 
taking a long time to become evident. The method of homologous recombination can be 
difficult and expensive, especially in species in which embryonic stem cells have not 
been isolated (Gerhard et al., 2004). In addition, the conventional knockout experiments 
require a lot of time and cannot keep pace with the new sequence information generated 
by different genome projects, further to the fact that knockout of many genes can be 
embryo lethal (Brusselmans et al., 2005; Schellander et al., 2007). For this reason 
selective degradation of transcripts by post-transcriptional gene silencing using dsRNA 
or RNA interference (RNAi) technologies, has emerged for the study of unknown gene 
functions in many organisms (Fire, 1999; Brusselmans et al., 2005; Schellander et al., 
2007). Initial studies using dsRNA injection into C. elegans resulted in degradation of 
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the targeted mRNA. Since then, RNAi has been successfully applied to several 
mammals, including human, mouse and pig (Brusselmans et al., 2005; Schellander et 
al., 2007). The process of RNAi is highly conserved and assumed to originate as an 
ancient self defence mechanism of cells against RNA viruses that acts either by 
suppressing transcription or by degrading the RNA (Lau, 2005). The technology is 
based on the functions of small RNA pathways that can negatively regulate gene 
expression by binding to complementary sequences in the 3´ UTRs of target mRNA 
transcripts leading to gene silencing (Fire, 1999). 
 
1.5.1 The role of small RNA pathways in reproduction 
Small RNA pathways have been identified as having important roles in both male and 
female reproduction (Fire, 1999). Small RNAs in general can be divided into different 
categories based on nucleotide length: (i) the more than 24 nucleotides P-element-
induced wimpy testis (PIWI) interacting RNA (piRNA), (ii) the less than 24 nucleotides 
micro RNA (miRNA) and (iii) the siRNA (Hawkins et al., 2011). The piRNA were first 
identified by their interaction with Piwi family members of D. melanogaster and their 
functions have been shown to mostly affect gametogenesis and to be necessary for 
mammal spermatogenesis and maintenance of the germline (Khurana and Theurkauf, 
2010). The piRNA loci are transcribed by the same strand as long primary transcripts. 
Individual piRNAs do not however have conserved sequences; instead, these precursor 
(pre)-RNAs are cleaved by Argonaute RNA endonucleases; which are PIWI subfamily 
members, in order to generate their 5´ ends (Hawkins et al., 2011). Germ cell formation 
in D. melanogaster has been shown to be controlled by Piwi and embryos lacking 
maternal Piwi were shown to have decreased germ cell formation (Megosh et al., 2006). 
This molecule has also been shown to co-localise with polar granule markers like Vasa 
which is an RNA helicase necessary for germ cell formation, therefore indicating that 
Piwi is a polar granule component (Hay et al., 1988). The Piwi molecule also associates 
with Dicer which is interrelated with miRNA generation and function (Bernstein et al., 
2001). In addition to this, the association of PIWI with a number of miRNAs and 
piRNAs suggests that the PIWI might act through the miRNA mechanism (Yin and Lin, 
2007). 
 
In mice, the 3 Piwi family members Miwi2, Mili and Miwi are expressed in different 
stages of the male germline cycle (Deng and Lin, 2002; Aravin et al., 2007b; Carmell et 
al., 2007). From these members, Mili and Miwi2 cause spermatogenic stem cell arrest 
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when their expression is disrupted (Carmell et al., 2007; Unhavaithaya et al., 2009). 
The above phenotype is most predominant in the Mili knockouts and the few stem cells 
that do not arrest can generate spermatocytes that arrest at the pachytene stage of 
prophase I (Kuramochi-Miyagawa et al., 2004). In Miwi2 knockouts, spermatogenesis 
is blocked at the leptotene stage of prophase I (Carmell et al., 2007).  
 
There is also some evidence from D. melanogaster and D. rerio for the function of Piwi 
molecules in oogenesis. In D. melanogaster, Piwi knockouts abolish germline stem cell 
division (Lin and Spradling, 1997). In addition, screens for mutations in abnormal D. 
melanogaster oocytes have indicated  mutations of the Aubergine locus which is a Piwi 
homolog (Schupbach and Wieschaus, 1991). Furthermore, embryos generated following 
the knockout also demonstrated abnormalities in the EGFR pathway (Schupbach and 
Wieschaus, 1991).  
 
The second category of small RNAs consisting of less than 24 nucleotides includes the 
miRNAs and siRNAs. The miRNAs are the best characterised endogenous small RNAs 
in eukaryotes and are mostly engaged in development and differentiation (Watanabe et 
al., 2008). These RNAs are processed from the pre-miRNA and regulate gene 
expression by repressing translation or by cleaving mRNA (Ambros, 2004). In contrast, 
siRNAs are generated from long dsRNAs and share similar functions with miRNAs 
(Shi et al., 2004).  
 
The pathway for miRNA synthesis in mammals involves the actions of the 
microprocessor complex DROSHA, the microprocessor complex subunit (DGCR8) and 
DICER, while only DICER is required for the synthesis of siRNAs (Figure 1.9). Mice 
lacking Dicer are unable to survive due to faults in the development of ESCs (Bernstein 
et al., 2003). In addition, argonaute 2 (Ago2) has also been shown to be necessary for 
early development; as mice lacking the molecule do not survive beyond embryonic day 
9.5 (Liu et al., 2004). Mice lacking Dicer also demonstrate an infertile phenotype with 
spindle defects, chromosome alignment and meiosis arrest at MI (Bernstein et al., 2003; 
Tang et al., 2007). Similarly, Ago2 knockout mice also demonstrate meiotic arrest along 
with chromosome and spindle flaws (Kaneda et al., 2009). Because Dicer is necessary 
for the biosynthesis of both siRNA and miRNA, absence of either or both of them could 
be responsible for the observed oocyte defects in the above studies. Transcript analysis 
conducted in the same studies showed that the transcripts affected were involved in 
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meiosis regulation and spindle formation demonstrating similarities with the defects 
associated with the deletion of piRNA in males (Liu et al., 2010).  
 
 
Figure 1.9: Biogenesis of siRNA and miRNA in animals. The siRNA is firstly transcribed with 
the transcripts forming a region of dsRNA. The miRNA are transcribed from RNA-polymerase 
II and fold into a hairpin structure containing a region of dsRNA called primary-miRNA (pri-
miRNA). These pri-miRNAs are then processed by the microprocessor complex which is 
composed of a nuclear type III endonuclease named RNASES/DROSHA and its cofactor 
DGCR8. The pri-miRNAs are cleaved and the pre-miRNA is excised and then exported from 
the nucleus by Exportin 5. When in the cytoplasm, a second RNase III endonuclease, DICER 
along with its cofactor TAR binding protein 2 (TARBP2) cleaves the 5´ overhangs of the 
siRNA precursor or the loop of the pre-miRNA as shown in the red triangles. The mature 
siRNA or miRNA produced are then loaded onto the AGO containing effector complex named 
RNA-induced silencing complex (RISC). In mammals there are 4 AGO molecules (AGO1-4) 
with the endonucleolytic activity for cleavage of mRNA contained in AGO2. Following the 
mRNA endonucleolytic cleavage, mRNA is decapped and exonuclease proceeds with the 
digestion. The other AGO molecules may also have alternative roles in the repression of 
translation. Adapted from Hawkins et al., (2011). 
 
In general, miRNAs and siRNAs negatively regulate gene expression by binding to 
complementary sequences in the 3´ UTR regions of target mRNA-transcripts leading to 
gene silencing (Fire, 1999). The importance of the small-RNA mechanisms to 
mammalian oocyte development were further clarified when Watanabe et al, (2008) 
found that the siRNAs produced in oocytes are depleted following Dicer knockout in 
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addition to mRNA up-regulation of siRNA targets. The above result demonstrates that 
siRNAs regulate endogenous targets in mammals (Watanabe et al., 2008). In a recent 
study, knockout of Dgcr8 in mouse oocytes resulted in reduced repression of translation 
(Ma et al., 2010). In another study where Dgcr8 was deleted, oocytes matured normally 
and had healthy offsprings with the mRNA profiles of Dgcr8 knockout oocytes being at 
similar levels with wild types, confirming that it is the siRNAs and not the miRNAs that 
cause the Dicer knockout phenotype in oocytes (Suh et al., 2010). The above studies 
demonstrate the necessity of siRNA production by Dicer for normal oocyte maturation 
with miRNAs not having such a significant role (Hawkins et al., 2011). Additionally, 
introduction of artificial 3´ UTRs with multiple target sites into mouse oocytes in 
addition to introduction of an excess of miRNAs did not result in increased suppression 
of mRNA stability translation (Ma et al., 2010). It can therefore be assumed that 
miRNA function is suppressed in fully grown oocytes even though miRNA biogenesis 
is not affected. One hypothesis is that suppression of miRNA function could be 
associated with the P-bodies which are lost in maturing oocytes; however it is unknown 
whether the loss of P-bodies is a primary or secondary consequence of the loss of the 
miRNA function (Flemr et al., 2010). An overview of the small RNA characteristics 
and tissue of function in mammalian reproduction is shown in Table 1.1. 
 
Table 1.1: Small RNA characteristics and tissue of function in mammalian reproduction. 
Adapted from Hawkins et al., (2011). 
/ piRNA siRNA miRNA 
Approximate size 25-30 nucleotides 18-24 nucleotides 18-24 mucleotides 
Major cell type Male germ cells Oocyte Multiple 
DICER-dependent No Yes Yes 
Drosha-dependent No No Yes 
DGCR8-dependent No No Yes 
Major function 
Suppression of 
transposon synthesis 
Cleavage of 
transposon mRNAs 
mRNA cleavage, 
translation repression 
Estimated number >10,000 >10,000 600-1000 
Types of RNAi 
delivery 
Transfection, Electroporation, Viral vector, Microinjection, Cell culture 
incubation, Feeding, Use of reagents,  
Examples of 
phenotypes in oocyte 
following RNAi 
c-MOS dsRNA (mouse): Spontaneous activation of oocytes 
Cyclin B1 dsRNA (mouse and bovine): Reduced activity of Mpf 
Msy2 dsRNA (mouse): Impaired resumption of meiosis II 
GDF9 dsRNA (mouse and ovine): Reduced cumulus expansion 
BMP15 dsRNA (mouse and ovine): Reduced cumulus expansion 
Has2 shRNA (mouse): Reduced cumulus expansion 
 
 
1.5.2 RNAi as means to moderate oocyte gene function 
Synthetic methods have also been developed to silence endogenous genes. The most 
common methods employ synthetic RNAi effectors (mimics of siRNA, short hairpin 
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RNA (shRNA) and pri-miRNA) that emulate different precursors of the endogenous 
pathway (Sibley et al., 2010). Also, second generation approaches involving 
asymmetric RNAi, small internally segmented interfering RNAs and RNA-DNA 
chimeras have been employed in order to reduce some of the off-target effects of RNAi 
effectors. These RNAs can limit sense strand activity and off-target effects of antisense 
strands (Sibley et al., 2010). In addition, alternative mechanisms of shRNA introduction 
by using alternative delivery mechanisms of shRNA to the cytosol can avoid some of 
the toxicity caused by Exportin 5, for which shRNA compete with endogenous miRNAs 
and is believed to cause fatality in mice (Grimm et al., 2006). The RNA effectors can 
also be used for transcriptional gene silencing that can induce epigenetic changes. 
Another advantage is that tandem siRNAs, tandem shRNAs and miRNA clusters can be 
used to target multiple sites (Sibley et al., 2010). 
 
The discovery of RNAi resulted in the generation of numerous studies in vivo and in 
vitro that evaluated the function of genes or encoded proteins. When it comes to the 
reproductive system, there are many unanswered questions concerning the complexity 
and changes that oocytes undergo during the final stages of growth and the acquisition 
of developmental competence. During the process of oogenesis, oocytes acquire the 
majority of transcripts correlated with maturation and early embryo development 
(Bachvarova, 1992). RNAi can therefore be used as a tool to study both the molecular 
and cellular events during oocyte development and maturation, by silencing the 
expression of single or multiple genes (Schellander et al., 2007). The procedure of 
RNAi involves the introduction of long dsRNA, siRNA or shRNA to serve as siRNA 
substrates (Roignant et al., 2003; Amanai et al., 2006; Sarnova et al., 2010). It is 
estimated that 10% of possible siRNAs will have significant off target effects in the 
genomes of H. sapiens, C. elegans, and Schizosaccharomyces pombe (Qiu et al., 2005). 
In most mammalian cells, siRNAs are preferred instead of dsRNAs because of the 
interferon response  caused by long dsRNAs (Reynolds et al., 2006). Interferon 
response is a form of innate immunity to any foreign genetic material. Mouse oocytes 
have been shown to lack the non-specific effects of RNAi triggered by the introduction 
of long dsRNA and consequently murine oocytes have been used as a model system for 
studying the effects of gene knockdown in mammals (Stein et al., 2005). 
 
The success of RNAi experiments is largely dependent on the design of the siRNA 
species used and the efficiency of their delivery into the cells of interest. Several 
48 
 
different techniques including microinjection, electroporation and transfection have 
been developed for introducing the RNAi mediators. The efficacy of the delivery 
strategies varies depending on the target cell or organism. Some organisms in particular 
are susceptible to several ways of siRNA introduction for example C. elegans that may 
be injected or fed (Tabara et al., 1998; Fire, 1999; Fraser et al., 2000); whereas in D. 
melanogaster, embryos can be microinjected, while cell culture incubation with siRNA 
has also proved effective in D. melanogaster (Kennerdell and Carthew, 1998; Clemens 
et al., 2000). Stable transfection with a plasmid encoding the sequence transcribing 
siRNA is another method being used for avoiding direct introduction of siRNA 
(Brummelkamp et al., 2002), while lentiviral vector systems allow an inducible control 
of transcription activation or deactivation, known as conditional RNAi (Tiscornia et al., 
2004). The effect of RNAi can also be achieved by RNA produced enzymatically from 
DNA-transcription. The method termed DNA-Directed RNAi (ddRNAi) allows use of 
standard transfection reagents and methods. Gene delivery can also be performed by 
using different reagents and methods including cationic lipids, calcium phosphate, 
polybrene-dimethyl sulfoxide (DMSO), diethylaminoethyl cellulose (DEAE)-dextran or 
electroporation (Caplen et al., 2001; Elbashir et al., 2001). From the above methods, 
electroporation is most frequently used and it functions by increasing electrical 
conductivity and by applying an electrical field to introduce into cells large highly 
charged molecules that would not passively diffuse across the cell membrane (Neumann 
et al., 1982). Morpholinos are also used as vehicles for the introduction of RNA species 
into cells by microinjection or electroporation. These are molecules that bind to 
complementary sequences of RNA and modify gene expression by preventing cells 
from making a targeted protein and also by modifying the splicing of pre-mRNA 
(Summerton, 1999; Draper et al., 2001).  
 
Microinjection has been shown to be an effective means of introducing RNA species 
into oocytes and embryos from a variety of species (Svoboda et al., 2000; Wianny and 
Zernicka-Goetz, 2000; Paradis et al., 2005). In comparison with electroporation and 
transfection, microinjection is easier to apply at the oocyte level and the volume injected 
can be regulated and thus allows a better control of the amount of dsRNA or siRNA that 
is introduced into the oocyte (Paradis et al., 2005). This is very important because the 
efficiency of targeted suppression of gene transcripts is believed to be dependent on the 
phenotype it produces. Developmental phenotypes have been related to the 
concentration of dsRNA introduced when different concentrations of dsRNA c-Mos 
49 
 
resulted in significant differences in the spontaneous activation of oocytes (Wianny and 
Zernicka-Goetz, 2000). None-the-less, microinjection frequently results in physical 
injury or stress to the oocytes being manipulated (Favetta et al., 2007). The original 
studies on RNAi in oocytes, involved injection of dsRNA in mouse oocytes that 
resulted in altered expression of targeted genes. Specifically, Wianny and Zernicka-
Goetz, (2000) showed that epithelial-Cadherin and c-Mos dsRNA injections into 
oocytes resulted in an 80% reduction of the target transcript and so produced 
phenotypes similar to those of null mice. Similar results were shown for injections of c-
Mos and tissue plasminogen activator dsRNAs (Svoboda et al., 2000). Since then, a 
number of studies have used RNAi in oocytes and embryos of different species 
targeting different genes and resulting in different levels of suppression. Specifically, c-
Mos introduction in bovine oocytes by microinjection was shown to reduce the target 
transcript by 70% (Nganvongpanit et al., 2006). In a different study conducted in mice, 
maternal mRNAs of different genes were suppressed by 90% (Xu et al., 2003). Lazar et 
al., (2004) showed that exposure of rat oocytes to Cyclin B1 dsRNA resulted in the 
complete degradation of this molecule. This result is important as the 2 subunits of 
Cyclin B1 (regulatory and catalytic) form Mpf (Nurse, 1990). Down-regulation of 
Cyclin B1 caused the down-regulation of its protein product and the resultant reduced 
activity of Mpf. The reduced Mpf activity resulted in suppression of the addition of 
poly-(A) tail to the c-Mos mRNA which impeded its translation. Translation of c-Mos is 
a critical step in oocyte maturation and specifically the control of meiotic progression. 
Knockout mice for c-Mos have been shown to have a reduced fertility in comparison to 
the controls due to the failure of mature oocytes to arrest during meiosis (Colledge et 
al., 1994). Specifically, c-Mos knockouts were shown to undergo GVBD and extrusion 
of the 2 polar bodies with some progressing through cleavage. These results highlighted 
the role of c-Mos in preventing spontaneous parthenogenetic activation of unfertilised 
oocytes. Conversely, treatment of mice with c-Mos dsRNA resulted in spontaneous 
activation of around 50% of the oocytes (Wianny and Zernicka-Goetz, 2000). Further 
elucidation of the role of c-Mos was conducted by examining MII arrest of mouse 
oocytes in conjunction with the c-Mos/Mapk pathway (Lefebvre et al., 2002). 
Specifically Mapk was shown to have an important role in maintaining spindle integrity 
at the oocyte arrest stage when dsRNA specific transcripts were injected. In addition, 
Mapk interacting and spindle stabilising protein was shown to be the substrate for the c-
Mos/Mapk pathway. By using RNAi, other important genes playing an important role in 
oocyte maturation were identified like the Msy2, which was shown to regulate maternal 
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mRNA translation during oogenesis and was essential for completion of meiosis II in 
mouse oocytes. Knockdown of this protein resulted in impaired resumption of the 
second meiotic division (Yu et al., 2004). However, a similar study in bovine revealed 
an alternative outcome. Introduction of C-MOS dsRNA into bovine oocytes resulted in 
only a 2.5% spontaneous activation of oocytes, although C-MOS transcription and 
translation were significantly lessened (Nganvongpanit et al., 2006). Overall, the above 
results show that phenotypical appearances following suppression of transcripts are 
different between species. Similarly, null mutation studies and suppression of other 
specific transcripts contributing to oocyte maturation such as Gdf9 and Bmp15 
supported these species specific differences in oocyte behaviour (Schellander et al., 
2007).  
 
The role of the oocyte-derived factors Gdf9 and Bmp15 in oocyte maturation has also 
been evaluated by RNAi. In order to study the relation between these oocyte-specific 
transcripts and cumulus expansion in mice, a long dsRNAi approach was used (Gui and 
Joyce, 2005). Evaluation of Has2 and Ptgs2 mRNA levels were used as markers of 
cumulus expansion and showed lower levels when Gdf9 was knocked-down in the 
oocyte in comparison to Bmp15 knockdown and controls. The above results in addition 
to the lower degree of expansion of mouse cumulus cells when cultured with oocytes 
injected with dsRNA for Gdf9, supports the concept that Gdf9 is a key mediator of 
oocyte enabled cumulus expansion in mice as has been previously suggested by the 
studies of Sugiura et al., in 2005 (Gui and Joyce, 2005).  
 
Following the successful application and potential of RNAi in determining functional 
characteristics of genes in mice, the technology has been applied to study other oocyte-
specific transcripts in other species including B. taurus, O. aries and Macaca mulata 
(Paradis et al., 2005; Wu, 2009; Tang et al., 2012). An RNAi approach to study gene 
function has been developed for bovine oocytes and Cyclin B1 dsRNA microinjection in 
GV oocytes successfully resulted in the decrease in Cyclin B1 mRNA and protein while 
Cyclin B2 mRNA levels were not affected (Paradis et al., 2005). In ovine oocyte 
maturation, injection of siRNA duplexes for GDF9 and BMP15 in denuded GV oocytes 
resulted in a lower degree of cumulus cell expansion when the knockdown oocytes were 
matured in vitro with compacted oocytectomised cumulus complexes (Cotterill, 2008). 
In addition, GDF9 or BMP15 dsRNA injections resulted to reduced mRNA levels for 
HAS2, while GDF9 dsRNA injections resulted to reduced GREMLIN1 mRNA levels 
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(Cotteril, 2008). In another study, targeted suppression of Has2 mRNA in mouse COC’s 
was accomplished by adenovirus mediated shRNA expression (Sugiura et al., 2009). In 
addition to the reduced expansion of cumulus cells, levels of Areg and Ereg mRNAs 
were decreased in Has2 mRNA targeted intact COCs, while Btc mRNA levels were not 
affected (Sugiura et al., 2009). Even though Has2 expression levels were reduced by 
more than 70%, expression levels of other genes required for cumulus expansion 
including Ptgs2, pentaxin related protein 3 and tumour necrosis α induced protein 6 
were not affected (Sugiura et al., 2009). It is worth mentioning, however, that the levels 
of these genes in the adenovirus infected COC’s were lower compared to controls and 
Egf treatment recovered their levels; suggesting that expression of these genes was 
stimulated by Egf (Sugiura et al., 2009). Although the enzyme hyaluronan synthase is 
critical for cumulus expansion, the role of Has2 isoform in the process remains 
unclarified. Several other isoforms for the enzyme are shown to be expressed in bovine 
and porcine oocytes (Kimura et al., 2002; Schoenfelder and Einspanier, 2003). Since 
the co-culture of denuded gene knockdown oocytes with intact oocytectomised cumulus 
shells regenerates the 2 compartments of COCs, further research using this approach 
will allow better understanding of the mechanisms behind COC development, 
maturation and signalling to and from each of the cellular compartments.  
 
While the application of RNAi as an effective tool for studying gene function in oocytes 
is emerging; the efficiency of this technology remains an important issue. One factor 
that has been shown to have an impact on the efficiency of RNAi is the siRNA 
sequence used. Indeed nucleotide mismatches within the siRNA can alter the specificity 
of target recognition (Holen et al., 2002). In particular, properties of the targeted mRNA 
such as the secondary structure, RNA-associated proteins and sub-cellular localisation 
of the mRNA can all affect the efficiency of gene knockdown (Holen et al., 2002). In 
addition, the culture conditions affect the target degradation by RNAi. In another study, 
sequence specific dsRNA efficiency of knockdown was shown to be directly related to 
the culture environment and it affected availability of transcripts during oocyte and 
embryo development (Tesfaye et al., 2007). Despite these criticisms, the application of 
RNAi technology and evaluation of the expression of siRNA at specific stages of oocyte 
and embryo development has great potential as a tool for basic research aiming at 
understanding the function of genes during gamete development.  
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1.6 AIMS AND OBJECTIVES 
A detailed understanding of the genes and mechanisms that regulate oocyte growth and 
maturation is essential for the development of improved methods of assisted conception. 
On the basis of the evidence reviewed here is clear that folliculogenesis in addition to 
oocyte development and maturation requires the coordinated interaction between 
multiple cell types and the timely expression of specific genes and transcription factors. 
A lot of research has been conducted on the factors that influence folliculogenesis and 
oocyte maturation in rodents, however less is known about follicle growth and 
development in monovular species such as human and sheep. From the literature it is 
now understood that the oocyte itself plays a crucial role in regulating most stages of 
folliculogenesis and this is highlighted by the actions of oocyte-derived factors which 
are facilitated by the cross talk between the oocyte and the somatic compartments of the 
follicle through growth and maturation. One of these oocyte-specific factors is GTSF1. 
GTSF1 is a putative marker of gamete developmental competence that is highly 
conserved across species but which demonstrates a sexual dimorphism in its function. 
The cellular distribution of function of GTSF1 in the regulation of gametogenesis of 
monovular species as the sheep has not yet been investigated. On the basis of the 
published literature it is hypothesized that the gamete specific expression of GTSF1 
along with its conserved domain containing 2 tandem copies of a CHHC Zn-finger, 
suggests that GTSF1 plays a role in gamete production in monovular species and that 
the function of the gene may relate to RNA-binding during oocyte development. The 
objectives of the research presented in this thesis were:  
1. To clone and sequence ovine GTSF1 and characterise the cellular 
distribution and expression patterns of the gene across all stages of ovine 
follicle, oocyte and early embryo development using molecular screening 
methods and ISH. 
2. To validate the efficiency of the microinjection of siRNA as a vehicle for 
gene knockdown on a known oocyte-derived factor; GDF9. 
3. To evaluate the function of GTSF1 during sheep oocyte maturation in vitro 
by studying the impact of GTSF1 knockdown on parameters such as: (i) 
meiotic maturation of ovine oocytes, (ii) cumulus mucification and 
expansion and (iii) gene expression pathways. 
4. To determine if GTSF1 was confined to the P-body of ovine oocytes and so 
provide preliminary insights into the role in RNA processing in this species.  
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Chapter 2: Materials and Methods 
 
The reagents used in the experiments of the thesis were purchased from Sigma-Aldrich 
(Dorset, UK) unless otherwise stated. Sterile culture plastics were purchased from Nunc 
(Nunclon, Roskilde, Denmark) unless otherwise stated. All addresses of suppliers are 
shown in Appendix I. All glassware used in the experiments was originally soaked 
overnight in a mixture of Trigene (Medichem International, Sevenoaks, Kent) and 
sterile-distilled H20 in a dilution of 1 in 50. Glassware was then rinsed twice with tap 
water and twice more with Milli-Q water (MQ-H2O, Millipore, Billerica, USA). 
Following washing, glassware was left to dry for 2 days in an oven at 30° C (Philip 
Harris Ltd, Shenstone, England). When dried, glassware was wrapped in foil and 
sterilised by heating in an autoclave at 180° C. New glassware was treated in a 5% (v/v) 
HCl before following the same procedure as detailed above. 
 
2.1 OVINE TISSUE COLLECTION AND IVM 
Sheep reproductive tracts were collected from the abattoir (J.C. Penny and sons, 
Rawdon, Leeds, UK) and placed in an insulated carrier at room temperature (RT) before 
being transported to the laboratory where the tissue was cleaned and prepared for 
analysis. The methods for ovine tissue collection and IVM of ovine oocytes have been 
described previously (Danfour, 2007; Cotterill, 2008, Cotterill et al., 2012).  
 
2.1.1 Tissue preparation 
Following arrival of the ovine tracts, the ovaries were cut from the tracts and washed 3 
times in an autoclaved glass beaker (Scientific Laboratory Supplies (SLS), Yorkshire, 
UK) containing 150 ml of ovary washing medium The ovary washing medium was 
prepared by adding 1 tablet of phosphate buffer saline (PBS, Invitrogen Ltd, Paisley, 
UK) to 500 ml of sterile-distilled H2O and 5 ml of antibiotic-antimycotic solution 
containing penicillin G (100 IU/ml), streptomycin sulphate (100 μg/ml) and 
amphotericin B (250 ng/ml). The values shown for each solution represent the final 
working concentration. Ovary washing medium was pre-warmed in a non-gassed 
incubator overnight at 39° C (Stuart hybridisation oven, SLS). Following cutting of all 
the ovaries and 2 additional 150 ml rinses with the washing medium, ovaries were 
placed in a 170 ml sterile plastic container (SLS) containing follicle isolation medium 
(FIM) at 39° C in the non-gassed incubator until processing. The composition of the 
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FIM medium is shown in Table 2.1. The solution was sterilised with a 0.2 μm cellulose 
acetate rapid vacuum filtration system (Techno Plastic Products, TPP, Trasadingen, 
Switzerland) and left to equilibrate overnight in the non-gassed incubator at 39° C prior 
to use. All culture media and additives were made-up as appropriate in sterile tissue 
culture grade embryo tested H2O. The composition of all stock solutions is shown in 
Appendix II. 
 
Table 2.1: Composition of follicle isolation medium (FIM) 
Component Stock Vol. (ml) Final Concentration 
MEM 10X stock - 50 - 
Buffer 10X stock - 50 - 
 *BSA  2.0% (w/v) 25 1 mg/ml 
Penicillin 6 mg/ml 2.5 0.06 mg/ml 
Streptomycin 5 mg/ml 2.5 0.05 mg/ml 
Heparin 5000 U/ml 2 20 U/ml 
Sodium Pyruvate  stock 47 mM 0.5 0.047 mM 
Make up to 500 ml with embryo tested sterile-distilled H2O 
Media was kept overnight at 39°C in a non-gassed incubator before use. Extra media 
was stored at 4°C for up to 2 weeks. MEM: Minimum essential medium, *BSA: Bovine 
serum albumen, fraction V cell culture grade. 
 
2.1.2 Aspiration of cumulus oocyte complexes 
The COCs were aspirated from antral follicles of approximately 2-5 mm diameter using 
a 20 ml sterile syringe (BD Plastipak
TM
, Drogheda, Ireland) attached to a size 19 gauge 
needle (Terumo UK Ltd, Surrey, UK) which was pre-loaded with 1 ml of pre-warmed 
Hepes buffered medium 199 (H199
+
). The composition of H199
+
 is shown in Table 2.2. 
The solution was sterilised with a 0.2 μm cellulose acetate rapid vacuum filtration 
system before use and was left to equilibrate overnight at 39°C in a non-gassed 
incubator. When 6 ovaries had been aspirated, the loaded COCs were dispensed into a 
sterile 90 mm plastic Petri dish containing H199
+
 and evaluated using a stereo 
microscope (Olympus Ltd, Southhall, Middlesex, UK) fitted with a heated stage set at 
39°C (MTG Medical Technology Verrtriebs GmbH, Altdorf, Germany). Before oocyte 
aspiration, parallel lines were drawn on the bottom of the 90 mm Petri dish using a 
marker pen in order to assist with COC searching. Multiple aspirates were pooled into a 
dish and the COCs with an intact oocyte cytoplasm and at least 3 layers of cumulus 
cells surrounding the oocyte were selected for culture and multiple COCs were pipetted 
into a sterile 35 mm nunc dish containing 2 ml of pre-warmed H199
+
. The dish 
containing the selected COCs was thereafter placed in the non-gassed incubator at 39°C 
and the same procedure was followed for all the remaining ovaries.  
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Table 2.2: H199
+
 oocyte holding media composition 
Component Stock Vol. Final Concentration 
M199 stock 10X (Gibco, UK) - 25 ml - 
Bicarbonate stock 250 mM 4 ml 4 mM 
Hepes Stock 250 mM 21 ml 21 mM 
Heparin 180U/mg 5 mg 0.02 mg/ml 
*BSA - 1g - 
Penicillin 
Streptomycin 
6 mg/ml 
5 mg/ml 
2.5 ml 1.2 mg/ml 
0.1 mg/ml 
Make up to 500 ml with embryo tested sterile-distilled H2O 
Media was kept overnight at 39°C in a non-gassed incubator before use. Extra media 
was stored at 4°C for up to 2 weeks. Osmolarity was in the range of 283±5. The pH was 
adjusted to 7.2-7.4 using 1 M HCl or NaOH. *BSA: Fraction V cell culture grade.   
 
2.1.3 In vitro maturation of COCs 
The COCs contained in the 35 mm nunc dishes were transferred to new sterile 35 mm 
nunc dishes containing 40 μl micro-drops of serum-free IVM media prepared as shown 
in Table 2.3 and overlaid with 2 ml of mineral oil. The serum-free IVM solution was 
sterilised with a 0.2 μm cellulose acetate syringe filter (Acrodisc, Pall Corporation, 
Portsmouth, UK) and left to equilibrate overnight in a humidified gassed incubator at 
5% CO2 in air at 39°C (New Branswick-Eppendorf, Stevenage, UK). Prior to use, the oil 
was also equilibrated overnight in the gassed incubator at 39°C. Groups of 10 COCs 
were washed twice in separate 40 μl serum-free IVM media drops before being 
transferred in a new culture drop. The plates containing the COCs were then placed in 
the humidified gassed incubator at 39°C for a 24 hour (h) culture. The methodology for 
the IVM of sheep oocytes has previously been extensively validated by Danfour, (2007) 
and Cotterill et al., 2012). 
 
Table 2.3: Serum-free IVM media composition 
Component Stock Vol. Final Conc. 
αMEM base  9.768 ml μg/ml 
Transferin 5 mg/ml 10 μl 5 
Sodium Pyruvate 47 mM 100 μl 0.47 mM 
Sodium Selinite 50 μg/ml 1 μl 5 ng/ml 
L-Glutamine (Gibco) 200 mM 100 μl 3 mM 
Bovine insulin* 10 mg/ml 10 μl 10 ng/ml 
Long-R3 IGF-1 100 μg/ml 1 μl 10 ng/ml 
Ovine FSH (0.91 U/ml) 200 μg/ml 5 μl 100 ng/ml  
Ovine LH (0.55 U/ml) 200 μg/ml 5 μl 100 ng/ml  
Media was made up to a total volume of 10 ml. Extra media was stored at 4° C for 1 week. 
*Bovine insulin stock was diluted 1:1000 in αMEM basic media immediately prior to use. 
 
2.1.4 Isolation of ovine follicles 
Follicles from the primordial to the early antral stages were isolated from ovine ovarian 
cortex using a collagenase and DNase digestion. The collagenase solution was 
56 
 
comprised of 90 ml of Leibovitz L-15 medium, 10 ml of fetal calf serum (FCS, 10% 
v/v) and 100 mg of collagenase (740 U/mg). The solution was then aliquoted in sterile 
universal tubes (BD Plastipak
TM
) each containing 10 ml of collagenase solution and 
stored at -20°C. The DNase was prepared by adding 1 ml of sterile PBS (pH 7.4) into a 
vial of DNase (0.5 mg) and creating aliquots of 42 μl (0.5 mg/ml) in sterile 0.5 
microcentrifuge tubes stored at -20°C. For the isolation experiments, 40 μl of DNase 
was added to the universal containing 10 ml of collagenase solution that was pre-
warmed at 37°C before use in a non-gassed incubator. The protocol for follicle isolation 
has been previously validated (Newton et al., 1999; Huntriss et al., 2002). Ovaries 
contained in the FIM media (Section 2.1.1) were transferred into a sterile glass Petri 
dish (SLS) where they were dissected. All the instruments used for the ovary dissection 
including scalpel blades and forceps were wet sterilised in 70% (v/v) ethanol in sterile-
distilled H2O for a minimum of 15 minutes (min) prior to use. The ovaries were 
originally halved using a scalpel blade and holding the ovary with forceps and the inner 
cortex was then removed so that the outer cortex retained. The same process was 
repeated for 6-8 ovaries and the retained cortex was minced into pieces of around 1-3 
mm in size. The pieces were then added to the 10 ml digestion solution containing the 
collagenase with DNase and the universal was left to agitate gently in a non-gassed 
incubator for 1 h at 39°C. The digestion solution was then removed and the tissue was 
washed twice in ‘stop’ medium containing 9 ml of Leibovitz L-15 media plus 10% v/v 
FCS (1 ml) at 4°C that has been filter sterilised with a 0.2 μm syringe filter and stored at 
-20°C until use. Follicles were isolated under the stereo microscope using 2 size 26 
gauge needles (SLS) attached to 2 ml syringes (SLS). Once isolated, follicles were 
transferred to a clean 35 mm nunc dishes containing 1 ml of cold FIM media (kept at 
4°C) and their diameter was measured using an occular graticule attached to the eye-
piece of an inverted microscope (Olympus Ltd). Follicles were classified according to 
their size and morphology (Huntriss et al., 2002) as follows: Primordial (20-30 μm), 
early primary (30-45 μm), primary (60-90 μm), secondary (100-150 μm), preantral 
(180-200 μm) and early antral (>250 μm). Classified follicles were grouped and 
transferred into separate wells of 4-well nunc dishes containing 500 ml of cold FIM. 
From there, different staged follicles were pooled into groups and transferred in 0.5 
sterile microcentrifuge tubes (Starlab, Milton Keynes, UK) containing lysis buffer 
(Section 2.2.1) and snap-frozen in liquid nitrogen before storage at -80°C, until use for 
molecular analysis as detailed in Chapter 3.  
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2.2 GENERAL MOLECULAR METHODS 
2.2.1 Library construction 
For the molecular work all pipette tips and microcentrifuge tubes were purchased from 
Starlab (Starlab, Milton Keynes, UK). All other reagents used in the experiments were 
purchased from Sigma-Aldrich unless otherwise stated. Libraries were constructed for 
all stages of ovine folliculogenesis (Section 2.1.4) as well as denuded GV and MII 
oocytes, somatic cell types of the ovary and early developmental stages, detailed in 
Chapter 3. In addition, archived ovine cDNA libraries were also obtained from Cotterill, 
(2008). For cDNA library construction, the selected tissue was originally washed twice 
in sterile Dulbecco’s Calcium (Ca2+) and Magnesium (Mg2+)-free PBS (DPBS, 
Invitrogen Ltd) solution and then placed in sterile 0.5 ml microcentrifuge tubes 
containing 10μl of Lysis buffer (Table 2.4). Samples were subsequently snap-frozen in 
liquid nitrogen and stored at -80°C for subsequent molecular analysis.  
 
Table 2.4: Lysis buffer 
Component Volume 
Dynal lysis buffer  (Dynal biotech)* 910 μl 
RNA later (Ambion)* 50 μl 
20% (w/v) Sodium Dodecyl sulphate (SDS) 20 μl 
Ipegal (0.08 mM) 20 μl 
Lysis buffer was made up to a total volume of 1 ml. *Dynal lysis buffer and RNA later were 
purchased from (Invitrogen Ltd).   
 
2.2.2 Isolation of mRNA 
Samples stored in lysis buffer were used for creating cDNA libraries based on 
methodology previously described by Huntriss et al., (2002). Samples were thawed and 
placed on a hot block set at 80°C for 10 min to make sure that lysis of the cells was 
complete. In order to isolate mRNA, the Dynabead mRNA extraction kit (Invitrogen 
Ltd) was used. The dynabeads were washed before use. To do this, 25 μl of Dynabeads 
and 25 μl of lysis buffer were mixed in a sterile 1.5 ml microcentrifuge tube and then 
placed on a magnetic holding apparatus as supplied by Invitrogen Ltd, allowing the 
beads to be attracted towards a magnet that pulls them to the periphery of the tube at the 
side of the magnetic apparatus that allows removal of the excess buffer using a Gilson 
pipette (Gilson Inc, Middleton, USA). A further 25 μl of lysis buffer was then added to 
the tube. All procedures were performed at RT. After removing the samples from the 
hot block and allowing them to cool for 2 min, the mixture of dynabeads in lysis buffer 
(50 μl) was added to the 0.5 microcentrifuge tube containing the tissue sample. The tube 
was then placed on a rotator (Labinco B.V, Bredo, Netherlands) for 30 min. During the 
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30 min incubation, the oligo d-Thymine of the Dynabeads paired with the poly-(A) tail 
of the mRNA. The mRNA was then separated from the cellular components by placing 
the tube in the magnetic apparatus so that the excess liquid could be removed. Samples 
were then washed twice in 40 μl of buffer A and twice in 40 μl of buffer B (Invitrogen 
Ltd) in consecutive steps according to the manufacturer’s recommendations, with the 
excess liquid being removed in each wash on the magnetic apparatus as described 
above. At each buffer step, the beads were thoroughly mixed with the buffers through 
vigorous pipetting avoiding the creation of any bubbles. Finally, following removal of 
the excess buffer the samples were re-suspended in 3 μl of sterile distilled water and 
stored at -80°C until use.  
 
2.2.3 Synthesis of cDNA 
The total mRNA gathered from the samples as detailed above was used for 
complementary DNA (cDNA) synthesis using primers described previously (Eberwine 
et al., 1992) as shown in Table 2.5 (Invitrogen Ltd). For cDNA synthesis the SMART 
system (Switching mechanisms at the 5´ end of RNA transcript) was used (Takara Bio, 
Saint-Germain-en-Lave, France). This technology can produce high-quality full-length 
cDNA libraries from nanograms of total RNA (50 ng). The primers were diluted to a 
concentration of 50 μg/ml. A mastermix was then created containing 1μl of oligo (dT)24, 
1 μl of template switching (TS) primer, 2 μl of 5 X first strand reaction buffer 
(Invitrogen Ltd), 1 μl  Deoxyribnonucleotide triphosphate (dNTP) mix (10mM, Bioline 
Ltd, London, UK), 1 μl diothiothreitol (DTT, 0.1M, Invitrogen Ltd) and 1 μl Superscript 
reverse transcriptase RNase-H  (200 U/μl, Invitrogen Ltd)  for each sample. A 7 μl 
aliquot of the mastermix was then added to each mRNA sample, producing a final 
volume of 10 μl. The sample was then incubated for 2 h at 42°C. 
 
Table 2.5: cDNA primer sequences 
Primer Sequence 
Oligo (dT)24 primer 
5´_AAACGACGGCCAGTGAATTGTAATACGACTCACT
ATAGGGCGCTTTTTTTTTTTTTTTTTTTTTTTT 3´ 
TS primer 5´ AAGCAGTGGTATCAACGCAGAGTACGCGGG 3´ 
 
2.2.4 Long distance PCR of total cDNA 
The 10 μl of cDNA obtained as detailed in Section 2.2.3 was used to create an amplified 
library. In order to perform the reaction, a mastermix was created containing 5 μl of 10 
X Advantage 2 PCR buffer (Takara Bio, Saint-Germain-en-Lave, France), 1 μl of oligo 
(dT)24 primer, 1 μl of TS primer, 1 μl of 50x dNTP mix (10mM), 31 μl of sterile 
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distilled H2O and 1 μl of 50x Advantage 2 Taq Polymerase Mix (Takara Bio) for each 
sample. From the mastermix, 40 μl were added to each of the 10 μl of cDNA and the 
PCR reaction was conducted by the Veriti 96 Well Thermal Cycler (Applied 
Biosystems, Foster City, USA). The program was set as follows: 
 1 cycle: 95°C for 1 min 
 35 cycles: 95°C for 30 sec followed by 65°C for 6 min  
 1 cycle: 72°C for 5 min 
Hold at 4°C 
 
2.2.5 Verification PCR 
The successful construction of each cDNA library was verified using specific 
housekeeping primers with the protocol previously validated by (Huntriss et al., 2002). 
In order to design primers, the sequences of ovine genes of interest were obtained from 
the National Centre for Biotechnology Information (NCBI) website (http://www.ncbi. 
nlm.nih.gov/.).  When the sequence of the gene of interest was not available for the 
sheep, sequences were obtained from species with close homology such as bovine and 
human. The obtained sequences were then inserted into the primer 3 program 
(http://frodo.wi.mit.edu/primer3/) to produce the different sets of primers. Widely 
expressed housekeeping genes with proven stable expression levels in both somatic and 
gametic cells at the relevant stages of follicle/oocyte development were used for the 
experiments detailed in the thesis. These included glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH), a gene involved in almost all cellular procedures with both a 
glyceraldehyde-3-phosphate dehydrogenase activity associated with glycolysis and a 
nitrosylate activity involved with nuclear functions (Ercolani et al., 1988; Barber et al., 
2005; Jeong et al., 2006). Another housekeeper gene used in the experiments was 
histone 2A (H2A), which encodes a conserved nuclear protein that together with other 
histones forms the eukaryotic nucleosome core and has high expression in oocytes 
regulating chromatin formation (Kleinschmidt et al., 1985; Thatcher and Gorovsky, 
1994). The beta actin (ACTB) gene that encodes 1 of the highly conserved actin proteins 
involved in cell motility, structure and integrity and also cytoskeleton formation and 
which is expressed in all eukaryotic cells was also used where appropriate as 
housekeeper, but this gene is known to have less stability during the early stages of 
development (Mamo et al., 2007; Perrin and Ervasti, 2010). Tyrosine 3-monooxygenase 
tryptophan 5-monooxygenase activation protein zeta polypeptide (YWHAZ) gene was 
also used. This is a highly conserved gene across many species encoding a protein 
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involved in signal transduction that binds to phosphoserine containing proteins and the 
gene has a stable expression across folliculogenesis and early embryo development 
(Tommerup and Leffers, 1996a; Mamo et al., 2008). Finally, the ZP2 gene which is 
specifically expressed in oocytes was used as a quality control for the oocyte and 
embryo cDNA libraries to confirm consistent library formation from low cell numbers 
of cells. The ZP2 human primers have been used in previous experiments and their 
expression in ovine samples has been confirmed (Huntriss et al., 2002). All primers 
were diluted to 25 pmol/μl before use. The primer sequences of the housekeeper and 
library verification genes are shown in Table 2.6 
 
Table 2.6: Primer sequences of housekeeper genes used for PCR verification of cDNA library 
generation (F: forward primer, R: reverse primer) 
Gene Primer Sequence Temp (°C) Reference 
GAPDH 
ovine 
F: 5´ GAACCACGAGAAGTATAAACA 3´ 
60 AF030943 
R: 5´ AGGAAATGAGCTTGACAAAG 3´ 
H2A 
ovine 
F: 5´ AGGTATGTCAGGCCGTGGTA 3´ 
60 AY074805 
R: 5´ AGCACAGCCTGGATGTTAGG 3´ 
ACTB 
ovine 
F: 5´ GGGCCAGAAAGACAGCTATG 3´ 
60 NM001009784 
R: 5´ GTGACACCATCCCCTGAATC 3´ 
YWHAZ 
ovine 
F: 5´ AGACGGAAGGTGCTGAGAAA 3´ 
60 NM001267887 
R: 5´ CCGATGTCCACAATGTCAAG 3´ 
ZP2 
human 
F: 5´ AACGTTGTCGTGGATGGCTGT 3´ 
60 
(Huntriss et al., 
2002) R: 5´ GGAGTCATCTGACAACAGGAG 3´ 
 
The controls set-up alongside the test samples included 0.5 μl of sterile-distilled H2O as 
a negative control (NC) and 0.5 μl of a previously verified MII cDNA library containing 
10 oocytes as a positive control (PC). In order to perform the PCR reaction, the 
BIOTAQ polymerase Kit was used (Bioline Ltd). The mastermix contained 1.25 μl of 
PCR buffer, 2 μl of dNTP (1.25 mM), 0.75 μl Mg2+ (50mM), 1 μl forwards specific 
housekeeper PCR primer (25 μM), 1 μl reverse specific housekeeper PCR primer (25 
μM), 5.9 μl H2O for each sample. A 12 μl aliquot of the mastermix was added to each of 
the microcentrifuge tubes containing 0.5 μl of cDNA and the RT-PCR reaction was 
conducted using the Veriti 96 Well Thermal Cycler (Applied Biosystems, Foster City, 
USA). The program was set as follows: 
 1 cycle : 95°C for 5 min 
 35 cycles: 94°C for 30 sec, followed by 60°C for 30 sec, followed by 72°C for 
30 sec 
 1 cycle : 72°C for 5 min 
Hold at 4°C 
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2.2.6 Agarose gel electrophoresis 
Agarose gel electrophoresis was performed immediately after the verification PCRs. 
The agarose gel was prepared by adding 100 ml of 1 X tris-borate 
ethylenediaminetetraacetic acid (TBE) buffer (Appendix II) to 1.5 g molecular grade 
agarose powder (Bioline Ltd) in a glass beaker, resulting in a final concentration of 
1.5% (w/v). The beaker was then heated for 2 min in a 750 V microwave oven until the 
agarose was dissolved and after cooling, 2.5 μl of ethidium bromide (10 mg/ml) was 
added. The gel was then poured into a gel clamp (Bio-Rad laboratories Ltd, 
Hertfordshire, UK) containing a 10, 15 or 20 well comb to allow regular spacing for the 
addition of each test sample when set and the gel was then allowed to settle for 40 min 
at RT. Loading buffer (Appendix II) was added to the samples (in a 1:3 ratio of loading 
buffer to sample) and samples vortexed. When the gel was set, it was placed in a Sub 
Cell GT Tank with Powerpac 300 (Bio-Rad), covered with 1 X TBE and then the comb 
was removed, resulting in spaced wells. The samples were then loaded. For all gels, 8 μl 
of a 100 bp molecular weight (MW) marker (Invitrogen Ltd) was pipetted into the first 
well of the gel. The subsequent samples were loaded separately into consecutive wells 
followed by the positive and negative controls as described in Section 2.2.5. The TBE 
electrophoresis was performed at 100 V for 60 mins at RT. Using a ultraviolet 
transilluminator (Bio-Rad), PCR products were visualised by their molecular weight 
size in the form of bands. Gel images were captured by the Grabber Version 2.0 
software (Nonlinear Dynamics, Newcastle, UK). 
 
2.3 CLONING AND SEQUENCING 
2.3.1 Gel extraction 
In order to obtain the nucleotide sequence of a gene of interest following agarose gel 
electrophoresis for a specific gene, the DNA fragment representing the gene of interest 
as determined by the ultraviolet transilluminator (Bio-Rad), was excised from the gel by 
a scalpel blade. The excised fragment was placed in a sterile 1.5 ml weighed 
microcentrifuge tube and the tube with the fragment was weighed again on a micro-
balance (Melter Toledo Ltd, Leicester, UK) to determine the weight of the gel fragment. 
For the gel extraction procedure, the QIAquick gel extraction kit (Qiagen Ltd, West 
Sussex, UK) was used according to the manufacturer’s recommendations. Accordingly, 
3 gel volumes of QC buffer were added and the sample was incubated at 50°C for 10 
min on a hot block, while flicking the tube with the finger during incubations to allow 
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proper mixing of the buffer with the sample. Thereafter, 1 gel volume of isopropanol 
was added and the sample was pipetted into a QIAquick spin column inserted into a 
sterile 2 ml collection tube as supplied in the kit. The sample was then centrifuged at 
13,000 rpm for 1 min at RT in a Micro centaur centrifuge (MSE/Sanyo, London, UK) 
and the column flow through was then discarded. Thereafter, 0.75 ml of PE buffer 
(provided) was added and the spin column was centrifuged again at 13,000 rpm for 1 
min at RT and the flow through was once again discarded. Another 1 min of 
centrifugation under the same conditions was used to ensure any residual PE buffer was 
removed and the column was then placed into a sterile 1.5 ml microcentrifuge tube. In 
order to elute the DNA, 20 μl of sterile-distilled H2O was added to the centre of the 
QIAquick spin column membrane and; after allowing the sample to stand for 1 min, the 
column was centrifuged at 13,000 rpm for 1 min at RT to elute the DNA in the flow 
through.  
 
2.3.2 Addition of poly-(A) tail 
Polyadenylation of the purified DNA from the gel extraction was undertaken 
immediately after the gel extraction step (Section 2.3.1). Polyadenylation is the addition 
of a poly-(A) tail consisting of multiple AMPs that will assist with the further ligation 
step. In order to add the poly-(A) tail, a mastermix was created containing 1 μl of 10 X 
reaction buffer (Bioline Ltd), 0.4 μl of Mg2+ (50 mM), 1 μl  of adenosine triphosphate 
(dATP, 2 mM), 0.1 μl Taq polymerase (5 U/ml, Bioline Ltd) and 0.5 μl of sterile-
distilled H2O for each sample. From the mastermix, 3 μl was added to 7 μl of the 
purified DNA contained in a sterile 0.5 ml microcentrifuge tube and the reaction tube 
was incubated for 20 min at 72°C on a hot block. Cloning was then performed 
immediately after the addition of the poly-(A) tail. 
 
2.3.3 Cloning into pGEM-Teasy 
The purified DNA with the poly-(A) tail was cloned into a pGEM-Teasy plasmid as 
shown in Figure 2.1 (Promega Ltd, Hampshire, UK). In order to perform this, the 
Promega pGEM-Teasy vector kit was used according to the manufacturer’s 
recommendations. For each sample, 1 μl of pGEM-Teasy vector (50 ng) was added to 1 
μl of T4 ligase (3 U/μl, Invitrogen Ltd), 6 μl of reaction buffer (Invitrogen Ltd) and to 1 
μl of dATP (2 μl).  To this reaction, 5 μl of DNA from Section 2.3.2 was added and the 
total 14 μl contained in the microcentrifuge reaction tube was allowed to ligate on the 
bench top overnight at RT.  
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Figure 2.1: Map of the pGEM-T Easy vector system (Promega, pGEM-T Easy Vector System 
technical manual: http://www.promega.com). 
 
2.3.4 Transformation into Escherichia coli 
Transformation is the genetic alteration of cells resulting from incorporation and 
expression of exogenous genetic material. This process occurs commonly in bacteria 
and the cells that are capable of transformation are called competent cells (Hanahan, 
1983; Inoue et al., 1990). For this process, Escherichia coli competent cells were used 
(TOP10, Invitrogen Ltd). Competent cells were thawed from -80°C and 5 μl of the 
ligated product was added to 50 μl of TOP10 cells in a sterile 0.5 ml microcentrifuge 
tube. The reaction was then placed on ice for 1 h followed by a heat shock at 42°C for 
45 sec on a heat block. The sample was then placed on ice and 450 μl of autoclaved 
Luria broth (LB) media was added comprising: 10 g Tryptone, 5 g Yeast extract and 
10g NaCl in 1L of sterile-distilled H2O which was heated to boiling to dissolve the agar, 
followed by incubation at 37°C for 1.5 h on an orbital shaker. Agar plates were prepared 
in advance by spreading high gel strength 1.5% (w/v) agar (Melford, Suffolk, UK) in 
sterile-distilled H2O containing 100 μg/ml of ampicillin, 40 μg/ml of 5-bromo-4-chloro-
3-indolyl-beta-D-galactopyranoside and 0.1 mM of isopropyl thiogalactoside into 9.5 
cm Petri dishes (SLS). Plates were allowed to set before use. A 100 μl aliquot of the 
cloned product was spread across the agar plate using a sterile polypropylene cell 
spreader (VWR, Lutterworth, UK) and the plate was placed in a non-gassed incubator 
set at 37°C overnight. On the next day, white colonies were removed from the plate 
using a sterile polystyrene loop (VWR) and they were placed in 0.5 ml sterile 
microcentrifuge tubes each containing 15 μl of sterile-distilled H2O. The samples were 
mixed by flicking the tube gently followed by repeat pipetting. From the 15 μl solution, 
12 μl was pipetted into a 10 ml falcon tube that contained 3 ml of LB broth with 3 μl of 
ampicillin (50 μg/ml). The above steps were performed next to a flaming Bunsen burner 
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to avoid contamination. The falcon tube was incubated overnight at 37°C in the 
humidified gassed incubator. The remaining 3 μl of product was used to perform 
verification PCR (Section 2.2.5) followed by agarose gel electrophoresis (Section 2.2.6) 
to confirm the presence of the gene of interest.  
 
2.3.5 Plasmid purification 
The Qiagen miniprep plasmid purification kit (Qiagen Ltd) was used to purify the 
plasmid DNA. Initially 1.5 ml sample of transformed plasmid was pipetted into a 1.5 ml 
sterile microcentrifuge tube and the sample was centrifuged for 5 min at 13.000 rpm in a 
bench top centrifuge at RT. The supernatant was removed by pipetting and another 1.5 
ml of the sample was added into the same tube followed by further centrifuging for 5 
min at 13.000 rpm at RT. At the end of centrifuging, the supernatant was once again 
removed and the pellet was resuspended in 250 μl of P1 buffer according to the 
manufacturer’s recommendations. Next, 250 μl of P2 buffer was added and mixed 
thoroughly by vortexing and immediately after, 350 μl of N3 buffer was added and 
immediately mixed. The sample was then centrifuged for 10 min at 13.000 rpm at RT 
on a bench top centrifuge. The supernatant was then added to a Qiagen spin column 
inserted in a 1.5 ml sterile microcentrifuge tube and centrifuged for 1 min at 13.000 rpm 
at RT. The supernatant was removed and 0.75 ml of PB buffer was added to the column 
followed by centrifugation for an additional 1 min. The flow through was removed and 
an additional 1 min centrifugation was performed to remove any residual ethanol 
contained in the buffer. The spin column was then placed into a 0.5 ml sterile 
microcentrifuge tube and in order to elute the DNA, 50 μl of sterile-distilled H2O was 
added to the centre of the spin column membrane. The sample was allowed to stand for 
1 min before centrifugation at 13.000 rpm for 1 min at RT to elute the DNA in the flow 
through. The cDNA sample was stored at -20°C until further analysis. 
 
2.3.6 Sequence analysis 
The concentration of the sample as provided from the previous step was measured and 
recorded using a Nanodrop ND 1000 spectrophotometer (Thermo-Scientific, 
Wilmington, USA). The sample was diluted to 50 ng/ml in sterile-distilled H2O and 10 
μl was used for sequence analysis. If the concentration of the sample was less than 50 
ng/ml, an additional PCR reaction was performed to increase the concentration. This 
PCR was based on amplification with M13 primers because of the pGEM-Teasy 
Vector’s M13 binding sites (pGEM-Teasy Vector Map and Sequence Reference Points, 
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Promega). The PCR program followed was the same as the verification PCR (Section 
2.2.5) with the annealing temperature set at 48°C. Following PCR, the sample was 
diluted to a concentration of 50 ng/ml. Sequencing was performed using the ABI prism 
sequencer (DNA sequencing services, Dundee, UK). 
 
2.4 REAL-TIME PCR ANALYSIS 
Real-time PCR (qRT-PCR) can result in a simultaneous quantitative gene expression for 
a few genes in many different samples and can be performed on samples containing 
only few cells (Heid et al., 1996). This method has dramatically improved studies 
requiring quantitative gene expression because of its speed, ease of use, high sensitivity, 
reproducibility and lack of radioactive materials (Radonic et al., 2004). The results of 
real-time PCR depend on the successful application of mRNA isolation, cDNA 
synthesis and the use of appropriate controls is necessary for the final analysis (Gal et 
al., 2006). Real-time analysis in this thesis was performed on the basis of relative 
quantification of the amount of mRNA in each sample. To facilitate comparisons across 
different tissue types and between treatments it was necessary to normalise the 
transcript levels against the transcript levels measured for the relevant housekeeper 
genes. The use of valid reference genes for normalisation is important in order to both 
interpret the real-time PCR results accurately and to understand the biological dynamics 
of events of oocyte and embryo development (Mamo et al., 2007). Different studies 
have compared a wide range of the most commonly used housekeeping genes in order 
to determine which housekeepers are more stable for normalisation of gene expression 
data in the early developmental stages (Gal et al., 2006; Jeong et al., 2006; Mamo et al., 
2007). Out of the different commonly used housekeeping genes, H2A has been shown to 
be 1 of the most stable gene tested in mouse oocytes and preimplantation staged 
embryos produced both in vivo and in vitro (Jeong et al., 2005). Recently a set of 
guidelines that propose a minimum standard for real-time PCR experiments has been 
established (Bustin, 2010). According to the minimum information for publication of 
qRT-PCR experiments (MIQE) guidelines, the utility of the housekeeper used for 
normalisation must be validated experimentally for particular tissues or cell and unless 
fully validated, normalisation should be performed against multiple reference genes, 
chosen from a sufficient number of candidates (Bustin et al., 2010). In the experimental 
series of this thesis, normalisation of gene expression was performed against 2 
housekeepers, H2A which has been validated in the oocyte  (Mamo et al., 2007) as well 
as GAPDH which has also been validated and previously used for normalisation of gene 
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expression in ovine oocytes (Cotterill et al., 2012). For the experiments, SYBR green 
technology (Applied biosystems) was used to quantify the total amount of each 
transcript. Different primers were designed using the primer 3 programme as described 
previously (Section 2.2.5) and the parameters of the primer design product size of 
~100bp, avoidance of the guanine-cytosine clamp at the 3´ (not more than 2 guanine or 
cytosine residues in the last 5 bases) and avoidance of base repeats. Primer specificity 
for each of the genes of interest used in the thesis was tested by verification PCR 
(Appendix III) and by generating dissociation curves following real-time PCR analysis 
on groups of ten oocytes for oocyte expressed genes or groups of 2 cultured cumulus 
shells for cumulus expressed genes. The primer information and sequences of 
housekeepers used for real-time PCR are shown in Table 2.7. 
 
Table 2.7: Primer sequences of housekeeper genes used for real-time PCR 
Gene Primer Sequence Size (bp) Reference 
GAPDH 
ovine 
F: 5´ TGATTCCACCCATGGCAAGT 3´ 
93 AF030943 
R: 5´ CGCTCCTGGAAGATGGTGAT 3´ 
H2A 
ovine 
F: 5´ GAGTAGGCGGCTGGTTCTC 3´ 
109 AY074805 
R: 5´ GGAGTCCTTCCCAGCCTTAC 3´ 
 
Forward and reverse primers were mixed with sterile-distilled H2O to a concentration of 
10 μM. The mastermix for the reaction was then set-up in a 1.5 ml sterile 
microcentrifuge tube with the addition of 12.5 μl of SYBR green master mix (Applied 
Biosystems), 1.25 μl specific primer set (500 pM) and 10.25 μl of sterile-distilled H2O. 
Different mastermixes were created for different genes and housekeepers. Out of the 
mastermix, 24 μl were added to 1 μl of each test sample. Test samples were evaluated in 
triplicates to minimise pipetting errors and increase stability of the results. In addition, 3 
negative controls were also set-up for each real-time PCR reaction to make sure that 
there was no contamination in the reaction reagents. In order to avoid non-specific 
amplification, dissociation curves were run with each real-time PCR experiment. This 
was achieved by progressively heating and cooling the real-time PCR products and by 
this way SYBR green was released as shown in Figure 2.2 (Ririe et al., 1997). The 
release of SYBR green resulted in the creation of either single peaks which resembled 
high specificity for the target gene, or multiple peaks that represented low specificity. 
Using this approach, only primers with a high specificity for the target gene were 
selected.  
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In order to obtain accurate relative quantification of an mRNA target, the expression 
levels of 2 endogenous control housekeepers were also obtain in at least 3 repeats along 
with the expression levels of the mRNA target in triplicates. The measurements from 
different repeats were averaged for both the gene of interest and the 2 housekeepers and 
the average concentration of the sample’s gene of interest was divided by the 
endogenous control concentration in order to normalise the data. The endogenous 
control concentration was defined as the average of the 2 housekeeper concentrations as 
defined by the number of repeats. The endogenous controls were therefore used as 
active reference in order to quantify target differences in the amount of total nucleic 
acid in each reaction. In this way, the differences in the expression levels of multiple 
genes between the different experimental samples and control samples were calculated. 
 
 
 
Figure 2.2: Image of a representative dissociation curve following real-time PCR. The 
dissociation curve was generated in triplicates using a cDNA library of 10 oocytes and GAPDH 
primers indicating high specificity for the target gene following real-time PCR. Each of the lines 
represents the absorbance value at a given temperature.  
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2.5 WESTERN BLOTTING 
Western blotting is an analytical technique employed to study the protein expression of 
samples of tissue that are either extracted or homogenised (Towbin et al., 1979). The 
technique is based on the electrophoretic separation of denatured proteins with the 
degree of separation being determined by the protein size. The separated proteins are 
then transferred onto a nitrocellulose membrane where a target protein can be stained 
with an antibody specific to that protein (Renart et al., 1979; Towbin et al., 1979).  
 
2.5.1 Tissue preparation 
For the series of experiments described in Chapter 3, gametes, gonadal tissue and 
somatic tissue was used for Western blotting analysis. Sample pieces of ovine ovary and 
bovine testis tissue were collected under sterile conditions into 1.5 ml sterile 
microcentrifuge tubes and snap-frozen in liquid nitrogen and then stored at -80°C until 
use. Similarly, ovine kidney and lung pieces were also stored.  For Western analysis, 
tissue was processed and lysed in lysis buffer made up in a final volume of 50 ml in 
sterile-distilled H2O. The lysis buffer was made up with 100 mM of potassium acetate 
(KOAc, 1 ml), 0.1% (v/v) Triton X-100 (50μl), 1 M Hepes (pH 7.4, 2.5 ml), 2 mM 
magnesium acetate (MgOAc, 0.5 ml), 10% (v/v) Glycerol and 1 tablet of Proteinase 
inhibitor (Roche, Sussex, UK). Originally 1 small piece of tissue of approximately 0.2 
cm
3
 was transferred into a porcelain pestle and mortar (SLS) that has been previously 
cleaned with 70% (v/v) ethanol in Milli-Q H2O (Millipore Ltd, Watford, UK) followed 
by a wash with Milli-Q H2O. The sample was then added to the clean pestle and mortar 
and submerged in liquid nitrogen. The sample was then ground to a fine powder until 
the liquid nitrogen evaporated. In case the tissue had not been completely processed, 
more liquid nitrogen was added. The pestle was then allowed to cool a little before 1 ml 
of lysis buffer was added. The powdered tissue was at that point mixed with the 1 ml of 
lysis buffer allowing the ground tissue to lyse and the lysate was collected up into a 1.5 
ml sterile microcentrifuge tube. All the samples were prepared in a similar way and kept 
on ice. The samples were then centrifuged at 13,000 rpm for 20 min at 4°C and the 
supernatant was retained and filtered with a 0.2 μm cellulose acetate syringe filter into a 
new 0.5 ml sterile microcentrifuge tube. Protein concentration was determined using the 
Nanodrop ND 1000 spectrophotometer. Samples were kept at -20°C until use.  
 
Oocyte samples were prepared in a different way. Specifically, following collection of 
intact COCs, GV denuded oocytes were harvested (Section 2.1.2). Following IVM 
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(Section 2.1.3), denuded MII oocytes were also collected. Both GV and MII oocytes 
were removed from the COC environment by denudation. This process involved using a 
flexi-pet (Cook Medical, Brisbane, Australia) attached to a 170 μm pipette tip (Cook 
Medical) followed by gentle repeat pipetting in order to separate the oocytes from the 
majority of the surrounding cumulus cells. In order to remove all the cumulus cells, the 
pipette tip of the flexi-pet was changed to 140 μm diameter pipette tip followed by 
further gentle repeat pipetting.  Denudation was performed in 4 well nunc dishes with 
10 oocytes/well contained in 400 μl of oocyte holding media  H199+ (Section 2.2.1). 
Oocytes were denuded before being transferred and washed twice in fresh wells 
containing 400 μl of DPBS (Invitrogen Ltd). From there, each group of oocytes was 
transferred in the minimum volume into a 0.5 ml sterile microcentrifuge tubes 
containing 10 μl of lysis buffer (Section 2.2.1) and the samples were immediately snap-
frozen by submerging the tube in liquid nitrogen. When all the samples were collected, 
protein concentration was determined using the Nanodrop ND 1000 spectrophotometer 
and samples were transferred to a -80°C freezer until further analysis.  
 
2.5.2 Sodium Dodecyl Sulfate-Polyacrylamide gel electrophoresis 
The method of Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-
PAGE) is a widely used biochemical method and proteins can be successfully 
fractioned using this method (Laemmli, 1970). The SDS itself is an anionic detergent 
that linearises proteins and conveys them a negative charge and with electrophoresis 
proteins are fractioned according to their approximate size (Shapiro et al., 1967; 
Laemmli, 1970). For the SDS-PAGE, the Mini-Protean Tetra Electrophoresis System 
(Bio-Rad Ltd) was used that contained combs, plates and casting accessories for 10-
well, 0.75 and 1 mm thick gels. Before setting up the gel, all glass casting plates were 
washed twice with 70% (v/v) ethanol in Milli-Q H2O and then dried with a soft tissue. 
The casting plates were then washed with Milli-Q H2O and dried with a soft tissue 
before being assembled into the gel clamp. Clamps were pressed together slowly and 
simultaneously to ensure even pressure was applied in order to prevent leaks. The 
clamps were then secured in the rack. A 10% (w/v) lower resolving gel was then 
prepared by adding 2.5 ml of sterile-distilled H2O, 1.25 ml stacking gel buffer (18.15 g 
Tris buffer in 100 ml of sterile-distilled H2O at a pH of 8.8), 0.52 ml 40% (w/v) 
acrylamide mix in sterile-distilled H2O, 25 μl 20% w/v SDS in sterile-distilled H2O, 100 
μl ammonium persulfate stock (APS, 0.1g APS in 1 ml of sterile-distilled H2O) and 10 
μl TEMED (Appendix II). Both APS and TEMED were added quickly and around 3.5 
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ml of the 10% resolving gel were quickly dispensed into the casting cassette. 
Immediately after dispensing the resolving gel, Milli-Q H2O was layered on top of the 
gel up to the top of the cassette to ensure that the gel set evenly. Water was dispensed 
slowly to avoid disturbing the gel. The gel was then left to set for at least 15 min. 
Thereafter, the water was removed by placing tissue paper in the top corner and tipping 
the casting tray up until all of the water has been drawn up by the tissue paper. A 4% 
(w/v) stacking gel was then made up by adding 3.2 ml of sterile-distilled H2O, 1.25 ml 
stacking gel buffer (6.05 g Tris buffer in 100 ml of sterile-distilled H2O at a pH of 6.8), 
0.52 ml 40% (w/v) acrylamide mix in sterile-distilled H2O, 25 μl 20% (w/v) SDS in 
sterile-distilled H2O, 100 μl APS and 10μl TEMED. Again APS and TEMED were 
added quickly and around 2 ml of the stacking gel were dispensed quickly on top of the 
resolving gel until the gel reached near the top of the glass plate. The comb was then 
carefully inserted and the gel was left to set for at least 30 min.  
 
At this point, the samples (Section 2.5.1) were prepared. Sample pieces of ovine cortex, 
bovine testis as well as non gonadal somatic tissue were diluted in a ratio of 1:1 with 2 
X SDS buffer and 40 μg of crude samples was used for loading. Oocyte samples were 
also diluted in a ratio of 1:1 with 2 X SDS buffer and the total 20 μl of each oocyte 
sample was used for loading. The 2 X SDS buffer was prepared by adding 5 ml of 
Stacking Gel buffer, 2 ml of 10% (w/v) SDS in sterile-distilled H2O, 1 ml of 0.1% (v/v) 
bromophenol blue in sterile-distilled H2O, 5 ml of 60% (v/v) glycerol in sterile distilled 
H2O, 1 ml β-mercaptoethanol and 6 ml of sterile-distilled H2O (Appendix II). If samples 
required further dilutions based on the intensity of the signal the antibodies produced, 
1:5 dilutions were created by adding 6 μl of sample to 9 μl of sterile-distilled H2O and 
15 μl of 2 X SDS buffer. Further dilutions where then made by diluting this stock. The 
samples were denatured by warming a glass beaker to boiling point and placing the 
samples in a foam rack so that the sample itself was in direct contact with the boiling 
water and the samples were boiled for 7 min.  
  
For the electrophoresis, 4 X running buffer was prepared by adding 57.6 g of glycine to 
12 g of Tris and 10 ml of 20% (w/v) SDS in Milli-Q H2O in 1 L of Milli-Q H2O at a pH 
of 8.3. From this stock, a 1 X running buffer was made fresh each time by mixing 250 
ml of running buffer with 750 ml of Milli-Q H2O. The SDS-PAGE gel that was 
prepared as described above was placed into a clamp and the clamp was inserted into 
the tank. The inner tank containing the clamp and the gel was filled with 1 X running 
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buffer and was left for 2 min to confirm that there were no leaks. If leaks were detected, 
the gel was re-clamped and the same process was repeated. The comb was then 
removed allowing the 1 X running buffer to insert into the wells and any excess 
acrylamide within the wells was removed using a long thin pipette tip by gentle 
pipetting the 1 X running buffer within the wells.  The outer tank was also filled with 
the remaining 1 X running buffer. The samples were then loaded into the wells. In the 
first well, 5 μl of precision plus protein standards (Bio-Rad) was used as a marker. The 
rest of the test samples were then loaded (20 μl) into the subsequent wells. 
Electrophoresis was conducted with a PowerPac basic power supply (Bio-Rad) set on 
160 V for 70 min at RT or until the coloured dye in the sample loading buffer began to 
elute from the bottom of the gel. 
 
At this stage, to test the efficiency of the electrophoresis on the samples, the separated 
protein bands in the polyacrylamide gel were visualised using an EZ blue Gel staining 
reagent (Diezel et al., 1972). In order to perform this, a probe fixation buffer was 
prepared by adding 50% (v/v) Methanol (50 ml) and 10% (v/v) Acetic acid (10 ml) in 
Milli-Q H2O (40 ml). Following electrophoresis, the gel was placed in a plastic tray 
with fixation buffer and left to agitate for 15 min at RT followed by 3 washes in Milli-Q 
H2O. The ready to use EZ blue Gel staining reagent (Sigma-Aldrich) was then added to 
the plastic tray (10 ml) and left to agitate for 1 h at RT. The staining reagent was then 
poured off and following 2 washes with Milli-Q H2O the separated proteins were 
stained blue and could be visualised on the gel.  
 
2.5.3 Protein transfer 
Transfer was conducted immediately after electrophoresis. This step is required to make 
the separated proteins accessible to antibody selection and it incorporates moving them 
from within the gel onto a membrane that can be either nitrocellulose or a 
polyvinylidene fluoride (PVDF) (Matsudaira, 1987). For this step the mini trans-blot 
cell was used (Bio-Rad). A 4 X transfer buffer was prepared by adding 12 g of Tris and 
57.6 g glycine making it up to 1 L with Milli-Q H2O. From this stock, the 1 X transfer 
buffer was made by adding 250 ml of 4 X transfer buffer to 200 ml of methanol and 
making it up to 1 L with Milli-Q H2O. Following electrophoresis the gel was removed 
from the clamp and the gel situated in between the spacer glass plate and the shorter 
plate was placed into a plastic tray containing Milli-Q H2O. The gel was then carefully 
removed from the glass plates and washed once with Milli-Q H2O. The gel was then 
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equilibrated through 2 10 min washes of 10 ml in 1 X transfer buffer on a shaking 
platform. For all experiments in this thesis the Immobilon PVDF membrane was used 
(Sigma-Aldrich). Originally, a piece of membrane covering the surface of the gel itself 
was wetted in 100% methanol for 30 sec followed by a rinse with Milli-Q H2O and 
equilibration with 2 X transfer buffer for 10 min on a shaker with agitation. Following 
the washes, the transfer clamp was opened and the black mesh was placed on each side 
of the clamp. Whatman filter papers were cut to the size of the gel and 3 of those papers 
were wetted with 1 X transfer buffer and placed on each side on top of the mesh. The 
gel was then placed on top of the Whatman paper on the black side of the transfer clamp 
making sure that no air bubbles were trapped beneath the gel. The gel was thereafter 
covered with the membrane and the transfer clamp was closed securing the gel with the 
membrane in between the Whatman papers. The transfer clamp was then placed inside 
the transfer tank. An icepack was then added into the tank and the tank was filled with 1 
X transfer buffer. Transfer took place for 60 min at 4°C set at 400 A on a PowerPac 
basic power supply.  
 
2.5.4 Blocking and Detection 
To avoid non-specific binding between the membrane and the antibody, the membrane 
was blocked in blocking buffer solution containing 1.5 g of non-fat dry milk powder 
and 50 μl of Tween-20 in 50 ml of 1% (v/v) PBS in Milli-Q H2O. Before this step took 
place, originally the membrane was removed from the transfer clamp and rinsed 3 times 
in a plastic tray containing 15 ml of 1% (v/v) PBS in Milli-Q H2O with 0.1% (v/v) 
Tween-20. Thereafter, 15 ml of the blocking buffer were added in the plastic tray and 
placed on a shaker for 1 h to block at RT. The membrane was then ready to be probed 
for the protein of interest using an appropriate primary antibody linked to a reporter 
enzyme that produces a colour when the enzyme is exposed to an appropriate substrate. 
This was performed with a 2-step process that was comprised of incubation with a 
primary and a secondary antibody. Initially, the blocking buffer was poured off and 
replaced with 15 ml of non-fat dry milk powder dissolved in 1% (v/v) PBS in Milli-Q 
H2O containing the appropriate primary antibody diluted to the manufacturer’s 
recommended concentration. The blot was then left to agitate in the solution overnight 
in a cold room at 4°C. The following day, the primary antibody was poured off the 
plastic tray and 3 subsequent washes of 15 ml in 1% (v/v) PBS in Milli-Q H2O with 
0.1% (v/v) Tween-20 in order to remove any unbound primary antibody were 
performed. This was followed by incubation with a secondary antibody that was 
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directed at a species specific region of the primary antibody and is usually linked to a 
reporter enzyme. The secondary antibody was reconstituted according to the 
manufacturer’s recommended concentration in 15 ml of non-fat dry milk powder 
dissolved in 1% (v/v) PBS in Milli-Q H2O. Following the washes, the reconstituted 
secondary antibody was added in the tray and placed on a shaker for 1 h at RT. 
Detection was performed with the Lumingen TMA6 kit (Amersham Biosciences, Little 
Chalfont, UK) according to the manufacturer’s recommendations. The Kit provides a 
substrate for chemiluminescent detection of peroxidise conjugates on the transfer 
membranes.  For the reaction, 1.5 ml of Solution A was added to 1.5 ml of Solution B 
and the mixture was added directly on top of the blot and left to agitate for 5 min at RT 
in day light. The blot was then removed from the detection solution and wrapped in 
cling film. Detection was then performed by a charged coupled device camera on a 
LAS-3000 imaging system attached to the Image Reader LAS-3000 computer software 
(Fujifilm UK Limited, Bedford, UK). Following detection the blot was wrapped in cling 
film to retain hydration and kept at 4°C for re-probing if required. 
 
2.6 GENERAL HISTOLOGY METHODS 
2.6.1 Fluorescence in situ hybridisation 
The fluorescence in situ hybridisation (FISH) technology uses a labelled 
complementary DNA or RNA strand (probe) in order to localise a specific DNA or 
RNA sequence in the tissue (Femino et al., 1998; Levsky and Singer, 2003). In order to 
perform this method successfully, ribonucleases (RNases) that catalyse the degradation 
of RNA must not come in contact with the tissue at any point (Nicholson, 1996). This 
was achieved by using sterile technique in conjunction with washing of all tissue and 
equipment with diethylpyrocarbonate (DEPC) treated H2O that inactivates the RNase 
enzymes in H2O and all other utensils. To prepare this product, 0.1% (v/v) DEPC was 
added to Milli-Q H2O followed by autoclaving (in order to hydrolyse it) before tissue 
collection. Using the same approach, PBS was made up by adding 2 tablets of PBS 
(Invitrogen Ltd) in 1 L of 0.1% (v/v) DEPC treated H2O followed by autoclaving. 
Before usage, all instruments were washed in 0.1 N NaOH (4g of NaOH in 1 L of 0.1% 
(v/v) DEPC treated H2O) for 2 h before being rinsed with 1% (v/v) DEPC treated H2O. 
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2.6.2 Tissue collection and processing 
Ovine tissue was collected as described previously (Section 2.1). Individual ovine 
ovaries were removed from FIM and transferred to an autoclaved 90 mm glass Petri 
dish (SLS) that was previously washed in 0.1 N NaOH for 2 h and rinsed with 0.1% 
(v/v) DEPC treated H2O. The ovaries were then cut into half using sterile scalpel blades. 
With the help of the scalpel blade, the stroma of the ovary was removed and the cortex 
was placed in 4% (w/v) paraformaldehyde (PFA) was added in 0.1% (v/v) DEPC 
treated PBS (2 g of paraformaldehyde powder in 50 ml of PBS in 0.1% (v/v) DEPC 
treated H2O). The PFA was prepared fresh on the day of use and was filter sterilised 
before use with a 0.2 μm syringe filter. Following 2 consecutive washes in different 100 
ml sterile glass beakers containing 50 ml of 4% (w/v) PFA in each, ovaries were 
transferred in a new 100 ml sterile glass beaker containing 50 ml of 4% (w/v) PFA and 
left overnight on the bench at RT. Approximately 6-8 ovary pieces were fixed each 
time. The volume of the fixative was always set to be at least 12 times that of the tissue 
volume and was adjusted accordingly if more tissue was used. The day after, PFA was 
replaced with 70% (v/v) ethanol in 0.1% (v/v) DEPC treated H2O and incubated for 2 h 
at RT. Finally, the tissue was washed twice with fresh 70% (v/v) ethanol in 0.1% DEPC 
treated H2O and stored at RT for no more than 3 months until embedding in wax. 
 
2.6.3 Tissue embedding 
After the tissue was fixed it was embedded according to the method previously 
described by Chambers et al., (2010). The tissue was manually embedded in paraffin 
wax (VWR). Pieces of tissue were placed in Histosette® II embedding cassettes 
(Simport, Beloeil, Canada) and the cassettes were placed in a 250 ml glass beaker 
containing 150 ml of 90% ethanol in 0.1% (v/v) DEPC treated H2O. If more cassettes 
were used, the volume of ethanol added was increased accordingly in order for the 
cassettes with tissue to be fully covered with ethanol. The beaker containing the 
cassettes was placed in a shaking hybridisation oven/shaker (Hybaid, SLS) at RT and 
left to agitate gently for 1 h. The 90% ethanol in 0.1% (v/v) DEPC treated H2O was then 
replaced with 100% ethanol and incubated at RT with agitation for a further 1 h. The 
ethanol was replaced with fresh 100% ethanol for a further hour under the same 
conditions. The ethanol was then replaced with 100% Histological clearing agent 
(Histo-clear, National diagnostics, North Humberside, UK) and the tissue was left to 
agitate for 1 h at RT. The histo-clear was then replaced with fresh reagent and the 
temperature of the hybridisation oven/shaker was set to 60°C with the samples agitating 
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for 30 min. At the same time a sterile glass beaker was filled with pellets of paraffin 
wax and the wax was left to melt on a hot plate (VWR) set at 100°C. When the wax was 
completely melted, the beaker was transferred to the shaking hybridisation oven/shaker 
at 60°C. To avoid damaging the tissue, a thermometer was used throughout all the steps 
that followed, to make sure that temperature of the wax did not exceed 60°C. After the 
cassettes had been washed for 30 min with histo-clear, wax was added to the histo-clear 
to an approximate ratio of 75% histo-clear to 25% wax, and the samples were left to 
agitate in the hybridisation oven/shaker at 60°C for 1 h. More molten wax was then 
added to the beaker with the cassettes resulting in a volume of 50% histo-clear to 50% 
wax and the samples were left to agitate at 60°C for an additional hour. At the end of 
the incubation time, more wax was added resulting in a volume of 75% wax to 25% 
histo-clear and the cassettes with the tissue were incubated with agitation at 60°C for 
another hour. Finally, all the wax and histo-clear was removed and replaced with fresh 
molten wax. The samples were then left agitating at 60°C overnight. The next day, the 
molten wax was replaced and left for 2 h under the same conditions. The ovary pieces 
were then transferred out of the cassettes with the help of forceps washed in 0.1% (v/v) 
DEPC treated H2O and each piece was transferred in stainless steel base molds (VWR) 
and blocked in wax. Blocks were left to solidify at RT and were then kept at -20°C until 
sectioning. Blocks were cut into 5 μm thin sections with a microtome (Thermo Fisher 
Scientific, Hempstead, UK). The cut sections were transferred on a mounting bath 
(Keison, Essex, UK) set at 37°C containing 0.1% (v/v) DEPC treated H2O  and from 
there they were placed on Superfrost plus glass slides (Thermo Fisher Scientific) until 
analysis. 
 
2.6.4 Template preparation 
The DNA template required for the FISH experiments was obtained following the 
cloning procedure as described in Section 2.3. Specifically, a PCR was run using 
primers for the gene of interest on an ovine MII cDNA library, the DNA fragment 
representing the length of the gene of interest was excised from the Agarose gel and the 
cloning processes were then applied. Sequencing that followed verified the specificity 
for the gene of interest. For FISH analysis, the FISH Tag RNA green Kit (Invitrogen 
Ltd) was used. This system is based on traditional in vitro transcription using a 2-step 
labelling approach in order to provide improved dye incorporation (Cox and Singer, 
2004). The first step employs incorporation of an amine-modified nucleotide into the 
probe template, whilst in the second step, incubation with the amine-reactive dyes 
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results in dye labelling of the purified amine-modified RNA-incorporation (Cox and 
Singer, 2004). For the experiment, initially in vitro transcription was performed to a 
final volume of 20 μl according to the manufacturer’s recommendations and 2 reactions 
were set up using different RNA polymerases T7 and SP6 that have opposite 
orientations. The RNA can be selectively synthesized from either strand of the DNA 
with the different polymerases (Figure 2.3). The use of the 2 different RNA 
polymerases for the synthesis of the amine-modified RNA in separate reactions, results 
in the generation of an anti-sense RNA probe and a sense RNA probe. The anti-sense 
RNA probe with complementary sequence to the target hybridises in situ to the 
specimen, while the sense RNA probe with identical sequence to the target does not 
hybridise and therefore serves as a negative control. 
 
 
Figure 2.3: Schematic representation of the plasmid construct for in vitro transcription using 
the FISH Tag kit. The DNA insert for the gene of interest is contained between different RNA 
promoter sequences (T7 and SP6) on opposite strands and ends of the vector. Based on the 
orientation of the DNA insert, T7 and SP6 polymerases create an antisense RNA probe 
complementary to the target that results in hybridisation and a sense RNA that does not result in 
hybridisation. One example is shown. Image from: www.invitrogen.com. 
 
2.6.5 Synthesis and labelling of amine-modified RNA 
The procedures were conducted accordingly to the manufacturer’s recommendations for 
the FISH Tag RNA green Kit (Invitrogen Ltd). The first step employed incorporation of 
an amine-modified nucleotide into the probe template, whilst in the second step, 
incubation with the amine-reactive dyes resulted in dye labelling of the purified amine-
modified RNA incorporation (Cox and Singer, 2004). For the experiment, in vitro 
transcription was performed to a final volume of 20 μl according to the manufacturer’s 
recommendations and 2 reactions were set up using different RNA polymerases T7 and 
SP6. The reactions were set up in sterile 0.5 ml microcentrifuge tubes as follows: 4 μl of 
5 X transcription buffer (either T7 or SP6), 2 μl of 10 X RNA nucleotide mix, 1 μg of 
DNA template (Section 2.6.4), 1 μl of RNase-OUT inhibitor and 1 μl of RNA 
polymerase (T7 or SP6). 1 μl of 0.1 M DTT was added for the reaction using T7 RNA 
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polymerase, while 2 μl of 0.01 M DTT was added for the reaction using SP6 RNA 
polymerase. The nuclease-free H2O provided in the kit was added to a final volume of 
20 μl. The transcription reaction was then mixed gently by pipetting the mixture and it 
was incubated at 37°C for 1 h on a hot block. Thereafter, 1 μl of DNase I was added and 
mixed gently by pipetting and the reaction was incubated at 37°C for 15 min. Next, 79 
μl nuclease-free H2O provided in the kit was added to the sample and the reaction was 
vortexed for 10 sec in order to inactivate the DNAse I.  
 
After in vitro transcription, the amine-modified RNA was purified. For this, 400 μl of 
binding buffer with isopropanol provided in the kit was added to the reaction 
microcentrifuge tube and mixed. The entire volume contained in the reaction tube was 
then pipetted into a spin column contained inside a sterile 2 ml collection tube. The 
column was centrifuged at 13,000 rpm for 1 min with the RNA binding to the column. 
The flow-through was then discarded and the column was washed with 650 μl wash 
buffer containing ethanol as recommended by the manufacturer’s recommendations. 
The column was then centrifuged at 13,000 rpm for 1 min and the flow through was 
discarded. An additional centrifugation was then performed under the same conditions 
to remove any residual wash buffer. A sterile 1.5 ml microcentrifuge collection tube 
was added to the spin column and 55 μl of nuclease-free H2O was supplied in the kit 
was applied to the centre of the column. The column was allowed to stand at RT for 1 
min followed by centrifugation at 13,000 rpm for 1 min. The purified amine-modified 
RNA contained in the collection tube was then precipitated. This was performed by 
adding 10 μl of 3M sodium acetate (pH 5.2), 1 μl glycogen and 39 μl nuclease-free H2O 
as supplied in the kit. From there, 300 μl of 100% ethanol was added and the sample 
was stored at -80°C for 30 min. The sample was subsequently centrifuged at 13,000 rpm 
for 10 min and the supernatant was removed without disturbing the pellet. The pellet 
was rinsed with 400 μl of 70% (v/v) ethanol in 0.1% (v/v) DEPC treated H2O, followed 
by removal of the supernatant with a second repetition of this rinse step. Using a pipette 
the residual ethanol was removed without disturbing the pellet and the sample was 
allowed to air-dry. Then 5 μl of nuclease-free H2O was added to the pellet and the 
sample was incubated at 37°C for 5 min. The sample was then vortexed to fully 
resuspend the RNA. The template was then ready to proceed immediately to the 
fluorescent dye labelling step. 
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To add a fluorescent label to the amine-modified RNA it was denatured by incubation at 
65°C for 5 min. The sample was then placed on ice for 3 min and centrifuged at 13,000 
rpm for 3 min. Next, 3 μl of sodium bicarbonate sodium as supplied in the kit was 
added to the sample. The reactive dye provided in a 1.5 ml microcentrifuge tube was 
resuspended in 2 μl DMSO and vortexing was performed to fully resuspend the dye. 
The 2 μl of the reactive dye in DMSO was then added to the RNA sample at RT and 
vortexed at maximum speed for 15 sec. The labelling reaction was then wrapped in foil 
and incubated in the dark for 1 h at RT. Thereafter, 90 μl of nuclease-free H2O was 
added to the sample and the fluorescent dye-labelled RNA was purified and precipitated 
as described in the above paragraph. Following air-drying of the pellet, 40 μl of 
nuclease-free H2O was added to the pellet followed by incubation at 37°C for 5 min. 
The sample was then vortexed to fully resuspend the dye-labelled RNA and it was 
stored at -80°C by wrapping in foil to protect it from light. The labelled amine-modified 
RNA with fluorescent dye was used within 2 weeks of preparation.  
 
2.6.7 FISH protocol 
For FISH, the selected slides were placed in a stainless steel slide rack (Thermo Fisher 
Scientific) and were de-waxed and re-hydrated by immersing the slide rack in 300 ml of 
reagents in different glass staining dishes (Thermo Fisher Scientific) at RT as follows:  
 10 min in Xylene 
 10 min in fresh Xylene 
 5 min in 100% ethanol 
 5 min in 70% ethanol in 0.1% (v/v) DEPC treated H2O 
 5 min in 50% ethanol in 0.1% (v/v) DEPC treated H2O 
 10 min in  0.1% (v/v) DEPC treated PBS 
 10 min in fresh 0.1% (v/v) DEPC treated PBS 
 
The slides were then treated with 4% PFA (w/v) in 0.1% (v/v) DEPC treated PBS by 
placing the slides in a coplin-jar (Thermo Fisher Scientific) filled with 4% (w/v) PFA 
(100 ml). Following treatment with 4% (w/v) PFA, the slides were transferred back to 
the slide rack and were washed twice as previously for 10 min in 0.1% (v/v) DEPC 
treated PBS. The slides were then treated with 0.2 N HCl in 0.1% (v/v) DEPC treated 
PBS for 10 min again in a staining dish followed by another 2, 10 min washes in PBS. 
Subsequently, the slides were treated with 1 mg/ml Proteinase K in phosphate buffer 
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Tween buffer (0.1% (v/v) DEPC treated PBS containing 0.1% Tween 20) for 10 min. 
For this step the slides were removed from the slide rack and after carefully wiping off 
the excess PBS on the glass slides with soft clinical tissues (Lotus Professional, 
Sheffield, UK), 200 μl of 1mg/ml Proteinase K in phosphate buffer Tween buffer were 
pipetted directly onto the tissue section and then covered by a piece of Parafilm (VWR) 
to assure that the tissue sections didn’t dry out. The slides were then once again 
transferred back into the slide rack and were washed twice for 10 min in 0.1% (v/v) 
DEPC treated PBS. The next step of hybridisation was the pre-hybridisation step, where 
the slides were incubated with pre-hybridisation solution at 53°C for 3 h. The pre-
hybridisation solution consisted of 50% (v/v) formamide in 0.1% (v/v) DEPC treated 
H2O, 4 X 3 M sodium chloride with 300 mM trisodium citrate (SSC) in 0.1% (v/v) 
DEPC treated H2O, 100 μg/ml denatured salmon sperm DNA, 50 μg/ml heparin, 0.1% 
(v/v) Tween 20 in 0.1% (v/v) DEPC treated H2O and 5% (w/v) dextran sulphate in 0.1% 
(v/v) DEPC treated H2O. 
 
 For the pre-hybridisation step, slides were initially placed in a metallic slide container 
(VWR) so that the tissue sections on each slide were facing upwards. After removing 
the excess PBS on the glass slides with soft clinical tissues, 200 μl of the pre-
hybridisation solution pre-warmed for an hour at 53°C was pipetted directly onto the 
tissue section and then covered by a piece of parafilm. The metallic container with the 
slides was then incubated for 3 h at 53°C in a non-gassed incubator. At the end of 3 h, 
the hybridisation step followed in which 1 μg/ml of dye-labelled RNA (Section 2.6.6) 
was added to new pre-warmed pre-hybridisation solution to form the hybridisation 
solution. This step was followed for both the T7 and the SP6 originating dye-labelled 
RNAs. Half of the slides were hybridised with the T7 dye-labelled RNA and half of the 
slides were hybridised with the SP6 dye-labelled RNA. The hybridisation solution was 
added to the slides (200 μl per slide) following the same procedure as the pre-
hybridisation solution. The metallic slide container was then closed to avoid light 
exposure and placed in the non-gassed incubator set at 53°C overnight.  
 
The following day, the slides were placed in a coplin-jar filled with pre-warmed 
washing solution (100 ml) at 53°C and the jar was incubated in the non-gassed 
incubator at 53°C for 10 min. The washing solution was consisted of 50% (v/v) 
formamide in 0.1% (v/v) DEPC treated H2O, 2 X Saline-sodium citrate buffer (SSC) in 
0.1% (v/v) DEPC treated H2O and 0.1% (v/v) Tween 20 in 0.1% (v/v) DEPC treated 
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H2O. The 2 X SSC was made up from the 20 X SSC stock of 3M NaCl and 300 mM of 
Sodium Citrate in sterile-distilled H2O, pH adjusted at 7.0 and sterilised by autoclaving 
(Appendix II). Washing was repeated for an additional 10 min with new pre-warmed 
washing solution. Following the 2 washes, the excess washing solution was removed 
with soft clinical tissues and a drop of antifade solution (supplied in the FISH Tag green 
kit) was added on the slides before being covered with a 24 X 50 mm cover slip 
(VWR). The slides were then wrapped in aluminium foil to avoid light exposure and 
were viewed under a fluorescent microscope (Zeiss Axioplan2, Carl Zeiss Ltd, 
Cambridge UK) fitted with a filter with an excitation wavelength range between 495 
and 520 nm to capture green fluorescence. Images were captured using the Cytovision 
4.5 computer software (Leica Microsystems Ltd, Milton Keynes, UK). 
 
2.7 STATISTICAL ANALYSIS 
Data generated in the thesis were processed using Microsoft Excel and PowerPoint. All 
statistical analyses were performed by Minitab 15.0 software. The Anderson-Darling 
test was used to test data for normality. Culture data were analysed using the Student’s 
t-test or chi-square for normally distributed data. Mann Whitney U tests were performed 
on data that were not normally distributed. In all analyses P values of <0.05 were 
considered to be statistically significant. 
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Chapter 3: Characterisation of ovine GTSF1 
 
3.1 INTRODUCTION 
Identifying the best oocyte for fertilisation in assisted reproduction is a daunting task. 
The methods that have already been established include morphological evaluations of 
oocytes as well as polar body analysis with FISH and comparative genomic 
hybridisation (CGH) in order to provide insights to oocyte genetics (Patrizio et al., 
2007). Assays both at the molecular and cellular level have allowed identification of 
many potential predictors of oocyte quality associated with the oocyte and the 
surrounding somatic cells (Wang and Sun, 2007). In addition, the cyclic growth of 
follicles and the atresia that occurs is likely to affect oocyte quality and be associated 
with changes in the follicular fluid composition (Hunter et al., 2005). The importance of 
identifying markers of gamete developmental competence and in particular oocyte 
quality cannot be emphasized enough, since identification of the functional significance 
of oocyte markers can provide improved fertility treatment options for patients with 
limited oocyte supply as detailed in Chapter 1, Section 1.1.  
 
Genes involved in gametogenesis are usually preferentially expressed in germ cells. 
There is a large number of ESTs available in databases that have allowed the analysis of 
gene expression profiles in silico. Gene expression profiling has revealed an abundance 
of genes vital for oogenesis and early embryo development (Zheng and Dean, 2007). 
The functional significance of these genes can be indicated by the generation of murine 
transgenic mutants that do not express the gene of interest and the subsequent 
examination of the resulting phenotype. Some of these germ cell specific genes have 
been shown to have important roles in folliculogenesis and oocyte maturation including 
the deleted in azoospermia like, Figlα, Nobox, Sohlh1, Y box binding protein 2 (Ybx2), 
cAMP response element binding protein 1 and Gdf9. Other genes are important for 
fertilisation like Zp1, Zp2 and Zp3; and others for early embryo development including 
nucleophosmin (Npm2), zygote arrest 1 (Zar1), nacht leucine rich repeat-pyrin 
containing leucine rich repeat and pyrin domain containing 5 (Nalp5) and dipeptidyl-
peptidase 3 (Dpp3) (Zheng and Dean, 2007). In  addition, although oocyte growth is 
controlled exogenously, the resumption of meiotic progression is controlled by genes 
that regulate chromatin and spindle like Cdk, histone H1oo, formin 2 and budding 
uninhibited by benzimidazoles 3 (Bub3) (Acevedo and Smith, 2005). Another putative 
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marker of gamete developmental competence is GTSF1. This gene belongs to the 
UPF0224 family that is highly conserved amongst different species. In silico analysis of 
gene expression profiles based on EST’s allowed the identification of several members 
of UPF0224 family, 1 of them being GTSF1 also known as Cue110. The predicted 
amino acid sequences that are encoded by non-mammalian genes were shown to have a 
28-48% identity with GTSF1 at the N-terminal and the protein shares 91% with 
FAM112B which is the protein encoded by the human orthologue (Yoshimura et al., 
2007).  
 
Characterisation studies in mice have shown that this gene is specifically expressed in 
differentiating germ cells of both the testis and the ovary (Yoshimura et al., 2007; Krotz 
et al., 2009). Specifically, ISH on adult murine ovarian tissue showed high degree of 
localisation of Gtsf1 to the cytoplasm of primary follicles and less to primordial follicles 
(Krotz et al., 2009). Anti-Gtsf1 staining in newborn mouse ovary was localised 
primarily in the cytoplasm of oocytes within germ cell cysts and primordial follicles. 
Staining of primordial and primary follicles was also noted in 8 week old ovaries. The 
above results indicate that Gtsf1 is expressed throughout the early stages of 
folliculogenesis (Krotz et al., 2009). With regard to the male, the same study indicated 
that on postnatal day 10 in the murine testis Gtsf1 was found in spermatogonia but not 
in spermatocytes (Krotz et al., 2009). Similar results were also shown by Yoshimura et 
al., (2007). Specifically, weak in situ hybridisation signals demonstrating Gtsf1 were 
observed in mouse primary oocytes of primordial, primary and secondary follicles but 
the protein was not detected by immunocytochemistry. In the testis, a faint signal was 
observed in the spermatocytes, mostly at the pre-leptotene stage and more clear in early 
elongating spermatids (Yoshimura et al., 2007). 
 
The interest for this gene as a putative marker of gamete development arises from the 
fact that male mice mutants for Gtsf1 have an infertile phenotype, while female mutants 
appear normal (Yoshimura et al., 2009). Although female mutants do not demonstrate 
an infertile phenotype, the gene could still have functional role in gamete developmental 
competence as the mechanisms of mammalian meiosis are more robust in females than 
males (Yoshimura et al., 2009). In addition, although it has been demonstrated that 
Gtsf1 expression can be successfully detected, the study did not detect Gtsf1 protein 
using immunostaining in oocytes of wild type animals although the protein was detected 
in male gametes and specifically pachytene spermatocytes and round spermatids 
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(Yoshimura et al., 2007). A further indication of the potential functional significance of 
GTSF1 as a molecular marker of oocyte development is enhanced by the 2 copies of a 
conserved CHHC Zn-finger domain found in GTSF1 homologs that can serve as an 
RNA-binding domain. The significance of RNA-binding in several cellular procedures 
including meiosis is detailed in Chapter 1, Section 1.4.2. In monovular species such as 
the cow and humans, research conducted in Leeds indicates that GTSF1 is present in 
gametes and undifferentiated cells of early development (Lu et al., 2012). In the bovine 
and human ovaries, analysis of GTSF1 by real-time PCR revealed expression at 
primordial, primary, and secondary follicles, GV and MII oocytes, zygotes and late 
stage preimplantation embryos with expression being highest in GV oocytes. The 
functional significance of GTSF1 in gamete development in monovular species has yet 
to be fully established 
 
3.1.1 Aims  
The aim of this study was therefore to characterise the expression and cellular 
distribution of GTSF1 in sheep. This study represents the first step towards investigating 
the function of this gene in a physiologically relevant monovulatory animal model to 
human. The sheep is generally considered as a good model for evaluation of human 
reproductive endocrinology and ovarian biology (Campbell et al., 2003). The 
developmental sequence of oogenesis and folliculogenesis and the size of the ovulatory 
oocyte is comparable between sheep and human ovaries (Campbell et al., 2003). 
Similarly, the mechanisms regulating follicle development and ovulation are similar 
between sheep and humans (Campbell et al., 2003).  
 
The primary aim of the current experiments was to sequence and map the expression 
pattern of GTSF1 in ovine follicles and oocytes and during early embryo development 
by interrogating verified cDNA libraries from all of these stages of development by 
PCR. Given the discrepancy in the published literature between gene expression and 
protein distribution across oogenesis, the work also aimed to further characterise the 
cellular distribution of GTSF1 by FISH analysis of ovarian sections and to detect 
GTSF1 protein. Cellular distribution of GTSF1 and protein analysis was also 
characterised in the testis. 
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3.2 MATERIALS AND METHODS  
3.2.1 Follicle, oocyte, embryo and ovarian somatic cell isolations  
The methods used for isolations of follicle stages, oocytes and granulosa cells  for 
cDNA library generation have been previously used and validated by Cotterill, (2008). 
Sets of 3 independent libraries were created for primordial, early primary, primary, 
secondary, preantral and antral follicles, GV and MII oocytes as well as cumulus and 
mural granulosa cells and ovarian cortex. Additionally, analysis was conducted on 
archived cDNA libraries of in vitro derived preimplantation sheep embryos prepared by 
Cotterill, (2008). These included 2 cell staged embryos (groups of 3 embryos), 4 cell 
staged embryos (groups of 3 embryos) and blastocyst staged embryos (groups of 3 
embryos) and 3 independent cDNA libraries were created for each developmental stage. 
For these preparations-in brief, ovarian follicles were isolated from abattoir-derived 
sheep ovaries as described in Chapter 2, Sections 2.1.2-2.1.4, and GV oocytes were 
obtained following aspiration of COC’s from 2-5 mm follicles. Groups of 10 GV 
oocytes were denuded in oocyte holding media (H199
+
) from the surrounding cumulus 
cells using a flexipet (Cook Medical) attached consecutively to a 170 μm and a 140 μm 
pipette tip as described previously (Chapter 2, Section 2.5.1). For generation of MII 
oocytes, collected COC’s were subjected to IVM for 24 hours in serum-free IVM 
medium as detailed in Chapter 2, Section 2.1.3, according to the protocol of Cotterill et 
al., (2012), followed by denudation of groups of 10 COC’s (Chapter 2, Section 2.5.1). 
After denudation, oocyte meiotic status was confirmed by detection of the presence of 
the first polar body using an inverted microscope. Verified MII oocytes were pooled in 
groups of 10 and snap-frozen in lysis buffer (Chapter 2, Section 2.1.1). For follicle 
isolations, groups of 50 primordial follicles, 40 early primary, 10 primary, 10 
secondary, 10 preantral and 6 antral follicles were generated according to the 
methodology described by Huntriss et al., 2002 as described in Chapter 2, Section 2.1.4. 
For isolation of mural granulosa cells, groups of dissected antral follicles were ruptured 
with a scalpel blade and their cellular contents were scraped into 100 μl of H199+ 
medium. Follicle-free ovarian cortex samples containing no visible follicles were 
prepared by cutting the ovary with a scalpel blade as described previously (Chambers et 
al., 2010). Each section was transferred to a 4 well dish containing 500 ml of ovary 
holding medium (FIM) with 50 mg/ml of neutral red (NR) dye. The NR dye stains 
lysosomes of living cells red and is commonly used as a viability stain (Samaj et al., 
2005). Following incubation, the presence of follicles was easy to determine under an 
inverted microscope. Only cortex tissue pieces that did not contain follicles were 
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selected for analysis. Cumulus granulosa cells were obtained following denudation of 
groups of 3 GV oocytes. All tissue was washed twice in a 4 well dish containing 500 ml 
of DPBS before being transferred into a 0.5 ml microcentrifuge tube containing 10 μl of 
lysis buffer (Chapter 2, Section 2.2.14). The tube containing the tissue was then snap-
frozen in liquid nitrogen and stored at -80°C. Sets of 3 cDNA libraries were created for 
each follicle/oocyte stage and cell type following mRNA isolation as described in 
Chapter 2, Sections 2.2.2-2.2.4.  
 
3.2.2 Somatic tissue cell isolations 
Further cDNA libraries were created from samples of sheep heart, liver, kidney, lung 
and adrenal cortex with the tissue obtained from the abattoir. In order to obtain the RNA 
from the tissue, the RNeasy plus kit (Qiagen Ltd) was used in accordance with the 
manufacturer’s recommendations. Small tissue pieces were collected from the animals 
and placed into a sterile 1.5 ml microcentrifuge tube and stored at -80°C until usage. 
Tissue was placed in a weighed 1.5 ml microcentrifuge tube and not more than 30 mg of 
tissue was added. The tissue was then disaggregated and homogenised within each tube 
using customized 1 ml pipette tips (Figure 3.1). 
 
 
Figure 3.1: Schematic representation of creation of modified tip by applying heat on the pipette 
tip edge with a Bunsen burner before placing it in an empty sterile tube.  
 
For tissue weights of 20-30 mg, 600 μl of RNeasy lysis buffer RLT plus (provided in 
the kit) was added to the tube for the lysis of the cells and inactivation of RNases to 
ensure isolation of intact RNA. The lysate was then centrifuged in a microcentrifuge for 
3 min at maximum speed. The supernatant was removed by pipetting and transferred to 
a gDNA eliminator spin column. Further centrifugation for 30 sec at 10,000 rpm was 
applied and flow through was kept. An equivalent volume of 70% (v/v) ethanol in 
sterile-distilled H20 was then added to the flow-through and mixed by pipetting. The 
sample was then placed in an RNeasy spin-column and centrifuged for 15 sec at 10,000 
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rpm. Flow-through was discarded and 700 μl of wash buffer RW1 (provided in the kit) 
were added to the column followed by centrifuging at the same conditions. Once again 
the flow-through was discarded and 500 μl of wash buffer RPE were added to the 
column followed by centrifuging for 2 min at 10,000 rpm. The column was then placed 
in a 1.5 ml sterile microcentrifuge tube and centrifuged at full speed for 1 min. The 
column was then placed in a new sterile microcentrifuge tube and 30 μl of RNase free 
H20 were added. The sample was then centrifuged for 1 min at 10,000 rpm and the 
RNA was eluted. Libraries of cDNA were then created for each stage and cell type as 
described in Sections 2.2.3-2.2.4 of Chapter 2.  
 
3.2.3 Molecular evaluation of the ovine developmental series 
The primers used for interrogation of the cDNA libraries across all stages of sheep 
oocyte, follicle and embryo development and as non-ovarian somatic tissue were 
designed as detailed in Section 2.2.5 of Chapter 2. The GAPDH, H2A, ACTB, and 
YWHAZ housekeeper primers along with the oocyte-specific ZP2 primer (Chapter 2, 
Section 2.2.5) were used to verify the consistency of the cDNA libraries. The libraries 
were then interrogated against GTSF1 with the primer sequences shown in Table 3.1 
 
Table 3.1: Primer sequences of GTSF1 for RT-PCR 
Gene Primer Sequence Temp (°C) Reference 
GTSF1 
bovine 
F: 5´ TCAAGTGCAGAAAGAATCATCC 3´ 
52 E3353A11 
R: 5´ TGCATTTCCATTGTTTTTCC 3´ 
 
Three cDNA samples for each stage of follicle, oocyte and early embryo development 
were analyzed by PCR as described in Section 2.2.5 of Chapter 2, with the temperature 
of the amplification step changing accordingly to the primer’s melting temperature 
(Tm). Following the PCR analysis, 10 µl of each sample was run on a 1% agarose gel at 
90 V for 60 min as described in Chapter 2, Section 2.2.6. Positive and negative controls 
were also run in each analysis to show PCR efficiency and lack of contamination. 
Sterile-distilled H20 was used as a negative control, while a previously established 
sheep MII library was used as a positive control.    
 
3.2.4 Cloning and sequencing ovine GTSF1  
3.2.4.1 Nested PCR 
In order to obtain a portion of the expressed ovine GTSF1 sequence, primers for GTSF1 
were designed from the bovine sequence retrieved from NCBI using the primer 3 
program as described previously (Chapter 2, Section 2.2.5), followed by verification 
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PCR with GTSF1 primers on ovine MII cDNA libraries. The cloning procedures were 
then performed as detailed in Chapter 2, Section 2.3. The first approach used to obtain 
the full sequence of ovine GTSF1, involved a nested PCR reaction and analysis. This 
strategy has previously been used by Huntriss et al., (2002) and the technology was 
based on designing 3 different sets of primers used in 3 successive runs of PCR, with 
the second set intended to amplify a secondary target within the product of the first PCR 
and with the third PCR reaction further amplifying a different target within the product 
of the second PCR reaction. For this purpose, 3 different sets of primers were designed, 
from the partially cloned ovine GTSF1 sequence obtained from Section 3.2.4. The 3 
primer sets are shown in Table 3.2.  
 
Table 3.2: Nested GTSF1 primer sequences 
Gene Primer Sequence Temp (°C) 
Nested GTSF1-(a) F: 5´  GCGGGATTAGCATTTCCAT 3´ 65 
R: 5´ TCCTGATGTCGCAAACAAAC 3´ 
Nested GTSF1-(b) 
F: 5´ AGCATTTCCATTGTTTTTCCA 3´ 
64 
R: 5´ GCAGGATGTTGTCAACCAAA 3´ 
Nested GTSF1-(c) 
F: 5´ ATGTTGCTTGCAGGGCTATT 3´ 
66 
R: 5´ GGATGTTGTCAACCAAACCA 3´ 
 
For this series of experiments, the pGEM-Teasy vector system (3000 bp, Promega Ltd) 
was used according to the manufacturer’s recommendations. This vector system 
includes M13 primer binding sites as well as T7 RNA polymerase transcription 
initiation site and T7 RNA polymerase promoter SP6 (Figure 3.2).  
 
Figure 3.2: Schematic representation of the pGEM-Teasy Vector sequence reference points 
including the T7 and SP6 transcription start points and the M13 forward and reverse primer 
sequencing binding sites. Adjusted from pGEM-Teasy technical manual, 
http://www.promega.com). 
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The template for the first PCR reaction was created by generating an ovine MII cDNA 
library (Chapter 2, Sections 2.2.1-2.2.4) followed by verification PCR to confirm the 
presence of the GTSF1 gene (Chapter 2, Section 2.2.5). The beads were then removed 
from the library using the magnetic apparatus and the cDNA library was pipetted into a 
new sterile 1.5 microcentrifuge tube. The library was then purified using the QIAquick 
PCR purification Kit according to the manufacturer’s recommendations. Specifically, 5 
volumes of buffer PB were added to 1 volume of the PCR reaction and mixed and the 
mixture was then transferred into QIAquick column inside a 2 ml collection tube. The 
tube was then centrifuged for 1 min at 13,000 rpm in a microcentrifuge at RT and the 
flow-through was discarded. Then 750 μl of buffer PE were added to the column and 
the tube containing the column was once again centrifuged for 1 min at 13,000 rpm at 
RT. Flow-through was discarded and the column was centrifuged for an additional 
minute under the same conditions. Flow-through was once again discarded and the 
column was placed in a clean sterile 1.5 ml microcentrifuge tube. Then 30 μl of sterile 
distilled H2O were added to the centre of the QIAquick membrane and was left to stand 
for 1min. The purified product was then eluted inside the 1.5 ml tube by 1 min 
centrifugation at maximum speed at RT. Following purification, the poly-(A) tail was 
added and the product was cloned into the pGEM-Teasy vector as described previously 
(Chapter 2, Sections 2.3.2-2.3.3). 
 
For each of the 3 consecutive PCRs, 4 reactions were set using different primers, in a 
final volume of 20 μl. Each of the reaction mixes was composed by 2 μl of 10 X buffer, 
4 μl of dNTPs (1.25 mM), 1.5 μl MgCl2, 2 μl of forward primer, 2 μl of reverse primer, 
0.2 μl of Taq polymerase, 7.3 μl sterile distilled H20 and 1 μl of cDNA sample. For the 
first PCR, 4 μl of template were used for each of the 4 reactions reducing the amount of 
sterile distilled H20 accordingly. The primers used in the first PCR were as follows:  
 A: M13 F primer and GTSF1 1F primer 
 B: M13 R primer and GTSF1 1F primer 
 C: M13 F primer and GTSF1 1R primer 
 D: M13 R primer and GTSF1 1R primer 
For the second PCR, 1 μl from each of the 4 products of the first PCR was used as 
template and 4 additional reactions were set up with primers based as follows:  
 A: M13 F primer and GTSF1 2F primer 
 B: M13 R primer and GTSF1 2F primer 
 C: M13 F primer and GTSF1 2R primer 
 D: M13 R prime and GTSF1 2R primer 
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For the third PCR, 1 μl of the 4 reactions of the second PCR was used as template with 
the primers for the 4 reactions being as follows: 
 A: M13 F primer and GTSF1 3F primer 
 B: M13 R primer and GTSF1 3F primer 
 C: M13 F primer and GTSF1 3R primer 
 D: M13 R primer and GTSF1 3R primer 
Because of the presence of T7 and SP6 transcription sites on the vector system, 4 more 
reactions were set up for the third PCR, once again using 1μl of the product of the 
second PCR as template with the primer sets being the following for each reaction:  
 A: T7 F primer and GTSF1 3F primer 
 B: SP6 R primer and GTSF1 3F primer 
 C: T7 F primer and GTSF1 3R primer 
 D: SP 6 R primer and GTSF1 3R primer 
The program for the PCRs was set for 1 cycle step of 3 min at 95°C, followed by 5 
cycle steps of 95°C for 30 sec, 65°C (changed to 64°C for the second PCR and to 66°C 
for the third PCR) for 30 sec and 72°C for 30 sec (first amplification step), 30 cycle 
steps of 95°C for 30 sec, 58°C for 30 sec and 72°C for 30 sec and 1 cycle step of 72°C 
for 5 min before holding at 4°C. 
 
3.2.4.2 Degenerate primer PCR  
An alternative approach used to obtain the full ovine GTSF1 sequence was the design 
and use of degenerate GTSF1 primers. This method is based on the amplification of 
unknown DNA sequences related to a known DNA sequence and is useful for 
identification of orthologous genes from different organisms (Lang and Orgogozo, 
2011). For this purpose the basic local alignment search tool (BLAST) was used on the 
NCBI website to compare the full sequence of GTSF1 in different species. (Altschul et 
al., 1990). Degenerate primers were designed from 4 species: Bos taurus (Zimin et al., 
2009), Pan troglodytes (NCBI reference sequence: XM_509113.2), Canis familiaris 
(NCBI reference sequence: XM_534784.2) and Sus scrofa (NCBI reference sequence: 
XM_001927807.1). The primers were designed by identifying the differences in 
nucleotide bases at the 5´ and 3´ end of the transcripts between them. All different 
nucleotide bases located were then introduced into degenerate primers. This was based 
on the IUPAC code. For example if in 3 out of 4 species the first base was A and in the 
fourth the equivalent base was T, the degenerate primer sequence included both A+T 
(IUPAC code: W). In the same way A+C+G is represented by V, A+T+G by D, T+C+G 
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by B, A+T+C by H, A+T by W, C+G by S, T+G by K, A+C by M, C+T by Y, A+G by 
R and A+G+C+T by N. The degenerate primers used are shown in Table 3.3.  
 
Table 3.3: Degenerate GTSF1 primer sequences 
Gene Primer Sequence Temp (°C) 
Degenerate GTSF1 
F: 5´ GCWYCTTMRTTYCCAACATGGAA 3´ 
68 
R: 5´ TCTTDYYATTTRASAGACACTGAA 3´ 
 
3.2.5 Characterisation of the cellular localisation of GTSF1 expression across ovine 
gametogenesis 
FISH technology was employed to localise the presence of GTSF1 sequence in the 
ovine ovary and testis.  The processes followed are described in detail in Chapter 2, 
Section 2.6. The cloned GTSF1 sequence generated using the methods described above 
(Section 3.2.4) was used as a template for the generation of the sense and antisense 
probes. After FISH, the presence or absence of GTSF1 was determined for all stages of 
follicle development and spermatogenesis. The different stages of folliculogenesis were 
classified according to the size and the morphological characteristics of the follicles at 
each stage as shown in Figure 3.3 (Lundy et al., 1999; Ireland et al., 2008).  
 
 
Figure 3.3: Histological classification of ovine follicles stained with hematoxylin and eosin 
(Stained ovarian slides were a courtesy of J Ping and L Blackwell). A: Follicles with a compact 
oocyte surrounded by a single layer of flattened granulosa cells classified as primordial follicles. 
B: Follicle containing an oocyte surrounded by a single layer of mixed flattened and cuboidal 
granulosa cells classified as early primary follicle. C: Follicle with the oocyte surrounded by 1 
layer of cuboidal granulosa cells classified as primary follicle. D: Follicle with the oocyte 
surrounded by 2 layers of cuboidal granulosa cells classified as early secondary follicle E: 
Follicle with the oocyte surrounded by multiple layers of cuboidal granulosa cells and no 
antrum classified as secondary follicle. F: Follicle with multiple layers of cuboidal granulosa 
cells with a fully formed theca interna and a forming antral cavity classified as early antral 
follicle. Bars= 20 μm.  
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Ovine testis from sheep prepubertal animals was supplied in collaboration with 
Professor Bruce Campbell (Faculty of medicine and health sciences, University of 
Nottingham) and Professor Alan McNeilly (University of Edinburgh). 
 
3.2.6 Western blotting 
To further characterise GTSF1, Western blotting was conducted to detect protein levels 
of the gene in ovarian tissue containing viable follicles as determined by neutral red, 
bovine testis, GV oocytes and somatic tissue of ovine kidney and lung. The 
methodology followed for tissue preparation and Western blotting is detailed in Chapter 
2, Section 2.5. A total of 3 repeat analyses were run for each different sample. For the 
series of experiments, a commercially made monoclonal antibody for GTSF1 was used 
(SC-240545, Santa Cruz Biotechnology, Midlesex, UK) in a concentration of 1:1000 in 
15 ml of non-fat dry milk powder dissolved in 1% (v/v) PBS in Milli-Q H2O. The 
secondary antibody was the Zymax HRP-Rabbit Anti-Goat IgG (H+L) conjugate 
(Invitrogen, Ltd), used in a concentration of 1:100,000 diluted in the same conditions as 
the primary antibody. An additional blot was performed for all the tissue analysed with 
the presence of a blocking peptide as a negative control (SC-240545p, Santa Cruz 
Biotechnology). The blocking peptide is used to neutralise the GTSF1 antibody; thus to 
determine any non-specific binding of the antibody to proteins other than the antigen. 
For the experiment, the GTSF1 antibody was neutralised by incubating it with an excess 
of peptide (5 X the concentration of primary antibody, 1:200 dilution) that corresponds 
to the epitope recognised by the antibody. This resulted in the binding of the antibody to 
the blocking peptide with the antibody no longer being able to bind to the epitope 
present in the protein on the Western blot. The blot containing the neutralised antibody 
was then compared with the blot containing only the antibody and any bands absent 
from the blot containing the neutralised antibody represented specific binding of the 
antibody. 
 
3.3  RESULTS 
3.3.1 Verification of cDNA libraries 
All cDNA libraries that were created were verified using GAPDH and ZP2 primers.  
Somatic cell libraries that failed to demonstrate expression of the GAPDH housekeeper 
gene and oocyte libraries that failed to demonstrate expression of both GAPDH and ZP2 
were discarded. The cDNA synthesis resulted in the generation of full-length clones 
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originating from the mRNA sequences for all stages of follicle and embryo 
development as well as for ovine somatic tissue.  
 
3.3.2 Expression analysis of GTSF1 across ovine oocyte and embryo development 
The profile of GTSF1 expression was analysed throughout development of the oocyte, 
follicle and early embryo using the created cDNA libraries. The analysis of oocyte-
specific gene ZP2 was also conducted along with the expression profile of different 
housekeeper genes (Figure 3.4).  
 
 
Figure 3.4: Montage showing expression profiles obtained by RT-PCR of different genes 
throughout ovine oogenesis and embryo development. Each developmental stage is represented 
by a triplicate of independent cDNA libraries. Lanes 1 contain 1 kb MW marker. Lanes 23 
contain sterile-distilled H20 and no cDNA library (NC), while lanes 24 contain a previously 
verified cDNA library of a cohort of 10 denuded GV ovine oocytes (PC). A: Lanes 2-22 contain 
cDNA libraries from pools of: Lanes 2-4: 50 primordial follicles; Lanes 5-7: 40 early primary 
follicles; Lanes 8-10: 10 primary follicles; Lanes 11-13: 10 secondary follicles; Lanes 14-16: 10 
preantral follicles; Lanes 17-19: 6 antral follicles; Lanes 20-22: 10 denuded GV oocytes. B: 
cDNA libraries from pools of: Lanes 2-4: 10 denuded MII oocytes; Lanes 5-7: 3, 2-cell 
embryos; Lanes 8-10: 3, 4 cell embryos; Lanes 11-13: 3, blastocysts; Lanes 14-16: Compact 
cumulus cells from 3 denuded GV oocytes; Lanes 17-19: Mural granulosa cells from 10 antral 
follicles; Lanes 20-22: Ovarian cortex containing no follicles. 
 
The data showed that GTSF1 was expressed from primordial to primary stages of 
follicle development as well as GV and MII oocytes and in the early stages of 
embryogenesis until the blastocyst stage. In contrast, the gene had either low expression 
or was not expressed at all in secondary, preantral and antral follicle stages, suggesting 
that even though the gene is gamete and early embryo specific, it is not expressed at all 
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stages of folliculogenesis. In addition, there was no expression of GTSF1 in mural 
granulosa cells of late follicular stages and in ovarian cDNA cortex samples that did not 
contain primordial follicles. These consistencies verify that expression of the gene is 
limited to the gamete and early embryo. The expression levels of GTSF1 appeared to be 
higher at the GV and MII stage. Not all cDNA libraries confirmed the expression of the 
gene at the early stages of development. Specifically, GTSF1 expression was only 
confirmed in 1 out of 3 primordial cDNA libraries and 2 out of 3 primary cDNA 
libraries. This could be attributed to the limited expression of the gene at these stages of 
development in comparison with the housekeeper genes and the variability of each of 
the cDNA libraries from the same devlopmental stage. 
 
The profile of ZP2 expession, showed that the gene is expressed in all stages of follicle, 
oocyte and embryo development until the 4 cell embryo stage while it was not 
expressed in other somatic tissue of the ovary confirming its oocyte and embryo specific 
pattern of expression and the validity of the cDNA libraries. Housekeeper expression 
levels of GAPDH and H2A also confirmed the validity of all cDNA libraries throughout 
the developmental series. The results also showed incosistencies in the expression levels 
of each gene between libraries originating from the same developmental stage as well as 
between libraries of different developmental stages as indicated by the width and 
brightness of the bands. In addition, some libraries appeared to lack expression of 
certain genes. For this purpose, all developmnetal stages were intorrogated in triplicates 
of cDNA libraries and 2 different housekeepers, GAPDH and H2A were utilised. The 
levels of housekeepers GAPDH and H2A were also variable amongst the different 
cDNA libraries. The observed differences could be attributed to grouping of samples 
with varied cell numbers in addition to the library construction methodology that can 
result in different levels of cDNA between samples. In addition to the above, the 
presence of more than 1 cell type for most developmental stages as well as the 
expression levels for each gene at different developmnetal stages could exlain the 
observed discrepancies.  
 
3.3.3 Expression of GTSF1 in somatic tissue 
The profile of GTSF1 expression was analysed in a series of 5 different non-ovarian 
somatic tissue. Specifically, GTSF1 expression was analysed for adrenal, lung, kidney, 
heart and liver tissue. The expression profile of housekeeper genes as well oocyte-
specific gene ZP2 was also conducted for each triplicate of cDNA libraries (Figure 3.5).  
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Figure 3.5: Montage showing expression profiles obtained by RT-PCR of different genes in 
non-ovarian tissue. Each somatic tissue of ovine adrenal, lung, kidney, heart and liver is 
represented by a triplicate of independent cDNA libraries. Lane 1 contains 1 kb MW marker. 
Lanes 2-4: Adrenal tissue; Lanes 5-7: Lung tissue; Lanes 8-10: Kidney tissue; Lanes 11-13: 
Heart tissue; Lanes 14-16: Liver tissue. Lane 17 contains sterile-distilled H20 with no cDNA 
library (NC). Lane 18 contains a previously verified cDNA library of a cohort of 10 denuded 
GV ovine oocytes (PC). 
 
The results showed that GTSF1 was consistenly not expressed in any of the somatic 
tissues tested confirming its specificity as a gamete and early development specific 
gene. The data also indicated the variability in housekeeper gene expression across 
different somatic cell types. For example ACTB expression was not detected in kidney 
or heart samples; whereas the same samples showed detectable expression of H2A in 
kidney samples and both GAPDH and H2A in heart samples. The  YWHAZ gene was the 
most variable of housekeepers tested. As expected, no ZP2 expression was detected in 
any of the somatic tissue confirming the value of this gene as an oocyte/ovary specific.  
 
3.3.4 Cellular localisation of GTSF1 expression in the ovine ovary and testis 
Three replicate FISH analyses were conducted. For each experiment, 3 slides of ovarian 
tissue containing follicles from all follicular stages and 3 slides of testicular tissue were 
used to hybridise with each of the 2 probes. An overview of the localisation of GTSF1 
in the ovine ovary and testis is shown in Figure 3.6. Following hybridisation, a total of 
30 primordial, 30 primary, 15 secondary, 10 antral and 6 preovulatory follicles were 
analysed for each of the positive and negative control probes. In the ovary, FISH 
analysis showed cell-specific localisation of GTSF1. Specifically, gene expression was 
detected in primordial follicles (25/30), primary follicles (28/30) and transitional 
follicles (27/30 follicles), while it was not detected in secondary (0/15), antral (0/10) or 
preovulatory staged follicles (0/6). At the stages of follicular development that GTSF1 
was detected (Figure 3.6, B-D), it was localised uniformly in the cytoplasm of the 
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oocyte, while it was not localised in any of the somatic cells (granulosa or theca cells). 
In the ovine testis seminiferous tubules, GTSF1 was detected in the cytoplasm of 
spermatogonia (29/30), primary spermatocytes (30/30), secondary spermatocytes 
(30/30) as well as round spermatids (27/30) (Figure 3.6, H-I).  
 
 
Figure 3.6: Representative images of the characterisation of GTSF1 gene expression in the 
ovine ovary and testis following FISH analysis A: Ovarian tissue overview of the noise from 
negative control probed by sense GTSF1 B-D: Hybridised anti-sense GTSF1 in ovary. B: 
Primordial follicles. C: Early primary follicle. D: Primary follicle. E-F: Non-hybridised 
follicles by anti sense GTSF1. E: Pre-antral follicle. F: COC complex from an antral follicle. G: 
Testicular tissue overview of the noise from negative control probed by sense GTSF1 
(spermatogonia and primary spermatocytes). H-I: Hybridised anti-sense GTSF1 in testis. H: 
Overview of seminiferous tubules showing GTSF1 signal in the spermatogenic cells. I: Primary 
spermatocytes. Scale bar: 20 μm. 
 
 
3.3.5 Analysis of the GTSF1 ovine sequence 
A partial sequence for GTSF1 was obtained by designing primers for GTSF1 based on 
the region of high homology with the GTSF1 sequence for the bovine species. Cloning 
using MII libraries as described in detail in Chapter 2, Section 2.2.2 and sequencing, 
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revealed a 377 nucleotide ovine sequence. This sequence showed a very close 
homology with the Bos taurus GTSF1 sequence (Figure 3.7).  
 
 
Figure 3.7: Sequence alignment of the ovine partially cloned GTSF1 sequence with the known 
Bos taurus GTSF1 sequence. The 2 species share a 98% nucleotide homology for the sequence 
with 371 out of the 377 being identical (http://blast.ncbi.nlm.nih.gov/). 
 
In particular, 371 out of 377 nucleotides were shown to be identical between the 2 
species, indicating a 98% homology with 0% gaps. The partial ovine sequence was 
shown to be 93% homologus with Macaca mullata, 92% homologus with Mus musculus 
and 91% homologus with Homo sapiens, Rattus norvegicus and Pan troglodytes, as 
determined by blast search (http://blast.ncbi.nlm.nih.gov/).  
 
Nested PCR was performed to try to obtain the full sequence of the ovine gene. This 
method reduced the contamination of PCR products caused by amplification of 
unexpected primer sites. The series of reactions based on combination of primers from 
the partially cloned GTSF1 sequence with opposite end primers located on the vector 
system should theoretically result in amplification of the ovine gene containing the 
unknown parts of the sequence of the gene. However, this approach did not result in 
specific amplification of the gene of interest and non-specific amplification was 
observed throughout the 3 steps of the reaction. A second approach using degenerate 
primer PCR was therefore tested in order to obtain the full sequence of the gene. The 
degenerate primers were used to amplify an ovine MII oocyte cDNA library with the 
agarose gel electrophoresis that followed shown in Figure 3.8. 
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Figure 3.8: Montage showing expression profiles of GTSF1 obtained by degenerate primer RT-
PCR. Lane 1 contains a 1 kb MW marker. Lane 2 contains an ovine MII oocyte cDNA library 
amplified with degenerate GTSF1 primers corresponding to the full length of the sequence. 
Lane 3 contains an ovine MII oocyte cDNA library amplified with bovine GTSF1 primers 
(Section 3.2.3) corresponding to a partial sequence of GTSF1. Lane 4 contains sterile-distilled 
H20 with no cDNA library (NC). Lane 5 contains a previously verified cDNA library of a cohort 
of 10 denuded GV ovine oocytes amplified with bovine GTSF1 primers (PC). 
 
The corresponding  molecular weight of the cloned product with the degenerate primers 
(Lane 2) was 630 bp in comparison with the 377 bp that was amplified using the bovine 
GTSF1 primers. The size of 630 bp, based on other species, corresponds to the expected 
full sequence of ovine GTSF1. The resulting PCR product was cloned into the pGEM-
Teasy vector system following the cloning procedure as described in Chapter 2, Section 
2.3. The nucleotide sequence of ovine GTSF1 retrieved following sequencing is shown 
in Table 3.4.  
 
Table 3.4: Full sequence of ovine GTSF1 obtained using degenerate primer PCR on an ovine 
MII cDNA library and cloning into the pGEM-Teasy vector system 
GTSF1  sequence 
5´_CCTTAGTTCCCAACATGGAAGAAACTTACATCGATACTCTGGACCCTGAAAAGCT
GTTACAATGCCCCTATGATAAAAACCACCAGATCAGGGCCTGCAGGTTTCCTTATCA
TCTAATCAAGTGCAGAAAGAATCATCCTGATGTCGCAAACAAACTGGCGACTTGTCC
CTTCAATGCTCGCCATCAGGTTCCTCGGGCTGAAATCAGCCATCATATCTCAAGCTG
TGATGACAAAAGCTGTATTGAGCAGGATGTTGTCAACCAAACCAGGAGCCTTGGAC
AAGAGACTCTGGCTGAGAGCACATGGCGGTGCCCTCCTTGCGATGAAGACTGGGAC
AAAGATTTGTGGGAACAGACCAGCACCCCATTTGTCTGGGGCACAGCCAACTACTG
TGGCAACAATAGCCCTGCAAACAACATAGTTATGGAACATAAGAGTAACCTGGCTT
CAGGCATGCGTGTTCCCAAGTCTCTGCCATATGTTCTCCCATGGAAAAACAATGGAA
ATGCACAGTAACTGAATATTTCATCAAATGCCAGACCCTGGAAGACTCTTCTTCCTG
CTACAGTGGGTTCTTCATTTTTTTTTCTCCTAATCTAATTATAGAAAGATAAACTGTC
TGTGACTT 3´ 
 
Following BLAST searching of the ovine GTSF1 sequence from the NCBI database 
(http://www.ncbi.nlm.nih.gov/), the ovine GTSF1 sequence indicated a total of 38 blast 
hits. Specifically the ovine sequence showed a 98% homology with the sequence for 
Bos taurus (Zimin et al., 2009), while there was a 91% homology with the published 
sequence for Mus musculus (Diez-Roux et al., 2011) and Rattus norvegicus (Strausberg 
et al., 2002) and 90% with Homo sapiens (Gerhard et al., 2004) as shown in Figure 3.9. 
The sequence was also aligned with the predicted sequence from several species like 
Sus scrofa (93%), Canis familiaris (93%), Pan troglodytes (90%) and several more.  
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Figure 3.9: Distribution of blast hits on the ovine nucleotide sequence for GTSF1. The score of 
each alignment is indicated by 1 of 5 different colours that show the range of scores in 5 groups 
(in bps). Alignment of ovine GTSF1 with: 1: Bos taurus GTSF1. 2: Alignment with Mus 
musculus GTSF1. 3: Alignment with Rattus norvegicus GTSF1. 4: Alignment with Homo 
sapiens GTSF1. The ovine GTSF1 sequence has an alignment of over 600 bp in comparison 
with the GTSF1 sequence of the other species. Image from: http://www.ncbi.nlm.nih.gov/. 
 
Further evaluation revealed that GTSF1 encodes a 167-amino acid protein of 19.11 
kilodaltons molecular weight. Multiple sequence alignment of the GTSF1 protein from 
different species by BLAST-P (http://www.ncbi.nlm.nih.gov/) indicated the high 
conservation of the protein. Specifically, the predicted ovine GTSF1 protein appeared to 
have 99% homology with that for Bos taurus, a 96% similarity with the protein 
sequence of GTSF1 for Homo sapiens and Sus scrofa, 92% with Pan troglodytes, 76% 
with Rattus norvegicus and Mus musculus and 61% with Xenopus laevis (Figure 3.10). 
This suggests a high degree of  conservation of the GTSF1 protein across species.  
 
 
Figure 3.10: Multiple sequence alignment of the predicted ovine GTSF1 protein from various 
species by BLAST-P (http:/www.ncbi.nlm.nih.gov) shows the high conservation of GTSF1. 
Identities for Ovis aries against: Bos Taurus (99%), Mus musculus (76%), Rattus norvegicus 
(76%), Homo sapiens (96%), Pan troglodytes (92%).  
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In addition, blast searches of the ovine predicted protein sequence against known 
protein superfamilies confirmed the presence of 2 CHHC-type Zn-finger domains in the 
ovine protein which were located at amino acids 17-37 and 51-71 as shown in the figure 
below (Figure 3.11). These Zn-finger domains were previously identified in 
spliceosomal U11-48K proteins, tRNA methyl-transferases TRM13 and gametocyte 
specific factors (Andreeva and Tidow, 2008). 
 
 
Figure 3.11: Schematic representation of the putative conserved domains detected by BLAST-P 
with the predicted ovine GTSF1 protein of 167 amino acids (aa). Scale bar represents the length 
of the ovine predicted GTSF1 protein of 167 aa. The 2 conserved CHHC Zn-finger domains 
were located at amino acids 17-37 and 51-71. 
 
The predicted ovine GTSF1 protein was then compared to the X. laevis D7 protein 
which is the only other member of the UPF0224 family that has been characterised. 
BLAST searches revealed that the predicted ovine GTSF1 protein was aligned with the 
D7 protein and shared a 47% homology accross these 2 species as shown in Figure 3.12. 
 
 
Figure 3.12: Protein sequence alignment following protein BLAST of the predicted ovine 
GTSF1 protein with the D7 protein in X. laevis. Identities 47/99 (47%), Positives 69/99 (70%), 
Gaps 4/99 (4%). 
 
The confirmed sequence of ovine GTSF1 isolated from ovine MII oocytes containing all 
its coding sequence and the predicted protein sequence along with the location of the 2 
CHHC Zn-finger domains are shown in Figure 3.13. 
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Figure 3.13: Confirmed sequence of the ovine GTSF1 gene isolated from ovine MII oocytes. 
The isolated PCR fragment includes the whole coding sequence (primers F to R) and the amino 
acids corresponding to the nucleotide sequence are shown. The 2 CHHC Zn-finger motifs 
possibly involved in RNA-recognition and binding are double underlined. The coding sequence 
is shown in red with letters indicating the translated amino acid.  
 
3.3.6 Expression of GTSF1 protein in the ovine ovary 
To further characterise the expression of the ovine GTSF1 gene, Western blotting was 
performed to confirm whether GTSF1 protein was expressed in the ovine ovary. Three 
replicate Western analysis were conducted. All 3 replicates showed the same result that 
the gene encodes a 20 kDa protein in the ovine ovary (Figure 3.14).  
 
 
Figure 3.14: Montage showing expression of GTSF1 protein in the ovine ovary obtained by 
Western blotting. Molecular weight marker represents weight in kDa. Lane 1 contains GTSF1 
antibody with GTSF1 blocking peptide. Lane 2 contains the GTSF1 antibody alone.    
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Since the data in this study as well as other studies have shown that the GTSF1 gene is 
expressed solely in the gametes, the protein expressed in the ovine ovary should be 
derived from the oocytes. To confirm this, a second series of 3 replicate Western blotts 
were performed and the expression of the GTSF1 protein was examined in a pool of GV 
oocytes as well as somatic tissues of ovine kidney and lung as shown in Figure 3.15. 
Due to the unavailability of ovine testis samples, the expression of ovine GTSF1 protein 
was compared with protein in the bovine testis and ovary. The results of the Western 
blotting showed that the ovine and bovine ovary both express a 20 kDa protein for 
GTSF1. Similarly the pool of GV oocytes expressed the GTSF1 protein of 20 kDa, 
further confirming the presence of the protein in the female ovine gamete. The protein 
was not expressed in the ovine somatic tissue of kidney and lung, while in the bovine 
testis, the protein was present in 2 forms, 1 of 20 kDa and 1 of 23 kDa.  All 3 replicates 
were consistent in these results.  
 
Figure 3.15: Montage showing Western blotting of GTSF1 protein in ovine ovary tissue, 
bovine testis, ovine somatic tissues of kidney and lung and a pool of GV oocytes. Molecular 
weight marker represents weight in kDa. For each pair of samples, lane 1 contains GTSF1 
antibody with GTSF1 blocking peptide and lane 2 contains the GTSF1 antibody alone. The pool 
of GV oocytes was created from 60 oocytes. 
 
3.4  DISCUSSION 
This study has demonstrated the successful construction of ovine cDNA libraries across 
all stages of folliculogenesis, oocyte development and preimplantation embryo 
development and has used the libraries to map the expression pattern of ovine GTSF1 as 
well as the housekeeper genes GAPDH and H2A and the oocyte-specific gene ZP2 by 
PCR. Specifically, GTSF1 was expressed from primordial to secondary staged follicles 
and in GV and MII oocytes as well as the early cleavage and blastocyst staged embryos, 
while it was not expressed at the secondary and antral stages of follicle development or 
in the ovarian cortex. Furthermore, interrogation of non-ovarian somatic tissue 
confirmed its specificity as a gamete specific gene. These results were confirmed by 
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FISH which showed the cytoplasmic localisation of the gene in the oocytes of early 
stage follicles and its absence from the cytoplasm of oocytes from pre-antral and antral 
follicles. Similarly in the testis, GTSF1 was detected in the cytoplasm of spermatogonia, 
primary and secondary spermatocytes as well as round spermatids. These data 
demonstrate that expression of GTSF1 is gamete specific in the ovine species. The full 
sequence of ovine GTSF1 gene was identified and showed high homology with Bos 
taurus, Mus musculus, Rattus norvegicus and Homo sapiens. Alignment of the predicted 
ovine GTSF1 protein sequence with different species showed a high evolutionary 
conservation of this gene suggesting that it might serve important functions regarding 
developmental processes in the ovine gonad.  
 
The expression analysis of GTSF1 across ovine folliculogenesis and embryogenesis 
reported here is in agreement with other studies performed in different species. 
Specifically, expression of GTSF1 showed similar oocyte-specific patterns in humans 
(JD Huntriss and HM Picton, unpublished data), in bovine (Lu et al., 2012) and mouse 
(Krotz et al., 2009; Yoshimura et al., 2009). The expression of GTSF1 from the early 
follicular stages suggests either that the gene might have a functional role from the early 
stages of development and the activation of early growth of the oocyte and/or that the 
gene might be stored and processed at a later stage of oocyte development. The absence 
of this gene’s expression at secondary and early antral stages might have been observed 
due to the dilution of the genetic material caused by the greater abundance of the 
somatic cells at those follicle stages compared to primordial to primary follicles. 
However, successive FISH analysis confirmed that the gene was not expressed by 
oocytes in secondary and antral follicles further confirming the accuracy of the PCR-
based expression data. The results also showed that the gene was expressed throughout 
the early stages of embryogenesis and following embryonic genome activation that 
occurs after the 8 cell stage in the sheep (Crosby et al., 1988). Even though expression 
of the gene at the earlier embryonic stages could represent residual carryover of 
maternal transcripts, expression at the blastocyst stage suggests that the embryo itself 
transcribes the gene (Crosby et al., 1988). Similarly, studies in humans, sheep, cow and 
mice have shown that the embryo itself expresses oocyte genes following maternal to 
zygotic transition (MZT) even though the timing of embryonic gene activation is 
species-specific (Braude et al., 1988; Crosby et al., 1988; Schultz, 1993; Viuff et al., 
1998). In mouse, MZT occurs at the 2 cell stage, in the bovine species at the 4 cell stage 
while in humans at the 8-16 cell stage (Braude et al., 1988; Schultz, 1993; Viuff et al., 
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1998). In marked contrast to the evidence presented for GTSF1, the majority of oocyte-
specific transcription factors such as NOBOX and FIGLA are known to be expressed in 
the oocyte but not in the subsequent stages of early embryo development (Huntriss et 
al., 2002; Huntriss et al., 2006). Interestingly, Gtsf1 has been shown to be down-
regulated in Nobox deficient mouse ovaries and this might suggest an important role of 
the gene in activation of follicle growth since Nobox in mammalian species is related to 
primordial follicle activation (Rajkovic et al., 2004). However, expression of GTSF1 
after MZT as shown by the results of this Chapter suggests that the gene might be up-
regulated by other transcription factors during preimplantation development. This is 
because the transcripts of NOBOX only exist as residual maternal transcript at the 
preimplantation stage of development and are depleted by the blastocyst stage as shown 
in humans (Huntriss et al., 2006).  
 
Despite some inconsistencies, the gene expression data in Figure 3.4, showed higher 
expression of GTSF1 at the primary follicle and GV and MII secondary oocyte stages, 
which might indicate different functions of the gene at the different stages of oocyte 
development. Similarly, the housekeepers that were selected also demonstrated 
variability in their expression from library to library. For this purpose, 2 widely 
expressed housekeeper genes GAPDH and H2A with relevantly stable expression levels 
in both somatic and gametic cells were included for analysis of their expression to 
verify the successful construction of each library (Jeong et al., 2006; Mamo et al., 
2008). Both of these housekeepers were characterised across oocyte, follicle and 
embryo development and the libraries were verified if at least 1 of the 2 housekeeper 
genes was expressed. Expression of the oocyte-specific zona pellucida gene ZP2 that 
encodes a part of the glycoprotein membrane that surrounds the plasma membrane of 
the oocyte was then examined (Conner et al., 2005). The oocyte-specific gene ZP2 was 
expressed at all stages of follicle and oocyte development while it was not present in the 
analysed somatic cells of the ovary, confirming its specificity as an oocyte expressed 
gene and further validating the successful creation of cDNA libraries. Furthermore, the 
demonstration of ZP2 expression in cDNA libraries from secondary and antral stages of 
follicle development for which GTSF1 was not present, indicated that the oocytes 
contained in these pooled follicle samples were capable of generating a detectable gene 
expression profile, thus confirming the authenticity of the GTSF1 results. ZP2 was also 
shown to be expressed throughout the early stages of embryogenesis, similarly to 
GTSF1, and following the MZT. The above observation is in agreement with other 
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studies in humans where ZP2 was shown to be expressed until the blastocyst stage of 
preimplantation embryo development (Huntriss et al., 2002). 
 
Somatic tissue cDNA libraries from ovine adrenal, lung, kidney, heart and liver tissue 
were examined in triplicate to evaluate the specificity of expression of GTSF1. The 
results showed that GTSF1 was not expressed in any of these somatic libraries 
confirming further its specificity as a germ cell expressed gene in the sheep. The 
housekeeper genes characterised across this series of somatic tissue included ACTB and 
YWHAZ (Chapter 2, Section 2.2.5). Out of the 4 housekeeper genes, GAPDH and H2A 
demonstrated the most stable expression pattern. Additional confirmation of the quality 
of the somatic cDNA libraries was derived from the lack of expression of ZP2 in any of 
the somatic tissue. On the basis of these observations, GAPDH, H2A and ZP2 were used 
as the housekeeper genes and oocyte-specific genes in all subsequent molecular 
analyses reported in this thesis.  
 
Previous studies in mice have shown that GTSF1 has higher expression levels in the 
male germline in comparison to the female (Yoshimura et al., 2009), a result also 
reproduced in the bovine (Lu et al., 2012). This observation could be due to the 
relatively small number of germ cells in the ovary in relation to the somatic cells in this 
tissue type, relative to the testis. To evaluate the expression of ovine GTSF1 in the male 
germline and to further confirm the results observed by RT-PCR in the female germline 
were correct, FISH analysis was conducted on both ovine ovary and testis samples. In 
the ovine ovary, the results showed that GTSF1 was localised in the cytoplasm of 
oocytes from primordial to transitional follicles while in the testis, expression was 
detected in spermatogonia, spermatocytes as well as spermatids. Similar results were 
observed in a study in mouse where ISH confirmed the expression of the gene in the 
oocytes of early stage follicles of the adult mouse (Krotz et al., 2009). The results 
obtained from the FISH analysis of the ovine ovary as reported here confirm the results 
of the PCR-expression mapping study reported earlier.  
 
To further characterise ovine GTSF1, experiments were undertaken to obtain the 
sequence of the ovine gene and protein. The data reported here represent the first report 
of the full coding sequence of the ovine GTSF1 gene. Ovine GTSF1 encodes a 167 
amino acid protein that belongs to the UPF0224 family (Yoshimura et al., 2007). 
Several genes of the UPF0224 protein family are found in several species, including 
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invertebrates, suggesting that the UPF0224 family is of evolutionary significance 
(Yoshimura et al., 2007). From this family, the X. laevis D7 protein has been reported 
and identified using a specific antibody (Smith et al., 1991; Smith et al., 1992). Ovine 
GTSF1 protein as reported here shares a 47% homology to the X. laevis D7 protein and 
is also homologous to other members of the UPF0224 protein family that have been 
previously studied (Yoshimura et al., 2007; Krotz et al., 2009). Like GTSF1, the X. 
laevis D7 appears to have the same oocyte-specific expression profile in oocytes and 
early embryos (Smith et al., 1988). Unlike mammalian GTSF1, D7 mRNA appears to 
be translationally repressed during oogenesis and is only expressed during oocyte 
maturation (Smith et al., 1988). Although it was shown that when D7 mRNA is 
depleted from the oocyte by oligodeoxynucleotide injections the oocyte delays its 
maturation, the effects of D7 in a subsequent study appeared to be non-specific (Smith 
et al., 1988; Smith et al., 1990). Indeed oocyte maturation was  confirmed to be normal 
following depletion of the gene’s mRNA (Smith et al., 1990). Protein D7 synthesis is 
induced by maturation promoting factors including c-Mos, Cyclin B and crude Mpf 
preparations and the D7 protein can be post-translationally modified (Smith et al., 
1992). The precise reproductive function of D7 protein and other proteins that belong to 
the UPF0224 remains to be elucidated.   
 
The deduced products of the UPF0224 family are characterised by 2 tandem copies of 
CHHC Zn-fingers that may be responsible for RNA-binding (Andreeva and Tidow, 
2008). In the Zn-finger motif, there are 2 Cystein and Histidine amino acids that 
associate with the core ion, thus allowing the other amino acids to form a loop structure. 
The α-helix of each loop can bind to specific sites on DNA or RNA (Brown, 2005). 
Both the U11-48K and TRM13 proteins that contain a copy of the CHHC Zn-finger 
motif interact with RNAs (Wilkinson et al., 2007; Turunen et al., 2008). These motifs 
may be involved with RNA-binding; however, at the time of writing, there are no 
reports that show a direct functional interaction between the proteins encoded by the 
UPF0224 family genes and RNAs. Therefore, it is not yet clear whether GTSF1 
functions as an RNA-binding protein during gametogenesis; but this suggestion merits 
further investigation. 
 
Members of the UPF0224 family that appear to be preferrentially expreessed in the 
female and male germline may play important roles during gametogenesis. This was 
shown by Yoshimura et al., (2009) who showed that Gtsf1 is involved in 
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spermatogenesis and retrotransposon suppression in murine testis. Specifically, it was 
shown that male mice deficient of Gtsf1 were infertile and that their spermatogenesis 
was disturbed in the early meiotic prophase I. This sterility was male specific and not 
shown in the Gtsf1 null female mice. Moreover the male Gtsf1 null mice had increased 
expression of Line1 and Iap retrotransposons, suggesting a possible role for Gtsf1  in 
their suppression. Mael, Mili and Miwi2 are other important genes that have been 
decribed to be important for suppression of retrotransposon activity in the testis 
(Carmell et al., 2007; Aravin and Bourc'his, 2008; Soper et al., 2008). Male mice that 
do not have these genes show an arrest of spermatogenesis at the early meiotic stages 
(Carmell et al., 2007), while female mice defficient in these genes do not appear to have 
any phenotypic defects. The reason for this sexual dimorphism  between male and 
female mice mutants has not been determined, but it might be that the cellular 
mechanisms that regulate meiosis I during mammalian meiosis are more stringent  in 
males than females (Hunt and Hassold, 2002).  
 
The Western blotting conducted in this thesis has confirmed the presence of the GTSF1 
protein in the ovine ovary and specifically in the GV oocytes which again supports the 
notion that GTSF1 may play a functional role during oocyte maturation. Specifically, 
GTSF1 encodes a 20 kDa protein present in ovine GV oocytes and the protein was not 
detected in the ovine kidney or lung tissues. Furthermore, in the bovine testis, GTSF1 
protein was shown to be present in 2 forms, 1 of a 20 kDa and 1 of 23 kDa. The 
presence of 2 forms of the protein might be suggesting a post-translational modification 
(PTM) of the protein in the male gonad. The PTM of proteins is considered essential in 
elucidation of complex cellular processes including cell division, growth and 
differentiation (Larsen et al., 2006). The modification of proteins involves changes in 
the polypeptide chain that can be the result of adding or removing specific chemical 
moieties to amino acids, proteolytic processing of protein termini or addition of 
covalent crosslinks between domains of the proteins (Larsen et al., 2006). Although 
there might be species-specific differences between bovine and ovine animals, the 
presence of a modified GTSF1 protein in the bovine testis that is absent from the female 
gonad might account for the sexual dimorphism observed between the sexes following 
Gtsf1 knockout. Other studies have also detected the presence of the GTSF1 protein in 
the gametes. Immunohistochemistry has shown the presence of GTSF1 protein in the 
cytoplasm of germ cell clusters and primordial follicles of newborn mice ovaries and in 
oocytes of secondary and antral follicles of 8-week adult ovaries (Krotz et al., 2009). 
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The above result suggests that species specific differences exist between animals and 
further signifies the importance of determining the role of GTSF1 in the regulation of 
oocyte development in monovular species.  
 
Initial experiments of characterisation of GTSF1 in monovular species conducted in the 
bovine species, showed that GTSF1 mRNA was found in round spermatids and matured 
sperm indicating that the gene acts during post-meiotic spermatogenesis in addition to 
its characterised functions during the early stages of spermatogenesis (Lu et al., 2012). 
In addition, GTSF1 protein was localised within the bovine chromatoid bodies in 
spermatocytes, suggesting that the protein is collaborating with piRNA and associated 
proteins in the regulation of retrotransposon suppression in the male germline, while in 
the bovine female germline, GTSF1 was localised in the P-body (Lu et al., 2012). The 
localisation of GTSF1 with chromatoid bodies and P-bodies in the cytoplasm of both 
male and female gametes adds further weight to the possibility that GTSF1 functions as 
a cargo shuttle to transport RNA and/or proteins between these sub-cellular organelles.  
In further support of this idea, knockout of GTSF1 in male mice demonstrated similar 
phenotypes to Mili and Miwi2 knockouts which are known to moderate meiotic arrest 
and retrotransposon activation (Aravin et al., 2007b; Carmell et al., 2007; Yoshimura et 
al., 2009). Collectively, these data indicate that GTSF1 could be associated with the 
piRNA related pathway for silencing retrotransposon activation during male meiotic 
division in spermatogenesis, while it could also interact with the siRNA pathway in the 
regulation of gene translation in both male and female.  
 
3.4.1 Conclusion 
This work has mapped the expression pattern and confirmed the cellular localisation and 
gamete specificity of GTSF1 in ovine gametogenesis. The high degree of homology of 
the ovine GTSF1 gene and protein sequence with other species together with the 
presence of 2 CHHC-Zn fingers and the cytoplasmic localisation of GTSF1 in the ovine 
oocyte along with GTSF1 protein expression in the oocyte, suggests that this gene may 
be functionally important in the regulation of oocyte development and maturation in this 
species. While the importance of GTSF1 in spermatogenesis and male fertility has been 
established in rodents, the functional significance of GTSF1 to the acquisition of oocyte 
developmental competence in species such as the sheep has yet to be established.  
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Chapter 4: Validation of targeted gene knockdown during the 
IVM of ovine oocytes by the microinjection of siRNA species 
 
4.1 INTRODUCTION  
The acquisition of fertile competence by oocytes and their abilities to support 
subsequent embryonic development encompasses a number of critical biological events 
(Chapter 1, Sections 1.2-1.3). Oocytes must go through cytoplasmic maturation that 
involves preparation for fertilisation, activation and early embryo development as well 
as nuclear maturation so that the chromosomes are reduced to a haploid state (Eppig, 
1996; Picton et al., 1998). When it comes to IVM of oocytes, the culture system must 
fulfil the biological requirements observed in vivo and so support both the cytoplasmic 
and nuclear maturation of fully grown secondary oocytes arrested in prophase I of 
meiosis I (Trounson et al., 2001). In a clinical setting, IVM has been proposed as a safe 
treatment for patients undergoing assisted conception in that it avoids or reduces 
ovarian stimulation with gonadotrophins and possible risks, such as ovarian 
hyperstimulation syndrome (Jaroudi et al., 1997). In humans, this technique was 
originally implemented for the treatment of patients with polycystic ovarian syndrome, 
but the indications are widening to include patients with poor quality embryos in 
repeated cycles of IVF and poor responders to stimulation (Trounson et al., 1994). This 
method is also being used for oocyte donors and fertility preservation in cancer patients 
undergoing gonadotoxic therapy with a number of pregnancies and live births being 
reported (Shalom-Paz et al., 2010). Both in vivo- and in vitro-derived fully grown 
immature oocytes are suitable for IVM. However, despite encouraging results, the 
pregnancy rates following IVM of human oocytes are frequently lower than 
conventional assisted conception treatment and there are many parameters that can 
affect maturation and developmental competence, such as culture media, cumulus 
granulosa cell associations and differentiation, follicle size and atresia at oocyte harvest 
and the inclusion or exclusion of serum in the IVM medium (Junk and Yeap, 2012). In a 
research setting, IVM can be used to study oocyte maturation and the biology of key 
genes involved in oocyte fertility, oocyte quality and early embryo developmental 
potential in vitro.  In the long-term, identification of such genes and factors that affect 
maturation can help improve IVM culture media and the success of assisted 
reproduction.  
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In order for IVM to be successful, the conditions and changes that occur during oocyte 
maturation in vivo must be replicated in vitro, including the autocrine and paracrine 
signalling between the cellular compartments of the follicle and the presumptive gamete 
as described in Chapter 1, Sections 1.2-1.3, that are important to promote oocyte 
meiotic progression (Gilchrist et al., 2006; Cecconi et al., 2008). These interactions 
between cell types in the COC are necessary to drive the preovulatory surged-induced 
changes that promote cytoplasmic and nuclear maturation in addition to a progesterone 
based environment established by granulosa cell steroid synthesis and also hyaluronic 
acid synthesis (Fulka et al., 1998). Hyaluronic acid production by the cumulus cells 
promotes mucification and expansion of the cumulus as well as the loss of gap 
junctional communication with the oocyte (Tirone et al., 1997).  
 
Many approaches have been developed for IVM in different species including sheep 
(Szollosi et al., 1988; O'brien et al., 1996) and human (Trounson et al., 1994). 
Maturation of oocytes can occur spontaneously in vitro as a result of removal of the 
oocytes from their surrounding cumulus cells (Pincus and Enzmann, 1935) or from their 
follicular environment in mice (Hartshorne et al., 1994; Leonardsen et al., 2000). In 
most studies, in vitro cytoplasmic and nuclear maturation is induced following the 
harvest of COCs and placing them in culture, although the time frame of the cultures for 
optimal maturation varies from 24-48 h between species (Trounson et al., 2001). The 
follicle size from which COCs are harvested also affects the developmental competence 
of IVM oocytes. Oocytes from more advanced human follicles as indicated by follicle 
diameter of >10 mm diameter and granulosa production of oestrogen and inhibin A 
have shown greater developmental competence, as indicated by higher maturation rates, 
as well as better fertilisation and embryo development rates when compared with 
oocytes harvested from small antral follicles (<10mm diameter) (Mikkelsen et al., 
2000).  
 
Many studies have shown that the composition and conditions of the IVM culture 
system have a significant effect on oocyte maturation capacity and embryo 
developmental potential (Chauchan et al., 1997; Wang and Day, 2002; Shabankareh et 
al, 2011). Addition of human or bovine serum to the culture media can be effective, but 
studies in several species including cow and sheep have shown that it can lead to 
epigenetic modifications that can result to the large offspring syndrome (Van 
Wagtendonk-De Leeuw et al., 2000; Young et al., 2001). Serum-free medium is 
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considered as a safer option to avoid these epigenetic errors and it is able to support the 
development of oocytes in many species (Keskintepe et al., 1995; Wynn et al., 1998). 
Even so, it has been shown that serum-free media in mouse cultures can lead to 
premature cortical granule release and subsequent hardening of the ZP (Schroeder et al., 
1990). Never-the-less, serum-free medium is considered a far safer option for oocyte 
maturation and embryo culture, while the effects of premature cortical granule release 
are not seen in species other than mice (Wynn et al., 1998; Gandhi et al., 2000). Culture 
of COCs and embryos in groups have been shown to be more beneficial for oocyte or 
embryo developmental competence than single COC and embryo cultures (O'Doherty et 
al., 1997; Brum et al., 2005; Otoi et al., 2002). It has also been shown that the 
blastocyst formation rates of single cultured embryos were significantly increased when 
conditioned medium derived from multiple embryo culture was added to the culture 
medium (Fujita et al., 2006). However the variety of experimental conditions in each of 
the studies does not allow for any joint comparisons.  
 
In an early study (Buccione et al., 1990b), the role of cumulus cells during oocyte 
maturation in vitro and the dialogue between oocytes and cumulus used intact bovine 
COCs collected by puncturing antral follicles from which the oocyte was 
microsurgically removed in order to produce oocytectomised complexes  These 
complexes can be cultured with or without bovine oocytes (Ralph et al., 1995). Results 
of studies of this nature showed that the oocytectomised complexes only expanded in 
the presence of the denuded oocytes showing that cumulus expansion enabling factors 
were released from the oocytes into the surrounding media (Ralph et al., 1995). Further 
studies have also verified the importance of oocytes in granulosa cell proliferation 
(Cecconi and Rossi, 2001; Eppig et al., 2002).  
 
A candidate oocyte-derived gene which contributes to these effects is considered to be 
GDF9 as detailed in Chapter 1, Section 1.2.7. The presence of receptors for GDF9 on 
the oocyte, binding to both TGFB type-1 receptors, ALK5 and BMPRII suggests an 
important role for GDF9 in cell to cell signalling during oocyte growth and maturation 
(Vitt et al., 2000; Mazerbourg et al., 2004). This gene has been shown to have several 
regulatory roles including: cumulus cell progesterone synthesis, suppression of LH 
receptor expression, regulation of granulosa cell growth and cumulus expansion 
(McGrath et al., 1995; Elvin et al., 1999; Elvin et al., 2000; Yan et al., 2001; Dragovic 
et al., 2005). 
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Several methods have been used to study the effect of candidate oocyte genes on follicle 
development. These include the generation of gene knockouts in mice (Koller et al., 
1989; Roy and Matzuk, 2006). Other techniques include the use of antibodies (Nepom 
et al., 1981), antagonists (Nakajima et al., 1995), Morpholino oligos (Heasman, 2002), 
ribozymes (Bertrand et al., 1994) and antisense transcripts of genes (Korneev et al., 
1999; Huppi et al., 2005). The use of RNAi is an alternative method which exploits the 
naturally occurring post-transcriptional gene silencing mechanism, triggered by 
miRNAs. RNAi can be used as a tool to study both the molecular and cellular events 
during oocyte development and maturation. This can be achieved by silencing 
expression of single or multiple genes at different levels (Schellander et al., 2007). 
Knockdown of specific genes within individual cells has the advantage over traditional 
knockout experiments in that this technique can be directly applied to specific stages of 
oocyte development rather than eliminating expression of the gene throughout all stages 
of oogenesis. Other synthetic methods besides the endogenous method of RNAi-
induced gene silencing, have also been developed, with second generation approaches 
involving the use of asymmetric siRNAs that reduce some of the off-target effects of 
RNAi effectors (Sibley et al., 2010). When it comes to studies of the oocyte and 
embryo, microinjection is the preferred delivery system for the introduction of siRNAs 
(Svoboda et al., 2000). In comparison with other techniques such as electroporation and 
transfection, microinjection is easy to apply to oocytes. With this method it is relatively 
easy to control the volume of siRNA introduced into the oocyte which is very important 
for it to produce the desired phenotype (Paradis et al., 2005). Microinjection and 
specifically intracytoplasmic sperm injection is routinely used in assisted conception 
treatment (Palermo et al., 1992).  
 
Within the last 2 decades, a small number of studies have used RNAi to target different 
genes in order to elucidate gene function in oocytes and embryos as detailed in Chapter 
1, Section 1.5.2. In order to investigate the effect of gene knockdown in GV oocytes on 
oocyte maturation, it is necessary to microinject siRNA species into denuded GV 
oocytes. As stated above, removal of the oocyte from the COC environment can trigger 
the spontaneous resumption of meiosis (Pincus and Enzmann, 1935). Therefore, in 
order to allow the injected siRNA species time to take effect, the oocyte meiotic 
maturation resumption has to be temporarily prevented. This can be achieved using 
inhibitory molecules that prevent meiotic maturation by antagonising the effects of a 
specific PDE as detailed in Chapter 1, Section 1.3. From the 5 PDEs that have been 
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identified to date, inhibitors of PDE3 can inhibit both second messengers cAMP and 
cGMP by hydrolysing the PDE bond (Conti, 2000). In this way MPF and MAPK are 
upregulated allowing the cell cycle to progress. The successful inhibition of meiotic 
maturation using PDE3 inhibitors has been shown in both sheep and mice (Cotterill, 
2008; Gui and Joyce, 2005).  
 
A candidate oocyte-specific gene whose role in oocyte maturation has been tested by 
RNAi is GDF9. Specifically, Gdf9 long dsRNAi injections into murine oocytes resulted 
in decreased cumulus expansion accompanied by a decreased mRNA level of Has2 and 
Ptgs2-both are markers of cumulus expansion (Gui and Joyce, 2005). Similarly, during 
ovine oocyte maturation, injection of dsRNA for GDF9 into denuded GV oocytes 
resulted in reduced cumulus cell expansion when oocytectomised cumulus shells were 
co-cultured with the injected oocytes (Cotterill, 2008). This effect was accompanied by 
lower mRNA expression levels of HAS2 and GREMLIN in the oocytectomised cumulus 
shells (Cotterill, 2008). In the above study the PDE3 inhibitors milrinone or cilostamide 
were used to inhibit meiotic progression of murine (Gui and Joyce, 2005) and ovine 
(Cotterill, 2008) oocytes respectively. Validation studies of the inhibitory efficacy of 
cilostamide for dsRNAi in sheep oocytes indicated that 20 mg/ml of cilostamide 
retained a higher percentage of oocytes at the GV stage compared to other cilostamide 
doses and to all concentrations of milrinone tested (Cotterill, 2008). Following siRNA 
uptake by the oocyte and the inhibition of meiosis, oocytes must then be removed from 
the inhibitory environment and the bi-directional communication between the oocyte 
and cumulus cells must be re-established to allow for maturation to progress. This can 
be achieved by oocytectomy of COCs as described by Buccione et al., (1990b) followed 
by co-culture with the dsRNA injected oocytes (Gui and Joyce, 2005; Cotterill, 2008). 
Further studies are needed to validate the use of IVM in conjunction with siRNA as a 
vehicle to study the function of novel genes during ovine oocyte maturation and 
cumulus expansion. 
 
4.1.1 Aims  
The aims of this chapter were therefore to use GDF9 as a candidate gene to establish 
siRNA as a means to knockdown genes in ovine oocytes and to study their effects on: 
1. Oocyte meiotic progression 
2. Cumulus mucification and expansion 
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The end points of gene knockdown evaluations will be based on morphological 
evaluations of the oocyte and cumulus cells as well as molecular evaluation of oocyte 
and cumulus gene expression following 24 h of co-culture with oocytectomised 
cumulus shells using a serum-free IVM system. 
 
4.2  MATERIALS AND METHODS 
This experimental series used the physiological, serum-free IVM system which had 
been previously been developed for sheep oocytes by Cotterill et al., (2012). The 
cultures were conducted during the sheep breeding season (Ortavant et al., 1988), 
between October 2008 and February 2009 as well as between October and November 
2009. Tissue was collected from the abattoir twice a week on consecutive days during 
this period. The procedures detailed in Chapter 2, Section 2.1 were used to harvest 
COCs. All culture media compositions and conditions were as described in Chapter 2. 
All oocyte recovery procedures and manipulations were conducted on a microscope 
fitted with heated stage at 39°C. All media were prepared the day before use and all 
culture dishes, media and oil were prepared a minimum of 3 h before use and allowed to 
equilibrate at 39°C under appropriate incubation conditions.  
 
4.2.1 Experiment 1: Pilot evaluations of microinjection methodology 
Before proceeding with the IVM of oocytes, a pilot experimental series was conducted 
to test the efficiency of the injection methodology developed by Cotterill (2008). The 
first experimental series consisted of 3 replicate cultures in which GV oocytes were 
injected either with a fluorescent dye or buffer and then visualised under a fluorescent 
microscope to confirm that (i) microinjection had taken place and (ii) that the oocytes 
survived the injection procedure. For each culture, following their collection, COCs 
with an intact cytoplasm and more than 3 layers of cumulus cells surrounding the 
oocytes were selected and the COCs were transferred to a 35 mm sterile nunc dish 
containing 2 ml of pre-warmed H199
+
. The COCs were then divided equally into 2 
groups. The oocytes from different groups were transferred into separate 35 mm nunc 
dishes that were prepared prior to the culture and kept in the non-gassed incubator at 
39°C. For this experiment, 2 sets of 5 oocytes were transferred into individual 20 μl 
drops of H199
+
 contained in each of the injection plates. One dish was used for 
treatment, the other contained control oocytes. Each of the 2 dishes was comprised of 4, 
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20 μl drops and 2 central drops containing 10 μl of H199+, overlaid with mineral oil as 
shown in Figure 4.1. 
 
Figure 4.1: Schematic representation of the constitution of the denudation and microinjection 
35 mm nunc dish. A, B, E, F: 20 μl drops containing H199+. C-D: 10 μl injection drops 
containing H199
+
. A-B: 5 oocytes are placed in each collection drop for denudation. E-F: 
Denuded oocytes are transferred in the wash drops before each group of 5 oocytes are 
transferred in drops C-D: where injections took place. The arrows indicate oocyte movements 
between drops.   
 
After transferring the COCs into the collection drops, both dishes were placed back in 
the non-gassed incubator. One dish at a time was taken out of the incubator and placed 
on the stereo microscope; COCs were denuded by gentle repeat pipetting using a flexi-
pet attached to a 170 μm pipette tip. Pipetting was performed for less than 1 min for 
each of the 5 oocytes. Denudation was then completed by additional repeat pipetting 
using a 140 μm pipette tip until all of the oocytes were completely denuded. The 2 sets 
of 5 denuded oocytes were transferred through the wash drop and placed into the 
adjacent 10 μl drops of H199+ located in the centre of each dish. The dish was placed on 
the stage of the micromanipulation system which consisted of an Olympus IX70 
inverted microscope fitted with Hoffman modulation contrast optics and heated stage at 
39°C (Olympus Ltd), Integra Ti micromanipulators (Research Instruments Ltd, 
Cornwall, UK) and a Sony ex-wave HAD digital camera  (Sony, Pencoed, UK). For this 
pilot experiment, 1 holding and 2 injection pipettes (bore of 5-6 μm) were adjusted on 
an angle of 35° (MIC-50-30, Humagen, Charlottesville, USA). The first injection 
pipette was preloaded with 0.557 mg/ml (w/v) carboxyfluorescein succinimidyl ester 
(CFSE, Invitrogen Ltd) in Ca
2+
 and Mg
2+
-free DPBS solution (Invitrogen Ltd). Loading 
was performed by applying negative pressure using an SAS air syringe (Research 
Instruments Ltd) with the injection pipette held on a Leica DM IL microscope (Leica 
Microsystems Ltd) inserted in a 10 μl drop of injection medium in a 35 mm nunc plate 
under oil. The loaded injection pipette containing CFSE and the holding pipette were 
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inserted into the Integra Ti micromanipulation system and were aligned to the same 
plane with 35° angle to the injection plate. Following adjustment of the tips so the 
pipettes were at the same level as the injection plate, the pipettes were lowered into the 
first drop that contained 5 denuded oocytes. The magnification of the microscope was 
then increased from low power (40X) to high power magnification (400X) to obtain 
better visualisation of the oocyte, alignment of the pipettes to the same plane and 
optimal control of the injection process. Each oocyte in the drop was consecutively held 
with the holding pipette by applying negative pressure by mouth pipetting and the 
injection pipette was used to puncture the ZP and oolemma and enter the cytoplasm of 
the oocyte. The injection pipette outflow was based on a constant outflow 
microinjection system (Femtojet, Eppendorf Ltd, Stevenage, UK). The appropriate flow 
rate for the microinjection system which provided the best survival rates was previously 
optimised at 40 hPa (Cotterill, 2008).  
 
Each oocyte was injected with approximately 10 pl of CFSE, before the injection 
pipette was removed. The injected oocyte was then released from the holding pipette 
and the rest of the oocytes in the drop were injected following the same procedure, 
ensuring that the injected oocytes were kept in different areas of the drop from the 
uninjected cells. After injecting all 5 oocytes in the drop, the magnification power was 
lowered, pipettes were lifted and the same process was repeated for the second drop 
containing the other 5 oocytes. After injection of all 10 oocytes with CFSE, the dish was 
placed back in the non-gassed incubator and held at 39°C. The same process was then 
followed for the dish containing the control group of COCs. Following denudation, the 
oocytes of this dish were injected with a different injection pipette loaded with DPBS 
solution, using the same process as described above.  
 
The CFSE injected oocytes were compared against the DPBS injected oocytes under a 
fluorescence microscope. In order to compare the 2 groups, oocytes were washed in a 4 
well dish containing 500 ml of DPBS to remove any excess CFSE and 10 μl of DPBS 
containing the oocytes were then transferred onto Superfrost Plus microscope slides 
(Thermo Fisher Scientific) and overlaid with a number 1 thickness coverslip (0.13-0.16 
mm) onto vaseline pillars. The oocytes from the 2 different groups were then visualised 
using an epi-fluorescence Zeiss Axiovert microscope (Carl Zeiss Ltd) attached to a 
digital smart capture image system (Applied Imaging International, Newcastle upon 
Tyne, UK) using spectrum green filter (495/520 nm). 
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4.2.2 Experiment 2: Optimisation of GDF9 knockdown using siRNA and IVM of 
ovine oocytes 
Following validation of the microinjection system, the physiological, serum-free, IVM 
system for ovine oocytes was used in conjunction with microinjection to assess the 
efficacy of 4 different GDF9 siRNAs in creating a gene specific knockdown. The 
previous studies of Gui and Joyce, (2005) and Cotterill, (2008) had both used dsRNA 
for oocyte gene knockdown. The siRNA oligos used for GDF9 knockdown here were 
synthesized by Invitrogen Ltd based on the sequence of ovine GDF9 and the oligo 
sequences used are shown in Table 4.1. Four siRNA oligos were generated and each 
oligo was assessed by the company to decrease homology with other genes in order to 
guarantee that at least 2 of the siRNAs would result in a gene specific knockdown. 
 
Table 4.1:  GDF9 siRNA oligo sequences 
Primer Sequence 
 
GDF9 siRNA-1 
 
Sense : r(CAG UGG AUG UGC UGU UUA UUA A)dTdT 
Antisense : r(UUA AAC AGC AGA UCC ACU G)dAdT 
 
GDF9 siRNA-2 
 
Sense : r(CGU UUA UAA AGA AUA UGA A )dTdT 
Antisense : r(UUC AUA UUC UUU AUA AGC G )dAdT 
 
GDF9 siRNA-3 
 
Sense : r(GAA CAU CAU CCA UGA GAA A)dTdT 
Antisense : r(UUU CUC AUG GAU GAU GUU C )dTdG 
 
GDF9 siRNA-4 
 
Sense : r(AGA GCU CCA UAC UCA UUU A )dTdT 
Antisense : r(UAA AUG AGU AUG GAG CUC U )dAdG 
 
The efficacy of these oligos in providing a GDF9 knockdown was assessed in a series 
of 4 replicate cultures each conducted using 1 of the 4 GDF9 siRNA sets of oligos. In 
each culture, oocytes were divided into 2 groups and injected either with 1 of the 4 
GDF9 siRNA species or Ca
2+
 and Mg
2+
-free DPBS buffer (controls).  The RNAi system 
utilised here was based on a 3 day culture system which had been extensively validated 
by Cotterill, (2008). This approach maintains the meiotic arrest of ovine denuded GV 
oocytes by 24 h incubation in 20 mg/ml of the PDE3 inhibitor cilostamide (Tsafriri et 
al., 2005). The following protocol was used: 
 
Day 1: siRNA microinjection and culture of oocytes 
Ovaries and COCs were collected as detailed in Chapter 2, Sections 2.2.1-2. After 
assuring that only good quality COCs had been selected, the oocytes were divided 
equally into 2 groups, the GDF9 siRNA injection group and the buffer injection control 
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group. For the microinjections, 2 injection pipettes were used in consecutive order, with 
the first injection pipette loaded with 1 of the 4 GDF9 siRNA species and the second 
loaded with DPBS for control oocytes. Three denudation and injection dishes were 
prepared for each group (a total of 6 dishes) similar to the dish as shown in Figure 4.1, 
with the difference that the central drops of 10 μl of H199+ were also supplemented with 
20 mg/ml cilostamide to prevent the GV oocytes from resuming meiosis. Up to 30 
oocytes were transferred to the denudation and injection dishes for each group per 
culture, based on the availability of good quality COCs. After denudation, wash and 
transfer of the oocytes into the central injection drop containing cilostamide, 1 
microinjection dish was processed for microinjection at a time.  
 
After injecting all 10 oocytes in the dish as detailed in Section 4.2.1, the oocytes were 
transferred to a fresh 35 mm nunc dish and washed in an 18 μl central drop containing 
serum-free media supplemented with 20 mg/ml cilostamide and basal levels of 
gonadotrophins (0.5 ng/ml of FSH, 0.1 ng/ml of LH), overlaid with mineral oil. These 
gonadotrophin concentrations represent the basal gonadotrophin levels required to 
support the growth of small antral follicles < 2 mm in vivo (Picton et al., 1990; Picton 
and McNeilly, 1991) and in vitro (Newton, 1998); this gonadotrophin concentration 
does not trigger preovulatory maturation. The culture dish was made up of 4 microdrops 
each containing 18 μl of serum-free culture media with 20 mg/ml cilostamide. A total of 
6 identical culture dishes were prepared for each group of 10 oocytes (3 dishes per 
treatment), to avoid exposuring the oocytes to adverse temperature and pH fluctuations. 
The microdrop volume used for serum-free media has previously been optimised as 2 μl 
per denuded oocyte (Danfour, 2001). Using a pipette, all 10 oocytes were transferred in 
a volume of 2 μl from the centre drop to an adjacent drop to wash and then they were 
transferred again into a volume of 2 μl to another drop to give a final culture drop 
volume of 20 μl (containing 10 oocytes). The dish was then placed in the gassed 
incubator at 5% CO2, 6% O2 and 89% N2 atmosphere and kept at 39°C for a 24 h 
culture. The time at which each dish was placed into culture was noted. The same 
process was then followed for the remaining 2 dishes containing denuded oocytes 
injected with the same GDF9 siRNA species. The process of denudation-injection and 
placing into culture was followed to completion for 10 oocytes at a time. After placing 
all 3 dishes of the same injection group into culture, the injection pipette was replaced. 
The new injection pipette was loaded with DPBS for injection of control oocytes and 
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the process was repeated for the remaining 3 dishes as detailed previously. The 
procedure used is summarised in Figure 4.2. 
 
 
Figure 4.2: Schematic representation of the siRNA procedure and culture system. 
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Day 2: Oocytectomy of COCs and IVM co-culture with gene knockdown oocytes 
Only the oocytes that survived the microinjections were selected for progression to the 
maturation stage of the experiment. The survival of oocytes was assessed after 24 h of 
culture using NR dye. This dye stains lysosomes red and is used as a vital stain because 
it can be applied to living cells without killing them (Winckler, 1974). This staining 
method has previously been validated for use on ovarian tissue by Chambers et al., 
(2010) and granulosa cells (Campbell et al., 1996). Furthermore, NR has been used to 
confirm the viability of ovine oocytes following microinjections (Cotterill, 2008). After 
24 h incubation (as noted by the time each dish was placed into culture), each group of 
10 injected oocytes was collected into a volume of 2 μl and added to a central drop of a 
35 mm nunc dish that contained 4, 18 μl micro-drops each comprised of serum-free 
media with cilostamide (as above) and further supplemented with 50 μg/ml NR 
solution. Once again a total of 6 dishes were prepared and allowed to calibrate at 39°C 
in the gassed incubator; oocytes were incubated in NR solution for 30 min. The viable 
oocytes stained red were selected for co-culture with cumulus shells on day 2, in order 
to assess the impact of GDF9 knockdown on meiotic progression and cumulus 
expansion and mucification. Oocytes which did not stain red were considered to be un-
viable and were discarded.  
 
In parallel, fresh COCs were collected from a second set of ovine ovaries. Freshly 
harvested oocytectomised COCs generated as described previously by Buccione et al., 
(1990b) and Cotterill, (2008), were cultured with viable, siRNA-injected oocytes to 
target the impact of gene knockdown on the 2 way communication between the oocyte 
and cumulus compartment. Approximately 30 COCs were oocytectomised for each day 
2 co-culture for which 3 injection dishes were prepared. Following, 2 groups of 5 COCs 
were placed in the 2, 10 μl drops of H199+ contained in each of the 35 mm nunc dishes 
and overlaid with mineral oil and placed back in the non-gassed incubator at 39°C. The 
Olympus microinjection system was setup as detailed for day 1, with the difference that 
the injection pipette was not loaded and a manually made holding pipette was used. The 
holding pipette was manually made using a microforge by pulling glass pipettes 
(0.78x1.00x80mm, Science Products, Hofheim, Germany) so that the diameter of the 
opening of the holding pipette was wider than the tip of the injection pipette but did not 
exceed the diameter of a GV oocyte (<120 μm). The pipettes were then aligned to the 
same plane at a 35° angle to the injection dish. One dish was then placed on the heated 
stage of the micromanipulation system and the pipettes were lowered and aligned with 
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the COCs. The magnification was then increased as in day 1 and each COC was held by 
the holding pipette operated by mouth suction while the injection pipette was manually 
guided to penetrate right-through both sides of the zona and oolemma of the oocyte and 
into the holding pipette. Slow movements of the injection pipette were applied in order 
to create an opening in the zona from where the cytoplasm and nucleus of the oocyte 
could be removed. By applying negative pressure on the holding pipette using mouth 
suction, the cytoplasm and nucleus of the oocyte was aspirated from the COC leaving 
an intact cumulus shell surrounding an empty oocyte. Cumulus shells were then graded 
for their degree of cumulus coverage ranging from 0-2 according to the system 
previously used (Wynn et al., 1998).  
Coverage classification 0:  0-3 layers of cumulus cells surrounding the oocyte. 
Coverage classification 1:  3-10 layers of cumulus cells. 
Coverage classification 2:  More than 10 layers of cumulus cells.  
The graded cumulus shells were then allocated equally into 2 groups based on their 
classification. The higher grade shells from each group were selected for co-culture with 
the denuded GDF9 siRNA- and buffer-injected control oocytes. Separate equilibrated 
IVM dishes were prepared for the co-cultures for each oocyte treatment. Each of the 6 
dishes contained 4, 18 μl drops of serum-free IVM media (Chapter 2, Table 2.3) with 
maturation-inducing levels of FSH (100 ng/ml, bioactivity 0.91 U/ml) and LH (100 
ng/ml, bioactivity 0.55 U/ml) overlaid with mineral oil and kept in a gassed incubator at 
39°C. The levels of FSH and LH used were equivalent to the preovulatory 
gonadotrophin surge measured in the peripheral circulation of sheep in vivo (Baird and 
McNeilly, 1981) and have previously been shown to drive high levels of sheep oocyte 
maturation in vitro (Cotterill et al., 2012). It was vitally important to use the appropriate 
volume of medium for the IVM and co-cultures with cumulus cells, as it is essential to 
maintain the paracrine interaction between the oocyte and the cumulus cells in co-
culture. The volume of medium used for IVM and co-culture here has previously been 
optimised at 4 μl for single oocyte and single cumulus shell pairs (Cotterill, 2008). After 
24 h of microinjection and knockdown culture in cilostamide and basal levels of FSH 
and LH, viable oocytes as indicated by NR positive staining were transferred into the 
central drop of each IVM dish. For each oocyte that survived the first 24 h of culture, 1 
oocytectomised cumulus shell was also transferred into the central drop. A group of 5 
injected, denuded oocytes along with 5 cumulus shells were then transferred to an 
adjacent drop in a pipette volume of 2 μl; the final IVM culture volume was 20 μl for 
each group of 5 oocytes and 5 cumulus shells. The volume of the culture drop was 
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adjusted to maintain the correct ratio of oocyte and cumulus shell/4 μl of medium when 
fewer or more oocytes from each plate had survived the first 24 h of culture. The dish 
was then placed in culture at 39°C for 24 h at 5% CO2, 6% O2 and 89% N2 atmosphere. 
The process was repeated for all culture dishes and the IVM start time was recorded for 
each culture dish.  
 
Day 3: Developmental assessments 
At the end of the 24 h IVM and co-culture period, oocyte survival was assessed by NR 
red as detailed above. Oocytes from each dish that survived the complete 48 h culture 
were separated from the cumulus shells and transferred to a 4 well dish containing 500 
μl of pre-warmed H199+. Oocyte maturation was then assessed by examining the MII 
progression of oocytes as determined by the presence of a polar body visualised under 
the stereo microscope. To confirm the meiotic progression of oocytes following 
injection with either GDF9 siRNA or DPBS buffer, additional staining with 4´-6 
Diamidino-2-phenylindole (DAPI) was applied. Half of the oocytes that progressed to 
the MII stage from each of the 2 injection groups were used for staining while the rest 
of the oocytes were used for molecular evaluation of gene knockdown. The DAPI 
reagent passes through intact cell membranes and it can stain both live and fixed cells 
by producing a blue fluorescence with excitation at 360 nm and emission at 460 nm 
(Kapuscinski, 1995). Oocytes were stained with 5 μg/ml DAPI in 500 ml of DPBS for 
15 min at RT. After this time, 10 μl of DPBS containing the oocytes were pipetted onto 
a glass slide and the oocytes were overlaid by a coverslip onto vaseline pillars and 
viewed using a fluorescence microscope. The oocytes that were not used for staining 
with DAPI were washed in 500 μl of DPBS in a 4 well dish and groups of 1-2 MII 
oocytes were transferred to a sterile 1.5 ml microcentrifuge tube containing 10 μl of 
lysis buffer (Chapter 2, Table 2.4). Samples were snap-frozen in liquid nitrogen and 
stored in -80°C for subsequent molecular analysis. The cumulus shells from the co-
cultures of the 2 injections groups were also assessed for their developmental 
competence. The degree of cumulus expansion was recorded according to the 3 
classifications as used previously (Wynn et al., 1998).  
Expansion classification 0:  Exhibited very poor or no expansion characterised    
                                             by compact cumulus bundle. 
Expansion classification 1:  Demonstrated a degree of partial expansion, where   
                                             the cumulus mass was partially loosened. 
Expansion classification 2:  Showed full expansion, where the cumulus mass  
                                             was fully mucified.   
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Cumulus shells were transferred into a well of a 4 well dish that contained 500 ml of 
DPBS where they were washed. From there, a set of 2 representative cumulus shells 
from each culture drop based on cumulus expansion assessment were transferred into a 
sterile 1.5 ml microcentrifuge tube that contained 10 μl of lysis buffer. Samples were 
then immediately snap-frozen in liquid nitrogen and stored in -80°C until subsequent 
molecular analysis. 
 
4.2.2.1 Molecular evaluation of GDF9 knockdown  
The stored pools of 1-2 knockdown MII oocytes for each of the GDF9 siRNA species 
along with their respective injection controls containing equal numbers of oocytes were 
thawed and the mRNA isolation procedure was followed as described in Chapter 2, 
Section 2.2.2. In the final step of the isolation and extraction procedure, samples were 
re-suspended in 3 μl of Tris-HCl (Dynal, Invitrogen Ltd) and placed on a hot block set 
at 90°C for 2 min, before the mRNA was separated from the Dynal magnetic bead 
apparatus. The cDNA synthesis by reverse transcription was then performed as 
described in Chapter 2, Section 2.2.3. Real-time PCR was used to quantify the transcript 
level of ovine GDF9 relative to the expression of housekeeper genes GAPDH and H2A 
for the 2 treatment groups (Chapter 2, Table 2.7). The primer sequence information used 
for ovine GDF9 is shown in Table 4.2. Real-time PCRs were run in triplicate per 
sample. The siRNA species that provided the highest levels of GDF9 knockdown in 
comparison with their respective controls were selected from each culture for 
subsequent molecular analysis.  
 
Table 4.2: Primer sequences of ovine GDF9 used for real-time PCR 
Gene Primer Sequence Size (bp) Reference 
GDF9 
ovine 
F: 5´ AGTAAGCTGGAACCGGAATCG 3´ 
95 
AF078545 
(ovine) R: 5´ GGTGGCCGACAAGAGAAGTCT 3´ 
 
4.2.3 Experiment 3: Assessment of the impact of GDF9 knockdown on ovine oocyte 
maturation and cumulus expansion in vitro 
Following evaluation of the efficacy of the siRNA species in creating a GDF9 
knockdown in GV oocytes, a series of 10 cultures were conducted using the most 
efficient siRNA species in creating a GDF9 knockdown. The methodology followed 
was the same as described above. An average of 100 COCs were collected per culture, 
from which around 60 oocytes were microinjected. For the 10 cultures, a total of 302 
oocytes were injected with GDF9 siRNA, while 301 oocytes were injected with buffer, 
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averaging around 30 oocytes per injection group per culture. The effects of GDF9 
knockdown on oocyte meiotic progression, cumulus expansion and gene expression 
were assessed. Morphological assessments of the knockdown included oocyte survival 
as assessed by NR at 24 and 48 h of culture as well as developmental assessments based 
on cumulus expansion after co-culture and morphological evaluation of oocyte nuclear 
status (presence/absence of the first polar body) in comparison with the buffer-injected, 
control oocytes. All the oocytes that progressed to the MII stage were used for 
molecular evaluations following the methodology described above (Section 4.2.2.2). 
Initial molecular evaluations were performed for each culture to determine the degree of 
GDF9 knockdown in cDNA libraries generated from pools of 1-2 MII siRNA-injected 
oocytes in comparison with their respective control cDNA libraries containing an equal 
number of MII buffer-injected oocytes. The mRNA levels of GDF9 were quantified 
relative to the expression of H2A and GAPDH, both of which have been shown to be 
stable for the normalisation of gene expression data in the oocyte and early embryo 
stages (Gal et al., 2006; Jeong et al., 2006; Mamo et al., 2007). Oocyte expression of 
BMP15 was also quantified relative to the 2 housekeeper genes to evaluate any off-
target effects of the GDF9 siRNA species. This method of evaluating the specificity of 
Gdf9 knockdown by interrogation of Bmp15 expression levels following RNAi has been 
used previously in murine studies (Gui and Joyce, 2005).  
 
The impact of oocyte GDF9 knockdown on the relative mRNA expression of a range of 
candidate genes in the cumulus shells generated following co-culture with siRNA-
injected oocytes and buffer-injected control oocytes was also assessed. Cumulus cell 
target analysis was conducted on the sets of 2 cumulus shells originating from the co-
culture drops with oocytes that progressed to the MII stage and demonstrated significant 
levels of GDF9 knockdown. These were compared to the sets of 2 cumulus shells 
originating from the co-culture drops with oocytes that were used as controls for the 
verification of GDF9 knockdown. The same process as described in Section 4.2.2.1 was 
followed for the generation of cDNA libraries from stored cumulus shell samples. The 
list of genes analysed included potential targets of GDF9 that are associated with 
cumulus mucification and expansion such as HAS2 (Usui et al., 1999) and GREMLIN1 
(Gui and Joyce, 2005), genes considered to be regulated by paracrine factors from the 
oocyte including AMH (Kitahara et al., 2012) and LDH1 (Moore et al., 2007), as well as 
members of the EGF family and signalling molecules including AREG (Cotterill et al., 
2012), EREG (Zimin et al., 2009) and BTC (Cotterill et al., 2012), which are induced by 
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LH in mural granulosa to bind to the EGFR and promote COC maturation (Salmon et 
al., 2004; Hussein et al., 2005; Hsieh et al., 2007; Sugiura et al., 2009). The relative 
levels of the receptors in the cumulus cells were also analysed for EGFR (Elsik et al., 
2009), FSHR (Chu et al., 2012a) and LHR (Bacich et al., 1994). The primers for the 
genes used for real-time PCR for the evaluation of the role of GDF9 knockdown are 
shown in Table 4.3. The cumulus samples for the real-time PCR analysis were run in 
triplicates and the mRNA levels of the target genes were quantified relative to the 
expression of GAPDH and H2A. 
 
Table 4.3: Primer sequences of targets genes following GDF9 knockdown used for real-time 
PCR 
Gene Primer Sequence Size (bp) Reference 
BMP15 
F: 5´ GGCAAAAGCTCTGGAATCACA 3´ 
102 
AF236079 
(bovine) F: 5´ TGCCATGCCACCAGAACTC 3´ 
HAS2 
F: 5´ GCCACGGTAATCCAGCTCTTC 3´ 
107 
NM174079 
(bovine) R: 5´ AGGCAGCTGGCAAAAGATGA 3´ 
GREMLIN1 
F: 5´ GAAGCGAGACTGGTGCAAAAC 3´ 
93 
AY942576 
(ovine) R: 5´ CCGTAGCAGAAGCGGTTGA 3´ 
AMH 
F: 5´ TGGTGCTGCTGCTAAAGATG 3´ 
99 
NM173890 
(bovine) R: 5´ GACAGGCTGATGAGGAGCTT 3´ 
LDH1 
F: 5´ ATCTCCAACATGGCAGCCTTT 3´ 
103 
BC146210 
(bovine) R: 5´ GCCCCAGCTGTGATAATAACCA 3´ 
AREG 
F: 5´ AAAAGGGAGGCAAAAATGGA 3´ 
170 
(Cotterill et al., 
2012) R: 5´ CTTTTCCCCACATCGTTCAC 3´ 
EREG 
F: 5´ AGTCCACAGCTGGCTAGGAA 3´ 
140 
XM2688367 
(predicted bovine) R: 5´ CGGGTTTTGTGGAAGACAAT 3´ 
BTC 
F: 5´ GACCGAGGCACTGGTACATT 3´ 
178 
(Cotterill et al., 
2012 R: 5´ GTCGGACAAAGCTGTTTGCT 3´ 
FSHR 
F: 5´ CAGGACAGCAAGGTGACAGA 3´ 
188 
NM1009289 
(ovine) R: 5´ GGCAGGTTGGAGAACACATT 3´ 
LHR 
F: 5´ CACGGTACCAGGAAATGCTT 3´ 
145 
L36329 
(ovine) R: 5´ CAGGTGTGCATTCTCCTTCA 3´ 
EGFR 
F: 5´ GAGGTGGTCCTTGGGAATTT 3´ 
137 
XM592211 
(predicted bovine) R: 5´ AGGTTTTCCAGCGGAATCTT 3´ 
 
4.2.4 Experiment 4: Assessment of the effect of gonadotrophins on maturation and 
cumulus expansion following GDF9 knockdown in ovine oocytes 
Due to the poor survival rates recorded in the early pilot studies, the effect of 
gonadotrophins on the survival and IVM potential of oocytes injected with GDF9 
siRNA and buffer was assessed. This was conducted by altering the concentration of 
gonadotrophins during the cumulus and IVM co-cultures established on day 2. The 
effect of high maturation-inducing levels of FSH (100 ng/ml) and LH (100 ng/ml) 
associated with the preovulatory surge (Baird and McNeilly, 1981; Cotterill et al., 2012) 
were compared to the basal concentration of gonadotrophins used to maintain follicle 
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growth in vivo and in vitro (0.5 ng/ml FSH, 0.1 ng/ml LH) (Picton et al., 1990; Picton 
and McNeilly, 1991; Newton, 1998). The effects of LH and FSH on oocyte nuclear 
progression and cumulus behaviour were assessed following 24 h of cumulus IVM co-
culture as described in Section 4.2.2. A series of 8 cultures were conducted as described 
in Section 4.2.2.1 with maintenance of the FSH and LH levels at basal concentrations 
during the IVM and cumulus co-cultures. Data from the high gonadotrophin IVM 
cultures reported in Experiment 3 were compared with the basal gonadotrophin culture 
series.  
  
4.2.5 Statistical analysis 
Chi-square tests were used to analyse the results of oocyte survival, meiotic 
progression, cumulus coverage and cumulus expansion according to proportional 
analysis of the total cohort of oocytes and cumulus within each treatment. All data were 
checked for normality using the Anderson-Darling test and Student’s t-test was used for 
normally distributed data including GDF9 and BMP15 mRNA levels in oocytes and 
HAS2, GREMLIN1, AMH, LDH1, AREG, EREG, BTC, EGFR, FSHR and LHR in 
cumulus cells. Values presented for real time data are the arithmetic means ±SEM for 
the number of observations shown. The presentation format used for both the culture 
data and real time data has previously been used by Cotterill et al., (2012). Results for 
IVM and gene knockdown were evaluated for the total numbers of oocytes treated 
across all cultures. 
 
4.3 RESULTS 
Overall, 1058 oocytes were microinjected over 4 experimental series; of these 538 
oocytes were microinjected with GDF9 siRNA and 520 control oocytes were 
microinjected with DPBS buffer in a total of 18 cultures. 
 
4.3.1 Experiment 1: Pilot evaluations of microinjection methodology 
A total of 30 denuded oocytes were injected with CFSE, while 30 oocytes were injected 
with DPBS buffer over 3 repeat cultures (10 oocytes per group per culture). The 
injection methodology is shown in Figure 4.3. 
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Figure 4.3: Microinjection of CFSE into an immature GV oocyte. A: The oocyte was stabilized 
by the holding pipette while the loaded injection pipette was positioned in the same plane as the 
denuded oocyte. B: The injection pipette was inserted into the oocyte until approximately 10 pl 
of solution based on a constant outflow system was injected into the oocyte. Scale bar: 120 μm. 
 
In the 3 repeat cultures, 22/30 (73.3%) CFSE injected oocytes showed cytoplasmic 
fluorescence, while buffer-injected oocytes were invisible when viewed under the 
fluorescent microscope (0/30, 0.0%, Figure 4.4). The cytoplasmic localisation of CFSE 
was clearly visible and confirmed the injection methodology as a mean to deliver 10 pl 
of a known substance within the oocyte. 
 
 
Figure 4.4: Oocytes injected with (i) DPBS buffer or (ii) CFSE. A: Brightfield image. B: 
Fluorescence image. Cytoplasmic localisation of CFSE is clearly visible. Scale bar: 120 μm. 
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4.3.2 Experiment 2: Optimisation of GDF9 knockdown using siRNA and IVM of 
ovine oocytes 
Following validation of the injection methodology, 4 cultures were carried out to 
quantify the efficiency of gene knockdown using the 4 siRNA species. In each culture, 
30 oocytes were injected with 1 of the 4 different GDF9 siRNAs (a different GDF9 
siRNA was used in each culture). An equal number of oocytes were injected with 
control buffer (n=30). The purpose of these preliminary cultures was to select the best 
siRNA species for GDF9 knockdown in comparison to controls. Due to the low number 
of oocytes surviving microinjection in this pilot experiment, no statistical analysis was 
performed on data collected after 48 h of culture. This experimental series also served 
as a pilot study to assess the efficacy of the IVM system when used in conjunction with 
the microinjection system and oocytectomised cumulus shell co-culture to study the 
effect of candidate gene knockdown on oocyte meiotic progression and cumulus 
function. Representative images of COCs prior and following oocytectomy are shown 
in Figure 4.5. 
 
 
Figure 4.5: Oocytectomy of COCs. A: Intact COCs retrieved from ovine ovaries. B: COCs 
following oocytectomy by micromanipulation. Scale bar: 120 μm. 
 
Oocyte survival was monitored at 24 and 48 h of each culture period by NR staining as 
shown in Figure 4.6 and Table 4.4. None of the 4 GDF9 siRNAs were lethal to the 
oocytes relative to the controls, with the proportions of the total number of oocytes 
surviving at 24 and 48 h for all siRNAs not significantly different to the proportions of 
the total number of controls (P>0.05). The majority of oocytes for both siRNA and 
controls were not viable after the first 24 h of culture following denudation, 
microinjection and culture in a serum-free media containing cilostamide. Almost all 
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oocytes surviving the first 24 h of culture remained viable after IVM co-culture for both 
the siRNA and control groups (Table 4.4). 
 
Table 4.4: Oocyte survival as quantified by NR staining 
NS = Not significant, NA = Not applicable 
 
 
Figure 4.6: Brightfield images showing: A: Denuded oocytes on day 1, 24 h after injection with 
GDF9 siRNA-2 and culture in serum-free media with 20 mg/ml cilostamide. Surviving oocytes 
were stained red (arrows). B: Oocytectomised cumulus shells before culture. C: Surviving 
oocytes (A), were placed into culture with equal numbers of compact cumulus shells (B) (only 3 
of 5 cumulus shells are shown). D: Co-cultured oocytes with cumulus shells stained with NR at 
the end of day 2, after 24 h of IVM co-culture. Surviving oocytes and expanded cumulus shells 
are stained red. Scale bar: 120 μm. 
Oocyte 
survival 
Culture 1 Culture 2 Culture 3 Culture 4 
Signifi
cance 
P<0.05 
GDF9 
siRNA-1 
(n=30) 
Buffer 
(n=30) 
GDF9 
siRNA-2 
(n=30) 
Buffer 
(n=30) 
GDF9 
siRNA-3 
(n=30) 
Buffer 
(n=30) 
GDF9 
siRNA-4 
(n=30) 
Buffer 
(n=30) 
24 h No. 5/30 8/30 8/30 8/30 6/30 8/30 12/30 10/30 
NS 
24 h % 16.7 26.7 26.7 26.7 20.0 26.7 40.0 33.3 
48 h No. 5/30 7/30 8/30 7/30 6/30 8/30 12/30 10/30 
NS 
48 h % 16.7 23.3 26.7 23.3 20.0 26.7 40.0 33.3 
24 h Vs 
48 h  
5/5 7/8 8/8 7/8 6/6 8/8 12/12 10/10 
NA 
100% 87.5% 100% 87.5% 100% 100% 100% 100% 
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The meiotic maturation of gene knockdown oocytes was quantified relative to buffer-
injected controls by assessment of MII progression rates after placing the oocytes that 
survived the first 24 h of culture into IVM co-culture with cumulus shells. In all 4 
cultures, oocytes from both treatment and control injection groups progressed to the MII 
stage after 48 h as assessed by the presence of the first polar body (Table 4.5). For all 
treatment groups, the numbers of MII oocytes were very low and meaningful statistical 
analysis was therefore not possible. The developmental competence of selected oocytes 
was assessed by DAPI staining. The GV nucleus was present in oocytes that remained 
at the GV stage whereas, condensed chromatin and discrete chromosomes were detected 
in MII oocytes as well as the first polar body (Figure 4.7) 
 
Table 4.5: Oocyte meiotic progression after knockdown of GDF9 at 48 h of culture 
MII 
progres
sion 
Culture 1 Culture 2 Culture 3 Culture 4 
GDF9 
siRNA-1 
Buffer 
GDF9 
siRNA-2 
Buffer 
GDF9 
siRNA-3 
Buffer 
GDF9 
siRNA-4 
Buffer 
No. 2/5 2/8 1/8 2/8 1/6 1/8 2/12 2/10 
% 40.0 25.0 12.5 25.0 16.7 12.5 16.7 20.0 
 
 
 
Figure 4.7: Day 2 verification of oocyte maturation following microinjection with siRNA or 
buffer and IVM, as determined by DAPI staining. A,B,C: Brightfield images of: A: Denuded 
GV oocyte before culture, B: Dead oocyte after 24 h of culture C: MII oocyte following IVM. 
D,E,F: Fluorescent images of DAPI staining following 48 h of culture: D: GV oocyte, E: MII 
control oocyte that had been subjected to buffer injection and co-cultured with cumulus shells. 
F: MII oocyte that has been subjected to GDF9 siRNA-1 injection and co-cultured with 
cumulus shells. Arrows indicate positions of polar body (C, E, F), GV nucleus (D) and oocyte 
chromosomes (E) as shown by DAPI staining. Scale bar: 120 μm.  
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Evaluation of the impact of gene knockdown and IVM on cumulus expansion following 
the co-cultures of denuded oocytes with oocytectomised cumulus shells are shown in 
Figure 4.8. The co-cultures of injected oocytes from the 2 injection groups with 
oocytectomised cumulus shells resulted in fully expanded cumulus cells as shown in 
Table 4.6. 
 
 
Figure 4.8: Cumulus shell morphology before and after IVM co-culture. A: Oocytectomised 
cumulus shell prior to culture. B-D: Oocytectomised cumulus shell expansion scores following 
24 h of IVM co-culture with control oocytes microinjected with DPBS buffer. Cumulus shell 
expansion scores are based on images B: Unexpanded (grade 0), C: Partially expanded (Grade 
1), and D: Fully expanded (Grade 2). Scale bar: 120 μm.  
 
Although the data is very preliminary in nature and the number of oocytes and cumulus 
complexes were too low per siRNA species for meaningful statistical analysis, the data 
demonstrated overall that the IVM co-culture of oocytectomised cumulus shells and 
denuded oocytes in serum-free IVM medium containing surge levels of FSH and LH 
supports cumulus expansion in vitro. 
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Table 4.6:  Evaluation of cumulus expansion following GDF9 knockdown and IVM co-culture 
Culture No. Treatment 
Cumulus expansion classification at 48 h 
Grade 0 Grade 1 Grade 2 
Culture 1 
GDF9 siRNA-1 2/5 (40.0%) 2/5 (40.0%) 1/5 (20.0%) 
Buffer 2/8 (25.0%) 3/8 (37.5%) 3/8 (37.5%) 
Culture 2 
GDF9 siRNA-2 2/8 (25.0%) 4/8 (50.0%) 2/8 (25.0%) 
Buffer 2/8 (25%) 3/8 (37.5%) 3/8 (37.5%) 
Culture 3 
GDF9 siRNA-3 2/6 (33.3%) 3/6 (50.0%) 1/6 (16.7%) 
Buffer 3/8 (37.5%) 2/8 (25.0%) 3/8 (37.5%) 
Culture 4 
GDF9 siRNA-4 7/12 (66.7%) 3/12 (16.7%) 2/12 (16.7%) 
Buffer 3/10 (37.5%) 4/10 (25.0%) 3/10 (37.5%) 
 
At the end of each culture, MII oocytes from each injection group were analysed for 
their GDF9 expression levels. For each treatment group, 1 MII oocyte was used for 
analysis. Because of the low numbers of oocytes that progressed to the MII stage from 
each of the 4 GDF9 siRNAs and their respective controls (up to 2 MII oocytes produced 
in each treatment), no repeat samples were generated. All samples were run in 
triplicates for each real-time PCR and 3 replicate real-time PCRs were conducted. The 
results showed that GDF9 transcript levels were reduced for 3 out of 4 siRNAs used, 
when GDF9 siRNA-injected oocytes were compared with their buffer-injected control 
oocytes using GAPDH and H2A expression to normalise data from real-time PCR. 
Specifically, the expression level of GDF9 was reduced when using GDF9 siRNA-1 
with relative expression value of 2.15 arbitrary (arb.) units, in comparison with the 
control (relative expression value of 5.3 arb. units). The expression of GDF9 was 
reduced much more when using GDF9 siRNA-2 (0.8 arb. units) in comparison with the 
control (6.6 arb. units) and when using GDF9 siRNA-3 (0.6 arb. units) in comparison 
with the control (4.7 arb. units). For GDF9 siRNA-4, interrogation of GDF9 transcript 
levels showed a small reduction in the GDF9 transcript following the knockdown (3.7 
arb. units) relative to the buffer-injected control (3.8 arb. units). These data are very 
preliminary. Analysis of the oocytes that were retained at the GV stage at the end of 
each of the 4 cultures following injections with the different GTSF1 siRNAs and control 
buffer injections verified the efficiency of the siRNA-2 and siRNA-3 in generating a 
GDF9 knockdown (data not shown). Based on these preliminary results, a mixture of 
GDF9 siRNA-2 and GDF9 siRNA-3 of equal proportions was used to study the effect 
of GDF9 knockdown on oocyte maturation and cumulus function in Experiment 3. The 
GDF9 mRNA is 1605 bp long and has 3 exons. The GDF9 siRNA-2 relates to a 
sequence located on the second exon of the ovine GDF9 (base pairs 1309-1329), while 
GDF9 siRNA-3 relates to a sequence located on the first and second exon of the gene 
(base pairs 1204-1224).  
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4.3.3 Experiment 3: Assessment of the impact of GDF9 knockdown on ovine oocyte 
maturation and cumulus expansion in vitro 
A series of 10 cultures were conducted to study the effect of GDF9 knockdown on 
oocyte maturation and cumulus function.  In these cultures a total of 302 oocytes were 
injected with the selected mixture of GDF9 siRNA-2 and siRNA-3 now referred to as 
GDF9 siRNA and 301 control oocytes were injected with DPBS buffer. 
  
4.3.3.1 Oocyte survival after microinjection 
Oocyte survival was assessed at 24 h and 48 h of culture. From all the cultures, a total 
of 61 oocytes (61/302, 20.7%) survived the first 24 h as assessed by NR staining when 
injected with GDF9 siRNA, while 73 control oocytes (73/301, 24.3%) survived the 
buffer injections. At 48 h, a total of 60 GDF9 siRNA-injected oocytes (60/61, 98.4%) 
remained viable, while 62 buffer oocytes remained viable (62/73, 85.0%). No 
significant differences were observed between the buffer and the siRNA-injected 
oocytes at the 2 time points as shown in Figure 4.9. These data indicate that the 
denudation and/or micromanipulation and culture with 20 mg/ml of cilostamide 
compromised oocyte viability, rather than extended culture in serum-free medium or the 
use of siRNA. 
 
 
Figure 4.9: Influence of GDF9 siRNA injection and buffer injection on oocyte survival at 24 
and 48 h of culture. Oocytes were microinjected with either GDF9 siRNA or buffer and cultured 
in serum-free basal gonadotrophin media with cilostamide (20 mg/ml) for 24 h. Surviving 
oocytes were then co-cultured with oocytectomised cumulus shells in serum-free IVM media 
and maturation inducing levels of gonadotrophins for an additional 24 h (total of 48 h). Values 
represent proportions of the total cohort of injected oocytes over 10 repeat cultures. Individual 
bars show the mean ±SEM for 10 independent cultures. The numbers of oocytes falling into 
each category are shown. No significant differences were observed between siRNA- injected 
oocytes and their controls at each time point (P>0.05). 
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4.3.3.2 The impact of oocyte GDF9 knockdown on meiotic progression in vitro 
The developmental competence of oocytes following GDF9 knockdown and IVM co-
culture with cumulus shells was assessed by confirming the MII progression of oocytes. 
The proportion of MII oocytes produced out of the oocytes that survived the first 24 h 
of culture following GDF9 siRNA injections were 13.1% (8/61 oocytes progressed to 
MII) that was significantly different (P<0.05) to the proportion of MII oocytes from the 
buffer injected treatment (26.0%, 19/73 oocytes) as shown in Figure 4.10. 
 
 
Figure 4.10: Impact of GDF9 knockdown on meiotic progression during IVM co-culture. 
Values represent proportions of the meiotic progression of viable GDF9 siRNA and buffer-
injected oocytes as determined at 24 h of culture that were subjected to an additional 24 h of 
IVM co-culture with cumulus shells. Individual bars show the mean ±SEM for 10 independent 
cultures. The numbers of oocytes falling into each category are shown. GDF9 siRNA-injected 
oocytes exhibited a significant reduced capacity to progress to MII (*=P<0.05) when compared 
to the buffer-injected control group.  
 
4.3.3.3 The effect of oocyte GDF9 knockdown on cumulus mass and expansion in vitro 
Cumulus shell mass and expansion were assessed prior to the start of the second phase 
of oocyte culture at 24 h and at the end of the 24 h IVM co-culture giving a total of 48 h 
in vitro. Equal numbers of cumulus shells and viable oocytes were co-cultured during 
IVM for each treatment. In total, 61 cumulus shells were oocytectomised and cultured 
with viable GDF9 siRNA-injected oocytes, while 73 cumulus shells were co-cultured 
with viable buffer-injected oocytes. Cumulus shells were divided equally for the 2 
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groups of oocytes based on their coverage scores at the start of culture and at the end of 
the culture, with the coverage scores of the cumulus reamained unchanged during the 
period of the co-culture for both treatments. Comparison of the cumulus coverage for 
the 2 groups did not show any significant differences as shown by the proportion of 
cumulus coverage for the 2 treatment groups at the end of the cultures (Figure 4.11).  
 
 
Figure 4.11: Effect of oocyte GDF9 knockdown on cumulus shell mass classification after 24 h 
of serum-free IVM co-culture with GDF9 siRNA or buffer-injected oocytes. Values represent 
proportions of the total numbers of cumulus shell mass classifications over 10 repeat cultures. 
Individual bars show the mean ±SEM for 10 independent cultures. The numbers of cumulus 
shells falling into each category are shown. No significant differences were observed between 
the 2 treatment groups (P>0.05).  
 
Analysis of cumulus expansion following IVM co-culture with microinjected oocytes 
showed that GDF9 knockdown in oocytes generated by siRNA injection significantly 
inhibited the capacity of cumulus shells to undergo full expansion during IVM co-
culture, as evidenced by the presence of a significantly reduced number of fully 
expanded cumulus shells (P<0.05) when compared to the buffer-injected control oocyte 
co-culture group. Cumulus expansion comparisons showed that there were more 
partially expanded cumulus shells following co-culture with GDF9 knockdown in 
comparison to controls but no significant differences were noted (P>0.05). This 
suggests that GDF9 knockdown impairs cumulus shell full expansion rather than partial 
expansion. Representative images for the 2 treatments following 24 h of co-culture are 
shown in Figure 4.12. Figure 4.13 illustrates the mean proportion of cumulus expansion 
for the 2 treatment groups. Since there was no significant effect of treatment on cumulus 
coverage, the morphological differences in cumulus expansion were not due to gross 
changes in cumulus coverage. 
135 
 
 
Figure 4.12: Impact of GDF9 knockdown on cumulus expansion following IVM co-culture. A: 
Representative images for full cumulus expansion in buffer-injected control oocyte following 
co-culture with cumulus shells. B: Representative image for partial cumulus expansion 
following oocyte GDF9 siRNA treatment and co-culture with cumulus shells. Scale bar: 120 
μm.  
 
Figure 4.13: Effect of oocyte GDF9 knockdown on cumulus expansion following 24 h of 
serum-free IVM co-culture. Values represent proportions of the total numbers of cumulus shell 
expansion classifications over 10 repeat cultures. Individual bars show the mean ±SEM for 10 
independent cultures. The numbers of cumulus shells falling into each category are shown. 
Cumulus shells that were co-cultured with oocytes microinjected with GDF9 siRNA exhibited a 
significantly reduced capacity to undergo complete expansion in vitro (*=P<0.05), when 
compared to buffer-injected control oocytes.  
 
4.3.3.4 Molecular analysis of gene expression following GDF9 siRNA 
microinjection 
A total of 6 cDNA libraries for each treatment were successfully generated from pools 
of 1-2 MII oocytes (4 cDNA libraries containing 1 MII oocyte and 2 cDNA libraries 
containing 2 MII oocytes for each treatment), originating from separate IVM culture 
microdrops within each culture. The number of cDNA libraries created was very limited 
because of the low number of oocytes surviving and progressing to the MII stage from 
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each treatment group. Oocytes from each of the 2 treatment groups were analysed for 
their GDF9 and BMP15 expression levels based on absolute mRNA levels of GDF9 and 
BMP15 normalised against both H2A and GAPDH as determined by real-time PCR 
(Figure 4.14). All individual MII cDNA libraries showed a reduction of >50% in their 
GDF9 transcript levels in comparison with their respective controls. Specifically, GDF9 
transcript levels were significantly reduced (P<0.05) in GDF9 siRNA-injected oocytes 
(0.7±0.2 arb. units, n=6) in comparison with controls (6.7±3.2 arb. units, n=6) following 
the targeted knockdown. The specificity of the targeted knockdown of GDF9 was 
evaluated by assessing the transcript levels of BMP15, another oocyte-derived gene 
which is also a member of the TGFB superfamily, on the same MII cDNA libraries. The 
data showed a small reduction in the expression levels of BMP15 following GDF9 
siRNA injections (1.4±0.3 arb. units, n=6) but this reduction was not significant 
(P>0.05) when compared to the BMP15 mRNA levels measured in control oocytes 
(1.7±0.3 arb. units, n=6), suggesting no/low off target effects that confirmed the 
specificity of GDF9 knockdown using siRNA (Figure 4.14). 
 
 
Figure 4.14: Real time quantification of the effect of GDF9 knockdown by siRNA injection on 
oocyte GDF9 and BMP15 mRNA levels, compared to buffer-injected control oocytes. The data 
was standardised against the oocyte GAPDH and H2A mRNA levels. Individual bars show the 
mean ±SEM for 6 independent cDNA libraries (each library analysed in triplicate). Each cDNA 
library contained 1-2 oocytes. GDF9 siRNA-injected oocytes exhibited a significant reduction 
of the GDF9 mRNA levels (*=P<0.05) when compared against the buffer-injected control 
group which contained a similar number of oocytes/sample, while no statistical difference was 
detected between the 2 treatments for the BMP15 mRNA levels (P>0.05). 
 
Analysis of the mRNA expression levels in cumulus shells for the 2 treatments was 
conducted following confirmation of GDF9 knockdown in the oocytes. Pools of 2 
representative cumulus shells from separate IVM culture microdrops within each culture 
were used to generate cDNA libraries. Only cumulus shells originating from co-cultures 
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with IVM oocytes that progressed to the MII stage and were confirmed as having 
significant reduction in their GDF9 transcript levels along with their respective controls 
were analysed. Out of the 6 sets of samples, 1 was discarded because the cDNA library 
failed to be generated, while another 3 libraries were discarded at different stages of 
analysis because of contamination. Cumulus levels of GREMLIN1, HAS2, AMH, LDH1, 
AREG, EREG, BTC, EGFR, FSHR and LHR were analysed (Figure 4.15).  
 
 
Figure 4.15: Effect of GDF9 knockdown on cumulus cell’s mRNA levels of (a):  Somatic 
marker and oocyte quality including genes GREMLIN1, HAS2, AMH and LDH1. (b): Regulin 
genes AREG, EREG, BTC and EGFR. (c): Cumulus cell receptors FSHR and LHR. Data for all 
3 graphs were normalised against the cumulus GAPDH and H2A mRNA levels. Individual bars 
show the mean ±SEM for the number (n) of repeat cDNA libraries (each library analysed in 
triplicate). Each cDNA library contained pools of 2 cumulus shells. Expression levels of HAS2 
in cumulus shells co-cultured with GTSF1 knockdown oocytes showed significant differences 
(*=P<0.05) when compared against cumulus cells co-cultured with buffer-injected controls. 
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Levels of HAS2 were significantly reduced (P<0.05) following GDF9 knockdown 
(1.3±0.7 arb. units, n=3) compared to cumulus shells co-cultured with buffer-injected 
control oocytes (3.7±0.4 arb. units, n=3). Although, cumulus GREMLIN1 expression 
was also reduced to (0.3±0.2 arb. units, n=5) following GDF9 knockdown compared to 
controls (0.7±0.3 arb. units, n=5), no statistical differences were noted (P>0.05). 
Interrogation of cumulus LDH1 mRNA levels indicated a reduction between the 2 
groups from 0.8±0.05 arb. units (n=3) following the knockdown to 1±0.2 arb. units 
(n=3) in the controls which was not significant (P>0.05), while cumulus levels of AMH 
were reduced to (0.2±0.1 arb. units, n=5) following GDF9 knockdown compared to 
controls (0.6±0.3 arb. units, n=5), but were also not significantly different (P>0.05) 
(Figure 4.15.a). Cumulus transcript levels of AREG, EREG and BTC were similar 
between cumulus shells co-cultured with GDF9 siRNA-injected oocytes (0.5±0.4 arb. 
units, n=3; 0.7±0.3 arb. units, n=3; 0.2±0.3 arb. units, n=3) respectively, compared to 
cumulus shells co-cultured with buffer-injected control oocytes (0.7±0.6 arb. units, n=3; 
0.7±0.3 arb. units, n=3; 0.3±0.4 arb. units, n=3) and were not statistically different 
(P>0.05) (Figure 4.15.b). In addition cumulus levels of EGFR were the same between 
the GDF9 knockdown (0.6±0.4 arb. units, n=4) and the controls (0.6±0.4 arb. units, 
n=4). Finally, interrogation of a range of receptors on cumulus cells did not show any 
significant differences between cells co-cultured with the GDF9 knockdown oocytes 
and buffer-injected control gametes, as no changes in the transcript levels were detected 
between groups (P>0.05). Cumulus FSHR and LHR transcript levels were 0.8±0.3 arb. 
units (n=3) and 0.8±0.1 arb. units (n=2), respectively, following oocyte GDF9 
knockdown in comparison with controls (0.8±0.4 arb. units, n=3; 0.8±0.1 arb. units, 
n=2) (Figure 4.15.c). 
 
4.3.4 Experiment 4: Assessment of the effect of gonadotrophins on maturation and 
cumulus expansion of GDF9 knockdown on ovine oocytes 
The effect of gonadotrophin concentration on oocyte meiotic progression and cumulus 
expansion following GDF9 knockdown was studied by reducing the concentrations of 
FSH and LH in the culture media during the IVM co-culture from preovulatory surge 
levels of day 2 (10 cultures, Experiment 3), to  basal levels (8 repeat cultures, 
Experiment 4). In the first instance, oocyte survival, maturation and cumulus expansion 
were compared between the 2 oocyte treatment groups (GDF9 knockdown and controls) 
following reduction of the gonadotrophin concentrations. Survival rates in the treatment 
and control groups were not significantly different (P>0.05) following culture with 
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basal levels of gonadotrophins. From the total of 236 GDF9 siRNA-injected oocytes 
and 219 buffer-injected oocytes, 63 (26.7%) oocytes injected with GDF9 siRNA 
survived the first 24 h of the culture, while 67 (30.6.%) oocytes survived the buffer 
injections. At 48 h, a total of 59 GDF9 siRNA-injected oocytes (59/63, 93.7%) 
remained viable, while 62 buffer oocytes remained viable (62/67, 92.5%). The 
proportions of MII oocytes produced out of the viable oocytes from the first 24 h of 
culture following GDF9 siRNA knockdown were 12.7% (8/63 oocytes) which was not 
statistically different (P>0.05) to the proportion of 11.9% for the buffer-injected control 
oocytes (8/67 oocytes). In the absense of the high levels of gonadotrophins, the cumulus 
shells from neither of the oocyte treatment groups (GDF9 knockdown or controls) were 
able to expand fully after 24 h of co-culture (Figure 4.16). In addition, although there 
were fewer cumulus shells partially-expanded following GDF9 siRNA, no significant 
differences (P>0.05) were noted in comparison with the controls suggesting that the 
gonadotrophins are the main drivers of cumulus expansion. 
 
 
Figure 4.16: Cumulus expansion following 24 h of co-culture with GDF9 gene knockdown 
oocytes compared to buffer-injected control oocytes in a basal gonadotrophin culture system. 
Values represent proportions of the total numbers of cumulus shell expansion classifications 
over 8 repeat cultures. Individual bars show the mean ±SEM for 10 independent cultures. The 
numbers of cumulus shells falling into each category are shown. No statistical differences were 
noted between the 2 treatments. 
 
The effects of surge level gonadotrophins vs. basal level gonadotrophins were then 
compared for the 2 treatment groups. The proportions of oocyte survival in the culture 
system with basal levels of gonadotrophins were similar to the proportions when 
preovulatory surge levels of gonadotrophins were used and no significant differences 
(P>0.05) were noted between the 2 different culture systems (Table 4.7). These data 
indicate that for both gonadotrophin cultures, the denudation, micromanipulation and 
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culture with 20 mg/ml of cilostamide compromise oocyte viability, rather than the use 
of siRNA or the extended culture in serum-free medium. Comparison between the 
preovulatory surge gonadotrophin IVM system and the basal level gonadotrophin 
system showed significant differences in the proportions of oocytes progressing to MII 
from viable oocytes at 24 h following control buffer injection (P<0.05). No differences 
(P>0.05) were observed for the MII progression proportions of viable oocytes at 24 h 
following injection with GDF9 siRNA, in the 2 different gonadotrophin levels (Table 
4.7). Analysis of cumulus expansion for the 2 gonadotrophin levels, confrirmed that the 
high levels of FSH and LH are significanly important to support full cumulus expansion 
in vitro following GDF9 injections (P<0.01)  and buffer control injections (P<0.005), as 
shown in Table 4.7. These results indicate that the concentration of gonadotrophins 
affects cumulus expansion and oocyte meiotic progression with GDF9 being important 
only when surge gonadotrophin concentrations are used.  
 
Table 4.7:  Comparison of the effect of cumulus co-culture basal or surge gonadotrophin 
supplementation following oocyte GDF9 knockdown 
Treatment Basal gonadotrophin levels Surge gonadotrophin levels Significance 
Oocyte survival at 24 h 
GDF9 siRNA 63/236 (26.7%) 61/302 (20.7%) NS 
Control buffer 67/219 (30.6%) 73/301 (25.4%) NS 
       Oocyte survival at 48 h (based on viable oocytes at 24 h) 
GDF9 siRNA 59/63 (93.7%) 60/61 (98.4%) NS 
Control buffer 62/67 (92.5%) 62/73 (85.0%) NS 
       Oocyte maturation of viable oocytes  
GDF9 siRNA 8/63 (12.7%) 8/61 (13.1%) NS 
Control buffer 8/67 (11.9%) 19/73 (26.0%) P<0.05 
      Cumulus expansion 
          Classification 0 
GDF9 siRNA 43/63 (68.3%) 23/61 (37.7%) P<0.05 
Control buffer 37/67 (55.2%) 19/73 (26.0%) P<0.05 
           Classification 1 
GDF9 siRNA 20/63 (31.7%) 30/61 (49.2%) NS 
Control buffer 30/67 (44.8%) 30/73 (41.1%) NS 
            Classification 2 
GDF9 siRNA 0/63 (0.0%) 8/61 (13.1%) P<0.01 
Control buffer 0/67 (0.0%) 24/73 (32.9%) P<0.005 
 
 
4.4  DISCUSSION 
The results showed that it was possible to create a targeted and functional knockdown 
of GDF9 in sheep oocytes over 24 h without compromising the potential for oocyte 
meiotic progression during IVM co-cultures with oocytectomised cumulus shells, 
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following removal of a specific PDE inhibitor. Gene knockdown by siRNA was specific 
to GDF9. Furthermore, the data from Experiment 3 showed a significant functional 
effect of oocyte GDF9 knockdown on the capacity of oocytes to complete meiosis as 
indicated by: (i) the significant decrease in MII progression of gene knockdown oocytes 
(P<0.05) and (ii) the significant reduction in full expansion of cumulus cells following 
the co-cultures of somatic cells with GDF9 depleted oocytes when compared to controls 
(P<0.01). In addition, the knockdown of oocyte GDF9 resulted in a significant decrease 
in the expression levels of HAS2 in the cumulus cells compared to controls (P<0.05). 
The results showed that ovine oocyte meiotic progression was significantly reduced 
when siRNA targeted against the first and second exons of ovine GDF9 gene were 
injected into the oocytes in comparison to the buffer-injected control gametes.  
 
These results provide proof of principle of the efficiency of the micromanipulation and 
IVM co-culture system for studying the function of novel oocyte-derived genes by the 
means of siRNA. Oocytes were able to survive through the 48 h culture and mature both 
meiotically and cytoplasmically as shown by MII progression and the ability of the 
oocytes to re-establish cell to cell communication after gene knockdown in vitro, 
through paracrine secretions. This study has confirmed extended previous observations 
of the potential of dsRNAi as a means of knocking down GDF9 and studying its 
function in the mouse (Gui and Joyce, 2005) and sheep (Cotterill, 2008). Similarly, the 
study has confirmed that the oocyte maturation and cumulus expansion observed were 
induced by preovulatory levels of LH and FSH exposure, rather than a spontaneous 
maturation and expansion as a result of in vitro conditions such as denudation and 
oocytectomy.  
 
4.4.1 The impact of GDF9 knockdown on oocyte meiotic progression and cumulus 
cell expansion in vitro 
One of the genes vital to the production of a fertile oocyte is Gdf9, as this oocyte-
specific factor orchestrates cumulus expansion during oocyte meiotic maturation 
(Buccione et al., 1990b). Other factors include Bmp15 (Su et al., 2004; Gui and Joyce, 
2005), LH (Elvin et al., 1999), Egf (Diaz et al., 2006), and the LH-induced Egf ligands 
Areg, Ereg and Btc (Park et al., 2004; Hsieh et al., 2007). From the above factors, the 
role of Gdf9 has been extensively detailed in the introductory Chapter 1. So far, the 
majority of research has been conducted in rodents and not much is known about the 
function of specific oocyte-secreted factors such as GDF9 in monovular species 
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including the cow and the sheep. An original approach for the study of oocyte secreted 
genes in monovular species has been recently applied by GDF9 and BMP15 targeted 
knockdown approach in sheep oocytes that resulted in a functional effect in both gene 
knockdowns (Cotterill, 2008). Specifically, injection of dsRNA for GDF9 and BMP15 
resulted in targeted gene knockdown associated with reduced oocyte maturation and 
cumulus expansion for both genes in comparison with controls. Knockdown of GDF9 
was also shown to directly regulate gene function within the COC microenvironment by 
moderation of HAS2 expression following GDF9 and BMP15 knockdown and by 
regulation of GREMLIN1 following GDF9 knockdown (Cotterill, 2008). Similarly, in 
this thesis there was an effect of GDF9 on oocyte maturation, cumulus expansion and 
on HAS2 expression levels, following oocyte GDF9 knockdown by siRNA. 
 
Understanding the effects of gonadotrophin stimulation on intracellular communications 
is very important in order to understand the mechanisms that regulate oocyte 
maturation. After the LH surge, soluble factors activate meiosis-inducing signalling 
molecules in the cumulus cells that are transmitted to the oocytes through gap junctions 
(Su et al., 2009). For example, evidence from mouse cumulus cells indicate that LH 
promotes Areg-induced progesterone induction in granulosa cells through Neuregulin1 
(Noma et al., 2010). In sheep granulosa and cumulus cells, recent evidence suggests that 
surge levels of LH rapidly induce a peak in AREG expression in vitro relative to the 
other regulin genes, suggesting that AREG is key to sheep IVM (Cotterill et al., 2012). 
The promotion of maturation may involve modulation of PDE3A activity (Sasseville et 
al., 2009). Indeed, relatively higher levels of AREG were detected in cumulus cells in 
the present study compared to EREG and BTC and although no direct effects of GDF9 
knockdown on AREG were recorded here, GDF9 has been suggested to act through 
differential gradients in bovine follicles (Hussein et al., 2005). Other studies suggest 
that the cumulus expansion is a result of the cumulative action of oocyte-secreted 
factors (Dragovic et al., 2005; Su et al., 2010). In fact, studies in cows have shown that 
BMP15 has an important role as an oocyte survival factor and mutant mice for Bmp15 
have been shown to have reduced cumulus expansion and Has2 synthesis (Su et al., 
2004; Hussein et al., 2005). Other murine studies have shown that together Gdf9 and 
Bmp15 can promote expression of the Egfr thus allowing cumulus cells to respond to 
the LH-induced Egf-like factors Areg, Ereg and Btc (Su et al., 2010). Other studies 
investigating the functional significance of both GDF9 and BMP15 in sheep have 
shown that mutations of these genes as well as the ALK6 receptor for BMP15 can 
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change the ovulation quota (Wilson et al., 2001; Hanrahan et al., 2004). Mutations have 
also been found in humans for both genes that have been associated with premature 
ovarian failure (Laissue et al., 2006). However, species specific differences have been 
identified for the actions of BMP15 in driving ovulation rate. Specifically, although 
mutations in the BMP15 gene in sheep results in an increased ovulation rate, knockout 
mice for Bmp15 have reduced fertility (Galloway et al., 2000; Yan et al., 2001). These 
differences could be species specific or they could be due to the different and/or 
synergistic roles that GDF9 and BMP15 have in the sheep (Moore et al., 2003). In fact 
an even higher ovulation rate is observed in heterozygous sheep for both GDF9 and 
BMP15 than in heterozygous sheep for only 1 of the 2 genes (Galloway et al., 2000; 
Hanrahan et al., 2004). From the above studies it can be suggested that BMP15 may 
have a role in cumulus expansion or that the nature of action of oocyte-derived factors 
may be species specific. Furthermore in relation to this thesis, the cumulative actions of 
GDF9 and BMP15 could explain why although there was a significant decrease in 
cumulus expansion following GDF9 knockdown by siRNA injection, some cumulus 
shells retained the capacity to undergo full expansion in the presence of surge levels of 
LH and FSH and/or that the high gonadotrophin levels are overriding some changes in 
paracrine regulation effects by GDF9 knockdown. Alternatively, GDF9 acts in concert 
with other LH-driven signalling molecules such as AREG in stimulating cumulus 
expansion.  
 
4.4.2 The impact of GDF9 on gene expression 
Although the selection of the most suitable siRNA species for generating the GDF9 
knockdown was based on results from 1 oocyte, the analysis of the oocytes that were 
retained at the GV stage following injections with the different GTSF1 siRNAs and 
control buffer injections verified the efficiency of the siRNA-2 and siRNA-3 in 
generating a GDF9 knockdown. The targeted functional knockdown of GDF9 by the 
selected mixture of siRNA injection in the present studies was verified by molecular 
evaluation with real-time PCR that showed a significant reduction (P<0.05) in the 
oocyte expression levels of GDF9 (0.72±0.2 arb. units, n=6) following GDF9 siRNA 
injection in comparison with buffer-injected control oocytes (6.7±3.17 arb. units, n=6) 
producing a high level knockdown for all oocytes analysed. The specificity of the 
knockdown for the target gene was then confirmed by assessing the transcript levels of 
another oocyte-secreted member of the TGFB super family namely-BMP15, which was 
not significantly different (P>0.05) relative to controls. This observation replicates the 
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work of Gui and Joyce, (2005) in mice as well as Cotterill, (2008) in sheep using 
dsRNA species. 
 
Following evaluation of the GDF9 and BMP15 transcript levels, the effect of the 
knockdown was assessed by examination of transcript levels of cumulus cell markers. 
Mouse knockout studies have identified certain genes as potential targets of Gdf9. One 
of such genes is the Has2 gene encoding the Has2 enzyme which is responsible for 
conversion of UDP-N-acetyl glucosamine to hyaluronic acid (HA). This enzyme holds 
together cumulus cells after expansion and mucification (Scott et al., 1991). 
Knockdown of Has2 in cumulus cells through adenovirus transfections  was shown to 
reduce cumulus expansion (Sugiura et al., 2009). In addition, reduction of the levels of 
Has2, resulted in a reduction of Areg and Ereg mRNA (Sugiura et al., 2009). Lower 
levels of HAS2 in human cumulus cells are associated with poor embryo quality (Cillo 
et al., 2007). In this thesis the results showed that GDF9 knockdown by siRNA 
injection in oocytes resulted in a significant reduction (P<0.05) of HAS2 mRNA 
expression in the cumulus cells in comparison with the controls which was marked by 
the reduced levels of cumulus expansion in the same cells. Similar findings were noted 
when the same system was used to inject dsRNA in order to induce a GDF9 knockdown 
(Cotterill, 2008). Previous studies in the mouse have also produced similar results 
(Elvin et al., 1999; Dragovic et al., 2005). In fact, genes involved in cumulus expansion 
including Has2 are thought to be stimulated by gonadotrophins and/or oocyte-derived 
factors (Dragovic et al., 2005; Dragovic et al., 2007).  
 
Another cumulus specific gene shown to moderate cross talk between Gdf9 and Bmp15 
via a regulatory loop is Gremlin1 (Pangas et al., 2004). Studies in mice have shown that 
this gene is up-regulated through paracrine actions from the oocyte and Gdf9 (Pangas et 
al., 2004). Gremlin is also considered an antagonist of BMP signalling (Canalis et al., 
2003) and is involved in the intra-follicular BMP signalling pathways as part of the 
negative feedback of thecal androgen production (Glister et al., 2005). In particular up-
regulation of GREMLIN1 induced by GDF9 antagonises BMP15 for receptor binding 
and promotes bovine oocyte-induced cumulus expansion (Hussein et al., 2005). This is 
because of the different receptors that GDF9 and BMP15 bind to, with GDF9 binding to 
both ALK5 and BMPRII receptors, while BMP15 recruits ALK6 and BMPRII (Vitt et 
al., 2002; Moore et al., 2003; Mazerbourg et al., 2004). The different receptor binding 
results in alternate-intracellular responses for GDF9, which signals through the SMAD 
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2/3 intracellular pathway, while BMP15 signals through SMAD 1/5/8. As an outcome, 
up-regulation of Gremlin1 antagonises BMP signalling induced from mural and theca 
cells, thereby allowing oocyte-derived factors like GDF9 to promote cumulus cell 
expansion and prevent apoptosis (Hussein et al., 2005). Because of this involvement in 
the COC regulatory loop, Gremlin has been identified as a marker for oocyte quality 
along with Has2 and Ptx3 (Mckenzie et al., 2004). The role played by Gremlin in 
relation to oocyte quality is not very clear. In this study there was a trend for reduction 
of GREMLIN1 mRNA levels following GDF9 knockdown (0.3±0.2 arb. units, n=5) 
compared to controls (0.7±0.3 arb. units, n=5), however due to the low number os 
samples and variability of the data, no statistical differences were noted (P>0.05). 
Injections of dsRNA for GDF9 in sheep oocytes have previously shown that cumulus 
GREMLIN1 expression was significantly reduced relative to controls (Cotterill, 2008). 
The reduction in the transcript level of GREMLIN1 mRNA following GDF9 
knockdown in comparison with controls observed in this thesis might prove to be 
significant with further experimentation.  
 
The expression of AMH was compared in cumulus cells following GDF9 knockdown in 
ovine oocytes. This gene is considered to have important roles in folliculogenesis. At 
the primordial follicle stage, Amh was shown to inhibit primordial follicle recruitment in 
the mouse (Durlinger et al., 2002a). At the preantral stage, Amh has been shown to 
inhibit follicle recruitment of growing follicles to the preovulatory stage  (Salmon et al., 
2004). In addition, Amh expression by follicular granulosa and cumulus cells is also 
considered to be regulated by paracrine factors from the oocyte because of the close 
proximity of Amh expression with other factors regulated by the oocyte such as Lhr, Kl 
and Ptgs (Salmon et al., 2004).  In this study, a reduction of AMH transcript levels was 
observed when GDF9 was knocked down (0.2±0.1 arb. units, n=5) compared to 
controls (0.6±0.3 arb. units, n=5), but due to the low number of samples analysed and 
the variability of the data, this difference was not significant (P>0.05). Similar data 
were observed following injection of dsRNA in sheep oocytes (Cotterill, 2008), while 
Amh levels have been significantly reduced following Gdf9 knockdown at the preantral 
stage of follicle development in mice (L Gui and HM Picton, unpublished data). 
Extension of the number of culture replicates in the present experimental series is 
required to confirm the significance of this observation. Furthermore, the relatively low 
levels of AMH and GREMLIN1 mRNA transcripts in cumulus cells compared to the 
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high levels of HAS2 mRNA expressions in cumulus cells may be linked to the 
significantly lowered levels of HAS2 expression observed following GDF9 knockdown.  
 
The effect of oocyte GDF9 knockdown on the expression of LDH1 in the cumulus cells 
was evaluated. This gene encodes a product of glycolysis and it is expressed by the 
cumulus cells (Sugiura et al., 2007). Glycolysis in cumulus cells is regulated by 
paracrine factors by the oocyte (Sugiura et al., 2005). Cumulus cells express higher 
levels of mRNA encoding glycolytic enzymes such as platelet phosphofructokinase 
(Pfkp) and Ldhα and when oocytes are removed from COCs the levels of these 
transcripts are reduced with the effect being reversed following co-culture with cumulus 
cells (Sugiura et al., 2005). The levels of LDH1 gene transcript were therefore 
investigated in this study to indicate whether GDF9 affects the metabolic pathways of 
the oocyte. No significant differences (P>0.05) were noted for the transcript in cumulus 
cells following oocyte GDF9 knockdown (0.8±0.05 arb. units, n=3) compared to 
controls (1±0.2 arb. units, n=3). Similar findings were demonstrated following dsRNA 
injection and GDF9 knockdown in sheep oocytes (Cotterill 2008). This observation 
agrees with a previous study conducted in the mice which showed that the paracrine 
factors that regulate glycolysis are Bmp15 along with Fgf8 (Sugiura et al., 2007).  
 
The expression of the 3 key members of the EGF family, AREG, EREG and BTC along 
with the EGFR were compared in cumulus cells following GDF9 knockdown in 
oocytes. The regulin genes are induced by LH in mural granulosa cells and bind to the 
Egfr and have been shown to induce COC maturation (Park et al., 2004; Hsieh et al., 
2007). These ligands are necessary for IVM as shown by their ability to induce oocyte 
maturation in COC cultures but not in cultures of denuded oocytes (Park et al., 2004). 
In addition, mutant mice for Egfr and Areg as well as double mutant animals are unable 
to promote COC maturation, further demonstrating that the Egfr network is vital in 
COC maturation in vivo (Hsieh et al., 2007). Knockout of Egfr was shown to reduce the 
expression of Gdf9 and Bmp15 in murine cumulus cells (Su et al., 2010) and removal of 
oocytes from COCs resulted in the reduction of cumulus Egfr with the levels restored 
after treatment with recombinant Gdf9 or mixture of recombinant Gdf9 and Bmp15 (Su 
et al., 2010). Recent work by Cotterill et al., 2012 has demonstrated the presence of 
AREG, EREG and BTC in ovine mural and granulosa cells. In particular, AREG 
appeared to be most important for LH signalling events in sheep cumulus and mural 
granulosa cells but not in oocytes (Cotterill et al., 2012). Analysis of transcript levels of 
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the EGF family members AREG, EREG and BTC in the present study did not indicate 
any significant differences (P>0.05) in cumulus cell expression following GDF9 gene 
knockdown in oocytes after 24 h of IVM culture (0.5±0.4 arb. units, n=3; 0.7±0.3 arb. 
units, n=3; 0.2±0.3 arb. units, n=3) compared to cumulus shells co-cultured with buffer-
injected control oocytes (0.7±0.6 arb. units, n=3; 0.7±0.3 arb. units, n=3; 0.3±0.4 arb. 
units, n=3) respectively. None-the-less, the results were quite variable and thus the 
experiment needs repetition. An alternative explanation for the observations in this 
experimental series is that induction of AREG expression occurs very rapidly and peaks 
after LH exposure (Cotterill et al., 2012). Therefore, the levels of AREG could have 
been dropped back down again during the 24 h exposure window of IVM in the present 
study. Investigation of the expression levels of the EGFR following the knockdown did 
not demonstrate a significant difference (P>0.05) between treatment groups. This 
receptor is the EGF-like ligand considered to facilitate communication with the secreted 
members of the EGF family through cumulus cells, resulting in a target cell response 
through the MAPK signalling cascade (Conti et al., 2006). In fact, the MAPK pathway 
has an established role in cumulus expansion and oocyte maturation (Panigone et al., 
2008). The kinases that act in this pathway are the Mapk1/3 and Erk1/2 and their 
phosphorylation has been shown to be sustained by the actions of Egfr in rat 
preovulatory follicles. Studies have shown that inhibition of EGFR results in reduced 
cumulus expansion and oocyte maturation in rats and primates (Nyholt De Prada et al., 
2009; Reizel et al., 2010). In sheep, the MAPK pathway is active in COCs during 
oocyte maturation and cumulus expansion (Cecconi et al., 2008). In addition, EGFR 
expression in sheep was detected in cumulus cells before and after gonadotrophin 
exposure in vitro, but EGFR expression did not reach to the same extent as AREG after 
LH surge in IVM, suggesting species specific differences and that AREG is the most 
important regulin and LH driven signalling molecule during the maturation of sheep 
oocytes in vivo and in vitro (Cotterill et al., 2012).      
 
Transcript levels of LHR and FSHR were also investigated in the cumulus cells to 
evaluate the physiological responses to gonadotrophins in the cumulus cells. Both 
gonadotrophin receptors need to be expressed in the somatic cells of the follicle for the 
gonadotrophins to be effective at stimulating growth, steroidogenesis and ovulation 
(Tisdall et al., 1995; Logan et al., 2002). The transcript levels of the FSHR and LHR 
were not statistically different (P>0.05) in cumulus cells after oocyte GDF9 knockdown 
(0.8±0.3 arb. units, n=3 and 0.8±0.1 arb. units, n=2) respectively relative to controls 
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(0.8±0.4 arb. units, n=3 for FSHR and 0.8±0.1 arb. units, n=2 for LHR), suggesting that 
oocyte-derived GDF9 plays no role in the regulation of cumulus cell FSHR and LHR 
levels. However, due to the low number of samples, this experiment requires further 
replication.  
 
4.4.3 The effect of gonadotrophins on maturation and cumulus expansion of GDF9 
knockdown on ovine oocytes 
The importance of gonadotrophins in the development of a physiological relevant IVM 
system was further enhanced by the results in this study following reduction of the 
surge level of gonadotrophins in the IVM system to a much lower concentration. The 
cultures conducted with lower concentrations of gonadotrophins significantly reduced 
oocyte maturation rates (P<0.05) in the buffer injection group in comparison with the 
IVM cultures conducted with surge levels of gonadotrophins. The reduction of the 
gonadotrophin levels also resulted in reduced expansion of the cumulus cells in 
comparison with the IVM system containing surge levels of gonadotrophins, with no 
cumulus reaching full expansion in either of the 2 injection groups. Although there were 
fewer partially expanded cumulus shells, in the GDF9 siRNA-injected group compared 
to the controls, no significant differences were noted (P>0.05). The IVM system used in 
this study is a gonadotrophin driven maturation system for sheep COCs and it has been 
shown that gonadotrophin exposure during IVM improved oocyte quality and blastocyst 
potential (Cotterill et al., 2012). Previous studies have also revealed the effects of 
gonadotrophin stimulation on the developmental capacity of oocytes matured in vitro. 
In the bovine species, inclusion of surge levels of both gonadotrophins in the culture 
media resulted in significantly more cumulus expansion and oocyte maturation 
compared with treatments containing either of the 2 gonadotrophins individually 
(Pandey et al., 2010). Similarly, in sheep, culture of COCs in serum-free IVM media 
without gonadotrophins has been shown to result in impaired cumulus expansion 
(Cecconi et al., 2008). The addition of gonadotrophins in vitro has been shown to 
increase oocyte progression to MII (Galli and Moor, 1991). Studies in humans have 
shown that nuclear maturation of the oocytes is possible in vitro and the concentration 
of gonadotrophins and the sequence of the FSH and FSH-LH exposure may impact on 
oocyte meiotic progression (Trounson et al., 2001). Finally, the gonadotrophins together 
with oocytes and oocyte-derived factors stimulate some important genes that are 
prerequisite for cumulus expansion (Dragovic et al., 2005; Dragovic et al., 2007). 
Addition of FSH to the media is known to affect oocyte maturation and this is mediated 
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through the cumulus cells as shown by studies where removal of the cumulus cells does 
not result in developmental progression (Gilchrist et al., 2008). In fact, the preovulatory 
levels of gonadotrophins induce the secretion of hyaluronic acid from the cumulus cells 
that results in their expansion and mucification (Schoenfelder and Einspanier, 2003). 
Together FSH and EGF signalling contribute to mouse oocyte maturation through the 
exchange of factors necessary for oocyte and early embryo development (Yeo et al., 
2009). The EGFR and LH driven AREG in sheep have also been shown to contribute to 
oocyte maturation (Cotterill et al., 2012). All the above published studies are therefore 
in agreement with the observations in the present study that gonadotrophins are the 
main regulators of cumulus expansion and that they override the effects of oocyte-
derived cumulus expansion factors like GDF9. 
 
The molecular basis of oocyte signalling is still being elucidated in an attempt to find to 
mechanisms that control oocyte growth and maturation. Recent studies have highlighted 
the potential association of oocyte-secreted factors with miRNAs. As stated in Chapter 
1, Section 1.5.1, small RNAs have important regulatory roles in many different cellular 
processes including cell proliferation, differentiation and apoptosis and may play 
important roles during development as shown by their tissue specific expression pattern 
and evolutionary conservation (Lewis et al., 2003). Dicer, an RNase III-containing 
enzyme, is considered the critical enzyme in small RNA-regulated cell development, 
required to process miRNA precursors or dsRNA into RNAi molecules for miRNA and 
siRNA pathways respectively (Carmell and Hannon, 2004; Jin and Xie, 2007). In a 
recent study, conditional knockout of Dicer1 in mouse ovarian tissue resulted in 
significant differences in the expression of follicle development-related genes including 
Gdf9, Bmp15, Amh, Inhba and Cyp17α1 (Lei et al., 2010). A similar phenotype to the 
Dicer1 knockouts including poor oocyte maturation associated with abnormal spindles 
and chromosomes that did not cluster properly was reported following Ago2 deletion in 
growing mouse follicles (Kaneda et al., 2009). The Argonaute family proteins including 
Ago2 are responsible for binding miRNA to mRNA within RISC that leads to 
repression of the target gene expression by either reducing the length of the poly-(A) tail 
of mRNA or by inhibiting translation (O'carroll et al., 2007). The above studies 
illustrate that the genes involved in RNAi can affect oocyte development through global 
regulation of miRNA stability that affects gene expression in developing oocytes. The 
association of the GDF9 gene with pathways such as the RNAi pathway through 
investigation of potential oocyte candidate genes following the gene specific 
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knockdown for GDF9 requires further investigation. Unfortunately, the oocyte cDNA 
libraries generated in this study for both treatment groups degenerated within a short 
time of creation and did not allow further investigation of genes and pathways 
associated with the knockdown. This is because each library was generated using 
reverse transcription of isolated mRNA from 1-2 oocytes. Thus there was a limited 
amount of nucleic acid in each oocyte library making the samples susceptible to 
degradation. A reduction of the target nucleic acid was also noted for the cumulus shell 
samples and this was proportional to the time taken for analysis by real-time PCR, 
however the relatively large number of cells contained in each sample allowed the 
completion of analysis for all cumulus cell markers. In future experiments, it will be 
important to use methods that better preserve oocyte cDNA within each sample, such as 
the generation of double-stranded DNA that is more robust than single stranded DNA.  
 
4.4.4 Optimisation of microinjection and IVM system 
A major limitation of the siRNA approach used in the present study was the low 
survival rates of the microinjected, denuded, oocytes.  The survival of oocytes was 
20.7% and 25.4% after the first 24 h of culture for the GDF9 siRNA and buffer-injected 
oocytes respectively. While these results indicate that introduction of siRNAs per se 
into the oocyte did not compromise survival, further damage to the oolemma induced by 
microinjection was a significant cause of oocyte loss. Microinjection of both control 
buffer or siRNAs resulted in expansion of oocyte volume with resultant membrane 
damage even though the constant flow injection system was operated on the lowest 
possible flow rate of 40 hPa. In addition, the majority of oocytes were lost within the 
first 24 h of culture following cumulus removal. The process of denudation itself 
therefore appears to have a major and negative impact on oocyte survival. Furthermore, 
mechanical stresses like the injection procedures are known to induce apoptosis in the 
oocyte (Paradis et al., 2005). The poor survival rates might be due to the osmotic stress 
inflicted to the oocyte and oocyte cell membrane.  
 
Another possible explanation for the low survival rates observed was the use of 
cilostamide to delay meiotic progression. For the culture system used in the present 
studies, inhibition of the meiotic progress during the first 24 h of culture is necessary to 
enable the knockdown of the target gene to occur before oocyte maturation progresses. 
Cilostamide, prevents binding of the phosphodiesterases to both cAMP and cGMP and 
stops hydrolysation of the 3´ phosphoester bond (Conti, 2000). In the bovine species it 
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has been shown that the higher levels of cAMP produced by the action of the PDE3 
inhibitor are able to maintain meiotic arrest in the oocytes (Mayes and Sirard, 2002). 
Previous dose response experiments have shown that culture with cilostamide at a 
concentration of 20 mg/ml resulted in GV retention of 38.2% of denuded oocytes with 
49% of ovine oocytes not surviving the process of denudation and subsequent culture 
(Cotterill, 2008). This concentration of cilostamide retained a higher percentage of 
oocytes at the GV stage when compared to the other cilostamide doses tested as well as 
a range of different concentrations of milrinone, another meiotic inhibitor (Cotterill, 
2008).  
 
Other components of the microinjection system which may affect experimental 
outcomes are temperature and pH. The temperature for the current cultures was set at 
39°C as this is the sheep body temperature and has previously been used in the 
validation of  RNAi and IVM for sheep oocytes (Cotterill et al., 2012). All oocytes were 
overlaid with oil in order to minimise temperature and pH fluctuations but even so, 
temperature variations are possible because of the time necessary to handle the oocytes 
and monitor their developmental progress. The meiotic spindle is highly temperature 
sensitive (Inoue, 1981). Cooling of sheep oocytes at selected stages during maturation 
has also been shown to affect their nuclear morphology, their ability to synthesize 
protein as well as their in vivo developmental potential (Moor and Crosby, 1985). For 
this reason, incubator temperature was checked on a daily basis. Also incubator doors 
were not opened for long periods to sustain temperature of the cultures. All microscopes 
used were fitted with heated stages to minimise this problem. 
 
The culture environment has a profound influence on the success of IVM systems. One 
of the most important parameters is the culture media. The composition of serum-free 
media is based on components of the follicular environment to which oocytes would be 
exposed during maturation in vitro (Picton, 2002). Importantly, this media supports 
high-levels of gonadotrophin-driven oocyte maturation and cumulus expansion whilst 
the cumulus cells remain sensitive to other culture additives, as the media has been 
carefully optimised to reflect the physiological needs of the somatic granulosa cells and 
oocytes across a range of species (Campbell et al., 1996; Picton et al., 1998; Cotterill et 
al., 2012). Another important parameter for optimisation is the culture media volume 
and the number of oocytes and cumulus shells or embryos cultured per microdrop of 
media. Culture drop volume is considered very important for the IVM culture not only 
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for the autocrine and paracrine signalling between the oocytes but also for the re-
establishment of cell-cell communication and signalling during the co-culture with the 
oocytectomised cumulus shells. Removal of the cumulus cells before IVM has been 
shown to be detrimental for oocyte maturation in many species such as mice, rats, cattle 
and pigs (Schroeder and Eppig, 1984; Vanderhyden and Armstrong, 1989; Chian et al., 
1994; Wongsrikeao et al., 2005). In contrast, the co-culture of COCs or oocytes with 
cumulus cells has been shown to partially restore the developmental competence of 
denuded oocytes in cows and mice (Zhang et al., 1995; Cecconi et al., 1996; Hashimoto 
et al., 1998). It is understood that cumulus cells play an important role in oocyte 
maturation in terms of regulating the meiotic progression and the support of 
cytoplasmic maturation (Tanghe et al., 2002). Cumulus cells promote oocyte maturation 
by the alteration of timing of nuclear maturation and redistribution of cortical granules, 
disturbance of spindle assembly, redistribution of mitochondria and increased MPF 
activity as shown in a mouse study, with the excessive increase of MPF activity being 
relieved following co-culture with cumulus cells (Ge et al., 2008). In the present study, 
the ratio of oocytes and cumulus shell number in each culture drop to medium volume 
was always kept the same to 2 μl per oocyte and 2 μl per cumulus shell or 4 μl per COC 
as previously optimised by Danfour, (2001). 
 
4.4.5 Conclusions 
In conclusion, these experiments have provided insight into the efficiency of siRNA and 
microinjection as vehicles to generate gene knockdowns in ovine oocytes and therefore 
to study the effect of novel genes in oocytes. The known oocyte-specific gene GDF9 
was used to test the validity of this approach as GDF9 has a proven role in oocyte 
maturation and cumulus behaviour established in a number of species. The present 
experimental series using siRNA microinjection, IVM and cumulus co-culture 
demonstrated the importance of GDF9 in oocyte meiotic progression by functional 
analysis of cumulus expansion as well as alteration of cumulus gene, HAS2 expression. 
On this basis, siRNA microinjection, IVM and cumulus co-culture will be used to test 
the role of GTSF1, during ovine oocyte maturation.  
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Chapter 5: Functional evaluation of the role of GTSF1 during 
the during the maturation of ovine oocytes in vitro 
 
5.1 INTRODUCTION  
The experimental results presented in Chapter 3 have shown that GTSF1 is localised in 
the cytoplasm of ovine oocytes and that GTSF1 is also expressed during 
spermatogenesis in the testis and during early preimplantation embryo development in 
this species. Furthermore, the gene and protein sequence appear to be being highly 
conserved across species. Although the importance of Gtsf1 in spermatogenesis and 
male fertility have been established in rodents (Yoshimura et al., 2009), the significance 
of this gene in acquisition of developmental competence of oocytes has not been 
established in monovular species such as the sheep. In polyovular mice, Gtsf1 knockout 
animals grew normally and appeared healthy, but the males were sterile due to apoptotic 
death of their germ cells after postnatal day 14 while the null female mice were fertile 
(Yoshimura et al., 2009). The null male meiocytes were shown to cease meiotic 
progression before the zygotene stage, thereby indicating the significance of this factor 
in meiotic progression beyond the early stages (Yoshimura et al., 2009). Although the 
effects of Gtsf1 knockdown did not result in infertility in female mice, it could be that 
the effects of the gene are more subtle in female mice. In particular, female Gtsf1 
knockout mice were fertile when examined over a period of 6 months and histological 
analyses did not show any abnormalities following the knockout in the ovaries. Mating 
of male Gtsf1 knockout mice with normal female C57BL/6 mice resulted in fertilisation 
as confirmed by the formation of vaginal plugs, but no pups were born since the male 
mice were infertile (Yoshimura et al., 2009). The lack of a major effect of Gtsf1 
knockout on oocyte growth and function is very surprising, considering the high degree 
of localisation of Gtsf1 to the cytoplasm of primary follicles and to lesser extend to 
primordial follicles following ISH in mice, as represented by Krotz et al., (2009). This 
is supported by expression analysis of GTSF1 in human ovarian tissue by real-time PCR 
that shows expression at primordial, primary, secondary, GV, MII, zygotes and late 
stage preimplantation embryos (JD Huntriss and HM Picton, unpublished data). The 
results of this thesis as shown in Chapter 3 are in agreement with the human data. The 
specific expression of the gene along with its conserved domain containing 2 tandem 
copies of CHHC Zn-finger that may be responsible for RNA-binding (Andreeva and 
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Tidow, 2008), makes GTSF1 as a very promising marker of oocyte quality in 
monovular species.  
 
As stated in the introductory Section 1.4.2, of Chapter 1, RNA-binding is involved in 
several cellular processes including regulation of meiotic procedures, post-
transcriptional and translational control of gene expression (Mootz et al., 2004; Song et 
al., 2007; Glisovic et al., 2008). More interestingly, cellular localisation of GTSF1 in 
bovine round spermatids and mature sperm indicates that the GTSF1 protein functions 
during post-meiotic spermatogenesis in addition to its already established role during 
the early primary spermatocyte development (Lu et al., 2012). It is possible therefore 
that GTSF1 is involved in RNA processing. 
 
piRNA and its interacting proteins have been shown to be involved in retrotransposon 
silencing in order to preserve the germ cell genome (Kuramochi-Miyagawa et al., 
2004). In addition to this, the association of Piwi with a number of miRNAs and 
piRNAs in D. melanogaster suggests that the Piwi might act through the miRNA 
mechanism (Yin and Lin, 2007). The increased transcription of Line1 and Iap 
retrotransposons and demethylations of their promoter regions following Gtsf1 
knockout in mice, suggests therefore a possible implication of Gtsf1 with  the RNAi 
mechanism (Yoshimura et al., 2009). It is apparent that if GTSF1 is involved in RNA 
processing, this might involve germinal granules including the chromatoid bodies in the 
sperm and P-bodies in the oocyte that contain RNA and RNA-binding proteins with 
known roles in differentiation of germ cells and early embryo development including 
RNA-storage and processing (Kotaja et al., 2006; Kotaja and Sassone-Corsi, 2007).  
 
The experimental results of Chapter 4 have validated the efficiency of siRNA 
microinjection as a vehicle for gene knockdown in ovine oocytes. In addition, the data 
have demonstrated that oocyte siRNA microinjection in conjunction with IVM and co-
culture with oocytectomised cumulus cells can be used to test the function of novel 
genes during ovine oocyte maturation. The cloning, sequencing and characterisation of 
ovine GTSF1 in Chapter 3 has enabled us to design ovine GTSF1 siRNA oligos and to 
use these with the microinjection and IVM system detailed in Chapter 4 to directly 
study the effects of GTSF1 on ovine oocyte maturation in vitro. 
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5.1.1 Aims  
The aims of this chapter were therefore to knockdown GTSF1 in ovine GV oocytes and 
study the effects of the knockdown on functional parameter of oocyte maturation in 
vitro including: 
1. Oocyte meiotic progression 
2. Cumulus mucification and expansion 
3. Analysis of candidate oocyte and cumulus genes which are markers of 
oocyte and cumulus maturation 
This experimental series used the validated IVM microinjection system detailed in 
Chapter 4 to produce the targeted knockdown of GTSF1. The functional end-points 
measured were based on morphological evaluations of oocyte meiotic progression as 
well as gene expression analysis of GTSF1 and other candidate genes by real-time PCR. 
Pilot studies of the effect of GTSF1 knockdown on oocyte meiotic spindle formation 
were also conducted by immunofluorescent detection of α-Tubulin staining in whole 
oocyte mounts. 
 
5.2  MATERIALS AND METHODS 
This experimental series utilised the physiological serum-free IVM and microinjection 
system which had been previously developed for sheep oocytes by Cotterill et al., 2012 
as described in Chapter 4. Following the experimental assessment of the efficacy of 
gene knockdown using 4 different GTSF1 siRNAs the experiment was conducted 
during the sheep breeding season between November 2010 and February 2011. 
 
5.2.1 Assessment of gene knockdown using 4 different GTSF1 siRNAs 
Tissue was collected from the abattoir on 2 consecutive days every week. All the 
procedures media used were as detailed in Chapter 2. The validity of 4 different GTSF1 
siRNAs in creating a gene specific knockdown was evaluated using the methodology 
described in Chapter 4, Section 4.2.2. The oligos were synthesized by Invitrogen Ltd 
based on the full ovine sequence of GTSF1 obtained in Chapter 3 (Table 3.4). The oligo 
sequences are shown in Table 5.1. The efficacy of these oligos in providing a GTSF1 
knockdown was assessed over a series of 4 replicate cultures each using 1 set of the 4 
siRNA oligos. In each culture, oocytes were divided into 2 groups and injected either 
with 1 of the 4 GTSF1 siRNA oligos or DPBS buffer. In brief, GTSF1 siRNA was 
microinjected into denuded GV oocytes and groups of 10 oocytes were incubated in 20 
μl of culture medium supplemented with basal gonadotrophin levels (FSH: 0.5 ng/ml, 
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LH: 0.1 ng/ml) containing 20 mg/ml cilostamide. After 24 h of culture, groups of 5 
viable oocytes as observed by NR staining from each treatment were co-cultured with 
groups of 5 oocytectomised cumulus shells in 20 μl of IVM medium supplemented with 
the high levels of gonadotrophins (FSH: 100 ng/ml, LH: 100 ng/ml). 
 
Table 5.1:  GTSF1 oligo sequences used to generate 4 species of GTSF1 siRNAs 
Primer Sequence 
 
GTSF1 siRNA-1 
 
Sense : r(GGC UGA AAU CAG CCA UCA UTT)dTdT 
Antisense : r(AUG AUG GCU GAU UUC AGC CCG)dAdT 
 
GTSF1 siRNA-2 
 
Sense : r(CUC AAG CUG UGA UGA CAA ATT)dTdT 
Antisense : r(UUU GUC AUC ACA GCU UGA GAT)dAdT 
 
GTSF1 siRNA-3 
 
Sense : r(AUA UGU UCU CCC AUG GAA ATT)dTdT 
Antisense : r(UUU CCA UGG GAG AAC AUA UGG)dTdG 
 
GTSF1 siRNA-4 
 
Sense : r(ACU GAA UAU UUC AUC AAA UTT)dTdT 
Antisense : r(AUU UGA UGA AAU AUU CAG UTA)dAdG 
 
At the end of the cultures, the oocytes that survived 48 h of culture and progressed to 
the MII stage from each culture microdrop were pooled into lysis buffer and snap-
frozen. These pools were used for mRNA isolation and real-time PCR to determine the 
level of knockdown as described in Chapter 4, Section 4.2.2-4.2.2.1. The primer 
sequence of ovine GTSF1 used for real-time PCR was obtained from the cloned ovine 
sequence (Chapter 3) and is shown in Table 5.2. The mRNA levels of ovine GTSF1 
were quantified relative to the expression of the housekeeper genes GAPDH and H2A 
(Chapter 2, Section 2.4).  
 
Table 5.2: Primer sequence of ovine GTSF1 used for real-time PCR 
Gene Primer Sequence Size (bp) Reference 
GTSF1 
ovine 
F: 5´ CTC TGG ACC CTG AAA AGC TG 3´ 
120 
Chapter 3, 
Table 3.5 R: 5´ GTT TGT TTG CGA CAT CAG GA 3´ 
 
5.2.2 Experimental assessment of the impact of GTSF1 knockdown during 
maturation of ovine oocytes in vitro 
Following the experimental assessment of the 4 different siRNA species in creating a 
GTSF1 knockdown in GV oocytes, a total of 11 cultures were conducted using the 
siRNA that was most efficient in generating a GTSF1 specific knockdown. The 
methodology followed was similar to the methodology described in Chapter 4, Section 
4.2.3., with a few differences in the experimental procedure. One difference was the 
injection pipette outflow applied for the injection of the oocytes of the different groups. 
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The constant outflow of the injection pipette was set at 40 hPa for the injections of both 
the GSF9 siRNA and control buffer during the validation experiments of Chapter 4. 
Although this method resulted in substantial levels of gene knockdown, it was 
hypothesised that the survival rates of oocytes could be improved by reducing the 
amount of siRNA or buffer injected into the oocytes. During the validation experiments 
of Chapter 4, the process of penetrating the oolemma and removing the injection pipette 
had to be extremely rapid in order to allow an equal amount of siRNA or buffer to be 
injected inside the cytoplasm of each oocyte and this could have inflicted damage to the 
oocytes reflected by the poor survival rates of the first 24 h of cultures for both 
treatments. In this experimental series therefore, the Femtojet microinjection system 
was used without a constant outflow. Instead, the oocytes were held with the holding 
pipette and after the injection pipette was inserted into the cytoplasm of the oocyte, the 
pressure of 40 hPa was applied using a start-stop button for approximately 0.5 sec. After 
stopping the outflow, the injection pipette was carefully removed from the oocyte 
avoiding further damage. The same process was applied to all oocytes from the different 
injection groups. All other experimental conditions were kept the same for day 2 and 
day 3 of the culture and all developmental assessments were recorded as described 
previously (Chapter 4, Section 4.2.2).  
 
For the last 3 cultures of this experiment, an additional group was created and used for 
injections. In addition to GTSF1 siRNA and control buffer-injected oocytes, a third 
group of oocytes were injected with non-coding, negative control siRNA (N.C. siRNA, 
Qiagen Ltd). This additional group was introduced into the experimental design, as the 
siRNA has no homology to any known mammalian gene that had previously been 
validated with Affymetrix GeneChip arrays and many cell based assays (Technical 
specifications, Qiagen Ltd). As recommended by the manufacturer, the N.C. siRNA 
enters RISC and ensures that the comparison of the gene specific siRNA to the N.C. 
siRNA reflects a genuine picture of the effects of the target gene knockdown on gene 
expression and phenotype, therefore offering a much more reliable control than buffer 
injection. All culture conditions and experimental protocols were kept the same 
throughout the experimental series. For the last 3 cultures, the oocytes were divided 
equally into 3 groups during day 1 of the cultures and oocytes from each group were 
inserted into pre-made injection dishes (2 dishes for each group) as described previously 
in Chapter 4, Section 4.2.2. Injections for the different groups took place using 3 
different injection pipettes with pipette loading and microinjections performed as stated 
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previously (Chapter 4, Section 4.2.2). At the end of the culture period, assessment of 
oocyte survival and maturation as well as cumulus expansion and coverage took place 
as previously described (Chapter 4, Section 4.2.2). All the steps followed are shown in 
the diagram below (Figure 5.1). 
 
 
Figure 5.1: Schematic representation of the GTSF1 siRNA procedure followed and the end-
points following generation of GTSF1 knockdown. 
 
5.2.2.1  Molecular evaluation of GTSF1 knockdown  
At the end of the first 8 cultures, all oocytes that survived the 48 h of culture were 
transferred individually to labelled 1.5 ml microcentrifuge tubes containing 10 μl of 
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lysis buffer and all samples were snap-frozen in liquid nitrogen and stored in -80°C for 
subsequent analysis. Similarly, individual cumulus shells from each drop were also 
placed in lysis buffer and snap-frozen until molecular analysis. The stored samples of 
single oocytes or cumulus shells originating from 8 co-cultures of injected oocytes for 
the different groups and oocytectomised cumulus shells were thawed and used for 
mRNA isolation as described in Chapter 2, Section 2.2.2 and then they were re-
suspended in 3 μl of Tris-HCl (Invitrogen Ltd, Dynal) followed by incubation on a hot 
block at 90° for 2 min. The mRNA was separated from the Dynal magnetic bead 
apparatus and the cDNA synthesis by reverse transcription was performed as described 
in Chapter 2, Section 2.2.3. At this point, a second-strand synthesis protocol was 
followed to synthesize second-strand cDNA from the 10 μl first strand reactions. This 
step was followed to increase stability of the cDNA libraries originating from single 
oocytes based on the results from the validation experiments for the microinjections 
(Chapter 4). Specifically, the previous cDNA libraries derived from samples containing 
groups of 1-2 injected oocytes as generated in Chapter 4, showed signs of DNA 
degeneration following a few cycles of freeze-thawing and did not allow further 
pathway analysis and investigations following the GDF9 knockdown.  
 
In the current experimental series where cDNA libraries were created for individual 
oocytes and individual cumulus shells, a Superscript Double-Stranded cDNA Synthesis 
Kit (Invitrogen Ltd) was used following the first-strand synthesis. To each of the 10 μl 
cDNA libraries, the following reagents from the kit were added: 18.2 μl of DEPC-
treated H20, 6 μl of 5 X second-strand reaction buffer, 0.6 μl of 10 mM dNTP mix, 0.2 
μl of E. coli DNA Ligase (10 U/μl), 0.8 μl of E. coli DNA Polymerase I (10 U/μl) and 
0.2 μl of E. coli RNase H (2 U/μl), resulting to a final volume of 36 μl. The tube was 
then vortexed gently and incubated for 2 h at 16° C. Following the 2 h incubation, 2 μl 
(10 units) of T4 DNA Polymerase (Kit) were added and the samples were incubated for 
an additional 5 min at 16° C. The samples were then subjected to heat-deactivation at 
95° C for an additional 5 min. At the end of the incubation the level of knockdown for 
each of the GTSF1 siRNA-injected oocyte in comparison with the oocyte injected with 
controls was determined by real-time PCR as described in Section 5.2.1 
 
5.2.2.2  Impact of GTSF1 knockdown on gene expression 
All single MII oocytes that produced a substantial level of GTSF1 specific knockdown 
following GTSF1 siRNA injection (>50% reduction in the GTSF1 transcript level) 
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along with their respective controls were selected for further molecular analysis. The 
cumulus shells originating from the same co-culture drops were also selected for 
analysis. Candidate gene mRNA expression was evaluated in both the cumulus shells 
and oocytes. The list of the genes analysed in oocytes included known oocyte-specific 
factors such as GDF9 and BMP15 as well as genes thought to be associated with GTSF1 
expression such as NOBOX2 situated upstream of GTSF1 (Krotz et al., 2009). Other 
oocyte targets included the CDC20 gene, the trinucleotide repeat-containing gene 6A 
(TNRC6A) gene, the like-Sm 14A (LSM14A) gene and the INCENP gene. The primers 
for the genes used in the real-time PCRs for the evaluation of the effect of the GTSF1 
knockdown on oocyte gene expression are shown in Table 5.3. In addition to oocyte 
gene analysis, candidate gene expression was also assessed in the cumulus shells 
originating from the co-cultures with the GTSF1 siRNA-injected oocytes in comparison 
with buffer-injected controls and N.C. siRNA-injected oocytes. The genes analysed 
were relevant to cumulus expansion and signalling and included HAS2, GREMLIN1, 
AMH, LDH1, AREG, EREG, BTC, EGFR, FSHR and LHR. 
 
Table 5.3:  Primer sequences of oocyte targets genes following GTSF1 knockdown used for 
real-time PCR 
Gene Primer Sequence Size (bp) Reference 
NOBOX2 
F: 5´ GTGCCTATTTCCTGCACCAT 3´ 
119 
HQ589330 
 (predicted bovine) R: 5´ CTCCTGTCTTCGTGGAGAGC  3´ 
CDC20 
F: 5´ CCCAGAGGGTTACCAGAACA  3´ 
86 
XM004023553 
(predicted ovine) R: 5´ GAATGTAGCGGCAGGTCTTC 3´ 
TNRC6A 
F : 5´ CAGACCAGCAAGCACAGGTA 3´ 
168 
XM614640 
 (predicted ovine) R : 5´ GCCCACTGTCTACGGGTTTA 3´ 
LSM14A 
F: 5´ GTGTGGTTGGTTCTGCCTTT 3´ 
129 
NM001034654 
(bovine) R: 5´ AGGCGGTCTGTACTGCTTGT 3´ 
INCENP 
F: 5´ TGCTCAGATCGACGAGAAGA 3´ 
156 
XM584352 
(predicted bovine) R: 5´ TCCTCCTGCTGTAGCCACTT 3´ 
 
5.2.2.3  Pilot assessment of the impact of GTSF1 knockdown on oocyte spindle 
integrity 
To determine the effect of GTSF1 on the structure of the oocyte meiotic spindle and the 
distribution of microtubules, α-Tubulin immunofluorescent staining was applied using a 
technique previously described (Li et al., 2006). Tubulin is a member of the globular 
proteins with the α-Tubulin and β-Tubulin family members of tubulins making up the 
microtubules (Weisenberg, 1972). For the last 3 cultures out of the 11 conducted, after 
the completion of culture, mature MII oocytes from each treatment group (GTSF1 
siRNA-injected, buffer-injected and N.C. siRNA-injected) were used for α-Tubulin 
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staining. Oocytes from the different groups were placed in separate drops of a 4 well 
dish and fixed in 500 μl of 4% PFA (w/v) in PBS overnight at 4ºC. The PBS solution 
was made by dissolving 1 PBS tablet (Invitrogen Ltd) in 500 ml of Milli-Q H20 
followed by filter sterilization with a 0.2 μm cellulose acetate Acrodisc syringe filter. 
The oocytes were then washed in a separate well of 500 μl of PBS at RT for 5 min and 
were then transferred into clean wells pre-filled with 500 μl of 1% (v/v) Triton X-100 
and 0.3% (w/v) BSA (lyophilized powder, ≥96%) in PBS at 37°C and incubated for 1 h 
at 37ºC. The oocytes were washed twice in 500 μl of 0.01% (v/v) Triton X-100 in PBS 
at RT for 5 min per wash and were then incubated in 500 μl of 150 mM Glycine and 1% 
(v/v) Triton X-100 in PBS for 1 h at 37ºC to block any residual fixative. Oocytes were 
then washed thoroughly in 500 μl of PBS at RT for 5 min. At this stage, all oocytes 
from each of the 3 treatments were transferred into separate wells of a 4 well dish, in 
which a small glass coverslip was placed onto the bottom of each well containing 25 μl 
drops of mouse monoclonal anti α-Tubulin antibody (1:400 working stock in 0.01% v/v 
sodium azide in PBS) overlaid with 400 μl of mineral oil. The oocytes were incubated 
for 1 h at 37ºC. Oocytes were then washed thoroughly in PBS and oocytes from each 
treatment then transferred into separate wells of a 4 well dish with an inserted small 
glass coverslip on the bottom of the well containing 25 μl of polyclonal FITC-
conjugated rabbit anti-mouse antibody (1:100 working stock in 0.01% v/v sodium azide 
in PBS) overlaid with 400 μl of mineral oil. Both the primary and secondary antibodies 
were purchased from Sigma-Aldrich. The oocytes were once again incubated for 1 h at 
37ºC. The oocytes were then washed in 500 μl of PBS for 5 min at RT before being 
incubated in 25 μl drop of DAPI (10 μg/ml in PBS) in 4 well dishes with a glass 
coverslip at the bottom and overlaid with 400 μl of mineral oil. The incubation period 
lasted for 15 min at RT in the dark. Oocytes were then washed once again in 500 μl of 
PBS at RT for 5 min before they were mounted on slides with 20 μl drop of Vectashield 
mountant (Vector Laboratories Ltd, Peterborough, UK). The Vectashield was placed 
onto the centre of a pre-cleaned Superfrost Plus glass microscope slide (Thermo Fisher 
Scientific) and 2-3 oocytes from each treatment were placed into the drop and were 
allowed a few minutes to sink to the bottom of the drop. A coverslip was then placed 
onto the drop and lowered slowly to avoid introduction of drops under the coverslip or 
squashing of the oocytes. Oocytes were kept at 4ºC in the dark and visualized under a 
fluorescent microscope (Zeiss Axioplan2, Carl Zeiss Ltd) using the Cytovision 4.5 
computer software (Leica Microsystems Ltd). Additionally, oocytes were also 
visualized under a confocal microscope (Zeiss LSM 510, Carl Zeiss Ltd) using the 
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confocal microscopy software 3.2 (Carl Zeiss Ltd). Both microscopes were fitted with a 
filter with an excitation wavelength range between 495 and 520 nm to capture green 
fluorescence and a filter with an excitation wavelength between 420 and 495 nm to 
capture blue fluorescence. 
 
5.2.4 Statistical analysis  
Chi-square tests were used to analyse the results of oocyte survival, meiotic 
progression, cumulus coverage and cumulus expansion according to proportional 
analysis of the cohort of oocytes and cumulus within each treatment. All data were 
checked for normality using the Anderson-Darling test. Normally distributed data for 
mRNA levels of GTSF1, GDF9, BMP15, NOBOX2, CDC20, TNRC6A, LSM14A and 
INCENP mRNA levels within oocytes and HAS2, GREMLIN1, AMH, LDH1, AREG, 
EREG, BTC, EGFR, FSHR and LHR within cumulus cells were compared using 
Student’s t-test. Values for real time data presented are the arithmetic means ±SEM for 
the number of observations shown. 
 
5.3  RESULTS 
Overall 1038 oocytes were microinjected over 2 experimental series; of these 465 
denuded oocytes were injected with GTSF1 siRNA, while 463 denuded oocytes were 
injected with buffer and 110 denuded oocytes were injected with N.C. siRNA in a total 
of 15 cultures.  
 
5.3.1 Assessment of the 4 different GTSF1 siRNA species in generation of 
knockdown following microinjection and IVM of GV oocytes 
A total of 4 cultures were conducted using the 4 commercially made GTSF1 siRNAs for 
the generation of knockdowns (30 oocytes injected per culture) with buffer-injected 
oocytes as controls (30 oocytes injected per culture). The observations through the 
cultures showed that none of the 4 GTSF1 siRNAs was lethal to the oocytes and no 
significant differences were observed between the 4 siRNAs and the controls at 24 and 
48 h (P>0.05, Table 5.1). The majority of oocyte losses occurred in the first 24 h of 
culture in both siRNA-injected and buffer-injected controls in response to denudation 
and/or membrane damage due to injection (Table 5.1). Additionally, assessment of 
oocyte developmental competence showed that oocytes from both injection groups for 
all 4 cultures progressed to the MII stage at the end of the 48 h of incubation as assessed 
by the presence of the first polar body as shown in Table 5.4. The numbers of MII 
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oocytes however were very low (1-2 per siRNA and control) and meaningful statistical 
analysis was therefore not possible. Cumulus expansion monitoring in cumulus cells co-
cultured with viable GTSF1 siRNA-injected oocytes and buffer-injected control oocytes 
showed that cumulus shells from the co-cultures of both the GTSF1 siRNA-injected 
oocytes and buffer-injected oocytes were able to fully expand following the 4 co-
cultures (Table 5.1). Although the data is very preliminary and the numbers of cumulus 
complexes were too low for meaningful statistical analysis, the data demonstrate that 
cumulus expansion is supported through the IVM co-culture of oocytectomised cumulus 
shells and denuded oocytes (Table 5.1). 
 
Table 5.4:  Comparison of the 4 different siRNAs following GTSF1 knockdown 
Treatment GTSF1 siRNA Control buffer Significance 
Oocyte survival at 24 h 
GTSF1 siRNA-1 2/30 (6.7%) 3/30 (10.0%) 
NS 
GTSF1 siRNA-2 7/30 (23.3%) 8/30 (26.7%) 
GTSF1 siRNA-3 2/30 (6.7%) 3/30 (10.0%) 
GTSF1 siRNA-4 5/30 (16.7%) 4/30 (13.3%) 
       Oocyte survival at 48 h (based on viable oocytes at 24 h) 
GTSF1 siRNA-1 2/2 (100%) 3/3 (100%) 
NS 
GTSF1 siRNA-2 7/7 (100%) 8/8 (100%) 
GTSF1 siRNA-3 2/2 (100%) 3/3 (100%) 
GTSF1 siRNA-4 5/5 (100%) 4/4 (100%) 
       Oocyte maturation of viable oocytes at 24 h 
GTSF1 siRNA-1 1/2 (50.0%) 1/3 (33.3%) 
NA 
GTSF1 siRNA-2 2/7 (28.6%) 2/8 (25.0%) 
GTSF1 siRNA-3 1/2 (50.0%) 1/3 (33.3%) 
GTSF1 siRNA-4 1/5 (20.0%) 1/4 (25.0%) 
      Cumulus expansion 
          Classification 0 
GTSF1 siRNA-1 0/2 (0.0%) 0/3 (0.0%) 
NA 
GTSF1 siRNA-2 0/7 (0.0%) 0/8 (0.0%) 
GTSF1 siRNA-3 0/2 (0.0%) 0/3 (0.0%) 
GTSF1 siRNA-4 0/5 (0.0%) 0/4 (0.0%) 
           Classification 1 
GTSF1 siRNA-1 0/2 (0.0%) 1/3 (33.3%) 
NA 
GTSF1 siRNA-2 5/7 (71.4%) 4/8 (50.0%) 
GTSF1 siRNA-3 1/2 (50.0%) 2/3 (66.7%)  
GTSF1 siRNA-4 3/5 (60.0%) 2/4 (50.0%) 
            Classification 2 
GTSF1 siRNA-1 2/2 (100%) 2/3 (66.7%) 
NA 
GTSF1 siRNA-2 2/7 (28.6%) 4/8 (50.0%) 
GTSF1 siRNA-3 1/2 (50.0%) 1/3 (33.3% 
GTSF1 siRNA-4 2/5 (40.0%) 2/4 (50.0%) 
 
Molecular analysis of GTSF1 transcript levels in oocytes showed a reduction for 3 out 
of 4 siRNAs when GTSF1 siRNA-injected MII oocytes were compared with buffer-
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injected MII oocytes using GAPDH and H2A as reference standards. The expression 
levels of GTSF1 were reduced when siRNA-1 was injected (19.1 arb. units) in 
comparison with the buffer-injected control oocyte (32.3 arb. units). When siRNA-2 
was injected there was a higher reduction in the transcript levels of GTSF1 following 
the knockdown (14.9±3.3 arb. units, n=2) in comparison to the control oocyte 
(43.7±10.9 arb. units, n=2). The highest reduction in GTSF1 levels was noted when 
siRNA-3 was injected (8.8 arb. units) in comparison to the control (49.1 arb. units), 
while there was a small reduction in the GTSF1 transcript levels when siRNA-4 was 
injected (22.5 arb. units) in comparison to its respective control (26.3 arb. units). 
Because of the low numbers of oocytes progressing to the MII stage (1-2 single MII 
oocytes available for analysis), further analysis of the oocytes retained at the GV stage 
at the end of the cultures verified the findings for the efficiency of GTSF1 siRNA-3 in 
generating a substantial level of knockdown (data not shown). On the basis of these 
preliminary results, the GTSF1 siRNA-3 was considered more suitable for generation of 
oocyte GTSF1 knockdowns. The GTSF1 siRNA-3 relates to a sequence located on the 
sixth exon (www.ensembl.org) of the GTSF1 sequence (base pairs 476-497) and was 
thereafter used in the subsequent experiments (referred to as GTSF1 siRNA) in order to 
study the effect of GTSF1 in oocyte development and cumulus function. 
 
5.3.2 Experimental assessment of the impact of GTSF1 knockdown during 
maturation of ovine oocytes in vitro 
In a total of 11 cultures, 345 denuded oocytes were injected with the selected GTSF1 
siRNA (GSF1 siRNA-3), while 343 denuded oocytes were injected with buffer and 110 
denuded oocytes were injected with N.C. siRNA. 
 
5.3.2.1 Oocyte survival after microinjection 
Oocyte survival was assessed at 24 h and 48 h of culture. From all the cultures, a total 
of 45/345 oocytes (13%) survived the first 24 h as assessed by NR staining when 
injected with GTSF1 siRNA, 56/343 oocytes (16.3%) survived the buffer injections and 
15/110 oocytes survived the N.C. siRNA injections (13.6%). At 48 h all IVM oocytes 
remained viable with 45/45 GTSF1 siRNA-injected oocytes surviving (100%), 56/56 
buffer-injected oocytes surviving (100%) and 15/15 N.C. siRNA-injected oocytes 
surviving (15/15%) as shown in Figure 5.2. No significant differences (P>0.05) in 
oocyte survival were observed between the 3 injection groups at the 2 time points 
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showing that neither the GTSF1 siRNA nor the N.C.siRNA per se were toxic to the 
oocytes.  
 
Figure 5.2: Influence of oocyte GTSF1 siRNA injection, buffer injection and N.C.siRNA 
injection on oocyte survival as assessed by NR uptake at 24 h and 48 h of in vitro culture. 
Before the first time point, oocytes were denuded, microinjected with either GTSF1 siRNA, 
control buffer or N.C. siRNA and cultured in serum-free media with cilostamide (20 mg/ml) 
and basal levels of gonadotrophins for 24 h. Surviving oocytes were then co-cultured with 
oocytectomised cumulus shells in serum-free IVM media and maturation inducing levels of 
gonadotrophins for an additional 24 h (total of 48h). Values represent the cohort of injected 
oocytes over 11 repeat cultures for GTSF1 siRNA and control buffer and 3 repeat cultures for 
N.C. siRNA. Individual bars show the mean ±SEM for independent cultures with the numbers 
of oocytes falling into each category shown. No significant differences were observed (P>0.05). 
 
5.3.2.2 The impact of GTSF1 on meiotic progression 
Developmental competence of oocytes following microinjection and IVM was assessed 
by confirming the MII progression rates of viable oocytes at 24 h after 48 h of culture 
(Figure 5.3).  
 
 
Figure 5.3: Impact of GTSF1 knockdown on meiotic progression of viable GTSF1 siRNA, 
buffer and N.C. siRNA-injected oocytes as determined at 24 h of culture that were subjected to 
an additional 24 h of IVM co-culture with cumulus shells. The 3 groups did not demonstrate any 
significant differences (P>0.05). Values represent proportions of surviving oocytes over 11 
repeat cultures for GTSF1 siRNA and control buffer and 3 repeat cultures for N.C. siRNA. 
Individual bars show the mean ±SEM for independent cultures with the numbers of oocytes 
falling into each category shown. No statistical differences were observed (P>0.05). 
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The proportion of viable oocytes following the first 24 h of cultures progressing to the 
MII stage was not significantly different between the 3 groups (P>0.05) with 33.3% of 
viable oocytes following GTSF1 knockdown progressing to MII (15/45 oocytes) in 
comparison to 19.6% of buffer-injected oocytes (11/56 oocytes) and 26.7% of N.C. 
siRNA-injected control oocytes (4/15 oocytes) (Figure 5.3).  
 
5.3.2.3 The effect of oocyte GTSF1 knockdown on cumulus expansion 
Cumulus shell mass and expansion were assessed prior to the start of the second phase 
of oocyte culture at 24 h and at the end of the IVM co-culture at 48 h. Equal numbers of 
cumulus shells and viable oocytes from the first phase were co-cultured per treatment. A 
total of 45 cumulus shells were oocytectomised and cultured with viable GTSF1 
siRNA-injected oocytes, while 56 and 15 cumulus shells were co-cultured with viable 
buffer-injected oocytes and viable N.C. siRNA-injected oocytes respectively. Cumulus 
shells were divided equally between the 3 groups of oocytes based on their coverage 
scores and at the end of the culture, with the coverage scores of the cumulus remaining 
unchanged during the period of the co-culture for all 3 treatments. There were no 
significant differences (P>0.05) between the 3 groups as shown by the mean proportion 
of cumulus coverage at the end of the cultures (Figure 5.4). 
 
 
Figure 5.4: Effect of oocyte GTSF1 knockdown on cumulus shell mass classification after 24 h 
of co-culture with GTSF1 siRNA, buffer or N.C. siRNA-injected oocytes. Values represent 
proportions of cumulus shell mass classifications over 11 repeat cultures for GTSF1 siRNA and 
control buffer and 3 repeat cultures for N.C. siRNA. Individual bars show the mean ±SEM for 
independent cultures with the numbers of cumulus shells falling into each category shown. No 
significant differences were observed (P>0.05).  
 
Analysis of cumulus expansion showed that cumulus shells underwent expansion over 
the 24 h of IVM culture as indicated by the progression of cumuls expnasion score 0 to 
expansion score 2 for all treatment groups. However, knockdown of GTSF1 in oocytes 
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generated by siRNA injection did not have a significant effect on the capacity for 
cumulus expansion (P<0.05) when compared with the control buffer and the N.C. 
siRNA-injected oocyte treatment groups. Figure 5.5 shows the mean proportion of 
cumulus expansion for the 3 treatment groups. This result indicates that GTSF1 does not 
affect cumulus-oocyte-cumulus interactions and the signalling required to drive 
cumulus expansion during 24 h of IVM. 
 
 
Figure 5.5: Effect of oocyte GTSF1 knockdown on cumulus expansion following 24 h of IVM 
co-culture. Values represent proportions of cumulus shell expansion classifications over 11 
cultures for GTSF1 siRNA and control buffer and 3 repeat cultures for N.C. siRNA. Individual 
bars show the mean ±SEM for independent cultures with the numbers of cumulus shells falling 
into each category shown. No statistically significant differences were noted between the 3 
groups (P>0.05).   
 
5.3.2.4 Molecular analysis of gene expression following GTSF1 knockdown 
The function of GTSF1 was further investigated by analysis of the expression of 
potential target genes associated with the knockdown in the oocyte and cross-talk with 
cumulus cells. Individual oocytes that progressed to the MII stage from the first 8 
cultures following GTSF1 siRNA and control buffer injections were used for molecular 
evaluations. A total of 15 MII oocytes from the GTSF1 siRNA injection group along 
with their respective controls from each individual culture (15 control oocytes) were 
analysed. Real time analysis showed that GTSF1 expression was reduced following 
GTSF1 siRNA injection (35.2±8.4 arb. units, n=15) in comparison with the control 
injected oocytes (78.0±20.3 arb. units, n=15), but this reduction was not significant 
(P>0.05) (Figure 5.6.a). This was based on absolute oocyte mRNA levels of GTSF1 
normalised against both H2A and GAPDH. The observed variability in the levels of 
GTSF1 knockdown between different samples in comparison with the controls could be 
the result of altering the injection methodology. The MII oocytes that showed a 
reduction in their GTSF1 expression level of >50% based on their relative expression 
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levels with the controls were selected from the cohort. The total of 4 individual oocytes 
were verified by real-time to have a significant reduction (P<0.05) in the GTSF1 
transcript levels following GTSF1 siRNA injection (10.7±3.2 arb. units, n=4) in 
comparison with controls (111.2±58.6 arb. units, n=4) (Figure 5.6.b). These oocytes 
along with their respective controls and single cumulus shells from their respective co-
cultures were selected for subsequent analysis.  
 
 
Figure 5.6: Real-time PCR quantification of the effect of GTSF1 siRNA injection on the 
GTSF1 expression levels of (a): All MII oocytes (n=15) injected with GTSF1 siRNA and their 
respective controls, (b): Selected MII oocytes (n=4), that showed a relative reduction in the 
GTSF1 expression level of over 50% in comparison with the controls. The data were 
standardised against the oocyte GAPDH and H2A mRNA levels. Individual bars show the mean 
±SEM for (a) 15 repeat cDNA libraries and (b) 4 repeat cDNA libraries (each cDNA library 
analysed in triplicate). Each cDNA library contained a single oocyte. The selected GTSF1 
siRNA-injected oocytes (b) exhibited a statistically significant difference for the GTSF1 mRNA 
levels (*=P<0.05) when compared against the buffer-injected control samples. 
 
The specificity of the knockdown for the target gene was thereafter further examined by 
assessing the transcript levels of oocyte-derived genes GDF9 and BMP15 as well as 
NOBOX2 (Figure 5.7.a). Expression levels of GDF9 were reduced to 0.2±0.1 arb. units 
(n=4) following GTSF1 knockdown in comparison with controls (0.4±0.1 arb. units, 
n=4) and BMP15 mRNA levels were reduced to 617.6±365.0 arb. units (n=4) following 
GTSF1 knockdown in comparison with controls (1189.8±433.6 arb. units, n=4), but 
neither of these reductions were significant (P>0.05). The mRNA levels of NOBOX2 
were increased in the GTSF1 siRNA-injected oocytes (0.4±0.3 arb. units, n=4) when 
compared to the controls (0.3±0.1 arb. u, n=4). These differences were not significant 
(P>0.05).  
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Figure 5.7: Real-time PCR quantification of the effect of GTSF1 siRNA injection on oocyte 
mRNA levels of: (a): Oocyte expressed genes: GDF9, NOBOX2 and BMP15. (b): Other 
candidate target genes for GTSF1 knockdown: CDC20, TNRC6A, LSM14A and INCENP. Data 
for both graphs were normalised against the cumulus GAPDH and H2A mRNA levels. 
Individual bars show the mean ±SEM for the number (n) of repeat cDNA libraries respectively 
(each library analysed in triplicate). Each cDNA library contained a single oocyte. No 
significant differences were observed for the 2 treatments (P>0.05). 
 
Other target gene transcripts were also evaluated following oocyte GTSF1 knockdown 
as shown in Figure 5.7.b.  Specifically, the mRNA transcripts of CDC20 were reduced 
in GTSF1 siRNA-injected oocytes (63.6±25.1 arb. units, n=4) in comparison with the 
control samples (141.0±68.2 arb. units, n=4), while the mRNA levels of TNRC6A were 
reduced (11.3±8.1 arb. units, n=4) in the GTSF1 siRNA-injected oocytes in comparison 
with controls (16.8±5.6 arb. units, n=4). The mRNA levels of LSM14A were increased 
(29.2±23.1 arb. units, n=4) following GTSF1 siRNA injection in comparison with the 
controls (23.1±15.9 arb. units, n=4) and the transcripts of INCENP were decreased in 
GTSF1 siRNA-injected oocytes (10.9±3.6 arb. units, n=4) in comparison with the 
buffer-injected control oocytes (18.3±9.0 arb. units, n=4). None of the 4 target genes 
analysed showed a significant reduction in the transcript levels for the 2 treatment 
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groups (P>0.05). Although the transcripts levels were considerably different for some 
target genes and in particular for CDC20, the data were too variable for any of the 
transcript differences to be confirmed as a result of a GTSF1 knockdown effect on 
subsequent gene expression in MII oocytes. For all gene transcripts analysed, all 4 
GTSF1 knockdown samples containing individual MII oocytes as well as their 
respective buffer-injected controls containing individual MII oocytes were used.  
 
The transcript levels of somatic genes in the cumulus shells were analysed in order to 
examine whether the GTSF1 knockdown in oocytes had an effect on the gene 
expression levels of cumulus shells. In particular, individual cumulus shells originating 
from co-cultures with MII oocytes for the 2 injection groups that were used for the 
molecular analysis above were selected for analysis of target genes in the cumulus. For 
all gene transcripts analysed, all 4 cDNA libraries from each treatment (each cDNA 
containing a single cumulus shell) were used and 1 sample was excluded during 
analysis due to contamination. Levels of HAS2 were reduced in the GTSF1 knockdown 
treatment group (10.7±2.0 arb. units, n=4) in comparison with the controls (55.0±35.8 
arb. units, n=4); while levels of AMH and LDH1 were increased in GTSF1 siRNA-
injected oocytes (0.1±0.1 arb. units, n=3; 0.5±0.2 arb. units, n=3) respectively, in 
relation with the controls (0.1±0.1 arb. units, n=3; 0.3±0.1 arb. units, n=3) (P>0.05) 
(Figure 5.8.a). The relative expression levels of GREMLIN1 and EREG were very low 
for accurate detection and were therefore not included (data not shown). Transcript 
levels of AREG were reduced in the GTSF1 knockdown treatment group (0.8±0.6 arb. 
units, n=4) in comparison with the control group (0.9±0.8 arb. units, n=4), while the 
levels of BTC were increased following GTSF1 siRNA injection (0.2±0.1 arb. units, 
n=4) respectively in comparison with the controls (0.1±0.1 arb. units, n=4) (P>0.05) 
(Figure 5.8.b). The expression of the receptors EGFR, FSHR and LHR was (EGFR 
0.3±0.1 arb. units, n=4; FSHR 1.5±0.9 arb. units, n=4; LHR 0.4±0.3 arb. units, n=4) 
respectively for the knockdown group in comparison with the controls (EGFR 0.3±0.2 
arb. units, n=4; FSHR 0.9±0.5 arb. units, n=4; LHR 0.3±0.3 arb. units, n=4) (P>0.05) 
(Figure 5.8.c). Even though there were high differences in the expression levels of 
several genes as shown for the 2 different treatment groups, variability of the data did 
not allow any connections to be made to a possible effect of the knockdown on gene 
expression in cumulus shells. Therefore for future experiments, a greater number of 
sample needs to be analysed and/or alternative strategies considered.  
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Figure 5.8: Effect of GTSF1 knockdown on cumulus shell gene expression as determined by 
real-time PCR. (a): Somatic marker genes: HAS2, AMH and LDH1. (b): Regulin genes AREG, 
BTC and EGFR. (c): Cumulus cell receptors FSHR and LHR. Data for all 3 graphs were 
normalised against the cumulus GAPDH and H2A mRNA levels. Individual bars show the mean 
±SEM for the number (n) of repeat cDNA libraries respectively (each library analysed in 
triplicate). Each sample contained individual cumulus shells that were co-cultured with injected 
oocytes for each treatment group. No significant differences were observed for the 2 treatments 
(P>0.05). 
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5.3.2.5 The impact of GTSF1 knockdown on oocyte spindle formation 
The functional association of GTSF1 was further investigated by immunostaining whole 
MII oocyte mounts for α-Tubulin. In this pilot study, oocytes produced from the last 3 
cultures were used to assess the impact of gene knockdown on meiotic spindle 
formation. A total of 11 MII oocytes were used for immunofluorescent staining for α-
Tubulin of which 3 were produced from GTSF1 siRNA injections, 4 from control buffer 
and 4 from N.C. siRNA injections (Figure 5.9).  
 
 
Figure 5.9: Immunofluorescent staining of α-Tubulin (green) and DAPI counter-staining of 
chromosomes (blue) following microinjections. A-B: Metaphase chromosomes of MII oocytes 
after spindle formation. A: Buffer control injected MII oocyte. B: N.C. siRNA-injected MII 
oocyte. C-D: Pro-metaphase II stage oocytes following GTSF1 siRNA injections (D: High 
power magnification). Scale bar: 5 μm. 
 
The results showed that all 4 MII oocytes from both the control buffer and N.C. siRNA 
treatment groups formed meiotic spindles which were of the expected shape as shown 
by the representative images of Figure 5.9 (A and B). A similar observation was made 
for 1 of the GTSF1 siRNA-injected oocytes while the other 2 oocytes injected with 
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GTSF1 siRNA also formed microtubules but these gametes demonstrated retardation of 
spindle polymerisation and appeared to be at the pro-metaphase II stage (Figure 5.9.C 
and D). A possible explanation is that the gene knockdown affects spindle formation at 
the MII stage. Further replicates are clearly needed to confirm these preliminary 
observations. However, it was decided to focus future efforts on generating sufficient 
MII oocytes for molecular evaluations which would incorporate a broader screen of the 
effects of GTSF1 knockdown on genes relating to spindle formation and chromosome 
segregation, so this pilot staining study was not repeated. 
 
5.4 DISCUSSION 
In this study it was shown that it was possible to generate a targeted knockdown of 
GTSF1 in sheep oocytes without compromising oocyte survival and oocyte meiotic 
progression following removal of a specific PDE inhibitor and co-culture with 
oocytectomised cumulus shells. Oocyte maturation and cumulus expansion data did not 
appear to be significantly affected based on oocyte MII progression or cumulus 
expansion levels following co-cultures of GTSF1 siRNA-injected oocytes with cumulus 
shells in comparison with the buffer-injected control oocytes and the N.C. siRNA 
controls. In addition, pilot data on α-Tubulin staining showed that there might be a 
relationship between gene knockdown and oocyte developmental competence but 
further experimentation is required. Analysis of mRNA expression levels for potential 
oocyte and cumulus cell gene targets following the knockdown did not indicate any 
significant differences between knockdown and control group due to the high levels of 
variability between samples. 
 
5.4.1 The impact of GTSF1 on meiotic progression and cumulus cell expansion  
The results of the experiments reported in this Chapter did not show any significant 
effect of GTSF1 knockdown on MII progression as illustrated by the extrusion of the 
polar body. The proportions of MII progression were slightly higher for the viable 
oocytes 24 h after injection with GTSF1 siRNA that were co-cultured with maturation 
inducing gonadotrophins (33.3%) in comparison with the viable buffer-injected oocytes 
(19.6%) and the viable N.C. siRNA-injected oocytes (26.7%), but no significant 
differences were noted (P>0.05). This suggests that GTSF1 is not essential for either 
meiotic progression or for cumulus expansion, as results between the treatment groups 
for cumulus expansion and mucification showed no significant differences (P>0.05). 
Specifically, 38.8% of cumulus shells from the GTSF1 siRNA treatment group were 
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shown to fully expand, compared to 38% and 22% of control buffer and N.C. siRNA 
group cumulus shells respectively (P>0.05). Cumulus expansion reflects oocyte 
developmental competence and factors derived from the ovary and termed cumulus 
expansion enabling factors are responsible for driving cumulus expansion (Buccione et 
al., 1990b). From the results it can be suggested that knockdown of GTSF1 does not 
affect the expression of the factors responsible for cumulus expansion. However, since 
not all MII oocytes were confirmed to have a significant reduction in their GTSF1 
expression levels following the knockdown in comparison with the controls, the GTSF1 
effect on maturation requires further experimentation. The group culture of oocytes that 
were subjected to different levels of GTSF1 knockdown did not allow evaluation of 
cumulus expansion based on each oocyte’s level of knockdown. For future experiments 
different strategies must be considered.  
 
The lack of impact of GTSF1 knockdown in GV oocytes during meiotic progression in 
vitro and the lack of effect on cumulus cell expansion does not exclude the potential 
function of GTSF1 as a factor of oocyte quality. It is well established that at MI, the 
paired homologous chromosomes are aligned in the middle of the meiotic spindle and 
separation of the paired homologous chromosomes is followed by the formation of the 
first polar body. At this stage the oocyte undergoes molecular reprogramming for the 
coordinated expression of essential genes and will construct mitochondria, large 
numbers of Golgi, generate receptors and gather nutritional reserves for embryonic 
development (Van Blerkom and Davis, 1995). With the role of GTSF1 likely to be 
connected to RNA-binding and storage it could be that the gene affects oocyte growth 
initiation and development prior to the formation of the secondary oocytes, and/or 
fertility and early embryo development. The mouse Gtsf1 knockout showed that female 
mice were found to be fertile (Yoshimura et al., 2009). However, even though GTSF1 
knockout female mice ovulated, it is still possible that the gene affects oocyte 
developmental competence and/or early embryo development. Furthermore there may 
be differences in gene function between polyovular and monovular species and 
therefore investigating fertility potential and early embryo development in the sheep 
would be important. Further studies containing more oocytes for gene knockdown are 
required to investigate the effect of oocyte GTSF1 knockdown on oocyte fertility and 
embryo development are required.  
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5.4.2 The impact of GTSF1 on gene expression 
Quantification of the levels of GTSF1 expression of all MII oocytes following GTSF1 
knockdown by real-time PCR did not show a significant difference in comparison with 
controls. The MII oocytes that showed  a reduction of more than 50% GTSF1 
expression were selected and verified by real-time PCR to have a significant reduction 
(P<0.05) in the levels of GTSF1 following the siRNA injection (10.7±3.2 arb. units, 
n=4) in comparison with their respective control buffer-injected oocytes (111.2±58.6 
arb. units, n=4). The transcript levels of target genes in the oocyte and the cumulus 
shells were assessed for these oocytes. Oocyte-derived genes GDF9 and BMP15 did not 
show significant differences in their expression levels relative to control samples 
(P<0.05) following GTSF1 knockdown. The expression of NOBOX2 was also evaluated 
in the oocytes because of its relationship to GTSF1. In particular, GTSF1 functions 
downstream of NOBOX and NOBOX is a homeobox gene that is preferentially 
expressed in the oocytes and has been shown to be essential for folliculogenesis with an 
oocyte-specific gene expression in mice and humans (Huntriss et al., 2006; Krotz et al., 
2009). The GTSF1 knockdown did not show significant differences in the transcripts of 
NOBOX2 in comparison with the controls (P>0.05). Generation of double stranded 
cDNA libraries in this experiment allowed for analysis of a total of 10 genes per sample 
by real-time PCR. Therefore, other than the 2 housekeeper genes and the 4 genes listed 
above, the expression of 4 additional candidate genes relevant to GTSF1 predicted 
functions were examined. Genes associated with the miRNA-mediated gene silencing 
such as the trinucleotide repeat-containing gene 6A (TNRC6A) was analysed (Nishi et 
al., 2013). The TNRC6A gene was selected in order to study the association of oocyte 
GTSF1 knockdown with the RNAi pathway. This gene navigates the AGO protein into 
the nucleus to lead to miRNA-mediated gene silencing (Nishi et al., 2013). Argonaute 
family proteins are responsible for binding of the miRNA to mRNA within the RISC 
that leads to repression of the target gene expression by either reducing the length of the 
poly-(A) tail of mRNA or by inhibiting translation (O'Carroll et al., 2007). Knockout of 
Ago2 in murine growing follicles was shown to result in oocyte maturation impairment 
which was accompanied by abnormal spindles and incorrect chromosome clustering 
(Kaneda et al., 2009). Expression of the LSM14A gene was evaluated because of its 
relationship to RNA-processing in P-bodies (Gache et al., 2010; Li et al., 2012). As 
stated in the introduction of this Chapter, Piwi is a polar granule component that 
associates with Dicer and piRNAs along with their interacting proteins and is involved 
in retrotransposon silencing (Kuramochi-Miyagawa et al., 2004). The association of 
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Gtsf1 knockout with retrotransposon activation as shown by (Yoshimura et al., 2009), 
suggests that examination of targets involved with RNA-processing and storage 
following the GTSF1 knockdown is worth investigating. The next 2 genes, INCENP1 
and CDC20 were examined because of the possible functional role of GTSF1 during 
meiosis, as indicated by its RNA-binding potential as well as the initial immunostaining 
experiments that indicated a possible association with cytokinesis of the chromosomes. 
Incenp is a regulatory protein in the chromosome passenger complex involved in the 
catalytic regulation of AURKB (Earnshaw and Cooke, 1991). In mouse oocytes it has 
been shown that the depletion of either Incenp or the combined inhibition of AurkB and 
AurkC activates the Apc/C before chromosome synapsis in meiosis I and prevents 
cytokinesis and inhibits the extrusion of the first polar body (Sharif et al., 2010). The 
CDC20 gene is the activator of APC/C. The Apc/C has been shown to have a role in the 
ubiquitination of Cyclin B and Securin and  to induce their degradation along with its 
involvement in the physiological M-phase progression and the meiotic maturation of 
oocytes in many species (King et al., 1995). Degradation of both Cyclin B and Securin 
during the first meiosis in mouse oocytes was reported to be mediated by Apc/C 
(Cdc20) activity, with Cdc20 initiating sister-chromatid separation (Reis et al., 2007). 
The results showed no significant differences (P>0.05) in the expression levels between 
the GTSF1 siRNA and the buffer control group for all genes investigated. The 
variability of the data throughout the interrogated cDNA double-stranded pooled oocyte 
samples was a restricting factor for interpretation of any trends in the data. Therefore 
increased numbers of samples and/or an alternative strategy should be devised for future 
experiments. Cumulus cell gene targets were also analysed for the cumulus shells that 
originated from co-cultures with the oocytes that were confirmed to have a significant 
level of GTSF1 knockdown. The cumulus cell targets did not show any significant 
differences between the 2 treatment groups for any of the genes analysed (P>0.05). This 
latter observation suggests that GTSF1 function is confined to the oocyte and that 
oocyte-derived GTSF1 does not affect cumulus cell expansion or gene expression in the 
cumulus cells, although further experimentation is needed. 
 
5.4.3 The impact of GTSF1 on microtubule formation  
A pilot study investigated the effect of GTSF1 knockdown on meiotic spindle formation 
as illustrated by immunostaining of α-Tubulin. As stated in Chapter 1, microtubules are 
cytoskeletal filaments involved in spindle formation which are constructed by 
asymmetric α/β-tubulin heterodimers  which confers microtubule polarity and serves to 
177 
 
transport molecules and organelles (Desai and Mitchison, 1997). Microtubule polarity 
controls transport to/from the end of the polymer and is mediated by microtubule motor 
proteins like Dyneins or members of the Kinesin superfamily (Kamal and Goldstein, 
2002). The meiotic spindle is formed in the ooplasm following GVBD by organisation 
of the microtubules and motor proteins as well as microtubule associated factors 
(Karsenti and Vernos, 2001; Eichenlaub-Ritter et al., 2004; Brunet and Maro, 2005). 
The results of this pilot study suggest that polymerisation of α-Tubulin on some degree 
of spindle formation had occurred in all 3 treatment groups (GTSF1 siRNA-injected 
oocytes, buffer-injected and N.C. siRNA-injected oocytes) as oocytes from each group 
had matured in vitro to the MII stage. However, unlike the control oocytes, 2 of the 3 
oocytes examined following GTSF1 knockdown failed to show chromosome alignment 
at the equator of the spindle during meiosis II but rather the oocytes were shown to be at 
the pre-metaphase stage of the second meiotic division. The kinetochore structures 
found at the centromeres of some species bind to the forming microtubules (Vogt et al., 
2008). This process is regulated by kinetochore motor proteins including cytoplasmic 
dynein, Cenp-E and Mcak (Schaar et al., 1997; Maney et al., 1998; Hunter et al., 2003). 
Cytoplasmic dynein is responsible for the direct movement of chromosomes, while 
Cenp-E contributes to chromosome alignment (Wood et al., 1997) and Mcak protein is 
associated with disassembly of kinetochore fibres that allows movement of the 
chromosomes during anaphase  (Hunter et al., 2003). Kinases including the AurkB 
kinase and Map kinases have been shown to activate Mcak and other proteins associated 
with the kinetochore (Zhao and Chen, 2006; Ma et al., 2010). AurkB in addition to 
other molecules like Incenp and Survivin that belong to the chromosomal passenger 
complex might be involved in cytokinesis due to the interaction of the chromosomal 
passenger complex with interpolar microtubules (Kelly et al., 2007). It is considered 
therefore that both Mcak and AurkB act upstream of the spindle assembly checkpoint 
that monitors microtubule attachment and tension on chromosomes in both meiosis and 
mitosis (Vogt et al., 2008). Although the number of oocytes examined in this study was 
very low, it is possible that GTSF1 knockdown affects cytokinesis of the chromosomes 
in a direct or indirect manner. More detailed investigation is required to substantiate this 
hypothesis. Unfortunately the difficulties in obtaining enough MII oocytes after gene 
knockdown prevented further experimentation to confirm the above observations. In 
addition, immunostaining was not compatible with molecular evaluations on the same 
cell which is needed to confirm the level of knockdown and establish a direct 
connection between spindle defects and the knockdown itself. Alternative molecular 
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methods for the examination of the effects of GTSF1 knockdown on oocyte maturation 
which include assessment of key genes involved in spindle formation and chromosome 
segregation therefore represents a more favourable alternative means of confirming and 
extending these preliminary observations on α-Tubulin and meiotic spindles.  
 
5.4.4 Optimisation of microinjection and IVM co-culture systems  
Generation of double-stranded DNA libraries successfully resolved the issue of DNA 
degeneration encountered in the validation experiments detailed in Chapter 4. In this 
series of experiments however, there was an observed variability in the GTSF1 
expression levels following the knockdown in comparison with the controls. This 
variability in the levels of knockdown could be attributed to the change of the outflow 
system during the microinjections, from a constant outflow of 40 hPa to a controlled 
start-stop outflow of 40 hPa. Based on the results presented here it is assumed that the 
latter method resulted in variable injection volume even though the pressure of 40 hPa 
was kept constant for about 0.5 sec. It is possible that the release of the flow (initiated 
by the start button) increased the ‘release’ pressure and therefore small variations in the 
time of injection could have resulted in differences of injection volume. Less volume 
injected into the oocytes could be responsible for the reduced levels of GTSF1 
knockdown. Furthermore, increased injection volume could be detrimental for the 
oocytes and this could be the reason for the reduced survival rates in comparison with 
the validation experiments of Chapter 4. For this reason, only the oocytes that showed a 
reduction of the GTSF1 transcript of more than >50% following the knockdown in 
comparison with the controls were selected. For future experiments, the constant 
outflow system should be reinstated. Another possible explanation for the observed 
differences in the levels of GTSF1 expression following GTSF1 knockdown was that 
the selected siRNA species was not optimal for generation of a gene specific GTSF1 
knockdown. Perhaps pooling GTSF1 siRNA-2 and siRNA-3 species would have been 
better since both siRNAs showed a significant reduction in the GTSF1 expression. 
None-the-less, analysis of the oocytes that were retained at the GV stage at the end of 
each of the 4 cultures following injections with the different GTSF1 siRNAs and control 
buffer injections verified the efficiency of the siRNA-2 in generating a high-level 
GTSF1 knockdown. 
 
Molecular analysis of target genes in the oocytes and the cumulus cells for the oocytes 
verified to have a significant reduction in their GTSF1 expression levels along with 
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cumulus shells from the same culture drop also showed discrepancies in the data. The 
group cultures could be responsible for the observed variability in the expression levels 
of target genes. Although the developmental advantages of oocyte group cultures have 
been established in the validation experiments for the applied microinjection system 
(Cotterill, 2008), the autocrine and paracrine signalling between the maturing oocytes 
and their surrounding cumulus shells could affect gene expression. Since oocytes in the 
same culture drop might have had different levels of GTSF1 knockdown, gene 
expression could be affected. Not all oocytes in the culture drop may have been 
competent to reach the MII stage. As a result, the different numbers of maturing oocytes 
present in each culture drop may have been present in each culture drop could have 
been responsible in part for the observed differences in gene expression from cells 
recovered from different drops. In addition, the effect of the morphogenic paracrine 
gradients as determined by the numbers and position of oocytes and cumulus shells 
within each culture drop may be a contributing factor in oocyte maturation (Hussein et 
al., 2005). All of the above culture conditions could have a cumulative effect on the 
observed variability of gene expression in the individual MII oocytes analysed for both 
treatment groups. Therefore, for future experiments, the culture method should be 
changed to single oocyte co-cultures with a single oocytectomised cumulus shell per 
drop.  
 
5.4.5 Conclusions 
In conclusion, these experiments generated GTSF1 knockdown in ovine oocytes by 
microinjection of gene specific siRNAs and have conducted pilot studies of the function 
of GTSF1 on oocyte maturation in this species. The gene appears not to affect the 
maturation potential of sheep oocytes in vitro. However there are indications that 
GTSF1 might have a functional role during oocyte maturation. Further investigations of 
the function of the gene in oocyte maturation and development are needed.  
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Chapter 6: Transcriptome analysis following GTSF1 
knockdown during ovine oocyte maturation in vitro 
 
6.1 INTRODUCTION  
Messenger RNA expression profiling has been developed in the recent years as a useful 
tool in order to identify factors that affect development in oocytes and early embryos 
(Chu et al., 2012b). There have been a number of studies that have indicated the 
relationship between oocyte maturation and quality through measurement of mRNA 
abundance in various groups of genes (Robert et al., 2000; Mourot et al., 2006; Dorji et 
al., 2012). The assessment of oocyte quality for these studies has been based on 
parameters such as (i) morphological evaluations (Fair et al., 1995), (ii) timing of 
embryo development (Lechniak et al., 2008), (iii) stage of follicular development and 
diameter of follicles during isolation of oocytes (Pfeffer et al., 2007), (iv) in vitro or in 
vivo development (Lonergan et al., 2003) and many more. 
 
The acquisition of comprehensive mRNA expression profiles from biological samples 
has been enhanced significantly by the advent of microarray technology. Microarrays 
were first developed in 1995 by printing DNA microarrays onto glass microscope 
(Schena et al., 1995). Since then, the development of microarrays into hybridisation-
based assays which facilitate the comparison of gene expression levels has 
revolutionised the field of gene expression analysis (Gautier et al., 2004). The goal of 
microarray analysis is to characterise genes and clusters of genes that coordinate gene 
expression during different biological states. In order to generate meaningful data, all 
components of the microarray mRNA expression measurements must be thoroughly 
evaluated. There can be numerous technical errors, hidden biological variances that are 
not relevant to the experimental processes as well as linear and non-linear systematic 
biases (Aimone and Gage, 2004). Technical variance can come from different sources 
including the array itself, different efficiencies of fluorescent dye labelling and 
hybridisation, location of array spots on the chip, gene-dye interactions and there can be 
technical variances in the RNA preparation method in addition to variations in the 
measurement method (Goryachev et al., 2001). It is therefore necessary for the 
microarray data to be normalised and correctly analysed in order to remove technical 
variation and to accurately reflect gene expression levels in cells of different biological 
states (Irizarry et al., 2003). The type of normalisation used depends on the type of 
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microarray platform used with the 2 main types being the 1 channel technology 
including Clontech membranes and Affymetric GeneChips that are hybridised with 
cDNA from 1 sample and the second being the 2 channel array that is hybridised with 
cDNA which is prepared from the 2 samples to be compared on 1 array (Shalon et al., 
1996). 
 
The Affymetrix oligonucleotide chips are now considered to be a standard in 
microarray-based analyses (Lockhart et al., 1996). These arrays have a high density of 
content and can be used not only for expression profiling but also for high-throughput 
mutation detection, chromosomal abnormalities detection and single nucleotide 
polymorphism genotyping. Their clinical applications include genetics, cytogenetics, 
oncology, pathogen recognition and pharmacogenetics (Ragoussis and Elvidge, 2006). 
The Affymetrix microarray system is based on photolithographic synthesis of 
oligonucleotides on microarrays, where a set of 11-20 oligonucleotide probes is used, 
each of which are 25 bases long to represent a gene. These GeneChips in particular 
represent a transcript, also called a probe-set, which contains 11 pairs of 2 nucleotides, 1 
being a perfect match (PM) oligo to the mRNA reference sequence and another 
corresponding mismatch (MM) oligo that has an identical sequence  to the PM oligo but 
with 1 central mismatch in the 25 bases as shown in Figure 6.1 (Irizarry et al., 2003). 
 
 
Figure 6.1: GeneChip expression array design. Image from: http://www.affymetrix.com. 
 
The presence of mRNA is detected by the series of probe pairs that differ in 1 
nucleotide. The use of the probe pair system allows the signals caused by non-specific 
cross hybridisation to be subtracted. The difference in signals between the probe pair is 
the indicator of specific target abundance. Gene expression is quantified by laser 
182 
 
scanning of the chip surface and the expression level for a gene represents the summary 
of the data from the whole probe set (Irizarry et al., 2003). As it is shown in Figure 6.2, 
GeneChips are packed in cartridges that protect the chip and it is where the 
hybridisation takes place; hybridisation of fluorescent mRNA to each probe on the chip 
is indicated by the intensity of the feature on the array. 
 
 
Figure 6.2: GeneChip in cartridge and fluorescent intensity image. A: GeneChip and Cartridge. 
B: Full expression array after scanning including all features C: Magnified view of a section of 
the array showing fluorescent intensity scan of 324 features. A wide range of intensities is 
observed. Black features represent no hybridisation to the probe (no intensity), while the 
intensity levels from highest to lowest by colour is: White, Red, Orange, Yellow, Green, Light 
Blue, Blue, Dark blue. Image from: http://www.affymetrix.com. 
 
All microarray mRNA expression measurements components must be thoroughly 
evaluated in order to accurately characterise the gene expression patterns that are truly 
attributable to biological differences between samples. Other than the normalisation of 
the data for the removal of technical variance, the experimental design also has a vital 
role for the success of the microarray experiment. If it is not carefully planned it can 
significantly add to the technical variance of the data (Churchill, 2002). The elements 
that have to be considered when designing a microarray experiment are primarily the 
nature of the experiment and the number of experimental factors involved (Churchill, 
2002). Other important points for consideration are the statistical power that is required 
in order to detect significantly differentially expressed genes between samples with a 
ratio greater or equal to a specific value. Consideration must also be given to the level 
of false discovery rate allowed, and the number of replicates required to provide more 
power for multiple significance testing (Hochberg and Benjamini, 1990). The presence 
of replicate spots of each cDNA oligonucleotide on the microarray slide provides 
technical precision for each hybridisation (Churchill, 2002).  
 
The categorisation of genes on the basis of their shared functions otherwise known as 
functional grouping is considered to be a very powerful component of microarray 
analysis (Smith and Rosa, 2007). It enables the effect of a treatment to be evaluated 
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across an entire functional group of genes. Functional grouping is based on the 
assumption that if several genes belonging to 1 functional category and demonstrate 
similar patterns of change under a specific treatment, then each of the genes borrows 
significance from the neighbouring gene; thus the significance characterises the whole 
group. Several studies have used functional grouping for data analysis following the use 
of microarrays in oocytes, cumulus cells and embryos (Dorji et al., 2012; O'shea et al., 
2012). Microarray studies can also be integrated from multiple studies of data that has 
already been normalised or by comparison of gene lists (Cahan et al., 2007). This kind 
of meta-analysis increases the statistical power and can detect important effects that did 
not appear in individual analyses (Choi et al., 2003). Using different datasets can 
therefore be an important tool to indicate candidate markers and biological pathways 
(Hong and Breitling, 2008). Meta-analysis on previously published microarray data on 
models of oocyte and embryo quality has been applied in a recent study that has 
identified candidate genes and networks of developmental competence in oocytes and 
cumulus cells (O'shea et al., 2012). From this study, many potential biomarkers 
associated with increased and decreased competence in the oocyte and surrounding 
cumulus cells were identified. These included the negative regulation of Wnt signalling 
in several animal models of oocyte competence; the alpha thalassemia/mental 
retardation syndrome X-linked expression which was associated with decreased 
competence in the oocyte and the cumulus cells as well as the up-regulation of 
methionyl aminopeptidase 2 linked to mRNA and protein synthesis in competent 
oocytes (O'shea et al., 2012).  
 
From the above it can be understood that careful execution of microarray analysis is 
required, in order to competently characterise the gene expression profiles that are 
associated with developmental and reproductive processes. Previous studies have shown 
that microarray analysis can reveal the differentially expressed genes between various 
stages representative of follicular and oocyte development. For example, comparison of 
GV and MII stage oocytes produced from IVM experiments of adult and prepubertal 
Japanese black cattle has identified a number of differentially expressed genes of which 
subsequent gene ontological classification has revealed genes that are up-regulated in 
adult oocytes are associated with signal transduction, transcriptional control and 
transport (Dorji et al., 2012). In a different study, the global analysis of gene expression 
in oocytes isolated from the early stages of human folliculogenesis has revealed a high 
expression of novel reproductive genes that are associated with functional categories 
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including RNA-binding, initiation of translation and structural molecule activity 
(Markholt et al., 2012). In another study, human GV and IVM-produced MII oocytes 
were analysed by miRNA microarray that showed dynamic changes of specific 
miRNAs during meiosis (Xu et al., 2011). The effects of the different ART protocols 
upon the in vitro production of cattle embryos at different laboratories have also been 
examined by microarrays and such analyses have proved useful for the confirmation of 
transferability of embryo production protocols (Plourde et al., 2012). Microarray studies 
of gene expression have also been conducted to assess whether there were specific 
mRNA transcript profiles of granulosa cells that were associated with the oocytes that 
did or did not reach the blastocyst stage of embryo development (Gilbert et al., 2012).  
 
In summary therefore, a number of different approaches have used microarrays to study 
mRNA expression and to identify gene pathways during mammalian oocyte 
development and under specific experimental conditions. The applications of 
microarray technology will also allow examination of the function effects of novel 
genes during oocyte development and maturation, such as GTSF1. This can be achieved 
by comparison of oocyte mRNA transcripts following targeted gene knockdown in 
comparison with the control oocyte samples. The results of the last 3 cultures of Chapter 
5 in which both buffer control and N.C. siRNA-injected oocytes were used as controls 
showed that there were no significant differences (P>0.05) in oocyte maturation levels 
or the degree of cumulus expansion for the 2 control treatment groups. Taking into 
consideration the advantages offered by the N.C. siRNA control in that it mimics the 
effect of the gene specific siRNA injection by entering RISC but ensuring minimal non-
specific effects on gene expression and phenotype, N.C. siRNA will be used as the 
preferred control in all subsequent gene knockdown studies. Therefore generation of 
GTSF1 knockdown oocytes and N.C siRNA control oocytes can be used for 
transcriptome analysis by microarray. The unique challenges faced in this thesis relative 
to other studies was (i) the creation of oocytes in which GTSF1 has been proven to be 
knocked down; (ii) the generation of verified quality libraries from single oocytes and 
(iii) the necessity to carry out the arrays on such small number of samples that limits the 
amount of RNA available for array experiments. To overcome the first problem, GTSF1 
knockdown must first be proven in each oocyte to be analysed by array. In order to 
overcome the last difficulty it is necessary to amplify the cDNA libraries as described 
previously (Chapter 2, Section 2.2.4), something that added to the complexity of the 
project. 
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6.1.1 Aims  
The aims of this chapter were therefore to generate GTSF1 knockdown oocytes and 
assess their ability to progress to the MII stage as well as cumulus expansion following 
co-culture with cumulus shells in comparison with N.C. siRNA controls. The levels of 
GTSF1 knockdown were then determined and a comprehensive microarray analysis 
using Affymetrix GeneChip microarrays was used to identify gene expression 
differences between the siRNA GTSF1 injected oocytes and N.C. siRNA-injected 
control oocytes. Bioinformatic analysis was used to further characterise the 
differentially expressed genes in these treatment groups by performing gene ontology 
analysis and functional annotation of the candidate genes. Finally, differentially 
expressed genes identified by the arrays were verified by real-time PCR. 
 
6.2 MATERIALS AND METHODS  
 
6.2.1 Generation of GTSF1 knockdown 
This series of cultures for the generation of the GTSF1 knockdown oocytes took place 
between October 2011 and February 2012 and a total of 17 cultures were conducted. 
The methodology followed was slightly different to the methodology described in 
Chapter 5. For this experimental series, only 2 injection groups were used: GTSF1 
siRNA and N.C. siRNA. Furthermore, the constant outflow system set at 40 hPa was 
reinstated as described in Chapter 4, Section 4.2.1 to try to compensate for the 
inconsistencies in the levels of GTSF1 knockdown and the poor oocyte survival 
observed in the Chapter 5 results. Additionally, the co-culture conditions of 
microinjected oocytes and oocytectomised cumulus cells were adjusted. Specifically, on 
the second day of the cultures, the co-cultures were established by culturing single 
oocytes with single oocytectomised cumulus shells instead of group co-cultures of 5 
oocytes with 5 cumulus shells. This alteration was implemented to increase the quality 
of the microinjection data such that results would originate from single oocytes with 
clear developmental checkpoints monitored and level of the knockdown established. 
The IVM dishes contained an additional 6 peripheral IVM drops; each containing 2μl of 
IVM media. The drops were overlaid with mineral oil. A total of 6 dishes were prepared 
prior to the culture and allowed to equilibrate at 39°C for 24 h at 5% CO2, 6% O2 and 
89% N2 atmosphere. The steps followed are shown in Figure 6.3. 
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Figure 6.3: Schematic representation of the GTSF1 siRNA procedure followed and the end-
points following generation of GTSF1 knockdown. 
 
The experimental process for the co-cultures of single oocytes with single cumulus 
shells was as follows: Viable oocytes were selected at 24 h of culture from both 
injection groups GTSF1 siRNA and N.C. siRNA. Equal number of COCs were 
oocytectomised and groups of 6 oocytes from each experimental group that survived the 
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injection process as indicated by the NR stain, were transferred in the central drop of 
previously prepared 35 mm IVM dish containing 20μl of IVM media (Chapter 2, Table 
2.3). For each oocyte that survived the first 24 h of culture, 1 oocytectomised cumulus 
shell was also transferred into the central drop. Single oocytes along with 1 cumulus 
shell were then transferred to 1 of the peripheral drops in a pipette volume of 2 μl to 
give a final culture volume of 4 μl per oocyte/cumulus co-culture. Cumulus coverage 
and expansion was scored at the start of IVM as described previously (Chapter 4, 
Section 4.2.2). The same process was followed for all dishes of the 2 treatments and the 
time at which each of the plates was placed into culture was noted. This alteration of 
culture conditions from group oocyte co-culture to single oocyte co-culture with a 
single oocytectomised cumulus shell was applied to help reduce interactions between 
oocytes with different levels of gene knockdown (as established at the end of the 
cultures) and oocytectomised cumulus shells contained within the same drop. All 
developmental assessments took place at the end of the 24 h period of IVM co-culture. 
These included oocyte survival, oocyte maturation, cumulus cell coverage and 
expansion. Single oocytes were then transferred in labelled 1.5 ml microcentrifuge tube 
containing 10 μl of lysis buffer (Chapter 2, Table 2.4). Single cumulus shell samples 
were also stored individually in lysis buffer. All samples were stored in -80°C until 
subsequent analysis.  
 
6.2.2. Molecular analysis 
This experimental series utilised the Affymetrix GeneChip bovine genome arrays 
(Affymetrix, High Wycombe, UK) to study the expression of over 23,000 gene 
transcripts. At the time that the analysis took place, no equivalent ovine genome arrays 
were available from Affymetrix, therefore the bovine genome arrays were selected 
because of the close relation of the genomes between the 2 species (Dalrymple et al., 
2007). In the recent years there has been a substantial amount of research conducted in 
cattle with several ESTs being available in public databases. The bovine genome has 
also been assembled (Womack, 2005). The sheep genome has not yet been fully 
sequenced (Dalrymple et al., 2007). The individual knockdown oocytes produced by the 
microinjection of GTSF1 siRNA and N.C. siRNA were compared to assess the function 
of GTSF1 during ovine oocyte maturation and the libraries from the 2 groups were then 
used for comparison of mRNA expression levels based on the analysis of the 
Affymetrix GeneChip bovine arrays. Next, the cDNA libraries from the 2 groups were 
hybridised to the Affymetrix GeneChip bovine arrays in order to ascertain whether 
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GTSF1 depletion affected global mRNA expression in ovine oocytes and to identify a 
series of gene targets that could clarify the function of GTSF1 in the mammalian oocyte. 
 
6.2.2.1 Experimental setup and sample preparation for microarrays 
The first step before proceeding with the microarray analysis was to assess the level of 
GTSF1 knockdown in the siRNA-injected oocytes. Microinjected oocytes for the 2 
injection groups were thawed and then subjected to the mRNA isolation as described in 
Chapter 2, Section 2.2.2. The samples were re-suspended in 3 μl of Tris-HCl followed 
by incubation on a hot block at 90° for 2 min. The mRNA was then separated from the 
Dynal magnetic bead apparatus and the cDNA was synthesised by reverse transcription 
as described in Chapter 2, Section 2.2.3. After cDNA synthesis, long distance PCR of 
total cDNA was performed for all individual oocyte libraries as detailed in Chapter 2, 
Section 2.2.4. The level of knockdown for each of the GTSF1 siRNA-injected oocytes 
in comparison with the control oocytes injected with N.C. siRNA from the same culture 
repeat was determined by real-time PCR as described in Chapter 2, Section 2.4. After 
analysing all individual oocyte MII samples, a total of 14 GTSF1 injected oocyte cDNA 
libraries were identified which demonstrated a significant reduction (P<0.005) in the 
GTSF1 knockdown level of >50% in comparison with the N.C. siRNA-injected control 
oocytes. The 14 GTSF1 siRNA-injected oocytes were divided based on their levels of 
GTSF1 knockdown, 5 showed a high-level knockdown, 5 showed a medium-level 
knockdown and 4 showed a low-level knockdown when compared with the N.C. siRNA 
controls. A total of 6 arrays were performed, 3 arrays to analyse the pools of oocyte 
cDNA from the GTSF1 siRNA-injected group (high-level knockdown, medium-level 
knockdown, low-level knockdown) and 3 arrays to analyse the pools of oocytes from 
their respective controls injected with N.C. siRNA. The microarrays were conducted on 
the basis of the levels of knockdown as follows:  
 Microarray set A: (based on high-level knockdown of GTSF1) 
Sample A1: 5 pooled GTSF1 siRNA-injected oocytes  
Sample A2: 5 pooled N.C. siRNA-injected oocytes 
Microarray set B: (based on medium-level knockdown of GTSF1) 
Sample B1: 5 pooled GTSF1 siRNA-injected oocytes 
Sample B2: 5 pooled N.C. siRNA-injected oocytes 
Microarray set C: (based on low-level knockdown of GTSF1) 
  Sample C1: 4 pooled GTSF1 siRNA-injected oocytes 
  Sample C2: 4 pooled N.C. siRNA-injected oocytes 
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All individual oocyte cDNA libraries were then purified from the residual PCR 
reactions components (primers, nucleotides, polymerases and salts) using the QIAquick 
PCR purification kit protocol and a microcentrifuge (Qiagen). Specifically, from each 
cDNA library, 15 μl were placed in a new sterile microcentrifuge tube and 5 volumes of 
buffer PB (75 μl) were added to 1 volume of the PCR sample and mixed by pipetting. 
The mixture was then added into a QIAquick spin column and the column was placed 
into a 2 ml collection tube (provided in the kit). To bind DNA, the tube was then 
centrifuged for 1 min at maximum speed. The flow-through was discarded and the 
QIAquick column was placed back into the same tube. For the next step, 750 μl of 
buffer PE were added to the QIAquick column and centrifuged for 1 min at maximum 
speed in order to wash the samples. The flow-through was once again discarded and the 
column was placed back in the same tube followed by an additional centrifugation for 1 
min at maximum speed to remove residual wash buffer. The QIAquick column was then 
placed in a clean 1.5 ml microcentrifuge tube and 20 μl of sterile-distilled H2O were 
added to the centre of the column. The column was then left to stand for 1 min at RT 
followed by centrifugation for 1 min at maximum speed in order to elute the DNA. The 
concentration of each of the purified cDNA samples was measured and recorded using a 
NanoDrop ND 1000 spectrophotometer (Thermo-Scientific). Subsequently, an aliquot 
of the cDNA from each of the individual oocytes was pooled together in order to create 
the pooled sample pairs (A1:A2, B1:B2, C1:C2) that were then used for array analysis. 
For each microarray, 2 μg of cDNA were required (total concentration per array) and 
therefore equal amount of cDNA were pooled into sterile 1.5 ml microcentrifuge tube to 
create a volume that was determined by the cDNA concentration of each of the 
individual samples. All 6 pooled samples were then vacuum-dried in a centrifuge 
(Savant Speed Vac, Thermo-Scientific) set at 35° C for 30 min at 5000 rpm before 
being sent for analysis. 
 
6.2.2.2 Microarray analysis 
Following mRNA extraction and cDNA synthesis (as described above), all pooled 
samples and arrays (total of 6 pooled samples and 6 arrays) were sent to for analysis 
(Figure 6.4). The microarray analysis was conducted by the University of Glasgow’s 
Affymetrix service (Glasgow Polyomics, http://www.gla.ac.uk/colleges/mvls/research 
institutes/gpf/microarrays/facilities-theaffymetrixservice/). For the microarray analysis, 
samples were labelled with Biotin by using uracil bases tagged with Biotin when cDNA 
was in vitro transcribed back to RNA (cRNA). Subsequently, the labelled cRNA was 
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randomly fragmented in pieces ranging from 30 to 400 base pairs length using an RNA 
fragmentation buffer and the fragmented Biotin-labelled cRNA was then hybridised to 
the array. Next, the arrays were washed in order to remove unbound RNA and then 
stained with Cy5 conjugated to streptavidin that binds to Biotin. Finally the whole array 
was scanned with a laser and to generate the gene expression data.  
 
 
Figure 6.4: Schematic overview of the different steps involved in an Affymetrix GeneChip 
experiment. Steps in box represent the steps that took place prior to sending the samples for 
analysis to the Affymetrix service (Downloaded from: http://www.affymetrix.com). 
 
6.2.2.3 Bioinformatic analysis 
The bioinformatic analysis that followed generation of the mRNA expression levels for 
the 2 treatment groups in each of the 3 array sets (A, B and C) for treatments and 
controls was performed in co-operation with Lee Hazelwood and Praveen Baskaran 
(Bioinformatics Technology Group, Biomedical and Health Research Centre, Faculty of 
Biological Sciences and Leeds Institute of Molecular Medicine, University of Leeds). 
As there were no replicates in each array, the arrays were grouped into AB (A1+B1 vs. 
A2+B2), BC (B1+C1 vs. B2+C2) and ABC (A1+B1+C1 vs. A2+B2+C2) for 
comparison assuming A and B microarray sets were replicated in AB (Section 6.2.2.1). 
Similarly for the ABC, A, B and C microarray sets were considered replicates. The AB 
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sample group was assumed as high-level knockdown, while the BC sample group was 
considered a low-level knockdown. The raw Affymetrix files were originally analysed 
using AFFY and affyPLM (Probe Level Models) packages and normalised using the 
Robust Multichip Averaging (RMA) method (Bolstad et al., 2004; Gautier et al., 2004; 
Alvord et al., 2007). AFFY is a package of functions for the storage, management and 
analysis of Affymetrix probe level data written in the statistical scripting language R 
(Gautier et al., 2004). This package includes analytic routines including some of the 
most widely used algorithms and the number of statistical routines included into R 
makes it operator friendly for customisation of existing functions (Gautier et al., 2004). 
The affyPLM package, extends and improves the functionality of the base AFFY 
package by implementing methods for fitting probe-level models and tools using 
models of compiled code for heavily used routines and includes several PLM based 
quality assessment tools (Alvord et al., 2007). The PLMs are used for high-density 
oligonucleotide microarrays with multiple probes per gene like the ones used in this 
study in order to obtain quality measures (Ritchie et al., 2006). In addition, the image 
plots of robust weights or residuals produced from robust PLMs can indicate artefacts 
on the array surface to assist quality assessment at the array level (Ritchie et al., 2006). 
The RMA procedure was used for normalisation of the arrays as this procedure is 
generally used for background correction, normalisation and summarisation of probe-
level data in order to obtain expression level data and find which genes are differentially 
expressed (Alvord et al., 2007). Following normalisation, the differentially expressed 
genes were identified using linear models for microarray data (LIMMA) R package 
using fold change=1.0 and P<0.05 as cut off value for gene selection (Ritchie et al., 
2006). Linear models provide a suitable tool for measuring and testing differential 
expression in microarray experiments by combining many different RNA sources (Kerr, 
2003; Smyth, 2004). This approach allows combination of a wide variety of microarray 
experiments including common reference experiments without complicating the 
analysis when compared with simple replicated experiments (Ritchie et al., 2006). 
Multiple testing corrections were then applied using the Benjamini-Hochberg method, 
however the adjusted P-values were greater than P>0.0.5 and the values were therefore 
used without corrections. Finally, the differentially expressed genes were annotated 
using the bovine.db package from bioconductor (Affymetrix bovine annotation data, 
chip bovine, http://www.bioconductor.org/packages/2.12/data/annotation/html/bovine. 
db.html). The differentially expressed genes under each condition were separated into 
up and down-regulated gene lists. Gene ontology analysis was performed using Bingo 
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in Cytoscape software (Cline et al., 2007). By using this software, the measurements of 
expression profiles were filtered and used to map cellular processes and their dynamics. 
This was conducted by combination of expression profiles with cellular network 
information including protein-protein interactions as well as DNA-protein interactions 
to reveal the mechanisms behind biological processes as well as genes and mechanisms 
affected by the different treatment groups from the arrays (Cline et al., 2007). For the 
analysis of this data set, over-represented ontologies were reported using the Hyper-
geometrix test with Benjamini-Hochberg False Directory Rate Correction. The cut off 
value was set at P<0.05. Functional annotation of the differentially expressed genes was 
then carried out using DAVID web tools (Huang et al., 2009). These enrichment tools 
play an important role and have been shown to contribute to the gene functional 
analysis of large gene lists for many different high-throughput biological studies such as 
microarrays (Huang et al., 2009). 
 
6.2.2.4 Real-time PCR verification of target genes 
The bioinformatic analysis revealed lists of potential gene targets that were either up-
regulated or down-regulated following GTSF1 specific knockdown in oocytes. Real-
time PCR was used to validate the expression profile of selected transcripts to confirm 
the differences in the expression levels of transcripts between the GTSF1 siRNA-
injected oocytes and the control N.C. siRNA-injected oocytes. The differential 
expression of candidate transcripts for the 2 different treatment groups was examined in 
individual oocyte cDNA libraries by real-time PCR as detailed in Chapter 2, Section 
2.4, relative to the expression of housekeeper genes GAPDH and H2A as detailed in 
Chapter 2, Section 2.4, with minor modifications. Only the oocyte cDNA libraries from 
the high knockdown group A and their respective N.C. siRNA controls were used for 
the real-time PCR analysis. Since the oocyte cDNA libraries used for the analysis were 
amplified by long distance PCR and were also PCR purified as described in Section 
6.2.2.1, 5 μl of each sample in a 1:100 dilution in sterile-distilled H20 were used for 
each individual oocyte analysis. This dilution was determined by serial dilution and 
real-time PCR analysis of 3 control cDNA libraries of single uncultured denuded 
oocytes that were created using the same methodology as the treated samples. Each 
individual oocyte cDNA library was analysed with 4 repeats for each test gene and 4 
repeats for the housekeeper gene. For each reaction the volume of sterile-distilled H20 
was reduced to 6.25 μl (Chapter 2, Section 2.4). The primer information and sequences 
used are shown in Table 6.1. 
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Table 6.1: Real-time PCR primer sequences of targets genes following GTSF1 
knockdown and microarray primary bioinformatic analysis 
Gene Primer Sequence Size (bp) Reference 
MYL9 
F: 5´ TCATCCATGAGGACCACCTT 3´ 
134 
(Harhay et al., 2005) 
(bovine) R: 5´ GCGGGTGAACTCCACATAGT 3´ 
MYL12A 
F: 5´ CATCCCTCCAAATCTGTGCT 3´ 
127 
(Harhay et al., 2005) 
(bovine) R: 5´ ATAGAACCTTCGGGGGCTAA 3´ 
CKAP2 
F: 5´ GGGCTGTGAAACTGATGCTT 3´ 
137 
(Zimin et al., 2009) 
(bovine) R: 5´ CAGCCAACCACTCTTGGAAT 3´ 
AURKA 
F: 5´ TTGGATCAGCTGGAGAGCTT 3´ 
154 
(Uzbekova et al., 
2008) (bovine) R: 5´ AGGCTCCAGAGGTCCACTTT 3´ 
CDK2 
F: 5´ GCTCACTGGCATTCCTCTTC 3´ 
134 
(Zimin et al., 2009) 
(bovine) R: 5´ ACCCATCTGCGTTGATAAGC 3´ 
COX17 
F: 5´ ATTGAAGCCCACAAGGAGTG 3´ 
124 
XM002684734 
(predicted bovine) R: 5´ TCAGCAAGGAACTCCCAAAG 3´ 
PCBP1 
F: 5´ CGGAATTGACTCCAGCTCTC 3´ 
153 
(Zimin et al., 2009) 
(bovine) R: 5´ GACATCTGGCGGATCTCATT 3´ 
FKBP4 
F: 5´ TTGCTGTAGCGACCATGAAG 3´ 
153 
(Zimin et al., 2009) 
(bovine) R: 5´ TCAGGTCCTCACCCTTGAAC 3´ 
ZNF706 
F: 5´ CGTGGACAGCAGAAGATTCA 3´ 
149 
(Strausberg et al., 
2002) (bovine) R: 5´ TTAGGGTCTGGCATTTGTGTC 3´ 
TECR 
F: 5´ GCGTGGATGGCCTATTACAT 3´ 
125 
(Zimin et al., 2009) 
(bovine) R: 5´ GCCATGTGGATGGAGAAGTT 3´ 
TIMP1 
F: 5´ CCCAGACATCCGATTCATCT 3´ 
140 
(Galloway et al., 
2000) (ovine) R: 5´ CAAAACTGCAGGTGGTGATG 3´ 
MYL: Myosin regulatory light polypeptide CKAP2: Cytoskeleton associated protein 2, 
COX17: Cytochrome c oxidase copper chaperone, PCBP1: Poly-(rC) binding protein-1, 
FKBP4: FK506 binding protein 4, ZNF706: Zinc finger protein 706, TECR: Trans-2,3-enoyl-co-
enzyme A reductase, TIMP1: Tissue inhibitor of metalloproteinase 1. 
 
6.2.2.5 Secondary bioinformatic analysis 
A secondary bioinformatic analysis was needed as the primary bioinformatic analysis in 
combination with the real-time PCR verification of target genes revealed discrepancies 
in the data. These differences could be attributed to the fact that the GeneChip arrays 
used in the study were based on bovine genome, while the samples were of ovine origin. 
This meant that although the 2 species share a close homology in their genome, there 
could still be a significant amount of incorrect hybridisation between the arrays and the 
samples. Therefore, a different approach bioinformatic analysis (secondary 
bioinformatic analysis) took place in which only the bovine probe sequences that 
aligned to the sheep genome sequence were selected. The secondary analysis was led by 
Dr. David Iles from the Faculty of Biological Sciences of the University of Leeds. For 
this analysis the latest release of the sheep genome (Oar3.1) was used to forge a 
Biostrings package BSgenome.Oaries. ISGC.Oarv3.1 for probe mapping. This latest 
release has been passed onto the University of California Santa Cruz (UCSC) and the 
NCBI by the sheep genome sequencing consortium for annotation and genome browser 
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track assembly, and also included a significant amount of unmapped scaffolds. These 
were written into the new package as well to maximise coverage of the sheep genome. 
All the individual bovine probe sequences were thereafter aligned to the mapped and 
unmapped sheep genome sequence. Only probes with perfect matches to the sheep 
genome were taken forward. The individual (raw, unprocessed) probe intensities were 
then extracted from the arrays and those that did not match the list of mapped probes 
were discarded. For quality control purposes, both PM and MM data were included. A 
novel algorithm (SCAN.UPC, http://www.bioconductor.org/packages/2.12/bioc/html/ 
SCAN.UPC.html) was then used for processing and normalising the bovine arrays. This 
code has been specifically written for difficult arrays such as those hybridised to RNAs 
extracted from fixed and embedded tumour samples, and allows therefore more 
flexibility than standard methods. In particular, rather than processing microarray 
samples as groups that can have biases and be more complicated, it normalises each 
sample individually by removing probe and array background noise using data from 
within each array. A LIMMA analysis was thereafter ran on the SCAN-normalised data. 
In the analysis the designated arrays A1, B1 and C1 were considered as factors in the 
matrix design along with A2+B2+C2 as control input (C) and A1 vs. C, B1 vs. C and 
C1 vs. C were contrasted using the ‘topTable’ function within Bioconductor to identify 
a gene list containing the transcripts with the most significant changes in expression 
from start to end of the experiment. The probes generated from topTable were annotated 
using the bovine probe Generic Feature Format 3 (GFF3, http://www.sequenceontology. 
org/gff3.shtml) from AFFY (Gautier et al., 2004). These probes were then attached to 
the individual probe intensities for each topTable transcript. From there some bovine 
probe sequences were found to hit multiple sites in the sheep genome, but others 
appeared to hit unique loci in the sheep genome, and the latter were shown to be well 
represented in the final results.  
 
6.2.2.6 Real-time PCR verification of target genes from the secondary 
bioinformatic mapped sequences 
The transcripts that were identified from the secondary bioinformatic analysis were 
analysed with real-time PCR to verify the microarray results. All transcripts analysed 
corresponded to bovine array probes that had been successfully matched to the ovine 
genome. A total of 9 candidate gene transcripts were analysed by real-time PCR. Real-
time analysis was performed as described in Chapter 2 with modifications as described 
in Section 6.2.2.4. Once again, only the individual oocyte cDNA libraries from the high 
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knockdown group A1 and the N.C. siRNA controls from A2 were used for the analysis. 
The primer information and sequences used are shown in Table 6.2. 
 
Table 6.2: Real-time PCR primer sequences of targets genes following GTSF1 
knockdown and secondary microarray bioinformatic analysis 
Gene Primer Sequence Size (bp) Reference 
TCOF1 
F: 5´ TTGTGACACCCCAAGTCAAA 3´ 
165 
XM004023527 
 (ovine) R: 5´ TGGCAGGACTAGGAGCAACT 3´ 
PARP12 
F: 5´ GGCTTGGACCACCTCAACTA 3´ 
105 
(Zimin et al., 2009) 
(bovine) R: 5´ CGGTCCATCTCCTTTGTTGT 3´ 
RPS8 
F: 5´ ACCGACAGTGGTACGAGTCC 3´ 
155 
(Harhay et al., 
2005) (bovine) R: 5´ ACTGCTGATTTTCGCGTTCT 3´ 
SREK1IP1 
F: 5´ TGTGCTTACCAGGTGCAGAC 3´ 
126 
XM004016940 
 (predicted ovine) R: 5´ TTTTAAAGGCGGCTACTGGA 3´ 
CACNA1D 
F: 5´ TGTCCAAAGGCCTTCAATTC 3´ 
125 
(Zimin et al., 2009) 
(bovine) R: 5´ TTGAGCTGGGAACTTGCTTT 3´ 
TARDBP 
F: 5´ CCGGAATCCAGTGTCTCAGT 3´ 
176 
(Zimin et al., 2009) 
(bovine) R: 5´ TCTGGACCGCTCTTTTCACT 3´ 
DHX35 
F: 5´ GGGTCAGACTGGGATGAAGA 3´ 
190 
XM004014573 
(predicted ovine) R: 5´ CTTCACGAAGCCACAGTCAA 3´ 
PELO 
F: 5´ CCGGCCTAGAATTTCTTTCC 3´ 
111 
XM004014573 
(predicted ovine) R: 5´ TCCTTCCTCACGAGCTTCAT 3´ 
IGFBP7 
F: 5´ ATTTGAGCTGCGAGGTCATC 3´ 
 
NM001145181 
(ovine) R: 5´ CACCCAGCCAGTAGCTTCAT 3´ 
TCOF1: Treacher Collins-Franceschetti syndrome 1, PARP12: Poly adenosine diphosphate 
(ADP)-ribose polymerase 12, RPS8: Ribosomal protein S8, SREK1IP1: Splicing regulatory 
glutamine/lysine rich protein 1 interacting protein 1, CACNA1D: Calcium channel, voltage-
dependent, L type alpha 1D subunit, DHX35: DEAH box polypeptide 35, PELO: Protein 
pelota homolog, IGFBP7: Insulin-like growth factor binding protein 7.  
 
6.2.3 Statistical analysis 
Chi-square tests were used to analyse the results of oocyte survival, meiotic 
progression, cumulus coverage and cumulus expansion according to proportional 
analysis of the cohort of oocytes and cumulus within each treatment. Normally 
distributed data for oocyte mRNA levels of GTSF1 as determined by Anderson-Darling, 
were compared using Student’s t-test. For the primary bioinformatic analysis, the raw 
Affymetrix files were analyzed using AFFY and AFFYPLM R packages and the data 
were normalized using the RMA method. The differential expressed genes were 
identified using LIMMA R package using fold change=1.0 and P<0.05 as cut off for 
gene selection. The Benjamini-Hochberg method was used for multiple testing 
correction, but the adjusted P-values were greater than 0.05. The P-values were 
therefore used without corrections. For gene ontology analysis using Bingo in 
Cytoscape, over-represented ontologies were reported using Hypergeometric test with 
Benjamini-Hochberg false discovery rate correction and cut off value P<0.05. 
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Secondary bioinformatic analysis used a novel algorithm (SCAN.UPC) to process and 
normalise the raw probe intensities extracted from the arrays that were aligned to the 
sheep genome. The differentially expressed genes were identified using the LIMMA R 
package using fold change=1.0 and P<0.05 as cut off for gene selection. For real-time 
PCR that followed primary and secondary bioinformatic analysis, normally distributed 
data for mRNA levels of MYL9, MYL12A, CKAP2, AURKA, CDK2, COX17, PCBP1, 
FKBP4, ZNF706, TECR and TIMP1 from the primary bioinformatic analysis and 
TCOF1, PARP12, RPS8, SREK1IP1, CACNA1D, TARDBP, DHX35, PELO and 
IGFBP7 from the secondary bioinformatic analysis were compared using Student’s t-
test. Values for real-time data presented are the arithmetic means ±SEM for the number 
of observations shown. The experimental plan followed for the Microarrays and the 
bioinformatics analysis is shown in Figure 6.4. 
 
Assessment of the level of GTSF1 k/d in the siRNA oocytes  
Selection of the oocytes with the higher levels of GTSF1 k/d 
along with their respective controls and grouping them into a 
total of 6 arrays for Microarray analysis  
Microarray analysis  
Bioinformatic analysis  Secondary bioinformatic 
analysis  
Quality assessment of 
the data  
Normalisation  using the 
RMA method 
Identification of differentially 
expressed genes using LIMMA 
Annotation of genes 
(Bioconductor) 
Gene ontology (Cytoscape) 
Functional annottation (DAVID) 
Real-time PCR verification of 
target genes 
Bovine probe sequences aligned to 
the sheep 
Normalisation  
(SCAN.UPC algorithm) 
Identification of differentially 
expressed genes (LIMMA) 
Annotation of genes 
(Bioconductor) 
Gene ontology (Cytoscape) 
Functional annottation (DAVID) 
Real-time PCR verification of 
target genes  
Figure 6.5: Schematic representation of the experimental plan followed for the microarray 
analysis after GTSF1 knockdown. 
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6.3 RESULTS  
6.3.1 Generation of GTSF1 knockdown oocytes 
In a total of 17 cultures, 425 oocytes were injected with the GTSF1 siRNA, while 415 
were injected with N.C. siRNA.  
 
6.3.1.2 Oocyte survival after microinjection 
Oocyte survival was assessed at 24 h and 48 h of culture. A total of 77/425 oocytes 
(18.1%) survived the first 24 h of culture when injected with GTSF1 siRNA and 
102/415 oocytes (24.6%) survived the N.C. siRNA injections (Figure 6.6). At 48 h the 
survival rates remained largely unaffected with a total of 74/77 GTSF1 siRNA-injected 
oocytes surviving (96.1%) and 100/102 N.C. siRNA-injected oocytes surviving (98%). 
No significant differences (P>0.05) in survival were observed between the 2 injection 
groups at the 2 time points demonstrating that knockdown of GTSF1 or injection of 
N.C. siRNA per se does not affect oocyte viability.  
 
 
Figure 6.6: Influence of GTSF1 siRNA injection and N.C. siRNA injection on oocyte survival 
at 24 and 48 h of culture. Before the first time point, oocytes were denuded, microinjected with 
either GTSF1 siRNA or N.C. siRNA and cultured in serum-free media with cilostamide (20 
mg/ml) and basal levels of gonadotrophins for 24 h. Surviving oocytes were then co-cultured 
individually with oocytectomised cumulus shells in serum-free IVM media and maturation 
inducing levels of gonadotrophins for an additional 24 h. Values represent proportions of the 
total cohort of injected oocytes over 17 repeat cultures. Individual bars show the mean ±SEM 
for independent cultures with the numbers of oocytes falling into each category shown.  No 
significant differences were observed (P>0.05). 
 
6.3.1.3 Impact of GTSF1 on meiotic progression 
The developmental competence of oocytes following microinjection and IVM was 
assessed by evaluating MII progression of oocytes after 48 h of culture. There were no 
significant differences (P>0.05) between the proportions of viable GV oocytes injected 
with GTSF1 siRNA at 24 h of culture, which progressed to MII (42/77 oocytes, 54.5%) 
in comparison to 47.1% of N.C. siRNA-injected control oocytes (48/102 oocytes) as 
shown in Figure 6.7.  
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Figure 6.7: Impact of GTSF1 knockdown on meiotic progression of viable GTSF1 
siRNA and N.C. siRNA-injected oocytes as determined at 24 h of culture that were 
subjected to an additional 24 h of IVM co-culture with cumulus shells. Values represent 
proportions of surviving oocytes over 17 repeat cultures. Individual bars show the mean ±SEM 
for independent cultures with the numbers of oocytes falling into each category shown. The 2 
groups did not demonstrate any significant differences (P>0.05). 
 
6.3.1.4 Effect of oocyte GTSF1 knockdown on cumulus expansion 
The cumulus shell mass and expansion were assessed at the start of oocyte and cumulus 
cell co-culture and at the end of the 24 h IVM co-cultures. Equall numbers of cumulus 
shells and viable oocytes were co-cultured individually (single oocyte with single 
cumulus shell) for each treatment. For this experimental series, a total of 77 cumulus 
shells were oocytectomised and co-cultured with viable GTSF1 siRNA-injected 
oocytes, while 102 cumulus shells were co-cultured with viable N.C. siRNA-injected 
oocytes. Cumulus shell mass classification remained unchanged during the period of the 
co-culture for both treatments and comparison of the cumulus coverage for the 2 groups 
at the end of the culutre showed no significnat differences (P>0.05) (Figure 6.8). 
 
 
Figure 6.8: Effect of GTSF1 knockdown on cumulus shell mass classifications after 24 h of 
individual cumulus shell co-culture with individual GTSF1 siRNA or N.C. siRNA-injected 
oocytes. Individual bars show the proportions of cumulus shells from 17 different cultures. The 
numbers of cumulus shells falling into each category are shown. Individual bars show the mean 
±SEM for independent cultures with the numbers of cumulus shells falling into each category 
shown. No significant differences were observed (P>0.05).  
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Analysis of cumulus expansion showed that knockdown of GTSF1 in oocytes did not 
have a significant effect (P>0.05) on the expansion of cumulus shells compared to the 
N.C. siRNA-injected control group (Figure 6.9).  
 
 
Figure 6.9: Effect of oocyte GTSF1 knockdown on cumulus expansion following 24 h of 
individual cumulus shell co-culture with individual GTSF1 gene knockdown oocytes compared 
to co-cultures of individual cumulus shells with individual N.C. siRNA-injected oocytes. 
Individual bars show the proportions of cumulus shells from 17 repeated cultures. The numbers 
of cumulus shells falling into each category are shown. Individual bars show the mean ±SEM 
for independent cultures with the numbers of cumulus shells falling into each category shown.  
No statistically significant differences were noted (P>0.05).  
 
Cumulus shells from the GTSF1 siRNA injection group were not able to expand fully 
but rather expand up to an intermediate stage between partially and fully expanded. 
Similar observations were made for the N.C. siRNA group. This suggests that group 
culture of oocytes and cumulus shells as used in Chapters 4 and 5 is better able to 
support cumulus expansion than the single oocyte/cumulus shell cultures used in the 
current experimental series. 
 
6.3.1.5 Molecular analysis of GTSF1 gene expression following GTSF1 knockdown  
All single MII oocytes were analysed for their expression of GTSF1 by real-time PCR. 
A total of 42 MII oocytes from the GTSF1 siRNA injection group along with their 
respective control N.C. siRNA MII oocytes (42 control oocytes) were analysed. Real 
time analysis showed that GTSF1 expression was significantly reduced (P<0.005) in all 
oocytes following GTSF1 siRNA injection (1.5±0.1 arb. units, n=42) in comparison 
with the N.C. siRNA controls (2.8±0.2 arb. units, n=42) (Figure 6.10.a). From the 
cohort of MII oocytes, a total of 14 MII oocytes had levels of GTSF1 transcript reduced 
by >50% in comparison with the control oocytes, indicative of a successful outcome of 
the siRNA experiments in these oocytes. Furthermore, these 14 oocytes were confirmed 
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by real-time PCR to have a significant reduction (P<0.005) in the GTSF1 transcript 
levels following GTSF1 siRNA injection (0.8±0.1 arb. units, n=14) in comparison with 
the N.C. siRNA controls (2.7±0.3 arb. units, n=14) (Figure 6.10.b). These oocytes were 
selected for transcriptome analysis using microarrays. 
 
 
Figure 6.10: Real-time PCR quantification of the effect of GTSF1 siRNA injection on the 
GTSF1 expression levels of (a): All MII oocytes (n=42) injected with GTSF1 siRNA and their 
respective N.C. siRNA controls, (b): Selected MII oocytes (n=14), that showed a relative 
reduction in the GTSF1 expression level of over 50% in comparison with the N.C.siRNA 
controls. The data were standardised against the oocyte GAPDH and H2A mRNA levels. 
Individual bars show the mean ±SEM for (a) 42 repeat cDNA libraries and (b) 14 repeat cDNA 
libraries (each cDNA library analysed in triplicate). Each cDNA library contained a single 
oocyte. The GTSF1 siRNA-injected oocytes exhibited a statistically significant difference for 
the GTSF1 mRNA levels (***=P<0.005) when compared against the buffer-injected control 
samples for both oocyte populations. 
 
Oocytes were further grouped on the basis of their GTSF1 transcript levels in 
comparison with the controls (Figure 6.11). The 5 oocytes producing the higher level of 
GTSF1 knockdown (0.5±0.1 arb. units, n=5) in comparison with the controls (2.9±0.4 
arb. units, n=5) were pooled together. Similarly, the 5 control oocytes injected with 
N.C. siRNA were pooled and both arrays consisted the microarray group A (A1 being 
the GTSF1 injected oocytes and A2 the N.C. siRNA-injected control oocytes). The next 
5 MII oocytes producing a medium-level of GTSF1 knockdown (0.9±0.1 arb. units, 
n=5) in comparison with the controls (2.5±0.2 arb. units, n=5) were also pooled together 
and the corresponding N.C. siRNA-injected control oocytes were also pooled to create 
the microarray group B (B1 and B2 respectively). The last 4 oocytes producing a low-
level knockdown of GTSF1 transcript (1.1±0.1 arb. units, n=4 following GTSF1 siRNA 
injection in comparison with controls (2.8±0.8 arb. units, n=4) and their associated 
controls comprised the microarray group C (C1 and C2 respectively).  
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Figure 6.11: Real-time PCR quantification of the effect of GTSF1 siRNA injection on oocyte 
GTSF1 mRNA levels for oocytes comprising each microarray group (treatment and control).  
The data was standardised against the oocyte GAPDH and H2A mRNA levels. Individual bars 
show the mean ±SEM for 5 individual oocytes (A, B) and 4 cDNA libraries containing 
individual oocytes (C) (each library analysed in quadruplicate). GTSF1 siRNA-injected oocytes 
exhibited a statistically significant difference for the GTSF1 mRNA levels (***=P<0.005) when 
compared against their respective N.C. siRNA-injected oocytes. 
 
6.3.2 Primary bioinformatic analysis 
Following microarray analysis, the first step for the bioinformatic analysis was the 
quality assessment of the data. In order to do that, an exploratory data analysis took 
place in which the image plots of the (PM and MM) probe-level data were observed for 
anomalies including spatial artefacts or other non-homogenous patterns. The image 
plots for the 6 conducted arrays appeared similar to each other with no obvious 
anomalies (not shown). The next step involved plotting box-plots and density plots of 
the probe-level data to determine whether any arrays were potentially defective.  
 
 
Figure 6.12: Box-plots of ovine probe intensities from 6 arrays. Probe level data A1, B1 and 
C1, corresponding to GTSF1 siRNA-injected oocytes and A2, B2 and C2, corresponding to 
N.C. siRNA-injected oocytes. 
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By plotting box-plots of the arrays, marginally different ranges or displaced boxes from 
the box-plots inter-quartile ranges (IQR) indicate defective arrays (Heber and Sick, 
2006). Similarly, by observing the density plots, defective arrays could be noticed when 
there were densities that were not in the other arrays, or when arrays have different 
shapes, bimodalities and other abnormalities (Heber and Sick, 2006). The box-plots as 
shown in Figure 6.12 showed a similar distribution on the log scale for the first 5 arrays 
(A1, A2, B1, B2 and C1) with their inter-quartile ranges overlapping to each other, 
while there was a different distribution of the probe intensities observed in the C2 array. 
From the density plots shown in Figure 6.13 there were no bimodalities or other 
abnormalities between the first 5 arrays (A1, A2, B1, B2, C1), whilst bimodalities were 
observed for the C2 array. Together the density plots and box-plots conducted for the 6 
arrays suggest good quality in 5/6 microarrays. 
 
 
Figure 6.13: Density plots of ovine probe densities from 6 arrays. Probe level data A1, B1 and 
C1, corresponding to GTSF1 siRNA-injected oocytes and A2, B2 and C2, corresponding to 
N.C. siRNA-injected oocytes. 
 
Exploratory plots were then created as an additional quality assessment of the 
microarrays. These plots are generally used when different arrays are to be compared 
(Alvord et al., 2007). For comparing more than 2 arrays, a synthetic approach is created 
by using the probe-wise medians across all arrays (Bolstad et al., 2004). Figure 6.14 
shows the MA plots for all 6 arrays with the median synthetic array centred at zero. The 
MA-plot is a plot of the distribution of the log of the red/green intensity ratio ('M') 
plotted by the log of average intensity ('A'). A locally weighted scatter-plot smoothing 
(LOESS) regression line (indicated by red colour) is also illustrated in each of the MA 
plots. The MA plot provides an overview of the distribution of the data. Since most of 
the genes in the array would not show changes in their expression levels, they would be 
located at 0 on the y-axis (M) since Log(1) is 0. The straight red LOESS regression 
lines for all 6 arrays passing close to 0 suggests that the arrays did not have quality 
issues. 
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Figure 6.14: MA plots of 6 arrays of probe level data versus the synthetic (median) array, 
centred at zero. A LOESS regression line was added to each of the plots. 
 
Using the Bioconductor package, RNA degradation was detected (Alvord et al., 2007). 
For all microarrays, individual probes were sequentially numbered from the 5´ end of 
the targeted transcript and if severe degradation of RNA occurs, the PM intensities were 
found to be elevated at the 3´ of the probe set in comparison with those at the 5´ end. 
The average of all probe’s RNA degradation within each array are shown in Figure 
6.15. No severe RNA degradation was noticed for the first 5 arrays (A2, A2, B1, B2 and 
C1), while some RNA degradation was apparent for the C2 array. 
 
 
Figure 6.15: RNA degradation plot for 6 microarrays.  
 
Following pre-processing of the data, it was necessary to transform results into a final 
expression value for each gene. For Affymetrix data sets, this usually involved 3 steps 
which are background adjustment, normalisation and summarisation (Huber and 
Gentleman, 2004). Background adjustment was necessary and observed intensities 
needed adjustment to avoid taking into account non-specific hybridisation caused by 
noise in the optical detection system. Normalisation was necessary to compare 
measurements between different array hybridisations that have much variability caused 
by several reasons including transcription efficiency, labelling, hybridisation and more. 
Finally, summarisation was necessary because the transcripts were represented by 
multiple probes and therefore for each gene, both adjusted background and normalised 
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probe intensities needed to be represented into 1 final value. The RMA method was 
used for this procedure and the probe-level data were transformed into expression level 
data with a single expression level value for each gene. The box-plot following RMA 
background adjustment, normalisation and summarisation is shown in Figure 6.16. The 
alignment of the expression level values following RMA transformation indicated the 
success of the normalisation and summarisation procedure and not the quality of the 
probe level data. 
 
Figure 6.16: Box-plots of ovine expression level data of the 6 arrays following RMA 
background adjustment, normalisation and summarisation. 
 
Following transformation of the data, the differentially expressed genes between the 2 
treatments were identified. Because there were no replicates for each array conducted, 
the arrays were grouped into AB, BC and ABC for comparison assuming A and B were 
replicates in AB grouping. Similarly for the ABC group, A, B and C were considered 
replicates, while B and C were considered replicates for the BC group. The 3 groups 
were compared and differentially expressed genes were identified using fold 
change=1.0 and a P<0.05 as the cut off for gene selection, but multiple testing 
correction did not reveal any statistical significance. Therefore the P-values were used 
without being corrected. The differentially expressed genes annotated using the 
bovine.db R package, were separated to down-regulated and up-regulated for each 
condition. The genes with altered expression levels for each group are shown in the 
Venn diagrams (Figure 6.17). From the diagrams, it can be observed, that there were a 
number of genes whose expression was altered for each group of arrays (AB, BC and 
ABC) in comparison with controls. There were only a few transcripts that were 
common in all groups. Some transcripts were identified to be differentially expressed in 
2 groups in comparison to controls, but most genes were either up-regulated or down-
regulated within individual groups. Out of these groups of arrays, the AB assumed as a 
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higher-level knockdown, was considered as the most important to follow-up. The list of 
down-regulated and up-regulated genes from the AB group as determined from the 
Venn diagrams are shown in Appendix IV. 
 
 
 
Figure 6.17: A: Venn diagrams showing number of differentially expressed genes that were A: 
down-regulated and B: Up-regulated, as determined by primary bioinformatics analysis of 
GTSF1 knockdown oocytes vs. control oocytes. Grouped arrays were compared to find common 
differentially expressed transcripts using a 1 fold change and no significance cut offs. 
 
Table 6.3: Ontology analysis of GTSF1 knockdown following primary bioinformatic analysis  
Biological Processes 
Down-regulated genes: The affected biological processes included oocyte development, 
oogenesis, oocyte differentiation, oocyte morphogenesis, oocyte growth, as well as RNA 
processing, actin cytoskeleton organisation, actin filament spindle assembly, maintenance of 
cell polarity, maintenance of apical/basal cell polarity. 
Up-regulated genes: Annotation of up-regulated genes revealed genes involved with  spindle 
assembly checkpoint, cell cycle checkpoint, regulation of chromosome segregation, post-
transcriptional regulation of gene expression, negative regulation of ossification and bone 
mineralisation, regulation of protein stability, steroid metabolic process, cellular component 
organisation, cell division and organelle organisation. 
Cellular components 
Down-regulated genes: Gene ontology analysis of down-regulated cellular components 
included intracellular organelle parts, non-membrane bounded organelles, microtubule 
organising centre, cytoskeletal part, microtubule basal body, ribonucleoprotein complex, 
macromolecular complex, protein complex as well as mitochondrial components.  
Up-regulated genes: The list of cellular components based on annotation of up-regulated 
genes included spindle, microtubule organising centre, condensed chromosome kinetochore, 
chromosomal part, protein complex, intracellular organelle part, endoplasmic reticulum part, 
intracellular membrane-bounded organelle, cytoplasm, endoplasmic reticulum membrane and 
nuclear membrane-endoplasmic reticulum network 
Molecular functions 
Down-regulated genes: Molecular functions affected following GTSF1 knockdown were 
nucleotide binding, DNA-binding, cell adhesion molecule binding, calcium ion binding, ATP 
dependent helicase activity, helicase activity, motor activity, pyro-phosphatase activity, 
hydrolase activity acting on acid anhydrides, hydrogen ion trans-membrane transporter 
activity, cytochrome c oxidase activity and oxido-reductase activity  
Up-regulated genes: These included structure-specific DNA binding, polyubiquitin binding, 
enzyme binding, protein kinase binding, metallo-chaperone activity, oxido-reductase activity, 
histone-kinase activity, serine/threonine kinase activity, cyclin-dependent kinase activity. 
 
Gene ontology analysis of the genes from the AB group was then carried out to define 
representing gene product properties. The ontology analysis covered 3 domains being 
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(i) the cellular component that includes cellular and extracellular environment; (ii) 
molecular function defined by the activity of the gene at a molecular level; and (iii) 
biological processes that portray the function of the cells. The ontology analysis 
generated for down-regulated and up-regulated genes from the AB microarray group 
following GTSF1 knockdown is shown in Table 6.3. The product properties from the 
gene ontology analysis incorporated several different properties, covering maturation, 
spindle formation, and RNA processing. Most of these processes are in agreement with 
the background information concerning the inferred function of GTSF1 and reveal the 
importance of this gene during the maturation stages of the oocyte. 
 
6.3.3 Real-time PCR verification of transcripts from the primary bioinformatic 
analysis 
Real-time PCR was used to verify the gene-targets originating from the primary 
bioinformatic analysis. The gene targets originated from the list of down-regulated and 
up-regulated genes that were identified to have different expression in the AB 
knockdown group (Appendix IV). The targets included AURKA, CDK2, COX17, 
ZNF706, TECR, PCBP1, FKBP4 and TIMP1 from the down-regulated gene list and 
MYL9, MYL12A and CKAP2 from the up-regulated gene list. Differential expression of 
the transcripts for the 2 different treatment groups was examined from the individual 
oocyte cDNA libraries of the high knockdown group (5 oocytes of A1) and the N.C. 
siRNA controls (5 oocytes of A2). One cDNA library from the treated samples was 
disregarded due to contamination; therefore a total of 4 individual cDNA libraries were 
interrogated for their expression levels of each of the target primers. Only a small 
number of oocytes were analysed in this experimental series and few of the data attained 
statistical significance. Never-the-less the results presented in Figure 6.17 show striking 
trends of the impact of GTSF1 knockdown on the expression of key genes which are 
known to have important functional roles in cell division. Further replicates are required 
to substantiate the current observations. Individual transcript levels of COX17, PCBP1, 
TECR and ZNF706 were very variable between the GTSF1 knockdown cDNA libraries 
and were therefore disregarded prior to the analysis (data not shown). As shown in 
Figure 6.18.a., transcript analysis of the down-regulated genes showed that expression 
levels of AURKA were reduced in the GTSF1 knockdown group (0.3±0.1 arb. units, 
n=4) in comparison with the controls (1.1±0.4 arb. units, n=4), but this reduction was 
not significant (P>0.05) due to the relatively small number of samples analysed. 
Similarly, FKBP4 and CDK2 transcript levels were reduced in the knockdown group 
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(0.4±0.1 arb. units, n=4; 0.3±0.1 arb. units, n=4) respectively in comparison with the 
controls (5.2±2.9 arb. units, n=4; 2.9±1.3 arb. units, n=4), but these reductions were not 
significant (P>0.05). For all 3 target genes, although there was a high rate of reduction 
in the expression levels between knockdown and controls, the control data were still 
quite variable between individual libraries and produced large error bars. Transcript 
levels of TIMP1 showed a significant reduction (P<0.05) between the knockdown and 
controls transcript levels (0.5±0.1 arb. units, n=4) in comparison with the controls 
(5.0±1.5 arb. units, n=4). Real-time PCR did not verify the results from the primary 
bioinformatic analysis for the up-regulated genes (Figure 6.18.b).  
 
 
Figure 6.18: Real-time PCR quantification of the effect of GTSF1 knockdown on target gene 
expression cDNA derived from high-level GTSF1 knockdown oocytes (n=4) that were analysed 
individually by real-time PCR shown together with the data for N.C. siRNA oocytes (n=4) 
based on (a): Down-regulated genes and (b): Up-regulated genes identified by primary 
bioinformatic analysis. The data was standardised against the oocyte GAPDH and H2A mRNA 
levels. Individual bars show the mean ±SEM for 4 individual oocyte cDNA libraries (each 
library analysed in quadruplicate). GTSF1 knockdown oocytes exhibited a statistically 
significant difference for the TIMP1 and MYL9 mRNA levels (*=P<0.05) when compared 
against the N.C. siRNA oocytes, while no other significant differences were observed (P>0.05) 
due to the variability of the control data. 
 
Gene transcript levels of MYL9 were significantly reduced (P<0.05) in the GTSF1 
knockdown oocytes (0.2±0.1 arb. units, n=4) in comparison with the controls (0.5±0.1 
arb. units, n=4). Transcript levels of MYL12A were also reduced (0.4±0.1 arb. units, 
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n=4) following GTSF1 knockdown in comparison with the controls (0.8±0.1 arb. units, 
n=4), while CKAP2 transcript levels were reduced (0.3±0.1 arb. units, n=4) compared 
with the controls (0.9±0.3 arb. units, n=4), but no significant differences were shown 
(P>0.05). 
 
6.3.4 Secondary bioinformatic analysis  
The variability of the data from the primary bioinformatic analysis and the lack of 
concordance between the array data and the real-time PCR verification data of target 
genes meant that there could have been a large number of incorrect hybridisations 
between the bovine arrays and the ovine samples. A different analytical approach was 
therefore necessary, in which the bovine probe sequences from the arrays were aligned 
to the sheep genome sequence and these were used to annotate genes and provide 
targets for real-time PCR verification. Only 2 bovine probes were matched to the sheep 
GTSF1 sequence. The microarray A1 containing the high-level knockdown oocytes, the 
microarray B1 containing medium-level knockdown oocytes and the microarray C1 
containing low level knockdown oocytes were all contrasted to controls (A2+B2+C2). 
After the secondary bioinformatic analysis, the list of candidate transcripts that were 
confirmed to be up-regulated in GTSF1 depleted oocytes was entirely different to those 
identified during the primary analysis. The number of genes with altered expression 
levels for each group is shown in the Venn diagrams in Figure 6.19.  
 
 
Figure 6.19: A: Venn diagrams showing number of differentially expressed genes that were A: 
down-regulated and B: Up-regulated, as determined by bioinformatic analysis of GTSF1 
knockdown oocytes Vs control oocytes. Microarrays A (high-level knockdown) and C (low-
level knockdown) were compared to find common differentially expressed transcripts using a 1 
fold change and no statistical significance cut-offs.  
 
Only 1 gene showed common transcript variation for all groups and that was the down-
regulated gene PARP12. A further 5 other genes showed common transcript reduction 
in the 2 groups. These genes were TCOF1, RPS8, SREK1IP1, CACNA1D and TARDBP. 
All these genes were selected as targets for real-time verification. Additionally, DHX35 
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from the high-knockdown microarray group (A1) against controls was selected to be 
followed by real-time PCR. The targets also included 2 genes from the up-regulated 
gene list from the high-knockdown microarray group (A1) against controls, PELO and 
IGFBP7. The list of down-regulated and up-regulated genes from the high-knockdown 
group (A1 against controls) is shown in Table 6.4. 
 
Table 6.4: Secondary bioinformatic analysis list of down-regulated and up-regulated genes 
from high knockdown microarray A1 against control microarrays (A2, B2, C2) 
Down-regulated genes 
A only (57 genes) 
DHX35, PARP12, UBE2O, PAPD7, SLC15A4, TOB2, SLC25A4, EZH2, C27H8orf40, 
MPHOSPH8, DERL1, BOLA2B, ALMS1, LOC787094, TTC4, CKAP2, MTMR2, SYS1, 
COX7C, ZBTB49, CIAPIN1, OSBPL7, RPL28, THAP7, RPL26, TSG118, ZMYND8, 
GADD45GIP1, DEPDC7, RPL26L1, ARHGAP32, MGC134282, PARD3B, SLC7A6OS, 
LOC785691, RPS25, LAMC1, EXOSC2, UTP14A, TMEM117, UBFD1, SUPV3L1, ARFIP1, 
LOC281370, CETN4, ATP5I, COX7B, RAB5A, RSL1D1, CNGB1, MRVI1, YBX1, PSMA7, 
LOC100295338, UPS7, ARPC2, DLG5, SUGT1 
Common to A-C (5 genes) 
TCOF1, RPS8, SREK1IP1, CACNA1D, TARDBP 
Common to A-B-C (1 gene) 
PARP12 
Up-regulated genes 
A only (17 genes) 
PELO, IGFBP7, MGC128036, PCBP2, MIR147, GUSB, GDPD1, DMBT1, TRAPPC6B, 
DUSP10, SPTLC2, LOC514296, SDC2, PTPN11, CDK2, PHOSPHO2, PABPC1 
 
Gene ontology analysis of the genes from the microarray A against controls was then 
carried out to define representing gene product properties as shown in Table 6.5. The 
analysis indicated that following GTSF1 knockdown, ribosome function and RNA-
binding were negatively affected. In particular, the biological processes of most of the 
genes that were down-regulated following the knockdown were associated with RNA 
processing and translation, while there were also genes associated with microtubule 
cytoskeleton organisation. In addition, the affected cellular components following the 
knockdown as indicated by the down-regulated genes were the RNPs and MTOCs, 
while the majority of the down-regulated gene’s molecular functions involved RNA-
binding. All these negatively affected biological processes, molecular functions and 
cellular components are in agreement and closely correlated with the proposed function 
of GTSF1 (Yoshimura et al., 2009; Lu et al., 2012). Functional annotation showed that 
the knockdown of GTSF1 affected the ribosome. Five genes in particular appeared to be 
down-regulated following GTSF1 knockdown as indicated from the high-knockdown 
array (Figure 6.20).  
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Table 6.5: Ontology analysis of GTSF1 knockdown following secondary bioinformatic analysis  
Biological Processes 
Down-regulated genes: The affected biological processes of down-regulated genes 
following the knockdown, were mostly associated with translation, rRNA processing, RNA 
processing, rRNA metabolic process, ribonucleoprotein complex biogenesis, ribosome 
biogenesis, ribosome assembly, regulation of transcription, protein transport and localisation, 
response to unfolded protein, tRNA metabolic processes, DNA modification, transcription, 
cell cycle, microtubule cytoskeleton organisation, chromatin organisation, actin 
polymerisation oxidative phosphorylation, intracellular signalling cascade and ion transport. 
Up-regulated genes: Affected biological processes from the up-regulated gene list were 
associated with cell cycle, cell cycle checkpoint, DNA damage checkpoint, activation of 
MAPK activity, translation, cell cycle, cell proliferation, protein amino-acid phosphorylation. 
Cellular components 
Down-regulated genes: Annotation of down-regulated genes revealed cellular components 
associated with ribosome, ribonucleoprotein complex, microtubule organising centre, 
cytoskeleton, mitochondrion, chromatin, proteasome complex, endoplasmatic reticulum and 
Golgi apparatus. 
Up-regulated genes: Cellular components from the up-regulated list included lysosome, lytic 
vacuole, spliceosome, cytosol, ribonucleoprotein complex, mitochondrion and extracellular 
region. 
Molecular functions 
Down-regulated genes: Annotation of down-regulated genes revealed molecular functions 
affected RNA binding, structural constituent of ribosome, rRNA binding, Zinc ion binding, 
ribonucleotide binding, DNA binding, chromatin binding, actin binding, cytoskeletal protein 
binding, ion channel activity and cytochrome c oxidase activity.  
Up-regulated genes: Finally molecular functions affected by up-regulated genes following 
the knockdown included scavenger receptor activity, ion binding, phosphatase activity, RNA 
binding and cytoskeletal protein binding. 
 
 
 
Figure 6.20: A functional analysis diagram showing the effect of the knockdown on ribosomal 
proteins following secondary bioinformatic analysis as determined using DAVID tools. Stars 
indicate proteins affected by down-regulated genes.  
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These genes were the ribosomal proteins (RP): RPL26, RPL28, RPS8 and RPS25 as 
well as the ubiquitin A-52 residue ribosomal protein fusion product 1 (RPS40). These 
genes encode proteins in both the large subunit (RPL26, RPL28, RPS40) and the small 
subunit of the ribosome (RPS8, RPS25). Functional analysis of these 5 genes showed 
very high relationship with ribosome, RNP complex, translation and structural 
constituent of ribosome (Kappa>0.75) and a high relationship with ribosomal subunits, 
structural molecule activity and the cytosolic ribosome (Kappa>0.5). The KEGG 
pathway, that is a collection of pathway maps and represents the existing knowledge on 
the molecular interactions and reaction networks, was used to examine the effect of 
GTSF1 knockdown on the ribosomes.  
 
6.3.5 Real-time PCR verification of transcripts from the secondary bioinformatic 
analysis 
The expression of the 7 down-regulated genes (TCOF1, PARP12, RPS8, CACNA1D, 
SREK1IP1, TARDBP, DHX35) and 2 up-regulated genes (PELO, IGFBP7) that were 
selected following secondary bioinformatic analysis, were analysed by real-time PCR to 
verify the bioinformatic analysis. The transcripts that were identified from the 
secondary bioinformatic analysis were assayed with real-time PCR to verify the 
microarray results. All transcripts analysed here therefore corresponded to bovine array 
probes that had been successfully mapped to the ovine genome.  
 
Target gene transcript levels were reduced in 7 out of 9 genes following GTSF1 
knockdown oocytes in comparison with the controls in agreement with the secondary 
bioinformatic analysis, with 4 gene transcripts having significant differences between 
the treatments (Figure 6.21). In particular, expression levels of TCOF1 were 
significantly reduced (P<0.05) following GTSF1 knockdown (2.0±1.0 arb. units, n=4) in 
comparison with controls (7.8±1.7 arb. units, n=4) oocytes, while transcript levels of 
RPS8 and CACNA1D were significantly reduced (P<0.01) following GTSF1 
knockdown (2.7±0.9 arb. units, n=4; 5.1±1.4 arb. units, n=4) respectively in comparison 
with controls (12.9±2.2 arb. units, n=4; 19.3±1.5 arb. units, n=4). The levels of 
SREK1IP1 had the most significant reduction (P<0.005) in the expression levels 
following the knockdown (3.0±0.7 arb. units, n=4) in comparison with the controls 
(16.4±0.7 arb. units, n=4). Transcript levels of PARP12, TARDBP and DHX35 were 
reduced following the knockdown (2.6±1.1 arb. units, n=4; 2.4±0.5 arb. units, n=4; 
1.7±1.1 arb. units, n=4) respectively, in comparison with controls (11.2±4.0 arb. units, 
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n=4; 6.8±1.2 arb. units, n=4; 4.3±1.8 arb. units, n=4), but significant differences were 
not noted (P>0.05). Finally the transcript levels of the 2 up-regulated genes PELO and 
IGFBP7 as identified by the secondary bioinformatic analysis were increased following 
the gene specific knockdown (5.9±3.9 arb. units, n=4; 8.5±4.2 arb. units, n=4) 
respectively in comparison with controls (5.3±2.2 arb. units, n=4; 3.2±1.1 arb. units, 
n=4), in agreement with the bioinformatic analysis, but significant differences were not 
noted (P>0.05). Therefore in summary, the real-time PCR verification experiment for 
the targets identified by the secondary bioinformatic analysis were closely aligned with 
the expected patterns of up or down-regulation as indicated by the microarray. This 
provides a high-degree of confidence that the alignment of the bovine probes to the 
ovine genome was a necessary step that improved the validity of the microarray data. 
 
 
Figure 6.21: Real-time PCR quantification of the effect of GTSF1 knockdown on target gene 
expression using cDNA derived from high-level GTSF1 knockdown oocytes that were each 
analysed individually are shown together with the data for N.C. siRNA oocytes based on 
secondary bioinformatic analysis. The data was standardised against the oocyte GAPDH and 
H2A mRNA levels. Individual bars show the mean ±SEM for 4 individual oocyte cDNA 
libraries (each library analysed in quadruplicate). GTSF1 knockdown oocytes exhibited a 
statistically significant difference for the TCOF1 mRNA levels (*=P<0.05), RPS8 and 
CACNA1D mRNA levels (**=P<0.01) as well as SREK1IP1 (***=P<0.005), when compared 
against the N.C.siRNA oocytes, while no other significant differences were observed (P>0.05). 
 
6.4 DISCUSSION  
Overall the results showed that it was possible to create and validate individual GTSF1 
knockdown oocytes. The targeted knockdown of GTSF1 in sheep oocytes did not affect 
oocyte meiotic progression or cumulus expansion. The microarray experiments 
performed on groups of GTSF1 knockdown in vitro matured MII oocytes and N.C. 
siRNA in vitro matured MII oocytes showed that a number of genes were differentially 
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expressed between the 2 treatment groups. The results of this study show the value of 
microarrays for studying the function of GTSF1 during maturation, however caution 
must be exercised when using heterologous arrays, where incorrect gene annotation and 
hybridisation can be a significant problem. Bioinformatic analysis showed that GTSF1 
knockdown is associated in a direct or indirect manner with several cellular processes 
and biological functions including translation, RNA-binding, oocyte development and 
meiosis, microtubule formation, cytoskeletal organisation, post-transcriptional 
regulation of gene expression and many more, further signifying the importance in 
identifying the function of the gene. Real-time PCR confirmation of the significant 
differences in the mRNA transcript levels of 6 candidate target genes from the separate 
primary (2 genes) and secondary (4 genes) bioinformatic analysis that are affected by 
GTSF1 depletion, suggests that GTSF1 knockdown is associated with production of 
ribosomal RNA, regulation of cytoskeletal microfilaments, post-transcriptional 
modification and gene transcriptional control.  
 
6.4.1 The impact of GTSF1 on meiotic progression and cumulus expansion 
The culture results showed that it was possible to generate a targeted knockdown of 
GTSF1 in sheep oocytes without compromising oocyte survival in agreement with the 
results of Chapter 5. The survival rates of the oocytes in this experimental series were 
not different for the 2 treatment groups at 24 h of culture indicating that neither the 
GTSF1 siRNA nor the N.C. siRNA were toxic to the oocyte. Prior to this series of 
experiments it was hypothesised that the volume of injection was an important 
parameter to improve in order to increase survival of the oocytes. Since the change from 
a constant outflow (Chapter 4) to a controlled injection (Chapter 5) under the minimum 
pressure of 40 hPa resulted in reduced survival of oocytes as shown by Chapter 5 
results, the constant outflow was reinstated as in Chapter 4. The survival proportions in 
this experimental series were much higher compared to Chapter 5 survival proportions 
and were slightly higher to the survival proportions obtained in Chapter 4 for the first 24 
h of culture, where the same system of constant outflow was used for the 
microinjections. The increased survival rates could be attributed to the change of the 
microinjection pressure system and the reduced volume of injection resulting to reduced 
osmotic stress in the ooplasm. 
 
The individual culture of oocytes meant that the morphological evaluations of the 
oocytes and cumulus shells along with the level of GTSF1 knockdown could be 
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monitored individually for each oocyte. Oocyte meiotic progression was not 
significantly different between the 2 treatment groups (54.5% for viable GTSF1 siRNA 
injected oocytes and 47.1% for viable N.C. siRNA controls). Furthermore, the 
maturation proportions of viable oocytes at 24 h that were matured with individual 
cumulus shells for both treatments were much higher than maturation proportions 
obtained from Chapter 4 and Chapter 5 results. The improved levels of maturation in 
this series of experiments could be explained because of the improvements to the 
culture system and microinjection technique as well as the tighter control of the timing 
of tissue processing. Cumulus shell expansion and mucification did not show 
differences between the 2 treatments groups. Although cumulus shells did not have the 
potential of fully expanding in this series of experiments, 25.7% of cumulus shells from 
the GTSF1 siRNA group and 24.3% of cumulus shells from the N.C. siRNA group were 
partially-fully expanded, demonstrating that GTSF1 does not affect expansion of the 
cumulus cells. The lack of fully expanded cumulus shells could be attributed to the 
change of group co-cultures to single oocyte and single cumulus shell co-culture. None-
the-less, even though the cumulus shells did not expand fully as in Chapter 4 and 
Chapter 5, oocyte maturation was not impaired as demonstrated from the maturation 
proportions for both injection groups.  
 
Furthermore, all 42 oocytes that progressed to the MII stage following injection with 
GTSF1 siRNA showed significant differences in their levels of GTSF1 knockdown in 
comparison with the N.C. siRNA controls (P<0.005), indicating that the single oocyte 
culture strategy used in the current experiments produced far more consistent gene 
knockdown data than the group oocyte culture approach used in Chapter 5. The effects 
of high levels of oocyte GTSF1 knockdown on oocyte meiotic progression and cumulus 
expansion in the present experiments were consistent with the results recorded for gene 
knockdown oocytes in Chapter 5.  
 
6.4.2 Microarray analysis following GTSF1 knockdown 
In order to identify the underlying molecular mechanisms and functions of GTSF1 
during the maturation stages, the effects of the depletion of the gene on the 
transcriptome of the oocyte needed to be acquired. It is well established that the causes 
of poor developmental competence of oocytes are complex and depend on several 
changes in the mRNA transcript levels of numerous genes (Donnison and Pfeffer, 
2004). A number of studies have shown that changes in the gene expression like GDF9 
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or BMP15 in oocytes or HAS2 in cumulus cells can be monitored in order to select 
oocytes for fertilisation as well as embryos for implantation (Elvin et al., 1999; Yan et 
al., 2001; Cillo et al., 2007). Gene expression studies can therefore identify factors 
involved in oocyte maturation as well as provide molecular markers for abnormal gene 
expression that can affect developmental competence (Gasca et al., 2007). Oocytes from 
such studies may have differences at the molecular level in the synthesis, degradation 
and modification of mRNAs and proteins which can be reflected in the differences of 
gene expression between the different conditions. It is apparent therefore that if GTSF1 
functions during maturation of the oocyte, this will be reflected by the mRNA transcript 
level. There have been studies where real-time PCR has been used to determine mRNA 
expression patterns in bovine oocytes and embryos (Oropeza et al., 2004; Zaraza et al., 
2010). In this thesis, speculative real-time PCR of candidate genes, following 
knockdown of GTSF1 as conducted in Chapter 5 did not reveal any specific differences 
on their expression levels. Application of the microarray technology that contains tens 
of thousands of gene probes was considered therefore very useful for the identification 
of targets following the gene specific knockdown. 
 
In a recent study conducted in mice, microarrays were used to identify germ cell-
specific genes in mammalian meiotic prophase (Li et al., 2013).  Similarly, genes from 
MII oocytes that correlated with the oocyte’s ability to develop to the blastocyst stage 
have been identified in another murine study (Biase et al., 2012). Microarrays have also 
been used for expression analysis of specific sets of genes or specific miRNAs during 
oocyte maturation and early embryo development (Xu et al., 2011; Mondou et al., 
2012). Molecular and hormonal characterisation of follicular fluid, cumulus cells and 
oocytes has been used to determine developmental competence (Jose De Los Santos et 
al., 2012). The in vitro culture of oocytes has been shown to affect gene expression and 
signalling pathways in bovine cumulus cells (Salhab et al., 2013). In fact microarrays 
have been used to study the transcriptome of cumulus and granulosa cells as non-
invasive predictors of oocyte maturation, embryo competence or live birth (Anderson et 
al., 2009; Feuerstein et al., 2012; Wathlet et al., 2012; Uyar et al., 2013).  
 
Microarrays have been used to study genes and mechanisms that affect oocyte 
development. Transcriptome analysis during the oocyte maturation stages of the oocyte 
can reveal a lot of information. In the past few years, a number of studies have argued 
on the subject of the timing of transcription initiation following the resumption of 
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meiosis in oocytes (Xu et al., 2011). A number of transcripts have been shown to be up-
regulated during oocyte maturation in cattle and humans between GV and MII oocytes 
(Assou et al., 2006; Mamo et al., 2011). In the bovine oocytes, a total of 1528 
transcripts were found to be significantly lower and 589 were significantly higher in 
IVM MII oocytes in comparison with GV oocytes (Mamo et al., 2011). In human 
oocytes, 803 genes were down-regulated and 444 genes were up-regulated in the MII 
oocytes compared to the GV (Assou et al., 2006). The genes that were found to be 
overexpressed might represent expression patterns that are related to the completion of 
meiosis (Xu et al., 2011). The approach of inflicting a gene specific knockdown by the 
means of microinjecting siRNA in GV oocytes followed by IVM and transcriptome 
analysis by microarrays in order to study the function of a novel gene has been 
successfully applied in a recent study, where Pcbp1 has been knocked down in mouse 
oocytes (Xia et al., 2012). In this study, knockdown of Pcbp1 resulted in remarkable 
changes in the transcriptional state of the oocytes with around 4000 transcripts up-
regulated following the knockdown; suggesting that knocking down the gene disrupted 
the quiescent status of transcription in MII oocytes and the regulation of global 
transcription silencing (Xia et al., 2012). A similar approach was followed in this thesis 
for the study of the function of GTSF1 during the maturation of ovine oocytes by 
injecting siRNA for GTSF1.  
 
The experimental procedure for the successful application of microarrays consists of 
multiple stages covering from RNA extraction, reverse transcription, amplification to 
labelling and hybridisation; each of which adds a possible systematic or random 
variation in the resulting data. This in addition to the selection of the appropriate 
statistical methods, as well as the large gene ontology databases, make the microarray 
experiments very complex and require a thoroughly evaluated experimental design 
(Uyar et al., 2013). In this thesis there was a finite number of GTSF1 knockdown 
oocytes, thus careful planning was needed. It is well established that oocytes able to 
mature to the MII stage do not necessarily have the same competency in developing to 
the blastocyst stage (Leoni et al., 2007). There can be severe differences at the 
molecular level in the synthesis, degradation and modification of mRNAs and proteins 
between oocytes, especially during the GV to MII transition where the transcriptome 
abundance is reduced (Leoni et al., 2007). The 14 oocytes that demonstrated >50% of 
GTSF1 knockdown (P<0.005) along with their respective N.C. siRNA oocytes were 
selected for microarray analysis. The oocytes compiling each microarray set used here 
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were separated based on their levels of GTSF1 knockdown into A1, B1 and C1 along 
with their respective controls A2, B2 and C2. 
 
6.4.3 Primary bioinformatic analysis 
Following normalisation of the arrays, GTSF1 knockdown arrays were grouped together 
(A1+B1, B1+C1, A1+B1+C1) and then compared against their respective control 
groups. Target genes were identified and gene ontology analysis that followed primary 
bioinformatic normalisation and grouping of the microarrays revealed that knockdown 
of GTSF1 down-regulated several biological processes such as oocyte development, 
actin cytoskeleton organisation, spindle assembly and cell polarity (AURKA, CDK2, 
p59, FKBP4) in addition to RNA processing (RNA binding motif 17 (RBM17), 
PCBP1). Similarly, down-regulated genes were mostly associated with cellular 
components associated with microtubule cytoskeleton, the myosin complex as well as 
mitochondrial components and membrane transporters (COX17, mammalian gene 
collection 80625 (MGC80625), AURKA) in addition to RNP components (RBM17, 
PCBP1), while down-regulated genes affected molecular functions including nucleotide 
binding, ATP dependent helicase activity, calcium ion and cell adhesion binding, motor 
activity, cytochrome c oxidase activity and ion trans-membrane transporter activity 
(FKBP4, MGC80050, MGC85413, RBM17, AURKA, COX17, ZNF706). Down-
regulated biological processes of oocyte development, oogenesis, oocyte growth and 
differentiation, developmental cell growth as well as the actin filament based processes 
and spindle assembly put forward the idea that GTSF1 affects the developmental 
competence of the oocyte. Down-regulated cell cycle and cell division processes 
indicate that GTSF1 might be important for development of the oocyte as well as the 
early embryo. Although in this thesis no developmental differences were observed 
between the IVM potential of ovine oocytes following GTSF1 knockdown (Chapter 5 
results and Chapter 6 culture results), the developmental competence of these oocytes 
could still be impaired as a result of defective spindle assembly and/or alterations in 
transcriptional and translational control which compromise oocyte quality. The ability 
of oocytes to resume meiosis, to be fertilised, to develop into blastocyst and to produce 
healthy offspring are all individual events and success in the first events does not 
guarantee subsequent success in the following events (Sirard et al., 2006). However, the 
molecular cascades that the oocytes acquire during maturation are necessary for 
subsequent embryonic genome activation and development to the blastocyst stage, thus 
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the molecular maturation of each oocyte defines its inherent capacity to continue its 
development (Sirard et al., 2006).    
 
Although nuclear maturation and cytoplasmic maturation are different processes, they 
are interlinked and occur at the same time, even if molecular programming initiates at 
earlier stages of oocyte growth (Sirard et al., 2006). Redistribution of cytoplasmic 
organelles is a necessity for successful cytoplasmic maturation and repositioning of the 
organelles occurs through the actions of cytoskeletal microfilaments and microtubules 
(Ferreira et al., 2009). Microtubules are directly involved in movement of organelles 
and they adhere to motor proteins such as Dynein and Kinesin that promotes their 
movement (Sun and Schatten, 2006). Microfilaments are associated with microtubules 
since the polarised movement of chromosomes is mediated by actin filaments (Sun and 
Schatten, 2006). In murine and bovine oocytes it has been shown that cytoskeleton 
associated processes during maturation are regulated by different molecules including 
AURKA that localises with chromosomes and so regulates chromosome segregation, 
maintenance of the MII state and formation of the polar body (Yao et al., 2004; 
Uzbekova et al., 2008).  In addition, cytoskeleton associated molecules, ATP binding 
and calcium ion binding, all transcripts that were down-regulated following gene 
ontology analysis in the present study, are usually found in abundance in dominant 
follicles in comparison to growing follicles; suggesting that competent gametes are 
enriched with these transcripts (Sirard et al., 2006; Ghanem et al., 2007). Furthermore, 
calcium signalling has been shown to be associated with successful implantation of 
blastocyst mouse embryos (Wang et al., 2002).  
 
Other than the microtubules and cytoskeleton, certain metabolic pathways involved in 
protein synthesis and phosphorylation, need to be activated in order for cytoplasmic 
maturation to progress. Mitochondria are crucial components of the metabolic 
machinery and supply the necessary energy that is consumed during the maturation 
stage (Stojkovic et al., 2001). These organelles in oocyte have vital roles in several 
physiological events including the first stages following fertilisation (Van Blerkom, 
2004). Mitochondrial components were also shown to be down-regulated following the 
GTSF1 knockdown. Additionally, cytochrome c oxidase activity which was also shown 
to be down-regulated, is the terminal enzyme of the mitochondrial respiratory chain and 
reductions of mRNA and protein expression of this oxidase have been shown to 
significantly increase apoptosis in mouse embryos (Cui et al., 2006). Studies have 
219 
 
shown that the mitochondria synthesize ATP during the maturation stage which is 
necessary for protein synthesis and subsequent embryo development (Krisher and 
Bavister, 1998; Stojkovic et al., 2001). In addition, the number of mitochondria is 
important, since reduced numbers have been shown to be responsible for abnormal 
distribution of the organelle during the early stages of embryogenesis (Shoubridge and 
Wai, 2007).  
 
Gene ontology analysis revealed that some genes were up-regulated following the 
targeted knockdown of GTSF1. These included cell cycle and spindle checkpoint genes, 
while genes associated with lipid and steroid biosynthesis and protein stability were also 
up-regulated (CKAP2, MAPK6, AT rich interactive domain 2 (ARID2), erzin (EZR) and 
oxysterol binding protein like 7 (OSBPL7). In addition, DNA-binding gene transcripts 
were up-regulated along (ARID2, DEAD box polypeptide 27 (DDX27), antagonism of 
C1 repression (ANT1). It is possible therefore that the knockdown of GTSF1 uncouples 
key components of oocyte maturation such that it down-regulates some molecules that 
are associated with maturation and may induce other transcripts to be up-regulated to 
compensate and thus assist with the progression of oocyte maturation. It is well 
established that during meiotic progression, oocytes are error-prone and that the spindle 
assembly checkpoints act to ensure the successful attachment of kinetochores to 
homologous chromosomes during MI as this has been shown in mouse oocytes 
(Wassmann et al., 2003; McGulnness et al., 2009). In particular it has been shown that 
the Apc/C spindle assembly checkpoint molecule is activated 5 h earlier in oocytes that 
lack Bub1, with depletion of Bub1 responsible for chromosome missegregation at 
meiosis I and loss of cohesion between sister centromeres (Mcgulnness et al., 2009).  
 
The primary bioinformatic analysis provided several targets for real-time PCR analysis 
including MYL9 and MYL12A that are non-muscle regulatory light chains of Myosin II, 
an actin-binding protein and normal levels of non-muscle regulatory light chains are 
vital for the maintenance of the integrity of myosin II and essential for cell structure and 
dynamics (Park et al., 2011). Another gene that appeared to be up-regulated following 
the primary bioinformatic analysis was the CKAP2 gene that was previously found to be 
co-localised with MTOC and microtubules in human cell lines illustrating that it might 
be associated with microtubule networks (Bae et al., 2003). Targets included the 
AURKA gene that transcribes an important mitotic kinase which plays important roles in 
the G2/M transition, centrosome maturation and separation and spindle formation in 
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somatic cells (Hannak et al., 2001). More importantly a recent study has shown that the 
gene regulates MTOC number and spindle length in mouse oocytes as well as gamma-
tubulin recruitment to MTOCs (Solc et al., 2012). Another gene shown to be down-
regulated was CDK2 which transcribes an enzyme that it is part of the CDK complex 
that regulates the G1/S transition, although cells lacking CDK2 have been shown to be 
viable and progress with the cell cycle (Berthet et al., 2003). A further target analysed 
was the cytochrome c oxidase copper chaperone (COX17) that is a terminal component 
of the mictochondrial respiratory chain and catalyses the transfer from reduced 
cytochrome c to oxygen (Amaravadi et al., 1997). The PCBP1 gene was also selected 
for analysis from the down-regulated gene list following GTSF1 knockdown. This gene 
contains 3, K-homologous domains that may be involved in RNA-binding and amongst 
others the protein that it encodes plays a role in the co-activation of poliovirus RNA and 
is also suggested to play a part in the formation of the alpha-globin mRNP complex 
associated with alpha-globin mRNA stability (Tommerup and Leffers, 1996b). Another 
gene analysed was the FKBP4 gene that encodes a protein that can act as a regulator of 
microtubule dynamics by inhibiting TAU protein that promotes microtubule assembly 
(Chambraud et al., 2010). The ZNF706 gene expression was also examined. Zinc 
fingers are small DNA and RNA-binding peptide motifs that are considered to be the 
building blocks for the construction of larger protein domains that bind to specific 
sequences (Klug, 1999). The TECR protein encoded by the TECR gene found in the 
endoplasmic reticulum catalyses the reduction of trans-2,3-enoyl-CoA to saturated acyl-
CoA as part of the elongation of microsomal chain fatty acids (Caliskan et al., 2011). 
Finally the TIMP1 gene transcript was analysed for the 2 treatment groups. The 
glycoprotein encoded by this gene has an inhibitory role against matrix 
metalloproteinases that control the degradation of the extracellular matrix and has also 
been shown to have an anti-apoptotic function acting to increase cell proliferation in 
several cell types in addition to a decreased collagenase activity (Reichenstein et al., 
2004). Real-time PCR analysis showed significant reductions in the transcript levels of 
only 2 genes, MYL9A and TIMP1. These genes are both involved in the cell cycle 
regulation. Specifically, functional annotation of MYL9A showed that this gene was 
involved in signal transduction mechanisms, cytoskeleton, cell division and 
chromosome partitioning in agreement with the gene ontology analysis, while TIMP1 is 
involved in cell cycle progression. Other than the 2 genes with significant reduction, the 
knockdown of GTSF1 showed a trend for reduced levels of AURKA and CDK2, both of 
which have known roles in microtubule formation and oocyte maturation (Solc et al., 
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2012). None-the-less, failure to verify the majority of gene targets from the primary 
bioinformatic analysis led to a different analysis approach. 
 
6.4.4 Secondary bioinformatic analysis 
Gene ontology based on the secondary bioinformatic analysis that used the matched 
ovine sequences to the bovine probe, revealed that knockdown of GTSF1 down-
regulated mostly ribosomal genes and RNPs (RPL26, RPL28, RPS8, RPS25, RPS40, U3 
small nucleolar ribonucleoprotein homolog A (UTP14A), in addition to RNA processing 
functions (DDX35, nuclease-sensitive element binding protein 1 (YBX1), TARDBP, 
TECR1). Ribosomes are important during maturation of the oocyte and are synthesized 
by the transcription of ribosomal RNA as well as the addition of several ribosomal 
proteins to their subunits. During MI of meiosis, the protein synthesis has been shown 
to be 3 times higher than the equivalent at GVBD (Ferreira et al., 2009). A previous 
study has shown that ribosomes produced at the GV stage together with the ribosome 
production for mRNA translation that follows means that more of these organelles are 
stored in the oocytes during the MI stage (Van Blerkom et al., 2000). At the MII stage 
however, the number or ribosomes are reduced which could be because of the high 
usage of these organelles during oocyte maturation (Tomek et al., 2002). Overall, these 
organelles are necessary for protein synthesis during important periods of development 
and the results of this thesis with several ribosomal genes down-regulated, suggests that 
the GTSF1 knockdown possibly affects translation. In addition, the RNPs are very 
important. It is well established that RNPs like P-bodies as well as stress granules, 
regulate mRNA metabolism (Balagopal and Parker, 2009). In particular, P-bodies 
regulate repression of translation and mRNA decay (Sheth and Parker, 2003). In 
addition, down-regulation of genes which are involved in maintaining the 
transcriptional repressive state of genes including the enhancer of zeste homolog 2 
(EZH2) further supports the postulation that GTSF1 is associated with gene 
transcriptional control and the RNAi pathway. 
 
Secondary bioinformatic analysis provided several targets for real-time PCR analysis. 
The TCOF1 gene encodes the treacle protein associated with the production of 
ribosomal RNA that drives the assembly of amino acids into proteins (Hayano et al., 
2003). The treacle molecule might be involved in nucleolar-cytoplasmic transport and 
might also have an important role in early embryonic development and the craniofacial 
complex development (Hayano et al., 2003). Next target was the PARP12 gene (Katoh, 
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2003). Members of the PARP family catalyse post-translational modification of proteins 
by the addition of several ADP riboses to the proteins (Virag, 2005).  The RPS8 gene 
(Davies and Fried, 1993) encodes a ribosomal protein that is a component of the 40S 
subunit and is co-transcribed with several other small nucleolar RNA genes (Poguegeile 
et al., 1991). Another gene on the list was SREK1IP1 gene (Barnard and Patton 2000). 
This encodes a member of the serine/arginine rich splicing proteins that contains RNA 
recognition motif domains and the encoded protein interacts with other serine/arginine 
rich proteins in order to alter the splice site (Zhang et al., 2002). Another gene analysed 
was CACNA1D (Bock et al., 2011). Voltage-dependent calcium channels have been 
shown to control the entry of calcium ions into cells that can be stimulated to create a 
tiny electrical current (excitable cells) have also been shown to be involved in other 
calcium-dependent functions such as muscle contraction, hormone release and gene 
expression as indicated by functional analysis. The TARDBP gene was also analysed 
(Ou et al., 1995). This gene has been shown to be involved in both DNA and RNA-
binding and to have several functions in transcriptional repression, pre-mRNA splicing, 
mRNA stability and transport as well as translational regulation (Strong et al., 2007; 
Kuo et al., 2009). Another target provided from the secondary bioinformatic analysis 
was the DHX35 gene. Members of the DEAH box including DHX35 are considered to 
be RNA helicases involved in several cellular processes including splicing, ribosome 
and spliceosome assembly and also possibly involved in embryogenesis, 
spermatogenesis and cellular division (Matsumoto et al., 2005; Buratti and Baralle, 
2010). The PELO gene that was shown to be up-regulated following secondary 
bioinformatic analysis was also analysed. This gene encodes the protein Pelota homolog 
(Shamsadin et al., 2000). The protein that this gene encodes has a conserved nuclear 
localisation signal and has been proposed to have roles in spermatogenesis, cell cycle 
control and meiotic cell division. In particular, PELO is associated with actin 
microfilaments of mammalian cells and has been shown to increase cell growth, 
cytoskeleton organisation and cell spreading (Burnicka-Turek et al., 2010). Lastly the 
IGFBP7 gene from the up-regulated gene list was analysed (Oh et al., 1996). The 
function of this protein has been established as being required for modulating the 
regulation of the availability of insulin-like growth factors in tissue as well as the 
control of IGF binding to its receptors (Oh et al., 1996). 
 
The results of the real-time PCR analysis verified significant reductions in the transcript 
levels of TCOF1, RPS8, CACNA1D and SREK1IP1. These genes are mostly associated 
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with post-transcriptional modification. In particular, the association of TCOF1 with the 
production of rRNA and its implication in the transport of molecules between the 
nucleus and cytoplasm suggests that this gene supports different functions necessary for 
development, such as protein synthesis which was negatively regulated following the 
GTSF1 knockdown. In addition, the gene associates with upstream binding factor to 
regulate rRNA transcription, however the precise mechanisms of the gene are still 
unknown (Lin and Yeh, 2009). This could be associated with the significantly lower 
transcript levels of a ribosomal gene, RPS8, upon GTSF1 depletion. The negatively 
expressed SREK1IP1 gene following GTSF1 knockdown encodes a protein that 
contains an RNA-recognition motif and is involved in post-transcriptional modification 
further enhancing the hypothesis that GTSF1 has an important role during maturation. 
The CACNA1D gene of which the transcripts were significantly reduced might also be 
important. Calcium channels are not only important for calcium-dependent processes 
like muscle contraction and hormone release but they are also involved in gene 
expression. Even though knockout of Gtsf1 in mice showed that fertility was not 
impaired, it is possible that knockdown of GTSF1 might affect fertility and/or early 
development in the sheep because of the pivotal role that calcium has in fertilisation and 
early development (Whitaker, 2006).  
 
The associated function of the genes affected by GTSF1 knockdown strongly supports 
the hypothesis that GTSF1 directly or indirectly affects RNA-packaging, transcriptional 
modification of RNA and translation in addition to spindle assembly, all of which are 
linked to the demonstration of oocyte developmental competence rather than maturation 
potential per se. The results of this Chapter do match the inferred function of GTSF1 as 
deduced by structural analysis (Krotz et al., 2009). In particular, the conserved domain 
of GTSF1 with 2 CHHC Zn-fingers that may function as an RNA-recognition and 
binding molecule is in agreement with the down-regulated transcripts that were shown 
to affect RNA storage and post-transcriptional modifications such as TCOF1, RPS8, 
SREK1IP1 and CACNA1D. Furthermore, the results of this study correlate with the 
Gtsf1 knockout study, where there was an increase in the Line1 and Iap 
retrotransposons and their promoter region leading to a retrotransposon activation in 
male mice following the knockout, while no effects were observed in female mice 
(Yoshimura et al., 2009). Although the results of this thesis did not show a direct 
relation of GTSF1 with the miRNA silencing mechanism, the association of the 
knockdown with transcripts related with RNPs, suggests that GTSF1 might have similar 
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effects in the female. Ongoing analysis of other target genes originating from the 
secondary bioinformatic analysis might reveal a possible involvement of GTSF1 with 
the RNAi silencing mechanism. 
 
6.4.5 The potential pitfalls of microarrays    
The complex data analysis that are required for the processing of the data from the 
microarray experiments poses significant challenges because of the many experimental 
procedures involved, the need for simultaneous multiple hypothesis testing and the size 
of the gene ontology databases that are used for identification of the differentially 
expressed genes (Uyar et al., 2013). The experimental design therefore has to be based 
on these factors in addition to the reliability, comparability and reproducibility of the 
microarray experiments (Uyar et al., 2013). It has been shown that data from different 
sites and platforms can produce diverse results (Chen et al., 2007). Comparison of the 
reproducibility of 18 microarray results from published articles showed that only 2 were 
reproduced with 6 being partially reproducible (Ioannidis et al., 2009). Therefore the 
correct analysis of the microarrays is of imperative importance for obtaining valid 
experimental results. In this experimental series, the limited number of oocytes 
available for analysis has increased the complexity analysis and has raised questions 
regarding the accuracy of data analysis. The use of heterologous bovine microarrays for 
the analysis of ovine samples added to the complexity. Unfortunately at the time of the 
analysis there were no GeneChip ovine arrays available. These are now commercially 
available (www.affymetrix.com). None-the-less, heterologous arrays have been used 
before to study gene expression profiles in sheep tissues (Graham et al., 2011). In this 
study, the Human GeneChip Affymetrix array was used and more than 20,000 
transcripts were detected in triplicate ovine skeletal muscle and liver samples (Graham 
et al., 2011). 
 
Even though the 2 species have many similar homologies in their genome, there were 
still many inconsistencies that resulted in incorrect hybridisations for some genes on the 
array, with the result that it was not possible to verify all array data. This problem was 
revealed when real-time PCR verification following primary bioinformatic analysis did 
not confirm the findings. The probe design for the microarrays is related to the genomic 
constitution of the species and this restriction limited the detection of unmapped genes 
and alternative splicing patterns (Uyar et al., 2013). The problem was partially resolved 
by a different approach secondary bioinformatic analysis in which the bovine probe 
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sequences were aligned to the sheep genome sequence. A total of 2 bovine probes were 
matched to the sheep GTSF1 sequence. Only matching probes were used to annotate 
genes and provide targets for real-time PCR verification. The data from the real-time 
PCR were in agreement with the secondary bioinformatic analysis and the expression of 
4 genes was shown to be significantly reduced following the knockdown.  
 
The experimental design could have been improved if the GeneChip ovine array now 
available was used. Conducting more arrays using the GeneChip ovine arrays with the 
necessary number of repeat arrays for each of the treatment (3 for each) are necessary in 
future experiments to avoid the inconsistencies presented in this study. In addition, 
microarrays cannot detect the compressed fold change in the expression levels of highly 
expressed genes (Uyar et al., 2013). An alternative approach that would avoid these 
pitfalls would be the use of RNA sequencing that provides a more precise 
characterisation of all RNA species (Mortazavi et al., 2008; Wang et al., 2009). The use 
of this technology has been shown to be quite reproducible with the data between 
Affymetrix arrays and RNA sequencing having 81% similarity in the number of 
differentially expressed genes (Marioni et al., 2008). The involvement of GTSF1 in 
RNA storage and processing during oocyte development can be also examined by 
immunofluorescent studies. 
 
6.4.6 Conclusion   
The creation and validation of individual GTSF1 knockdown oocytes proved invaluable 
in progressing knowledge of the functional role of GTSF1. The validation of some 
selected transcripts with real-time PCR suggests important implications of GTSF1 in 
key biological processes during oocyte maturation. From these observations it can be 
proposed that GTSF1 affects the expression of genes that could be involved in RNA 
storage and processing such as TCOF1, RPS8, SREK1IP1 and CACNA1D as well genes 
that could influence spindle assembly and cellular cytoskeleton and oocyte 
developmental competence, such as MYL9A and TIMP1. However, it appears that the 
molecular effects following knockdown of GTSF1 are quite complex and accordingly, 
may have a profound effect on oocyte quality and subsequent development. Analysis of 
additional GTSF1 knockdown oocytes is required to determine if the trends observed in 
the real-time PCR results have functional significance in relation to oocyte meiosis. 
Further studies are also needed to confirm the role played by GTSF1 in post-
transcriptional modification of RNA in oocytes.  
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Chapter 7: Localisation of GTSF1 protein during ovine 
oogenesis 
 
7.1 INTRODUCTION  
Both male and female gametes have post-transcriptional modifications in place that 
control mRNA stability and translation (Watanabe et al., 2008). Translation initiation 
and repression is mainly controlled by a 3´ UTR regulating element called the 
cytoplasmic polyadenylation element (CPE) as well as its binding partner along with the 
polyadenylation response element (PRE) and its binding partners (Charlesworth et al., 
2004). The chromatoid bodies in mammals that contain RNA and RNA-binding 
proteins have established roles in differentiation of germ cells and early embryo 
development (Kotaja et al., 2006; Kotaja and Sassone-Corsi, 2007). In this context Vasa 
is an evolutionary conserved germ cell specific Dead-box RNA-helicase essential for 
germ cell development and oogenesis which acts by regulating target mRNAs (Saga, 
2008; Siomi and Kuramochi-Miyagawa, 2009). The mouse Vasa homolog (Mvh) is also 
germ cell specific as is its Vasa homolog (Toyooka et al., 2000) as knockout of Mvh has 
been shown to block spermatogenesis at the first meiotic cell division, while PGC 
development was not affected (Tanaka et al., 2000). The Mvh protein has been shown 
to be localised in the chromatoid bodies of round spermatids of adult male mice (Kotaja 
and Sassone-Corsi, 2007). Localisation of Mvh protein in the chromatoid body, 
suggests that Mvh is likely to have important roles in RNA processing in male germ 
cells (Kuramochi-Miyagawa et al., 2010). The Mvh protein along with the mouse Piwi 
family members Mili and Miwi2 are indispensable for piRNA processing with Mili and 
Miwi2 knockouts resulting in elevated retrotransposon expression (Tanaka et al., 2000; 
Kuramochi-Miyagawa et al., 2004; Carmell et al., 2007). The Mvh protein is also 
involved in piRNA processing and gene silencing of retrotransposons (Kuramochi-
Miyagawa et al., 2010).  
 
The cellular localisation of GTSF1 in bovine round spermatids and mature sperm 
suggests that the GTSF1 protein functions during post-meiotic spermatogenesis in 
addition to its already established role during the early primary spermatocyte 
development (Lu et al., 2012). Chromatoid bodies have similarities with the somatic P-
bodies that are highly evolutionary conserved in many organisms and found in somatic 
cells and the oocytes (Kotaja et al., 2006). Dicer and components of miRISC including 
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members of the Argonaute family and several miRNA species are found in the 
chromatoid body which further supports the functional analogy with the P-bodies 
including RNA-storage and processing (Kedersha et al., 2005; Kotaja et al., 2006). The 
microarray results of Chapter 6 suggest that GTSF1 may play a role in post-
transcriptional modification in the oocyte. In order to extend these findings on the 
functional role of GTSF1, further studies are needed to investigate how GTSF1 
functions during post-transcriptional modification of RNA in gametes. 
 
7.1.1 Aims  
The aim of this study was to evaluate the relationship between GTSF1 and the P-body 
in ovine oocytes by immunofluorescent microscopy MVH to locate P-bodies in 
histological preparations across sheep oogenesis. 
 
7.2 MATERIALS AND METHODS 
This study utilised immunofluorescence microscopy to pinpoint GTSF1 expression 
during ovine gametogenesis. For this experimental series, immunofluorescense was 
used on histological preparations of the ovine ovary and on isolated ovine GV and MII 
oocytes. Preparations of the ovine testis were used as positive and negative scoring 
control tissues. Ovine testis and ovary were fixed overnight in 4% (w/v) PFA in 0.1% 
(v/v) DEPC treated PBS and sequentially washed in 70% (v/v) ethanol in 0.1% (v/v) 
DEPC treated H20 and embedded in paraffin as described in Chapter 2, Sections 2.6.2-3. 
The ovary and testis embedded tissue were then cut into 4 μm sections and mounted on 
Superfrost Plus slides (VWR). The slides were de-waxed, rehydrated, and post-fixed in 
4% (w/v) PFA in 0.1% (v/v) DEPC treated PBS for 10 min as described previously 
(Chapter 2, Section 2.6.7). The cellular localisation of MVH was examined by 
immunofluorescence along with GTSF1 to examine whether there was co-localisation 
between these 2 proteins in ovine gametes. Anti-MVH (Ab 13840, Abcam, Cambridge 
UK) and Alexa Flour 488 (A21441, Life Technologies, Paisley, UK) were used to 
detect MVH, while Anti-GTSF1 antibodies (SC-240545, Santa Cruz Biotechnology, 
Wembley, UK) and Alexa Flour 594 (A11058, Life Technologies) were used to detect 
the cellular localisation of GTSF1. The blocking peptide SC-240545p (Santa Cruz 
Biotechnology) was used to neutralise the GTSF1 antibody and was used as negative 
control. For this purpose, a 5 times excess concentration of the blocking peptide (10 
μg/ml) was incubated with GTSF1 antibody (2 μg/ml) for 1 h in a 1.5 ml sterile 
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microcentrifuge tube on a shaking incubator at RT, before this combined solution was 
applied as the primary antibody for the negative control slides. Statistical analysis for 
the co-localisation of GTSF1 and MVH at the different stages of development was 
conducted by chi-square analysis of the numbers at each stage that demonstrated co-
localisation out of the cohort analysed compared with the numbers at the same stage 
where co-localisation of the 2 proteins was found out of the cohort when using the 
blocking peptide (negative controls)    
 
7.2.1 Immunofluorescence of ovarian and testicular tissue 
Three replicate experiments were conducted. In each individual experiment, 3 slides 
containing sections of ovine ovarian tissue and 3 slides containing sections of testicular 
tissue positive control were initially permeabilised in freshly made 0.5% (v/v) Triton X-
100 PBS with 2% (w/v) BSA (lyophilized powder, ≥96%) by adding 200 μl of the 
solution to each slide for 15 min at RT.  The PBS solution was made by dissolving 1 
PBS tablet (Gibco) in 500 ml sterile-distilled H20 followed by 0.2 μm cellulose acetate 
filter sterilization. The slides were then blocked in blocking buffer containing 2% (w/v) 
BSA in PBS with 0.05% (v/v) Tween-20. Specifically, 200 μl of the blocking solution 
was added to each slide and covered with a piece of parafilm to prevent drying out. The 
slides were blocked for 1 h at RT. The ovarian and testicular slides were then divided 
equally into 2 groups (3 ovarian and testicular slides per group), 1 being the 
experimental group and 1 the negative control group. The slides of the experimental 
group were incubated with 2 μg/ml primary antibodies (anti-GTSF1 and anti-MVH) in 
blocking buffer overnight at 4°C in the dark, while the slides of the negative control 
were also incubated in a similar manner with 2 μg/ml of primary antibodies but with 
GTSF1 antibody being incubated in advance with blocking peptide (10 μg/ml) as 
described above. A volume of 200 μl was applied to each slide and the slides were 
covered with a piece of parafilm prior to incubation. All slides were sequentially 
washed 3 times in PBS for 15 min at RT in the dark in a coplin-jar. The secondary 
antibodies were then applied (1:200 dilution) in blocking buffer. A volume of 200 μl 
was applied to each slide and the slides were covered with a piece of parafilm and 
incubated for 1 h at RT. The slides were then inserted in a coplin-jar containing PBS. 
The slides were counterstained with 1 μg/ml DAPI in 2 X SSC (Appendix II) by 
applying 20 μl of the solution on each slide and covering them with a coverslip. The 
slides were wrapped in aluminum foil and kept at 4ºC until visualization (Section 7.2.2). 
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7.2.2 Immunofluorescence of oocytes 
Three replicate experiments were conducted. The denuded GV oocytes were obtained 
from ovine COCs as described previously (Chapter 3, Section 3.2.1), while denuded 
MII oocytes were obtained following IVM of COCs as described previously (Chapter 2, 
Section 2.1.3). A similar approach was used for the immunofluorescent analysis of the 
GV and MII ovine oocytes. In each of the 3 replicate experiments, the isolated GV and 
MII oocytes (approximately 30 for each stage) were placed in separate wells of a 4 well 
dish and fixed in 500 μl of 4% PFA (w/v) in PBS overnight at 4ºC. The oocytes were 
then washed in 500 μl of PBS at RT for 5 min in clean wells and were then pre-treated 
in clean wells of a 4 well dish containing 500 ml of freshly made 0.5% (v/v) Triton X-
100 (Sigma-Aldrich) in PBS with 2% (w/v) BSA (lyophilized powder, ≥96%) in PBS 
for 15 min at RT. Both GV and MII oocytes were then divided into 2 equal groups, 1 
being the experimental group and 1 the negative control group and they were placed in 
separate wells of a clean 4 well dish each containing 500 μl of blocking buffer followed 
by incubation for 1 h at RT. The oocytes were then transferred in a clean 4 well dish and 
1 set of GV and MII oocytes were incubated in a 40 μl drop containing 2 μg/ml of 
primary antibodies (anti-GTSF1 and anti-MVH) in blocking buffer overnight at 4°C in 
the dark, while the other set of GV and MII oocytes were incubated with 2 μg/ml of 
anti-GTSF1 antibody incubated with pre-incubated blocking peptide along with 2 μg/ml 
of anti-MVH antibody. Prior to incubation, the 4 well dishes were wrapped in parafilm 
to avoid evaporation of the solution in each of the wells. The oocytes were then 
transferred into separate wells of clean 4 well dishes and sequentially washed 3 times in 
500 ml of PBS for 15 min at RT in the dark followed by 2 h incubation in clean wells of 
4 well dishes containing a 40 μl drop of secondary antibody (1:200 dilution in blocking 
buffer) at RT. Once again the 4 well dishes were wrapped in parafilm to avoid 
evaporation. Oocytes were then washed in clean wells containing 500 ml of PBS 
(similar to Section 7.2.1). Oocytes from each drop (3-4 oocytes each time) were pipetted 
onto clean Super-frost Plus slides containing a 20 μl drop of 1 μg/ml DAPI in 2 X SSC 
and were covered with a coverslip using vaseline pillars. Slides were wrapped in 
aluminum foil and kept at 4ºC. All slides used for immunofluorescent analysis of 
oocytes and ovarian and testicular sections were visualized with a Zeiss Axioplan2 
microscope fitted with different wave length filters to capture blue, green and red 
fluorescences (420-495 nm; 495-520 nm; 590-650 nm; respectively). 
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7.3 RESULTS 
By using immunofluorescence, signals of GTSF1 and MVH were detected in both the 
male and female germline with the overall results for the immunofluorescent analysis of 
GTSF1 and MVH in the ovary and testis shown in Table 7.1. In the figures that follow, 
representative images of GTSF1 and MVH localisation along with the merged images 
of the 2 proteins are shown at the different stages of development (Figure 7.1, Figure 
7.2). The GTSF1 protein was located in the cytoplasm of primary spermatocytes in the 
male germline (Figure 7.1 B). The protein was also located in spermatogonia and 
secondary spermatocytes (images not shown). In the ovine ovary, immunofluorescence 
analysis showed a strong and even cytoplasmic staining pattern of GTSF1 in the oocytes  
at the primordial (Figure 7.1 C), primary (Figure 7.1 C), and transitional stages of 
follicle development (image not shown), in agreement with the detection of mRNA 
transcripts at these stages of development (Chapter 3). The negative control lacked 
GTSF1 expression as shown in the control image of testicular tissue (Figure 7.1 A), 
further confirming the findings. Simultaneous immunofluorescent staining for GTSF1 
and MVH showed that MVH was expressed in abundance in the cytoplasm of the 
oocytes and also showed that granular aggregates of GTSF1 were associated with 
chromatoid bodies in the sperm and P-bodies in the oocyte (Figure 7.1 B-D).  
 
Table 7.1: Immunofluorescent analysis of GTSF1 and MVH protein co-localisation 
Stage of follicle and oocyte development 
Ovary 
Primordial 
follicle 
Primary 
follicle 
Transitional 
follicle 
Secondary 
follicle 
GV 
oocyte 
MII 
oocyte 
Cellular 
localisation 
Ooplasm Ooplasm Ooplasm Ooplasm Ooplasm Ooplasm 
No. of stage  
analysed 
30 30 26 12 33 28 
GTSF1 and 
MVH co-
localisation 
29/30  
follicles 
(96.7%) 
28/30 
follicles 
(93.3%) 
22/26 
follicles 
(73.3%) 
0/12 
follicles 
(0.0%) 
31/33 
oocytes 
(93.9%) 
27/28 
oocytes 
(96.4%) 
Statistical 
significance 
P<0.005 P<0.005 P<0.005 NS P<0.005 P<0.005 
Stage of spermatogenesis 
Testis Spermatogonia Primary spermatocytes Secondary spermatocytes 
Cellular 
localisation 
Cytoplasm Cytoplasm Cytoplasm 
No. Of stage 
analysed  
23 30 29 
GTSF1 and 
MVH co-
localisation 
23/23 
spermatogonia 
 (100%) 
28/30 
spermatocytes 
 (93.3%) 
27/29 
spermatocytes  
(93.1%) 
Statistical 
significance 
P<0.005 P<0.005 P<0.005 
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Figure 7.1: Characterisation of GTSF1 and MVH localisation by immunofluorescence during 
ovine follicular development and in the ovine testis. A: Negative control in primary 
spermatocyte in which anti-GTSF1 was neutralised in 5 X excess of its specific blocking 
peptide before immunofluorescence. B-D: GTSF1 (Red) and MVH (Green) localisation in the 
cytoplasm of: B: Ovine primary spermatocytes (positive control). C: Primordial follicle, D: 
Primary follicle. The first of the 3 columns represents GTSF1 staining, the second represents 
MVH staining and the third represents the merged images of GTSF1 and MVH counterstained 
with DAPI. Arrows in magnified images for each stage indicate co-localisation of GTSF1 and 
MVH granules (Yellow). Scale bar: 10μm. 
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Figure 7.2: Characterisation of GTSF1 and MVH localisation by immunofluorescence in GV 
and MII oocytes. A: GTSF1 (Red) located in GV oocytes associated with P-bodies (anti-MVH, 
Green) as indicated by arrows in the magnified merged image (Yellow). B: GTSF1 (Red) 
located in the polar body of an MII oocyte associated with P-body (anti-MVH, Green) as 
indicated by arrows in the magnified merged image (Yellow). C-D: Negative control of C: GV 
and D: MII oocytes in which anti-GTSF1 was neutralised with 5 X excess of its specific 
blocking peptide before immunofluorescence. Co-localisations of GTSF1 and MVH are 
highlighted by arrows in the merged images of A and B. The first of the 3 columns represents 
GTSF1 staining, the second represents MVH staining and the third represents the merged 
images of GTSF1 and MVH counterstained with DAPI. Scale bar: 1μm. (PB: Polar body). 
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Immunofluorescent staining for GTSF1 in the isolated GV and MII oocytes also showed 
localisation of the GTSF1 protein in the ooplasm of GV and MII oocytes (Figure 7.2 A-
B). In GV oocytes, GTSF1 immunofluorescence showed a number of small granules 
distributed throughout the oocyte cytoplasm. In the same oocytes, numerous MVH 
granules were found. Further analysis showed that a few of the GTSF1 granules were 
co-localised with the MVH located P-bodies in most of the oocytes analysed (Figure 7.2 
A merged image). In MII oocytes, GTSF1 staining was concentrated mostly within and 
around the polar body as shown in the figure below (Figure 7.2 B). In MII oocytes, the 
MVH protein was still observed to be in granular form, however there were much fewer 
granules present compared to the GV stage oocyte. The few MVH granules were 
dispersed throughout the cytoplasm including the polar body where the GTSF1 protein 
was located (Figure 7.2 B). The above observations were confirmed by the negative 
control staining in which GTSF1 protein was completely blocked in both the GV and 
MII oocyte, while the MVH protein was not affected, with numerous granules located in 
the GV oocytes and fewer granules in the MII oocyte (Figure 7.2 C-D).  
 
7.4 DISCUSSION  
The results show that GTSF1 is expressed during ovine gametogenesis and confirms the 
previous findings for the characterisation of GTSF1 in this study (Chapter 3) in the 
sheep and by others in mice (Yoshimura et al., 2007; Krotz et al., 2009). The results 
also show that GTSF1 is localised to the P-body in the GV and MII ovine oocyte which 
suggests that GTSF1 may be involved in small RNA post-transcriptional regulation as 
has been reported for the P-body in other species (Kedersha et al., 2005; Kotaja et al., 
2006). These findings agree with a recent study conducted in the bovine, in which the 
GTSF1 protein was shown to be localised to the chromatoid body in male and the P-
body in female gametogenesis (Lu et al., 2012). Localisation of GTSF1 to the P-body in 
GV oocytes suggests that there are similarities between meiotic progression in the male 
and female (Aravin et al., 2007b; Carmell et al., 2007). In previous studies conducted in 
mice, expression of GTSF1 in gametogenesis was only detected in the cytoplasm of 
sperm and not in the oocytes (Yoshimura et al., 2007). Expression of the GTSF1 protein 
in ovine oocytes in this study but not in the mouse study could be attributed to species 
differences between monovular species such is the sheep in contrast to the polyovular 
mice, or to different sensitivities of the assays applied.  
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Localisation of GTSF1 within the P-body in GV oocytes shows that GTSF1 may be 
involved in post-transcriptional gene expression during meiotic maturation from the GV 
to the MII stage. The gene could also be involved in retrotransposon repression similar 
to the findings of the mouse study following the Gtsf1 knockout of male mice 
(Yoshimura et al., 2009). Moreover, a potential 3´ UTR PRE domain has been 
identified in the sequence of GTSF1 of several species including bovine, human and 
mouse, with this domain being vital for the translational activation of several genes 
following progesterone stimulation, including D7, proto-oncogene serine/threonine-
protein kinase MOS, FGFR1, AURKA, B4 and G10 (Lu et al., 2012). Comparison of the 
ovine GTSF1 sequence as acquired in this study also showed sequence alignment for the 
potential 3’ UTR PRE domain as in the other species. This suggests that GTSF1 may be 
important during the meiotic progression from the GV to the MII stage. The AURKA 
gene has been shown to be involved in resumption of meiosis, spindle formation and 
oocyte progression as an MTOC (Saskova et al., 2008). Furthermore the microarray 
analysis following GTSF1 knockdown showed a trend in the reduction of the transcripts 
of this gene in comparison with the controls following the knockdown (Chapter 6). 
Moreover, MOS is also involved in microtubule organisation and polar formation during 
oocyte maturation (Choi et al., 1996). Identification of this putative PRE domain within 
the 3´ UTR signifies the finding of this study in that the GTSF1 appears to be translated 
during the maturation stages and functions during this stage by affecting RNA 
processing and translation. The expression of GTSF1 protein in MII oocytes in this 
study was restricted to the first polar body and the area surrounding it, while the few 
MVH granules were localised in both the first polar body and the ooplasm of the 
oocyte. The expression of these MVH granules suggests that P-bodies might be present 
in MII oocytes. This is in agreement with the findings in the bovine species, where 
MVH staining was also observed in the MII oocyte (Lu et al., 2012). Previous studies in 
mice have shown that P-bodies are not present in MII oocytes but rather they disappear 
during in vitro meiotic maturation and that they are completely absent in MII-arrested 
secondary oocytes (Swetloff et al., 2009). The differences observed in the murine 
species could be due to species differences or to the different antibodies used. 
Furthermore, localisation of GTSF1 in the polar body and not in the cytoplasm of the 
MII oocyte suggests that the protein is not active in the oocyte following polar body 
extrusion. A possible explanation for the gathering of the GTSF1 protein within the 
polar body at the MII stage as observed in this study could be that GTSF1 carries its 
binding RNAs to the first polar body for them to be excluded from further function 
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during the fertilisation and early development of the zygote. The presence of the GTSF1 
transcript during the early embryo stages until the blastocyst stage as observed here in 
Chapter 3 as well as in human and bovine tissue (Lu et al., 2012) suggests that GTSF1 
may function during early development through association with other RNAs. In order 
to confirm this initial observation, further experimentation is required. Generation of 
ovine embryos and culture to the blastocyst stage following GTSF1 knockdown in GV 
oocytes would confirm the impact of GTSF1 knockdown on oocyte developmental 
competence. 
 
7.4.1 Conclusion   
In summary, the co-localisation of GTSF1 within the P-body during development of the 
ovine oocyte from the GV to the MII stage suggests that GTSF1 may be involved in 
RNA binding and be associated with the RNAi pathway. 
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Chapter 8: General Discussion 
 
The results presented in this thesis have extended our understanding of the biology of 
GTSF1 during sheep oocyte maturation. The data presented has mapped the expression 
of GTSF1 transcript and its translated protein across gametogenesis. Furthermore, 
experiments using siRNA have provided preliminary insights into the roles played by 
GTSF1 during the GV to MII transition in oocytes in vitro. Overall, the data suggest that 
GTSF1 is involved in post-transcriptional control of RNA processing, translational 
regulation and RNA storage which may impact on oocyte developmental competence.  
 
8.1 Characterisation of ovine GTSF1 
Identification of markers of gamete developmental competence (quality) is of 
importance for providing improved treatment options for patients undergoing assisted 
conception. Gene expression profiling has revealed a number of novel genes expressed 
in germ cells with GTSF1 being 1 of these putative markers of oocyte development. 
This gene is highly conserved across species and has previously been shown to have a 
sexual dimorphism in its function in mice, where male mutants for Gtsf1 had an infertile 
phenotype, whereas female mutants demonstrate normal ovarian function. The cellular 
distribution of function of GTSF1 in the regulation of gametogenesis of a monovular 
species such as the sheep which is a physiological relevant model to the human has not 
been investigated. In order to study the role of this novel gene in the regulation of 
follicle development and oocyte maturation in sheep, it was necessary to sequence the 
ovine gene and to characterise the expression pattern of GTSF1 across all stages of 
ovine follicle, oocyte and embryo development to the blastocyst stage by interrogating 
staged cDNA libraries. To further interpret the expression of this gene in 
gametogenesis, the cellular distribution of GTSF1 mRNA was characterised by FISH 
and the presence of protein was confirmed by Western blotting. 
 
The results indicated the gamete specific expression of GTSF1 throughout ovine 
gametogenesis. GTSF1 was expressed in the male germline and in the female primordial 
to the secondary stage follicles, GV and MII oocytes as well as the early embryo. 
Conversely, GTSF1 was not expressed in oocytes from secondary and antral stage 
follicles and was absent from all somatic cells of the ovary. Furthermore, GTSF1 was 
not expressed in non-ovarian somatic tissue, further confirming its specificity as a 
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gamete specific gene. The data from Chapter 3 also illustrated that GTSF1 was localised 
in the cytoplasm of the oocyte of early staged follicles and not in the oocytes from pre-
antral and antral follicles, while in the testis, the expression of the gene was detected in 
spermatogonia, spermatocytes and spermatids.  
 
Comparison of the ovine GTSF1 sequence showed high homology with several other 
species. The alignment of the predicted ovine GTSF1 protein sequence confirmed the 
high conservation of this gene in evolution. Moreover the existence of 2 tandem copies 
of CHHC Zn-fingers in the conserved sequence of GTSF1 capable of binding RNA, 
suggests that GTSF1 might be important for functions regarding the developmental 
processes of the gonad (Andreeva and Tidow, 2008). Other studies were consistent with 
our observations and also showed that GTSF1 transcripts were expressed in the oocytes 
and preimplantation embryos in mice (Yoshimura et al., 2009), humans (JD Huntriss 
and HM Picton, unpublished data) and bovine (Lu et al., 2012) with highest expression 
being observed in secondary oocytes at the GV stage of development. The results of the 
characterisation of ovine GTSF1 during gametogenesis reported in Chapter 3 provided 
the basis for the investigation of the function of the gene during the IVM of oocytes 
from this species. 
 
8.2 Validation of targeted gene knockdown during IVM of ovine oocytes by 
microinjection of siRNA species 
It was hoped that targeted gene knockdown during IVM of ovine oocytes by 
microinjection of siRNA species would support investigation of the function of novel 
genes such as GTSF1. In order to achieve this, the IVM system ought to be able to 
stimulate and support the resumption of meiosis and the cytoplasmic maturation in fully 
grown meiotically competent prophase I oocytes  (Picton, 2002). The autocrine and 
paracrine signalling between the oocyte and the somatic cells of the follicle have been 
shown to be necessary in order to lead to the induction of the preovulatory surge that 
promotes cytoplasmic and nuclear maturation in addition to a progesterone environment 
established by granulosa cell steroid synthesis and to hyaluronic acid synthesis (Fulka et 
al., 1998). Creation therefore of a targeted knockdown in sheep oocytes in vitro should 
not compromise oocyte survival or oocyte meiotic progression. A 2 day culture system 
involving microinjection of oocytes with siRNA and culture with a specific PDE 
meiosis inhibitor (cilostamide), followed by removal of the inhibitor and co-culture with 
oocytectomised cumulus shells in order to re-establish the paracrine interaction 
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necessary for oocyte maturation was therefore utilised as described previously 
(Cotterill, 2008). The known oocyte-derived gene Gdf9 (Dong et al., 1996) was used to 
validate the microinjection system and to establish the validity of microinjection of 
siRNAs as a means to knockdown genes in ovine oocytes and to study their effect on 
oocyte maturation. The previous study of Cotterill, (2008) used dsRNA as the vehicle to 
effect gene knockdown in sheep oocytes. In this thesis, introduction of siRNA species 
was validated and reported in Chapter 4. As stated in the introductory Section 1.5.1 of 
Chapter 1, introduction or expression of dsRNA triggers the RNAi pathway. The Dicer 
cleaves the dsRNA into 21-23 bp siRNAs that then unwind and assemble into RISC 
with the antisense siRNA strand guiding RISC to complementary RNA molecules to 
cleave the mRNA resulting to gene silencing (Hawkins et al., 2011). However, since 
most mammalian cells build-up an antiviral response following the introduction of 
dsRNA that are longer than 30 bp, the introduction of 21-23 bp siRNAs to induce RNAi 
without eliciting the antiviral response is considered a better strategy for gene 
knockdown (Dewitte-Orr et al., 2009). 
 
Transcript levels for GDF9 were significantly reduced (P<0.05) following GDF9 
siRNA injection in GV oocytes followed by IVM co-culture of gene knockdown 
oocytes with compact oocytectomised cumulus cells (0.7±0.2 arb. units, n=6) in 
comparison to buffer control injected oocytes (6.7±0.2 arb. units, n=6). Off-target 
effects were assessed by analysing levels of BMP15 following the GDF9 knockdown 
and levels of BMP15 following GDF9 knockdown (1.4±0.3 arb. units, n=6) were not 
significantly different (P>0.05) to the control values (1.7±0.3 arb. units, n=6), 
suggesting that there were low/no off target affects incurred by the knockdown of this 
oocyte-specific gene. The function of GDF9 was then evaluated following gene 
knockdown, by morphological evaluations of oocytes and cumulus cells and by meiotic 
progression. The latter was significantly reduced (P<0.05) when GDF9 siRNA was 
injected into the oocytes (13.1% of viable oocytes injected with GDF9 siRNA 
progressed to MII) in comparison to the buffer-injected control oocytes (26.0% of 
viable oocytes injected with control buffer progressed to MII). Meiotic maturation of 
sheep oocytes is known to be induced by paracrine factors released by gonadotrophin 
stimulated oocyte cumulus cell complexes (Buccione et al., 1990b). The meiotic 
progression results combined with molecular analysis presented in this thesis confirmed 
that GDF9 plays a regulatory role during cumulus expansion. The culture system was 
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proven to be suitable for studying the role of oocyte genes in meiosis and cumulus 
maturation. 
 
The function of oocyte-derived GDF9 on cumulus cells was assessed by morphological 
evaluations of cumulus expansion and mucification and also by direct assessment of the 
effect of oocyte gene knockdowns on the function (expression) of specific cumulus cell 
genes that have been shown in mouse studies to be controlled by oocyte-derived factors. 
These genes were HAS2 (Elvin et al., 1999), GREMLIN1 (Pangas et al., 2004), AMH 
(Kitahara et al., 2012) and LDH1 (Moore et al., 2007), as well as members of the EGF 
family, AREG (Cotterill et al., 2012), EREG (Zimin et al., 2009) and BTC (Cotterill et 
al., 2012); all induced by LH in mural granulosa to bind to the EGFR and promote COC 
maturation (Salmon et al., 2004; Hussein et al., 2005; Hsieh et al., 2007; Sugiura et al., 
2009). Cumulus expansion was significantly reduced (P<0.05) in cumulus shells 
following gene knockdown in comparison with the controls (12.6% and 32.9% 
respectively for fully expanded cumulus shells). In addition, cumulus cell mRNA 
expression levels of HAS2 were significantly reduced (P<0.05) in the cumulus cells 
following GDF9 knockdown (1.3±0.7 arb. units, n=3) in comparison with the controls 
(3.7±0.4 arb. units, n=3), while there was a trend for reduction of GREMLIN1 and AMH 
mRNA levels following the knockdown (0.3±0.2 arb. units, n=5; 0.2±0.1 arb. units, 
n=5) respectively in comparison with controls (0.7±0.3 arb. units, n=5; 0.6±0.3 arb. 
units, n=5) that were not significant (P>0.05). The transcript levels of the regulin genes 
were then evaluated. Transcript levels of these genes are induced by LH in mural 
granulosa cells and bind to the EGFR and have been shown to induce COC maturation 
(Park et al., 2004; Hsieh et al., 2007). These ligands are necessary for IVM as shown by 
their ability to induce oocyte maturation in COC cultures but not in cultures of denuded 
oocytes (Park et al., 2004). In addition, mutant mice for Egfr and Areg as well as double 
mutant animals are unable to promote COC maturation, further demonstrating that the 
EGFR network is vital in COC maturation in vivo (Hsieh et al., 2007). Furthermore, 
removal of oocytes from COCs resulted in the reduction of Egfr in cumulus cells with 
the levels restored after treatment with recombinant Gdf9 or mixture of recombinant 
Gdf9 with Bmp15 (Su et al., 2010). Recent work by Cotterill et al., (2012) has 
demonstrated the presence of AREG, EREG and BTC in ovine mural granulosa cells and 
cumulus cells. In particular, AREG appeared to be most important for LH signalling 
events in sheep COCs but it was absent from oocytes (Cotterill et al., 2012). In this 
thesis, transcript levels of AREG, EREG and BTC were similar between cumulus shells 
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co-cultured with GDF9 siRNA-injected oocytes (0.5±0.4 arb. units, n=3; 0.7±0.3 arb. 
units, n=3; 0.2±0.3 arb. units, n=3) respectively, compared to cumulus shells co-
cultured with buffer-injected control oocytes (0.7±0.6 arb. units, n=3; 0.7±0.3 arb. units, 
n=3; 0.3±0.4 arb. units, n=3) and were not statistically different (P>0.05). An 
explanation for these observations is that induction of AREG expression occurs very 
rapidly and peaks after LH exposure (Cotterill et al., 2012). Therefore, the levels of 
AREG could have been dropped back down again during the 24 h exposure window of 
IVM in this study.  
 
The results in this thesis confirm and extend the results obtained from the knockdown of 
GDF9 in ovine oocytes by the means of dsRNA (Cotterill, 2008). Specifically, 
knockdown of GDF9 by injecting dsRNA into ovine oocytes using the culture system 
detailed here significantly altered the degree of unexpanded and fully expanded 
cumulus shells when compared to the buffer-injected control group and oocyte GDF9 
knockdown was also associated with significantly reduced levels of HAS2 and 
GREMLIN1 (Cotterill, 2008).  
 
The Gdf9 protein has been shown to bind to the Tgfβ type I receptor ALK5 which then 
recruits the secondary receptor BmprII (Moore et al., 2003; Mazerbourg et al., 2004). 
Binding of Gdf9 to the receptors present on the cumulus cells will recruit Smads2/3 and 
the co-Smad 4 (Mazerbourg et al., 2004). Future follow up studies after GDF9 
knockdown should involve the assessment of receptor proteins and intracellular SMADs 
that are involved downstream of GDF9 signalling as well as to study the association of 
GDF9 with the RNAi pathway. 
 
Overall, these morphological evaluations of oocyte meiotic maturation and cumulus cell 
expansion along with transcript analysis of candidate genes in oocytes and cumulus 
cells have proven that the siRNA microinjection approach and IVM culture system 
detailed can be used for the creation of targeted gene specific knockdown of novel 
genes such as GTSF1 during IVM of ovine oocytes. The system reported in Chapter 4 
therefore formed the basis for the study of GTSF1 function in ovine oocytes in Chapters 
5 and 6. 
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8.3 Studies of the targeted knockdown of oocyte GTSF1 using siRNA 
Investigation of the molecular basis of oocyte-secreted factors and their function in 
signalling pathways are valuable means of advancing understanding of the mechanisms 
that control oocyte growth and maturation in different species. Recent studies have 
highlighted potential association of oocyte secreted factors with miRNAs.  Small RNAs 
have important regulatory roles in many different cellular processes including cell 
proliferation, differentiation and apoptosis and may play important roles during 
development as shown by their tissue specific expression pattern and evolutionary 
conservation (Lewis et al., 2003). The Dicer enzyme required to process miRNA 
precursors or dsRNA into RNAi molecules for miRNA and siRNA pathways 
respectively has resulted in significant differences in the expression of follicle 
development-related genes including Gdf9, Bmp15, Amh, Inhba and Cyp17α1, 
following its knockdown (Lei et al., 2010). Similarly, Ago2 deletion was associated 
with abnormal spindles and improper chromosome clustering in mouse growing 
follicles (Kaneda et al., 2009). These studies illustrate that the genes involved in RNAi 
can affect oocyte development through global regulation of miRNA stability that affects 
gene expression in developing oocytes. 
 
Cellular localisation of GTSF1 in bovine round spermatids and mature sperm indicates 
that the GTSF1 protein functions during post-meiotic spermatogenesis in addition to its 
already established role during the early primary spermatocyte development (Lu et al., 
2012). The chromatoid bodies in the male germline and their equivalent P-bodies in 
oocyte are cytoplasmic aggregates that contain RNA and RNA-binding proteins. They 
are highly evolutionary conserved and have established roles in differentiation of germ 
cells and early embryo development (Kotaja et al., 2006; Kotaja and Sassone-Corsi, 
2007). Dicer and components of miRISC like the Argonaute family and several miRNA 
species are found in the chromatoid body and P-body and have functional roles in RNA 
storage and processing. The specific pattern of expression of GTSF1 in the germline 
along with the gene’s conserved domain with 2 tandem copies of CHHC Zn-finger that 
may be responsible for RNA-binding both suggest that GTSF1 might be associated with 
the above processes. In addition, knockout of Gtsf1 in male mice has been shown to 
increase transcription of the retrotransposons Line1 and Iap as well as demethylation of 
their promoter region leading to their activation (Yoshimura et al., 2009). The 
expression of these retrotransposons in the male gonad is regulated by a transcriptional 
silencing mechanism that requires Piwi family members Mili and Miwi2 and this 
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mechanism itself is responsible for regulating the expression of retrotransposons in the 
germline so that they are not overexpressed and become deleterious for the offsprings 
(Aravin et al., 2007b). In general, piRNA have been shown to be necessary for mammal 
spermatogenesis and maintenance of germline (Khurana and Theurkauf, 2010). Except 
from the association in gametogenesis; Piwi also associates with Dicer and therefore 
might act through the miRNA mechanism (Bernstein et al., 2001; Yin and Lin, 2007). 
Even though Gtsf1 knockout female mice have normal ovarian function, the similar 
expression patterns in male and female germ cells may imply that GTSF1 functions in 
the maintenance of the oogonia population during ovarian development and oocyte 
meiotic progression during oogenesis of monovular species such as the sheep. 
 
To examine the function of GTSF1 during IVM of fully grown, secondary ovine 
oocytes, the ovine sequence of the gene acquired in Chapter 3 was used to design 
siRNA specific primers for GTSF1. Four siRNA species were tested and oocyte-specific 
GTSF1 knockdowns were created using the microinjection and IVM system detailed in 
Chapter 4. The effects of GTSF1 knockdown were examined on oocyte meiotic 
progression and cumulus mucification and expansion and candidate oocyte and cumulus 
genes and structural analysis of oocyte spindles by α-Tubulin immunostaining.  
 
The data generated showed that a significant reduction (P<0.05) in GTSF1 expression 
was induced following GTSF1 siRNA injection (10.7±3.2 arb. units, n=4) in 
comparison with buffer injected controls (111.2±58.6 arb. units, n=4) without 
compromising oocyte survival and oocyte meiotic progression. Analysis of the 2 other 
oocyte-specific factors GDF9 and BMP15 expression showed that both GDF9 was 
reduced following GTSF1 knockdown (0.2±0.1 arb. units, n=4) and BMP15 mRNA 
levels were reduced to (617.6±365.0 arb. units, n=4) in comparison with controls 
(0.38±0.1 arb. units, n=4; 1189.8±433.6 arb. units, n=4) respectively but these 
reductions were not significant (P>0.05). At the time the analysis took place, there was 
limited knowledge about GTSF1. More suitable candidates to confirm no off-target 
effects would include genes belonging to the same family as GTSF1 (UPF0224), for 
examples the U11/U12 small nuclear ribonucleoprotein 48 kDa protein identified in H. 
sapiens and M. musculus (Ota et al., 2004). 
 
Knockdown of GTSF1 did not significantly affect (P>0.05) oocyte meiotic progression 
and cumulus expansion. The knockdown experiments of Chapter 6 resulted in higher 
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survival and maturation rates in comparison with experiments in Chapter 5, but no 
significant differences (P>0.05) were observed between GTSF1 injected oocytes and the 
control oocytes in either of the 2 experimental series. In particular, maturation rates of 
viable oocytes following the knockdown (33.3%) in Chapter 5 were not significantly 
different (P>0.05) to viable buffer-injected oocytes (19.6%) or viable N.C. siRNA-
injected control oocytes (26.7%), while maturation rates of viable oocytes following the 
knockdown (54.5%) in Experiment 2 were no significantly different (P>0.05) to viable 
N.C. siRNA-injected control oocytes (47.1%). Similarly, cumulus shells co-cultured 
with injected oocytes for the different treatments were able to initiate expansion in both 
studies, but there were no significant differences between GTSF1 siRNA-injected and 
control oocytes for the 2 experiments (P<0.05).  
 
Preliminary studies of GTSF1 in relation to meiotic spindle formation were undertaken. 
Although the numbers of were very low and extreme care must be taken in 
interpretation, the preliminary indications were that spindle formation might be affected 
by gene knockdown. Follow-up experimentation is needed to confirm these pilot results. 
Alternatively, interrogation of genes associated with spindle formation by real-time 
PCR could be used to confirm these effects. 
 
The function of GTSF1 was further investigated by gene expression analysis of 
potential target genes associated with the knockdown, based on its estimated function. 
The oocyte targets selected included NOBOX which is situated upstream of GTSF1 
(Krotz et al., 2009), CDC20 (Reis et al., 2007), TNRC6A (Nishi et al., 2013), LSM14A 
(Li et al., 2012) and INCENP (Earnshaw and Cooke, 1991), while the list of candidate 
genes examined in the cumulus cells was the same as used for the validation 
experiments of Chapter 4. The oocyte expressed genes were selected because of their 
involvement with meiotic maturation (CDC20, INCENP), the RNAi pathway 
(TNRC6A), RNA processing and spindle formation (LSM14A). Following the targeted 
knockdown of GTSF1, the selected gene transcripts of both the oocyte and the cumulus 
cells were found not to be significantly different between knockdown oocytes and 
controls (P>0.05). The lack of significant effects in any of the genes analysed could be 
attributed to the low number of MII oocytes available following the knockdown and the 
cultures. Although GTSF1 knockdown did not appear to affect the capacity of GV 
oocytes to complete meiotic progression over 24 h of IVM, it could still have functional 
importance for oocyte developmental competence. The limited number of oocytes and 
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the variability of the data meant that alternative ways to study the function of the gene 
should be considered. Additional GTSF1 knockdown oocytes were therefore generated 
in Chapter 6 to facilitate more comprehensive microarray screening of the impact of 
GTSF1 knockdown on maturation. 
 
8.4 Transcriptome analysis of the impact of GTSF1 knockdown in GV oocytes on 
MII oocytes derived by IVM 
In an attempt to identify the genes and pathways downstream of GTSF1 during oocyte 
maturation, the Affymetrix GeneChip bovine arrays were used to compare gene 
expression following GTSF1 knockdown in MII oocytes in comparison with N.C. 
siRNA-injected oocyte. The IVM microinjected oocytes with transcript levels for 
GTSF1 reduced by over 50% which were generated in Chapter 6, were divided in 3 
groups based on the reduction of GTSF1 transcript levels (0.5±0.1 arb. units, n=5; 
0.9±0.1 arb. units, n=5; 1.1±0.1, n=4) respectively, following GTSF1 siRNA injection 
in comparison with N.C. siRNA-injected control oocytes (2.9±0.4 arb. units, n=5; 
2.5±0.2 arb. units n=5; 2.8±0.8 arb. units, n=4) and were sent for hybridisation onto the 
bovine arrays along with their respective controls. Primary bioinformatic analysis and 
normalisation, identified a total of 231 differentially expressed genes between the 
knockdowns and the controls (51 down-regulated and 180 up-regulated). Gene ontology 
analysis of the genes from the high-level knockdown group, revealed that knockdown of 
GTSF1 affected biological processes such as oocyte development, actin cytoskeleton 
organisation and spindle assembly. In addition, the knockdown had a negative effect on 
cellular components associated with microtubule cytoskeleton as well as mitochondrial 
components and membrane transporters, while molecular functions such as ATP 
dependent helicase activity, calcium ion and cell adhesion binding, cytochrome c 
oxidase activity and ion trans-membrane transporter activity were also affected. 
Candidate genes including AURKA, CDK2, COX17, PCBP1, FKBP4, ZNF706, TECR, 
TIMP1 appeared to be down-regulated following GTSF1 knockdown, whereas MYL9, 
MYL12A and CKAP2 appeared to be up-regulated following GTSF1 knockdown. The 
impact of GTSF1 knockdown on the gene transcripts obtained from the primary 
bioinformatic analysis was tested by real-time PCR of the original individual samples 
that were used for microarray experiments. These analyses confirmed a significant 
reduction (P<0.05) of only 2 genes following GTSF1 knockdown. In particular, 
transcript levels of TIMP1 were significantly reduced (P<0.05) following GTSF1 
knockdown (0.5±0.1 arb. units, n=4) in comparison with the controls (5.0±1.5 arb. 
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units, n=4) in addition to MYL9 transcript levels that were significantly reduced 
(P<0.05) in the GTSF1 knockdown oocytes (0.2±0.1 arb. units, n=4) in comparison with 
the controls (0.5±0.1 arb. units, n=4). Transcript analysis of AURKA, FKBP4 and CDK2 
were reduced following GTSF1 knockdown (0.3±0.1 arb. units, n=4; 0.4±0.1 arb. units, 
n=4; 0.3±0.1 arb. units, n=4) respectively in comparison with controls (1.1±0.4 arb. 
units, n=4; 5.2±2.9 arb. units, n=4; 2.9±1.3 arb. units, n=4), but these reduction were not 
significant (P>0.05). 
 
The variability of the data from the primary bioinformatic analysis and the failure to 
verify the majority of the targets by real-time PCR meant that there could have been a 
number of incorrect hybridisations between the bovine arrays and the ovine samples. A 
secondary bioinformatic analysis using a completely different approach than the 
primary bioinformatic analysis was thereafter performed to align the bovine probe 
sequences to the sheep genome sequences in order to provide more robust data for 
analysis. Gene ontology analysis following secondary bioinformatic analysis showed 
that GTSF1 knockdown did affect a few transcripts associated with microtubule 
cytoskeleton in agreement with the primary bioinformatic analysis, however most of the 
down-regulated transcripts were associated with translation, ribosomal function and 
RNA-binding, all in-tune with the inferred function of GTSF1 based on the background 
information and the previous results of this thesis. Several candidate genes were 
selected from the secondary bioinformatic analysis to be confirmed by real-time PCR, 
including the down-regulated genes, TCOF1, PARP12, RPS8, SREK1IP1, CACNA1D, 
TARDBP, DHX35 as well as the up-regulated genes PELO and IGFBP7. The impact of 
GTSF1 knockdown on the candidate gene transcripts obtained from the secondary 
bioinformatic analysis was therefore tested by real-time PCR conducted on the original 
individual samples used for microarray experiments. The levels of TCOF1 were 
significantly reduced (P<05) following GTSF1 knockdown (2.0±1.0 arb. units, n=4) in 
comparison with controls (7.8±1.7 arb. units, n=4), while transcript levels of RPS8 and 
CACNA1D were significantly reduced (P<0.01) following the knockdown (2.7±0.9 arb. 
units, n=4; 5.1±1.4 arb. units, n=4) respectively, in comparison with controls (12.9±2.2 
arb. units, n=4; 19.3±1.5 arb. units, n=4). The levels of SREK1IP1 had the most 
significant reduction (P<0.005) in their transcript levels following the knockdown 
(3.0±0.7 arb. units, n=4) in comparison with controls (16.4±0.7 arb. units, n=4). 
Transcript levels of the other 3 down-regulated genes (PARP12, TARDBP, DHX35) as 
determined by the secondary bioinformatic analysis had decreased levels of expression 
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following the knockdown that were not significantly different to the controls (P>0.05), 
while the 2 up-regulated genes (PELO, IGFBP7) as determined by the secondary 
bioinformatic analysis showed increased levels of expression following the knockdown 
that were not significantly different to the controls (P>0.05). Even though, not all the 
targets originating from the secondary bioinformatic analysis were shown to have 
significantly altered transcript levels, confirmation of the reduced or increased transcript 
levels in down-regulated and up-regulated transcripts following the knockdown 
respectively, provided confidence that the alignment of the bovine probes to the ovine 
genome improved the validity of the microarray data. Unfortunately the limited number 
of oocytes in this study did not allow statistical confirmation of these genes. Generation 
of more knockdown samples in future experiments would allow repeat arrays to be 
analysed that would provide more robust and statistically verified targets for analysis by 
real-time PCR. 
 
None-the-less, the variety of functions of the genes with significant reductions in their 
expression levels following the knockdown, suggests that GTSF1 directly or indirectly 
affects several different biological processed linked with development. Even though 
meiotic progression of ovine oocytes during IVM was not affected by GTSF1 
knockdown based on the morphological evaluations of the MII oocytes, the microarray 
analysis in Chapter 6 showed that GTSF1 knockdown did appear to have a molecular 
impact on oocyte maturation in this species. Functional annotation of the confirmed 
candidate genes affected by GTSF1 knockdown indicated that these genes are involved 
in many important processes including RNA processing, translation and developmental 
competence. The TCOF1 gene could be involved in protein synthesis of proteins 
necessary for the development of the oocyte and/or the early embryo because of its 
involvement with the production of rRNA and its implication in the transport of 
molecules between nucleus and cytoplasm (Hayano et al., 2003). The RPS8 gene that 
showed a significant reduction in its expression levels following the knockdown could 
be an rRNAs affected by the actions of TCOF1. The RPS8 gene is involved in post-
transcriptional modification because the ribosomal subunit that it encodes is involved in 
the activation of translationally inactive mRNA (Brown and Schreiber, 1996; Tomek et 
al., 2002). It is possible therefore that GTSF1 in this way affects translation of 
molecules important for maturation and for latter stages of development including 
fertilisation and early embryo development. This is further enhanced by the significant 
reduction in the transcript levels of SREK1IP1 involved in post-transcriptional 
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modification, while down-regulation of a gene associated with the calcium channel, 
CACNA1D, could be associated with fertilisation  because of the role that calcium plays 
in the cortical reaction. Another gene that showed significant reduction in its transcript 
levels was MYL9, associated with the cell-cycle, cytoskeleton and signal transduction, 
which could also be involved in calcium ion binding (Park et al., 2011). Other cell cycle 
genes were also affected, like the TIMP1. Furthermore, the AURKA and CDK2 genes 
that showed a trend in the reduction of their transcript levels in the knockdown have 
known roles in microtubule formation and oocyte maturation (Solc et al., 2012).  
 
The evidence presented in this thesis suggests that GTSF1 is associated with 
cytoplasmic maturation and molecular maturation during the GV to MII stage transition. 
The molecular machinery that the oocytes acquire during their growth and maturation 
are vital for fertility and subsequent embryonic genome activation and development to 
the blastocyst stage. Thus the molecular maturation of a mature oocyte represents its 
inherent future developmental competence or quality (Sirard et al., 2006). Follow-up 
studies of the results generated here for the role of GTSF1 should involve evaluation of 
the effect of the gene on fertilisation potential and subsequent early embryo 
development. Based on the literature and the results presented in this thesis it is 
hypothesised that GTSF1 might play an important role in fertilisation and the maternal 
to zygotic transition. 
 
8.5 Localisation of GTSF1 protein during ovine oogenesis  
During maturation of the oocyte, mRNA transcription as well as post-transcriptional 
modification of mRNA and storage is crucial for translation of important proteins for 
maturation, fertilisation and early embryo development and it is necessary for these 
proteins to be stored until the stage that need to be employed (Sirard, 2001). These 
developmental stages are regulated by translation of maternal mRNAs that must be 
stored in the oocyte and activated at the specific time of development (Colegrove-Otero 
et al., 2005). The P-bodies in the oocyte are foci supposed to mediate this function 
along with miRNA induced mRNA silencing. The Mvh protein is localised in P-bodies 
and along with the mouse Piwi family members Mili and Miwi2 have been shown to be 
vital for piRNA processing (Tanaka et al., 2000; Kuramochi-Miyagawa et al., 2004; 
Carmell et al., 2007). Based on the background information for GTSF1 (Yoshimura et 
al., 2009) and the results of the microarray analysis in this thesis, the association of 
GTSF1 with the P-bodies was examined by assessing the localisation of GTSF1 and 
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MVH protein across oogenesis during oocyte progression from the GV to the MII stage 
in vitro. Immunofluorescence staining showed that GTSF1 is expressed during ovine 
gametogenesis in both the oocytes and spermatocytes. The results of Chapter 7 also 
showed that GTSF1 co-localises with MVH protein indicating that GTSF1 associates 
with the P-body in the secondary GV oocyte in sheep. This data further supports the 
belief that GTSF1 is involved in mRNA post-transcriptional regulation. It is also 
possible that the gene could be involved in retrotransposon repression similar to the 
findings of the mouse study following the GTSF1 knockout in male mice (Yoshimura et 
al., 2009). The findings reported here in the sheep are in agreement with recent studies 
conducted in the bovine, in which the GTSF1 protein was shown to be localised to the 
chromatoid body in male and the P-body in female gametogenesis (Lu et al., 2012). 
Furthermore, the potential 3´ UTR PRE domain that has been identified in the sequence 
of GTSF1 has been found to be vital for the translational activation of several genes 
including MOS, FGFR1, AURKA, B4 and G10 (Lu et al., 2012). Several mechanisms 
have been shown to be involved in the activation of translationally inactive mRNA 
including phosphorylation of factors that initiate translation including the eukaryotic 
initiating factor (eIF)-4F, the 40S ribosomal subunit and the dephosphorylation of 
poly(A)-polymerase (Thach, 1992; Colgan et al., 1996; Gavin and Schorderetslatkine, 
1997; Tomek et al., 2002). This model suggests that polyadenylation of the cytoplasmic 
mRNA stimulates the release of repressor molecules at the 5´ end resulting in the 
initiation of translation (Ferreira et al., 2009). This finding supports the evidence 
presented in this thesis and in particular the reduction of the expression levels of RPS8 
following GTSF1 knockdown as indicated by microarray analysis and verified by real-
time PCR, with RPS8 encoding a ribosomal protein that is a component of the 40S 
subunit.  
 
8.6 Future studies 
On the basis of the published results and the data presented here, it is possible to 
propose that GTSF1 regulated oocyte meiotic maturation and acquisition of 
developmental competence in sheep (Figure 8.1). During the GV to MII transition, 
GTSF1, expressed by the oocytes, associates with P-bodies in the cytoplasm of the 
oocyte (Chapter 7). It is hypothesized that GTSF1 is involved in RNA storage and 
processing; affecting genes associated with post-transcriptional modifications and 
subsequent translational activation such as TCOF1, SREK1IP1, RPS8 and CACNA1D 
(Chapter 6). It is also hypothesized that the miRNA pathway might be involved in these 
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processes. The actions of these key genes seem to have an important effect on the 
dynamics of the cytoskeletal filaments and the molecular maturation as shown by the 
expression levels of certain genes such as MYL9, TCOF1 and TIMP1 following the 
knockdown (Chapter 6). In order to test this hypothesis, it will be necessary to conduct 
RNA immunoprecipitation experiments with GTSF1 antibody in order to isolate the 
protein as well as the RNAs bound to it. The purified RNA-protein complexes can be 
separated by RNA extraction and the identity of the RNAs can be determined by cDNA 
sequencing or verification RT-PCR (Keene et al., 2006). 
 
The initial GTSF1 characterisation studies showed a high expression of the gene during 
the early stages of follicle development followed by a lack of expression during the 
secondary to antral stage. It is possible therefore that the gene also has an effect on the 
early stages of development regulating gene expression necessary for the activation of 
oocyte and/or follicle growth. Gtsf1 has been shown to be down-regulated in Nobox 
deficient mouse ovaries supporting the idea that GTSF1 plays an important role of the 
gene in activation of growth, since NOBOX in mammalian species is related to 
primordial follicle activation (Rajkovic et al., 2004). Future research is necessary to 
characterise the actions of GTSF1 during early oocyte growth and follicle development 
in monovular species and these should include targeted knockdown of GTSF1 in 
primordial follicles using viral infection of primary oocytes in combination with 
microinjection to induce GTSF1 knockdown and examination of the function of the 
gene during the early stages of development. In addition, generation of a cohort of 
GTSF1 knockdown oocytes following injection at the secondary oocyte GV stage and 
IVM to the MII stage is necessary for a new series of microarrays using the Affymetrix 
GeneChip Ovine arrays. Finally, fertilisation and in vitro embryo development of 
GTSF1 knockdown MII oocytes is necessary to confirm the effect of the gene on oocyte 
developmental competence.  
 
A major problem throughout this thesis has been the limited number of oocytes 
available for analysis due to the low survival number following the microinjections. The 
knowledge gained over the years, suggests that generation of future targeted 
knockdowns should be performed manually using an SAS air syringe instead of the 
femtojet outflow system as a vehicle for delivering the siRNA into the oocytes. It is 
believed that this modification in the culture system will significantly improve oocyte 
survival after siRNA injection. 
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8.7 Conclusion   
Overall this thesis has shown that GTSF1 may play a functional role during oocyte 
development in the sheep and specifically cytoplasmic and nuclear maturation of 
oocytes. Characterisation of GTSF1 mRNA and protein expression and cellular 
localisation will inform future investigations of the role of GTSF1 in oocyte and follicle 
development. Validation of the microinjection system for the creation of a gene specific 
knockdown following siRNA injection will allow investigation of other novel genes that 
might be important during gametogenesis.  
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Appendix I – Suppliers Addresses 
 
Abcam, 330 Cambridge Science Park, Cambridge, CB4 0FL, UK 
Acrodisc, Pall Corporation, 5 Harbourgate Bussiness Park, Southampton road, Portsmouth, 
PO6 4BQ, UK 
Affymetrix, Mercury Park, Wycombe Lane, Wooburn Green, High Wycombe, HP10 0HH, UK 
Amersham Biosciences, Amersham place, Little Chalfont, Buckinghamshire, HP7 9NA, UK 
Applied Biosystems, 850 Lincoln Centre Drive, Foster City, CA 94404, USA 
Applied Imaging International, Square Scotswood Road, Newcastle upon Tyne, NE1 4EP, 
UK 
Becton, Dickinson and Company (BD Plastipak
TM
), Drogheda, Ireland 
Bioline Ltd, 16 The Edge Bussiness Centre, Humber road, London, NW3 6EW 
Bio-Rad Laboratories Ltd,  Bio-Rad House, Maxted Road, Hemel Hampstead, Hertfordshire, 
HP2 7DX 
Carl Zeiss Ltd, 509 Coldhams Lane, Cambridge, CB1 3JS, UK 
Cook Medical, Brisbane Technology Park, 12 Electronics Street, Eight Mile Plains, Brisbane, 
QLD 4113, Australia 
Eppendorf Ltd, Eppendorf House, Gateway 1000 Whittle Way, Arlington Business Park, 
Stevenage, SG1 2FP, UK 
Fujifilm, St Martins Business Centre  St Martins Way, Bedford MK42 0LF 
Gilson Inc, 3000m Parmenter street, P.O. Box, 620027, Middleton, WI 53562-0027, USA 
Humagen Fertility Diagnostics, 2400 Hunter’s Way, Charlottesville, VA22911, USA 
Invitrogen Ltd, 3 Fountain Drive, Inchinnan Bussiness Park, Paisley, PA4 9RF, UK 
Keison International Ltd, 122 New London Road, Chelmsford, Essex, CM2 0RG, UK 
Labinco B.V, Zinkstraat 64, 4823, Bredo, Netherlands 
Leica Microsystems Ltd, Davy Avenue, Knowlhill, Milton Keynes, MK5 8LB, UK 
Life Technologies Ltd,, 3 Fountain Drive, Inchinnan Business Park, Paisley, PA4 9RF, UK 
Lotus Professional, Oughtibridge Mill, Oughtibridge, Sheffield S35 0DN, UK 
Medichem International, Sevenoaks, Kent, TN15 0JL, UK 
Melford Laboratories Ltd, Bildeston Road, Chelsworth, Ipswich, Suffolk, IP7 7LE, UK 
Melter Toledo Ltd, 64 Boston Road, Beaumont Leys Leicester, LE4 1AW, UK 
Millipore Ltd, Croxley green bussiness park, Watford, WD18 8YH, UK 
MTG Medical Technology Verrtriebs GmbH, Opalstrasse 32 D, 84032, Altdorf, Germany 
Millipore, 290 Concord Road, Billerica, MA 01821, USA 
MSE/Sanyo, Worsley Bridge Road, Lower Sydenham, London, SE26 5AZ, UK 
National diagnostics, Unit 4  Fleet Business Park, Itlings Lane, Hessle, North Humberside, 
HU13 9LX, UK 
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New Branswick-Eppendorf, Gateway 1000 Whittle Way, Arlington Bussiness Park, SG1 2FP, 
Stevenage, UK 
Nonlinear Dynamics, Keel House, Garth Heads, Newcastle upon Tyne, Tyne and Wear, NE1 
2JE, UK 
Nunclon, Kamstrupvev 90, Postbox 280, DK-4000, Roskilde, Denmark 
Olympus UK Ltd, (Microscopes), Great Western Industrial Park, Dean Way, Southhall, 
Middlesex, UB2 4SB, UK 
Olympus UK Ltd (Cameras), 2-8 Honduras Street, London, EC1Y 0TX, UK 
Philip Harris Ltd, Shenstone, Lichfield, WS14 OEE, UK 
Promega UK Ltd, Delta House, Southampton Science Park, Southampton, Hampshire, SO16 
7NS, UK  
Research Instruments Ltd, Bickland Industrial Park, Falmouth, TR11 4TA, Cornwall, UK 
Roche Diagnostics Limited, Charles Avenue, Burgess Hill, West Sussex, RH15 9RY, UK 
Santa Cruz Biotechnology, Wembley, Middlesex, HA9 7YN, UK 
Sigma-Aldrich Company Ltd, The Old Brickyard, New Road, Gillingham, Dorset, SP8 4XT 
Science Products, Hofheimer Str 63, Hofheim, 65719, Germany 
Scientific Laboratory Supplies (SLS), Head office, Orchard House, The Square, east riding of 
Yorkshire, HU13 0AE, UK 
Simport, 2588 Bernard-Pilon, Beloeil, QC J3G 4S5, Canada 
Sony, Pencoed Technology Park, Pencoed, South Wales, CF35 5HZ, UK 
Starlab, Unit 4 Tanners Drive, Blakelands, Milton Keynes, MK14 5NA, UK 
Takara Bio, 2 Avenue du Président John Fitzgerald Kennedy, 78100, Saint-Germain-en-Lave, 
France 
Techno Plastic Products (TPP), Zollstrasse 7, CH-8219 Trasadingen, Switzerlans 
Terumo UK Ltd, The Causeway, Egham, Surrey, TW20 9AW, UK 
Thermo Fisher Scientific, Stafford House, Boundary Way, Hemel, Hempstead, HP2 7GE, UK 
Thermo-Scientific, NanoDrop products, 3411 Silverside Rd, Bancroft Building, Wilmington,  
DE 19810, USA 
Qiagen Ltd, Qiagen house, Fleming Way, Crawley, West Sussex, RH10 9NQ, UK 
Vector Laboratories Ltd, 3 Accent Park, Bakewell Road, Orton Southgate,  
Peterborough, PE2  6XS, UK 
VWR International, Hunter Boulevard, Magna Park, Lutterworth, Leistershire, LE17 4XN,  
UK 
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Appendix II – Stock solutions 
 
A. TISSUE CULTURE STOCK SOLUTIONS 
 
A1. Transferrin (5 mg/ml) suitable for cell culture (T0665, Sigma-Aldrich) 
100 mg of holo-transferrin powder dissolved in 20ml of MEM containing 0.1% (w/v) fraction V 
cell culture grade BSA (85040C, Sigma-Aldrich) followed by filtration with a 0.2 cellulose 
acetate syringe filter. Aliquots of 20 μl stored at -20°C for 3 months. 
A2. Sodium selenite (50 μg/ml) suitable for cell culture (S5261, Sigma-Aldrich) 
1mg of sodium selenite dissolved in 20ml of MEM containing 0.1% (w/v) fraction V cell 
culture grade BSA followed by filtration with a 0.2 cellulose acetate syringe filter. Aliquots of 5 
μl stored at -20°C for 3 months. 
A3. Insulin (10 mg/ml) suitable for cell culture (I6634, Sigma-Aldrich) 
10 mg of insulin dissolved in 20ml of MEM containing 0.1% (w/v) Fraction V cell culture grade 
BSA followed by filtration with a 0.2 cellulose acetate syringe filter. Aliquots of 5 μl stored at -
20°C for 3 months. 
A4. Long-R3 IGF1 stock (100μg/ml) suitable for cell culture (I1146, Sigma-Aldrich) 
500 μg of long R3 IGF1 dissolved in 5 ml of MEM containing 0.1% (w/v) fraction V cell 
culture grade BSA followed by filtration with a 0.2 cellulose acetate syringe filter. Aliquots of 5 
μl stored at -20°C for 3 months. 
A5. Sodium Pyruvate (47 mM) suitable for cell culture (P5280, Sigma-Aldrich) 
51.7 mg of sodium pyruvate dissolved in 10ml of embryo tested sterile H20 followed by 
filtration with a 0.2 cellulose acetate syringe filter. Stored at 4°C for 1 week. 
A6. Ovine LH (200 μg/ml) (L5269, Sigma-Aldrich) 
9 mg of LH dissolved in 4.5 ml of 10% (w/v) BSA, fraction V cell culture grade and added to 
40.5 ml of MEM followed by filtration with a 0.2 cellulose acetate syringe filter (bioactivity: 
0.55 U/ml). Aliquots of 20 μl stored at -20°C for 3 months. 
A7. Ovine FSH (200 μg/ml) (F8174, Sigma-Aldrich) 
9 mg of FSH dissolved in 4.5 ml of 10% (w/v) BSA, fraction V cell culture grade and added to 
40.5 ml of MEM followed by filtration with a 0.2 cellulose acetate syringe filter (bioactivity: 
0.91 U/ml). Aliquots of 20 μl stored at -20°C for 3 months. 
A8. Sodium bicarbonate stock (250 mM) 
1.05 g of NaHCO3 with 3 drops of phenol red and embryo tested sterile H20 up to 50 ml, 
followed by filtration with a 0.2 cellulose acetate syringe filter. Stored at 4°C for 2 weeks. 
A9. Hepes stock (250 mM) 
3.254 g of Na Hepes added to 3 g of Hepes, 3 drops of phenol red and embryo tested sterile H20 
up to 100 ml, followed by filtration with a 0.2 cellulose acetate syringe filter. Stored at 4°C for 2 
months. 
A10. Penicillin/Streptomycin stock (10,000 Units penicillin and 10 mg/ml streptomycin) 
suitable for cell culture (P4333, Sigma-Aldrich) 
600 mg of penicillin G (6 mg/ml) added to 500 mg of streptomycin sulphate (5 mg/ml) in 
embryo tested sterile H20 up to 100 ml, followed by filtration with a 0.2 cellulose acetate 
syringe filter. Aliquots of 5 ml stored at -20°C for 3 months. 
A11. α-MEM base stock suitable for cell culture (M4526, Sigma-Aldrich) 
150 ml of α-MEM basis added to 1.5 ml Penicillin/Streptomycin stock  and 0.15 g of fraction V 
cell culture grade BSA followed by filtration with a 0.2 cellulose acetate syringe filter. Stored at 
4°C for 2 weeks. 
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B. MOLECULAR BIOLOGY STOCK SOLUTIONS 
 
B1. 1X TBE 
108 g of tris base added to 55 g of boric acid, 7.4 g of EDTA and Milli-Q H20 up to 10 litres. 
B2. Gel loading buffer 
0.125 g of bromophenol blue added to 0.125 g of xylene cyanol FF, 15 ml of glycerol and 35 ml 
of sterile-distilled grade H20. 
B3. 100 bp ladder 
12 μl of 100bp marker (Invitrogen) added to 20 μl of loading buffer, 0.4 μl of 5M NaCl and 
67.6 μl of sterile-distilled H20. 
 
 
C. SDS-PAGE AND WESTERN BLOTTING STOCK SOLUTIONS  
 
C1. Acrylamide-Bisacrylamide, 40% (w/v) acryl, 1.5% (w/v) bis 
40 g of acrylamide added to 1.5 g of bis filled up to 100 ml in sterile-distilled H20. 
C2. Stacking gel buffer (0.5 M Tris) 
12.1 g of Tris filled up to 200 ml in sterile-distilled H20 with pH adjusted at 6.8. 
C3. Lower gel buffer (1.5 M Tris) 
36.3 g of Tris filled up to 200 ml in sterile-distilled H20 with pH adjusted at 8.8. 
C4. 20% (w/v) SDS 
20 g of SDS filled up to 100 ml in sterile-distilled H20. 
C5. 1.5% (w/v) Ammonium persulfate (APS) 
1.5 g of APS filled up to 100 ml in sterile-distilled H20  
C6. 0.5% (v/v) TEMED 
1 ml of TEMED filled up to 200 ml in sterile-distilled H20  
C7. Western blotting sample buffer (2X SDS) 
5 ml of Stacking Gel buffer added to 2 ml of 10% (w/v) SDS in sterile-distilled H20, 1 ml of 
0.1% (v/v) bromophenol blue in sterile-distilled H20, 5 ml of 60% (v/v) glycerol in sterile-
distilled H20, 1 ml β-mercaptoethanol and 6 ml of sterile-distilled H20. 
C8. 10X running buffer 
144 g of Glycine added to 30 g of Tris base, 25 ml of 20% (w/v) SDS in sterile-distilled H20 
filled up to 1 L in Milli-Q H20 with pH adjusted to 8.3 
C9. 10X Wash buffer  
1% (v/v) PBS in Milli-Q H20 with 1% (v/v) Tween-20 in Milli-Q H20 
C10. Blocking buffer 
1.5 g of non-fat dry milk powder and 50 μl of Tween-20 in 50 ml of  1% (v/v) PBS in Milli-Q 
H20  
C11. 10X Transfer buffer 
144g of Glycine added to 30 g of Tris base and 20% (v/v) methanol filled up to 1 L in Milli-Q 
H20  
 
 
D. HISTOLOGY STOCK SOLUTIONS 
 
D1. 20 X SSC  
175.3 g of NaCl and 88.2 g of Sodium Citrate with a few drops of HCl in 1 L of sterile-distilled 
H2O with pH adjusted at 7.0 and sterilised by autoclaving.   
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Appendix III  
 
Verification of real-time PCR primers  
 
 
 
Montage showing expression profiles obtained by RT-PCR to verify the validity of the real-time 
PCR primers used throughout the thesis. A, C, D, E: Expression profiles of the target genes in a 
previously verified cDNA library containing a cohort of 10 denuded GV oocytes. B: Expression 
profiles of the target genes in a previously verified cDNA library containing 2 oocytectomised 
cumulus cells. N.C: Contains sterile-distilled H2O and no cDNA library. P.C: Expression 
profile of previously verified real-time GAPDH primers in a previously verified cDNA library. 
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Appendix IV  
 
Primary bioinformatic analysis table of down-regulated and up-regulated genes from 
microarray group AB following GTSF1 knockdown 
 
Down-regulated genes 
AB only (20 genes)  
MGC140822, PCBP1, hnRNP-E1, FKBP52, FKBP4, MGC127596, CDK2, MGC127596, 
CDK2, MGC133632, ZNF706, GPSN2, MGC127748, TECR, AURKA, MGC134472, COX17, 
MGC128036, RBM17, TIMP1 
Common to AB-ABC (4 genes) 
CFDP2, MGC128687, BCNT, p97 
Common to AB-BC-ABC (4 genes) 
LOC616942, AHSG, AFFX-r2-Ec-bioC-5_at, AFFX-r2-Ec-bioC-5_at 
Up-regulated genes 
AB only (12 genes) 
Bt.22353.1.S1_at, CKAP2, MGC148979, LOC787094, MGC139901, MRCL3, MRCL2, 
MYL12A, MYL9, Bt.22834.1.S1_at, DDX27, MGC139525 
Common to AB-ABC (7 genes) 
EZR, VIL2, Bt.77.1.S1_at, ANT1, SLC25A4, C21H15orf63, HYPK 
Common to AB-BC-ABC (11 genes) 
ARID2, OSBPL7, Bt.20481.1.S1_at, Bt.29800.1.A1_at, RPL26L1, Bt1237.1.S1_at, ARFIP1, 
MGC151527, MGC165765, UBFD1, MAPK6 
 
 
